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ABSTRACT
The studies reported examined the feasibility of assessing QoL, and the factors that 
influence QoL perceptions, in persons with late-stage neurodegenerative illness. 
Residents with a range of diagnoses from the Royal Hospital for Neuro-disability, 
Putney, took part in five studies. The first assessed the psychometric properties of 
the SEIQoL-DW and the SF-36. The SEIQoL-DW, which measures QoL from the 
patient’s perspective, was valid and responsive to reported life changes within this 
population. The health-based SF-36 was unresponsive and produced floor and 
ceiling effects. The SEIQOL-DW was retained for use across studies 2 to 5.
The relationship between social comparison processes, cognitive functioning and 
QoL was examined in study 2, results suggesting that cognitive ability to make 
comparisons and life changes influence the potentially negative consequences of 
making comparisons with one’s own past when evaluating present QoL. Memory 
ability also affected perceived QoL; individuals with autobiographical memory 
deficits reported a higher QoL than those without this deficit. Across studies 1 and 
2, time spent outside and time spent in one-to-one company were frequently 
nominated areas on the SEIQoL-DW. Intervention studies 3 and 4 suggested that 
both these activities may improve patient QoL, whilst time spent on the ward 
unaccompanied may be detrimental to perceived QoL.
Study 5 examined the feasibility of using the WHOQOL-BREF with persons with 
severe neurological disability. Results suggested that the WHOQOL-BREF may 
provide a useful alternative where reduced cognitive functioning limits the utility 
of the SEIQoL-DW. Additionally, further investigation of the relationship between 
comparison strategy and QoL assisted in the development of a theoretical model of 
social comparisons and QoL in persons with severe neurological disability. The 
present research demonstrates that it is possible validly to assess QoL within this 
population using a person-centred approach, and that this provides valuable 
information that may assist in enhancing individual patient QoL.
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Notes relating to contents
1. A manuscript based upon the content of Chapter 2, entitled ‘Quality of life and 
neurological illness: A review of the literature’ has been accepted for 
publication and will appear in Neuropsychology Review
2. The content of Chapter 3 has been accepted for publication and will appear in 
the British Journal o f Health Psychology, 4 (1999).
3. In Studies 1 and 2, Hotellings multivariate test was employed where Mauchly’s 
test of sphericity was not significant and ANOVAs were to be conducted. 
However, fi*om Study 3 onwards, the Huynh-Feldt Epilson procedure of 
adjusting degress of freedom was used when the assumption of sphericity of 
data was not met. SPSS Version 8, used to analyse the data from Study 3 
onwards, introduces the user to the Huynt-Feldt procedure, which Howell
(1987) has also recommended for use. The Huynt-Feldt procedure is not 
available on SPSS Versions 7 and 7.5, which were used to analyse the data 
from Studies 1 and 2.
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CHAPTER 1
Multiple Sclerosis and Other Neurodegenerative Diseases: 
A Review of the Literature
25
1.1 General introduction
The majority of the present chapter is devoted to a detailed review of the current 
research literature on MS. This reflects the large proportion of individuals with 
MS (between 70-100% across studies) who have taken part in research for the 
present thesis. Following this literature review, a brief overview is presented of the 
neurodegenerative diseases other than MS that one, or at most three individuals in 
each study have been diagnosed with. The research literature on some of these 
disorders is relatively sparse in comparison to that related to MS. This undoubtedly 
reflects the lower prevalence rates that accompany many of the diseases outlined 
within Sections 1.13 to 1.18 of the present chapter.
1.2 Multiple sclerosis: An introduction
Multiple Sclerosis (MS) is a chronic progressive neurological disease characterised 
by demyelination of the central nervous system nerve fibres. This produces a 
variety of neurological symptoms, depending on which parts of the brain and spinal 
• are affected. These may include numbness; impaired mobility; paralysis, 
problems with bladder control; cognitive deterioration; communication difficulties; 
fatigue and spasticity.
The onset of MS primarily occurs between the ages of 20 and 40 years. Women 
are thought to be more susceptible than men, the suggested female: male ratio 
generally ranging from 1.2:1 to 1.5:1 across studies (Pryse-Phillips, 1990). MS 
follows an unpredictable course with great variation between and within 
individuals. The disease is most usually characterised by exacerbations (periods in
26
which new symptoms appear and existing ones worsen) and remissions (periods in 
which symptoms decrease or disappear) (Vanderplate, 1984).
Difficulty in walking is probably the most common symptom in MS, the frequency 
almost certainly reaching 100% with time (Barnes, 1993). The majority of persons 
with MS live a near-normal life span. The aetiology of MS remains largely 
unknown, and no diagnostic tool has yet gained general acceptance as a reliable 
indicator of the disease. Although many of the complications of MS may be 
treatable to some extent and in some cases, at the present time there remains no 
cure for MS, no treatment that significantly influences the overall trajectory of the 
illness, nor any preventative measures (Schapiro, 1994; Sibley, 1990; Svenson, 
Woodhead and Platt, 1994).
1.3 The pathology of multiple sclerosis
MS is characterised by patches of inflammation, both varied in size and random in
cofd
distribution throughout the brain and spinal e h ^ .  These patches appear where
Cord
myelin, a fatty protein substance that insulates brain and spinal chord fibers, is
replaced by scar tissue. Although these plaques can occur anywhere within the
CNS they tend to occur more fi*equently in the optic nerves, the periventricular
white matter, the thickly myelinated areas of the brain stem and close to the surface
of the spinal (Cochrane, 1990). Their disposition is sometimes symmetrical,
C ofd
and their shape and size partly dependent on their location. In the spinal e h ^ ,
lesions are especially common in the anterior columns. In severe cases, where all
Cord Cord
myelin has disappeared from the spinal eheW, the whole ehefd appears atrophic
and grey (Prineas, 1990).
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Oppenheimer (1978) suggests that lesions occur more frequently in the optic nerves
Cord
and the spinal eherd-because these are the regions of the CNS that are subjected to 
the most mechanical stress. However, many other anatomical explanations have 
been put forward for plaque formation, including exposure to something in the 
cerebrospinal fluid, and the system of perivascular spaces (Prineas, 1990). 
Although quantitative measurement of magnetic resonance imaging (MRI) defined 
lesions can provide an index of the extent and activity of disease in multiple 
sclerosis, the relationships between these indices and clinical features are not well 
understood. Recent studies have suggested that with magnetic resonance 
spectroscopy (MRS) it may be possible to define chemical changes that better 
reflect the pathological changes in multiple sclerosis (Matthews et al., 1996). MRS 
techniques are also thought to offer improved definition of the nature of individual 
lesions, the dynamics of their evolution, their effects on normal appearing white 
matter, and their relation to clinical disability (Arnold, Wolinsky, Matthews and 
Falini, 1998).
1.4 The epidemiology of multiple sclerosis
Geographical variation in prevalence of the disease has been accepted since the 
1950s (Limburg, 1950). It varies according to the distance from the equator, 
increasing with latitude both north and south of the equator. Prevalence ratios 
reported from Bombay (21/100 000) (Bharucha, Bharucha and Wadia, 1988), Saudi 
Arabia (8/100 000) (Al-Din, 1986), Kuwait (8.3/100 000) (Yaqub and Daif, 1988) 
and Libya (4/100 000) (Radhakrishnan, Ashok, Sridharan and Mousa, 1985) 
confirm the comparitive rarity of MS among those who live in warm climates. In
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Great Britain, on the other hand, the prevalence rate is 51 per 100 000, and 102 per 
100 000 in the Orkney and Shetland islands (Cochrane, 1990).
Thus it is generally reconised that European people are more likely to be affected 
than non-Europoids. Kurtkze, Beebe and Norman (1985) suggest that the non- 
white incidence rate is about half or less of that of whites living in the same 
geographic area of the United States. More recently, Hader, Elliot and Ebers
(1988) reported that in Detroit, where black people represent half of the population, 
only 17% of them represent the MS population. Furthermore, despite the latitude 
in Japan, the prevalence ratio there is only 1.4/100 000, although a north-south 
gradient is still evident (Araki, Uchino and Kumamoto, 1987).
1.5 The aetiology of multiple sclerosis
Data from migration studies have long indicated that environmental factors play a 
causal role (Pryse-Phillips, 1990). It is generally agreed that people retain the 
endemic risk of their native land if they leave it after the age of 15 years. If they 
leave before reaching this age, they acquire the risk of the land to which they 
emigrate. Elian and Dean (1987), for example, showed that West Indian 
immigrants to the United Kingdom have one eighth of the risk carried by native- 
born residents, but the risk in their children rises to or exceeds that of Northern 
Ireland residents at 7.7 per 100 000.
In addition, accumulated evidence suggests there is an inherited predisposition to 
MS. Sadovnick and Baird (1988) suggested that recurrence risks for children and 
siblings of white MS patients in a high risk area were higher by a factor of 30-50
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than those of the general population in that area. Siblings were also said to be at 
greater risk than offspring by a factor of approximately 1.5. Cochrane (1990) has 
since reported a 2-17 fold increase in the prevalence of MS among the first degree 
relatives of patients, the risk increasing with the degree of closeness of the 
relationship.
That a genetic factor exists is also suggested by several studies of the association 
between the human leukocyte antigen (HLA) system and multiple sclerosis (i.e. 
Haile, Hodge and Iselius, 1983; Jerslid, Svejgaard and Fog, 1972; McDonald, 
1986). Because MS involves an abnormal immune-system attack on nerve tissue, 
and some of the genes in the HLA region help determine what the immune system 
will attack, this region has long been suspected of containing genes related to 
multiple sclerosis (Compston and Ebers, 1990). However, a recently completed 
multinational research project reported that genes in as many as 23 areas may 
contribute to susceptibility to MS, although only 12 of these appear to have a 
strong effect (National Multiple Sclerosis Society, 1996).
Many studies have demonstrated an increased frequency of certain HLA antigens 
(A3, B7, DR2 and DRw2) among European individuals with MS. The closest of 
these associates, DR2, is thought to occur in 20% of controls and 55% of MS 
patients in England (McDonald, 1987). This link becomes slightly obscured by the 
fact that the frequency of DR2 also increases in controls as one looks north. In 
Orkney, for example, one of the highest areas of MS prevalence world-wide, the 
prevalence of DR2 reaches up to 50% in both patients and controls (Roberts, 
Roberts and Poskanzer, 1979, Swingler and Compston, 1986).
30
As Pryse-Phillips (1990) concludes, “...ascription of the relative importance of 
genetic and environmental factors is a semantic matter, having about the same 
validity as claiming pre-eminence for one or the other wheel of a bicycle” (p. 12). 
Whatever the precise elements in causation may be, it must by now be obvious that 
the two factors are not mutually exclusive of one another. Gluten sensitivity 
(Hadjivassiliou et a l, 1996); socioeconomic factors such as educational level 
(Hammond, McLeod, Macaskill and English, 1996) and excess fact in the diet 
(Ben-Shlomo, Davey Smith and Marmot, 1992; de Andres and Liedo, 1997) have 
also been postulated as playing causal roles in the onset of MS, but with little 
conclusive evidence for support.
Multiple sclerosis is now becoming more generally accepted as a disease of 
multifactorial origin (McCarthy, 1999). Although the cause of multiple sclerosis 
remains unknown, current thinking suggests that MS is an autoimmune disease 
produced by a combination of factors including a genetic predisposition and 
environmental agents, probably viral in origin (Ebers and Sadovnick, 1994; 
McDonald, 1994; Poser, 1992).
1.6 Multiple sclerosis: It g natural history
Although life expectancy is shortened in multiple sclerosis, mortality rates have 
undoubtedly declined over the last 20 years. The estimated median survival time in 
the 1970’s was about 35 years from onset (Kurtzke, Beebe, Nagler, Kurland and 
Auth, 1977). In comparison, it is currently thought to be greater than 40 years from 
onset, with 88% of patients still living at this stage (Weinshenker, Bass and Rice,
1989). However, the course of the disease is both variable and unpredictable. The
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population of persons with MS is composed of several distinct sub-groups 
according to differentiated disease course (Evers and Kamilowicz, 1996). The four 
most common patterns are as follows:
1. Intermittent relapse followed by remissions. In this case the remissions are
less complete with each attack, and after a variable period of time 
(generally between 10 and 20 years) substantial disability occurs. 
Individuals in the latter stage of this disease course are often referred to as 
having ‘secondary progressive’ MS.
2. A benign course, throughout which attacks are infrequent and there are long
periods of remission.
3. Progressive deterioration with no regression.
4. A rapid deterioration, with numerous relapses. Here, severe incapacity
occurs within two years of the onset.
It is generally recognised that about 65% of patients will have the relapsing 
remitting course at the onset of the disease, with a further 15% having the 
progressive course with superimposed acute episodes. The remainder of patients 
will have the chronically progressive course from onset (Matthews, Acheson, 
Batchelor, and Weller, 1985; Weinshenker et a l, 1989). Eventually the majority of 
individuals will convert to the progressive course. Weinshenker et al. (1989) report 
that 41% of patients had done so within 15 years, this figure rising to 65% within 
25 years. Approximately 10% of total MS population cases are thought to have the 
relatively benign course (McAlpine, 1964).
There is a great deal of speculation concerning whether such patterns of disease 
progression can be predicted in the early stages after onset. The time between onset
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and start of the progressive phase may provide one useful prognostic indicator. 
Compston (1987), for example, suggests that if the disease becomes progressive 
within a relatively short time period, affected individuals are more likely to have an 
aggressive form of the disease. Weinshenker et aVs (1989) study suggests that the 
median time taken to reach Kurtzke Disability Status Scale (DSS) levels 3, 6 and 8 
from the onset of the progressive phase was 1.4 years, 4.5 years and 24 years. If 
this is the case, one would expect many people to progress slowly once a level 
approximating to Kurtzke DSS 6 is reached.
Prediction of the disease course is also possible, to some extent, from consideration 
of initial symptoms observed. Generally, cerebellar symptoms and signs carry a 
poor prognosis, as does a polysymptomatic onset. Increasing age of onset, 
particularly when after 40 years of age, is another poor prognistic indicator (Poser, 
Raun and Poser, 1982). Monosymptomatic onset and early visual and sensory 
symptoms are thought to be good prognostic indicators. The general absence of 
pyramidal or cerebellar signs 5 years after onset as also a fair indication of a benign 
course (Kraft, Freal and Coryll, 1981).
It is uncertain whether Magnetic Resonance Imaging (MRI) scans can assist in 
predicting disease course. Koopmans, Li and Grochowski (1989) compared the 
extent of disease detected by MRI in 64 MS patients; half with benign multiple 
sclerosis and half with a chronic progressive form, concluding that the latter had a 
higher mean lesion load than those in the benign group. However, Thompson, 
Kermode and MacManus (1990) compared the MRI scans of 41 MS patients. 
Twelve of these patients had a benign disease course; 16 had secondary progressive 
MS; and 13 had primary progressive MS. Findings suggested that there was no
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relationship between degree of clinical disability and the extent of abnormality 
shown by MRI scans; individuals with clinically benign MS often had extensive 
abnormalities and those with primary progressive MS had surprisingly few lesions. 
Although MRI scans are extremely useful in diagnosing MS (see Section 1.6), their 
ability to predict extent of disability remains uncertain.
1.7 Diagnosing multiple sclerosis
No definitive test is yet available for diagnosing MS, and diagnosis is based on the 
identification of lesions at two or more sites in the white matter of the CNS and the 
history of relapses and remissions. When faced with a patient whose symptoms 
and neurological examination suggest MS, all other possible causes, such as a brain 
tumour or stroke, must first be ruled out.
MRI scans, computerised tomographic scans, cerebrospinal fluid analysis and
evoked potential testing can all help in locating lesions to the CNS. At the present
time, MRI is recognised as the most sensitive of techniques, providing positive
diagnosis in 50-65% of cases (Giang et al., 1994; Offenbacher et al., 1993). Whilst
the MRI is invaluable in detecting lesions, this technique should not be used as the
sole diagnostic method, as the abnormalities detected are not always specific to MS
(Sibley, 1990). Similar MRI lesions are also seen in several other conditions,
including Lyme disease, HIV encephalitis, vasculitis, migraine, hypertension and
Cord
Bingswanger’s disease (Triulzi and Scotti, 1998). Furthermore, spinal ehoEâlesions 
are not always detected using MRI techniques, as they are relatively small in size. 
The small size of the optic nerve also complicates the identification of lesions 
within this area (Fazekas, Barkhof and Filippi, 1998; Sibley, 1990).
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1.8 Clinical features of multiple sclerosis
Each symptomatic attack develops over a couple of days and begins to remit 
between two to six weeks later. The scattered demyelination may affect nerve 
fibres anywhere in the hemispheres, brainstem and spinal & A , and many of the 
resulting symptoms are outlined below:
al Motor Svmntoms
Corticospinal tract involvement most often results from demyelination within the 
cord
spinal ehord. It occurs with the initial attack of MS in 32-41% of cases, but is 
present to a significant degree in up to 62% of chronic cases (Kurtzke, 1970). 
Symptoms may include heaviness, stiffness and pain, the legs being more 
frequently affected than the arms. When both are involved the legs are usually 
affected earlier. Involvement often begins with one leg, although in most patients, 
both are eventually affected. Weakness is asymmetrical, and in the upper limbs is 
mainly in extension at the elbow, wrist and fingers and in the lower limb in 
dorsiflexion and eversion of the foot. Flexor spasms can occur, which have also 
been associated with chronic low back pain (Moulin, Foley and Ebers, 1988).
bl Somatosensory Svmntoms
For between 21 and 55% of persons with MS, sensory complaints are the earliest 
symptom (McAlpine, 1972). These occur at some stage during the course of MS 
for between 52-70% of patients (Kurtzke, 1970; Muller, 1949). Patients generally 
experience tingling, burning, tightness, or a “sensation that a garment such as a 
glove or a girdle is being worn” (Miller, 1990). Such objective sensory signs 
usually reflect involvement of the myelinated posterior columns.
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Reduced sensations to a pinprick or a predosposition to altered thermoregulation is 
slightly less common, and have a variable pattern of distribution. In extreme cases, 
tendencies to chronic hypothermia have been reported (White, Scoones and 
Newman, 1996). This may occur due to direct involvement of the hypothalamus, or 
from combined lesions affecting hypothalamic outflow to the brainstem and spinal 
ph^rîÈ A more specific sensory symptom of MS is Lhermitte’s sign (Kanchandani 
and Howe, 1982), where patients complain of sudden electric like sensations 
momentarily radiating down the spine or extremities. This usually occurs when the 
neck is flexed.
cl Brain Stem Svmntoms
Visual impairments are most commonly encountered with abnormal brain stem 
fimction. The most frequent of these, occurring in 40-70% of such cases, is 
nystagmus (McAlpine, 1972, Muller, 1949). In most patients, this is 
asymptomatic, but for others it may be combined with blurred vision, images 
jumping (oscillopsia) or sometimes double vision (Miller, 1990).
Dysarthria is also common in MS, particularly in more advanced, chronic cases. 
“Scanning speech” has long been considered most typical of MS, although it does 
not normally interfere with communication (Miller, 1990). In such cases, the voice 
tends to be loud and speech is jerky. There is a pause after every syllable and 
consonants are not properly formed, causing indistinct words. Other types of 
dysarthria (i.e. nasal speech and stuttering) occur less frequently (Dailey, Brown 
and Goldstein, 1972). Vertigo is another frequent complaint, associated with other 
signs of brainstem dysfunction.
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d) Optic Nerve Symptoms
Optic neuritis is one of the most common presenting manifestations of MS, 
occuring in 14-23% of cases (Kurtzke, 1970, McAlpine, 1972). In its most usual 
form, vision is dimmed unilaterally. This is often accompanied by pain aggravated 
by eye movement. Visual loss is seldom total. Other optic clinical abnormalities 
may include diminished visual acuity, impairment of colour vision (Steinmetz and 
Kearns, 1956), abnormal visual field examination (Stanley and Baise, 1968) or 
pupillary defects. Many patients experience bilateral optic nerve dysfunction, but 
blindness is relatively uncommon.
el Cerebellar Manifestations
Cerebellar dysfunction is common in MS, causing discoordination, ataxia and 
dysarthria. Specific features may include musclar hypotonia, diminished or 
pendular tendon reflexes, fatiguability of muscles and abnormal rate and force of 
movements (Cochrane, 1990). Gait ataxia is common in chronic patients, as are 
limb ataxia or intention tremor, which have been reported in 45-50% of chronic 
patients (Kurtzke, 1970, Muller, 1949).
f) Olfaction
Only rarely has impairment of smell has been reported in MS (Wender and Szmeja, 
1971; Matthews, Acheson, Batchelor and Weller, 1985; Miller, 1990). Anecdotal 
reports of some pathologic involvement of these structures exists, although detailed 
information remains sparse.
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g) Fatigue
Fatigue is probably the most common symptom in multiple sclerosis, and may be 
considered abnormal in as many as 78% of patients (Freal, Kraft, and Coryell, 
1984). A particular feeling of depletion occurs, severe enough to totally disrupt 
social ftmctioning, work, and overall role performance (Miller, 1990; Schwartz, 
Coulthard-Morris and Zeng, 1996). This specific type of fatigue in MS seems to be 
unrelated to depression and degree of disability (Krupp, LaRocca, Muir-Nash and 
Steinberg, 1988), and anxiety and disease duration (Iriarte, Carreno, and de Castro, 
1996), and yet remains poorly understood.
hi Bladder and Bowel Dysfunction
Bowel and bladder disturbance are very common features of MS, occuring in up to 
78% of patients ‘at some time’ during the course of illness (Miller, Simpson and 
Yates, 1965). The most common urinary symptom is urgency, though urge 
incontinence and fi*equency are often reported as well. Symptoms associated with 
bladder hypoactivity are less usual, but still occur in 20-30% of patients in most 
reports published (Anderson and Bradley, 1976; Hald and Bradley, 1982; Miller, 
Simpson and Yates, 1965). Bowel function abnormalities, especially constipation, 
are also common in MS and are frequently aggravated by patients tendency to 
restrict fluid intake, in the hope that urinary disturbances will be improved. Bowel 
urgency and incontinence may also, less frequently occur (Miller, 1990).
il Sexual Dysfunction
There remain relatively few studies on this topic, one that is still somewhat under­
recognised by health professionals in general. Mattson, Petrie, Srivastava and 
McDermott (1995) suggest that approximately 78% of men and 45% of women
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have sexual difficulties. These figures broadly agree with most other published 
articles, although women’s estimates are sometimes slightly higher than this (e.g. 
Dupont, 1995; Foley and Sanders, 1997; Valleroy and Kraft, 1984).
In men, erectile dysfunction is common, and women often report having problems 
with vaginal lubrication. Both sexes have problems with diminished libido and 
decreased sensation (Bames, 1993; Mattson et al., 1995; Miller, 1990). Later in 
the disease, paresis, spasticity, ataxia, defective vision, loss of self-esteem, 
dependence, anxiety and urinary incontinence are additional barriers to healthy 
sexual ftmctioning. The cause of sexual dysftmction in MS remains unresolved, 
and it is generally concluded that a combination of both organic and psychological 
factors is involved (Dupont, 1995).
il Pain and Paroxysmal Svmntoms
Pain is an increasingly recognised problem in multiple sclerosis which, if 
unrecognised can lead to major psychological difficulties. The management of 
chronic pain is more difficult than that of acute pain, but a combination of physical 
and cognitive strategies is often employed.
Many cases of stereotyped, repetitive paroxysmal symptoms and signs have been 
reported in the literature, tonic seizures most frequently (Bergner, Sheremata and 
Melamed, 1984; Heath and Nightingale, 1986, Twomey and Espir, 1980). Patients 
suddenly experience impaired muscle tone (dystonia) posturing of most typically 
the hand or arm. This lasts for between 30 seconds to 2 minutes, and can be 
painful in some cases. Episodes may occur infrequently or many times a day and 
tend to cluster for periods of weeks to months. Other paroxysmal symptoms can
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include paroxysmal dysarthria, ataxia, diplopia, itch and burning pain (Clifford and 
Trotter, 1984; Matthews, 1975; Yamamoto, Imai and Yamasaki, 1989).
1.9 Psychological features of multiple sclerosis
Each person who receives a diagnosis of multiple sclerosis begins a lifetime of 
individualised patterns of management. They must confront and attempt to cope 
with the profound stresses associated with multiple sclerosis, including the 
unknown cause, variability of symptoms, ambiguity of diagnosis, unpredictability 
of disease course and lack of a cure. They will also be aware of the changes 
affecting employment, personal and familial relationships, social functioning and 
financial status. The extent of adjustment to multiple sclerosis varies enormously 
from person to person and there has been much interest in the psychological 
aspects of the disease. Emotional disturbances of euphoria, pathologic weeping 
and laughing, depression and mania have been researched since their early 
description by Charcot (1877), and shall be discussed in greater detail below.
a) Euphoria
In comparison to the depressive state, there has been little research conducted on 
the euphoric response to MS. No consistent operational definition exists, although 
it is distinguishable from mania and manic-like states, and is generally 
“characterised by an exaggerated feeling of well-being inappropriate to apparent 
events” (Baretz and Stephenson, 1981, p. 117). Widely varying estimates of the 
prevalence of this condition in MS exist, ranging from 0% to 90% (Rabins, 1990). 
Herndon (1990), however, suggests that this feature is probably not as common as 
first imagined.
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Some patients classified as euphoric may exhibit persistent cheerfulness and 
optimism about the future, even though they are fully aware of their disabilities. 
Others may simply appear unaware or unconcerned about their condition, in which 
case they may be termed as being eutonic. Additionally, it has been noted that 
individuals who appear euphoric may report feeling depressed if specifically asked 
(Schiffer, Herndon and Rudick, 1985; Surridge 1969).
The available literature indicates that euphoria is caused by brain demyelination, 
with lesions in the periventricular areas principally responsible (Rabins, 1990). 
This form of emotional response has also been associated with a progressive 
disease course, greater social and physical disability and cognitive disability severe 
enough to be detected by neuropsychological testing (Rabins et al., 1986), although 
these ideas remain somewhat speculative. Euphoric moods are not specific to MS 
patients, and have also been reported in patients with frontal lobe tumours, 
Wernicke’s aphasia, general paresis, focal brain lesions, Alzheimers disease and 
Korsakoff s syndrome (Reiser, 1975).
bl Pathologic Laughing and Weeping
In this emotional disorder, laughing or crying may be triggered with little or no 
provocation. The emotional display is totally unrelated to the actual mood of the 
individual. Although, again, there is a paucity of literature on this particular 
response in MS patients, although recent studies indicate prevalence rates of about 
7%-10% (Feinstein, Feinstein, Gray and O’Connor, 1999; Minden and Schiffer, 
1990). Although the anatomical basis of the pathologic laughing and crying 
remains unknown, studies with stroke patients suggest that lesions in the pons or in
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pathways that connect the pons to the right cerebral hemisphere may be the cause 
(Minden and Schiffer, 1990).
c) Chronic Sorrow
The term chronic sorrow refers to a pervasive sadness that is permanent, periodic 
and progressive in nature (Burke, 1989). It is characterised by the recurrence of 
feelings experienced during initial diagnosis of chronic disease (i.e sadness, guilt, 
frustration and fear) when something reminds the individual of their situation. 
Chronic sorrow has been observed in a variety of other long-term and terminal 
illnesses, including persons with Parkinson’s disease and their spouses (Lindgren, 
1996); and persons diagnosed with cancer (Bakes, 1993).
There remains a paucity of literature regarding chronic sorrow and MS. 
Hainsworth (1994) interviewed 10 individuals with MS using the Burke/NCRCS 
Chronic Sorrow questionnaire. Her findings suggest that 80% of this sample 
experienced chronic sorrow in their lives. Although further research is required 
with larger and more representative samples, chronic sorrow may be an integral 
part of the MS experience. As Hainsworth (1994) states, this must be recognised 
before appropriate intervention strategies can be planned.
d) Depression
Even though the majority of research on MS and emotional response has been 
focussed on the state of depression, the available literature still remains 
contradictory. Prevalence rates range between 6% and 54% in various studies to 
date (Minden and Schiffer, 1990). This discrepancy may reflect the use of different 
samples (i.e. hospital versus community based) with varying disease duration (i.e.
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early versus late stage); and differences in the sensitivity and validity of diagnostic 
instruments (Berrios and Quemada, 1990). As Beatty (1993) points out, self report 
instruments used to measure the severity of depression, such as the Beck 
Depression Inventory (Beck, Ward, Mendolson, Mock and Erbaugh, 1961) and the 
General Health Questionnaire (Goldberg, 1978), may overestimate the severity of 
depression. Many items that load positively for depression on these scales, such as 
fatigue and loss of libido, are common symptoms of MS.
Arguments have also developed concerning whether depression may precipitate the 
initial episode of the disease or trigger exacerbations, whether it remains a direct 
result of brain lesions, or whether it is simply a psychological response to the 
disease itself. At the time of writing, there is no solid evidence for the first two 
explanations, although the studies that have addressed both issues have generally 
been compromised by difficulties associated with valid and sensitive measurement, 
potentially biasing effects of memory distortions, and over-reliance on archival 
records (Berrios and Quemada, 1990). On this basis, s a fe s t  it may be most 
appropriate to conclude that neither hypothesis has yet been tested adequately.
Research has, however, indicated that functional loss and disease activity are more 
likely to contribute to increased emotional distress and depression (Devins and 
Seland, 1987). Depression has also been shown by several researchers to be more 
prevalent early on in the disease course, in line with the slow process of adjustment 
that takes place after a clinically definite diagnosis is made (Mclvor, Reznikoff and 
Riklan, 1984; Surridge, 1969; Whitlock and Siskind, 1980). Several studies have 
also indicated that depression occurs independently of cognitive deficits (e.g.
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Krupp, Sliwinski, Masur, Friedberg and Coyle, 1994; Peyser, Edwards, and Poser,
1980X
e) Cognitive Disturbances
In 1877, Charcot first described the nature of cognitive dysfunction in MS. He 
observed that, at a certain stage of the disease, persons with MS may show marked 
enfeeblement of the memory, conceptions that are formed slowly, and impaired 
intellectual and emotional abilities. The most commonly encountered cognitive 
impairments associated with MS include deficits of secondary memory, working 
memory, attention and information processing speed, executive functions and 
visuospatial perception. Current prevalence estimates range from 43 to 65% of MS 
patients, on neuropsychological testing (Rao, 1996). Severe dementia is observed 
in approximately 20-30% of these cases (Rao, Hammeke, McQuillen, Khatri and 
Lloyd, 1984). Less than 10% of patients experience a severe dementia which 
affects multiple cognitive domains. For others, relatively isolated cognitive deficits 
may develop.
The occurrence of cognitive impairment cannot be predicted from knowledge of 
the individual patient’s age, duration of disease, disease type or performance on 
standard mental status examination testing (Beatty et al., 1995, Rao, 1996). It is 
perhaps for these reasons, and other misconceptions about the nature of the 
disorder, that clinicians and researchers have been so slow to recognise the extent 
of cognitive impairment in MS. However, it is now recognised that cognitive 
dysfunction can be just as disabling as physical impairment for MS patients, 
causing disruption to employment, social functioning, and many other activities of 
daily living (Beatty, 1993; Rao, 1996; Rao et al., 1991).
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Several authors have suggested that chronic progressive MS is associated with 
more severe cognitive impairment than is relapsing-remitting disease (e.g. Filley, 
Heaton, Thompson, Nelson and Franklin, 1990; Heaton, Nelson, Thompson, Burks 
and Franklin, 1985). However, other investigators have failed to support this 
hypothesis, suggesting that early cognitive deficits are evident even at a time when 
there is little physical disability (e.g. Grant, McDonald, Trimble, Smith and Reed, 
1984; Janson and Cimprich, 1996; van den Burg, van Zomeron, Minderhoud, 
Prange and Meijer, 1987).
Two independent meta-analytic studies have recently been conducted, both 
attempting to address the inconsistencies of previous research, and assess the nature 
and magnitude of cognitive impairment in MS. Wishart and Sharpe (1997) 
analysed 37 neuropsychological studies of MS listed fi*om 1974 to 1994 in a 
computerised search of the PsycLIT Journal Article Database. Thornton and Raz 
(1997) analysed 36 studies, identified through a computerised search of MedLine 
(1996-1995) and PsycLIT (1974-1995) and a joumal-by journal search o ï Archives 
of Neurology, the most frequent publisher of the articles in the targeted domain at 
the time of study. Given the inconsistencies in previous research, it is perhaps 
unsurprising that Wishart and Sharpe (1997) concluded that disease subtype was 
not consistently related to cognitive status, whereas Thornton and Raz (1997) 
concluded that persons with a chronic progressive disease course showed more 
pronounced cognitive deficits.
The fact that study results are often inconsistent may be largely due to 
methodological problems. For example, Franklin, Nelson, Heaton and Filley (1990) 
argue that brief mental status examinations generally classify as normal many
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individuals who would test impaired on standard neuropsychological tests. 
However, MS symptoms such as fatigue and communication difficulties may 
render the use of more lengthy assessment tools impractical. Few instruments are 
both sensitive enough to detect cognitive impairment and appropriate for persons 
with physical and visual disabilities (Janson and Cimprich, 1996). As Filley et al 
(1990) suggested, data on the longitudinal course of cognitive status is required if 
the full impact of MS is to be understood.
f) Stress
It is well recognised that persons with MS experience an increased amount of stress 
related to physical and psychological disabilities (Buelow, 1991). However, the 
role of both physical and psychological forms of stress in precipitating either onset 
or exacerbations of MS remains unclear (Warren, 1990). Measurement of 
psychological stress has been very difficult and many methodological problems 
have also been encountered. These include over-reliance on retrospective designs, 
which are subject to recall bias; small or highly selected samples; failure to 
incorporate a valid control group; and failure to examine the influence of mediating 
factors such as individual coping strategies (Miller, 1990; Warren, 1990). LaRocca 
(1984) suggests that the most accurate model of stress and MS may be a circular 
one, in which MS produces stress and enhances the impact of other life events, in 
turn precipitating disease activity. At the time of writing, the precise mechanics of 
this relationship remain uncertain.
Personalitv. Coning and the Course of Adjustment 
Theorists have long considered that adaptation to chronic disease may be greatly 
hindered or helped, by individual state of mind. Among the first proponents of this
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notion were Matson and Brooks (1977), who devised a model of adjustment partly 
based on Kubler-Ross’s (1969) model of reactions to death and dying. Having 
interviewed MS patients at varying stages of the disease, four stages of adaptation 
were outlined; denial, resistance, affirmation and integration, each level being more 
‘psychologically healthy’ than the one before. Given the diversity of the disease 
itself, patients were likely to move back and forth along this continuum, rather than 
move straight from a to b and so forth.
Whilst theoretical perspectives have introduced some degree of organisation into 
the somewhat unpredictable life course that characterises MS, Matson and Brook’s 
suggestions are rather simplistic, operationalising adaptation as a unidimensional 
variable. Furthermore, no empirical testing of this model was carried out. It has 
since been suggested that females generally show greater levels of positive 
adjustment than men. Hours of employment, living arrangement and extent of 
disease activity (Counte, Bieliauskas and Pavlou, 1983) are also thought to be 
related to the adjustment process, as is greater knowledge about MS and source of 
major coping strategy (ie. religion, family or acceptance of the disease itself) 
(Matson and Brooks, 1982).
Although adjustment is a continual response to the changing disease process, 
longitudinal studies suggest that most adjustment takes place in the early stages 
after diagnosis (Matson and Brooks, 1982). However, persons with MS are not 
homogenous in terms of their psychological responses. Since the disease consists 
of several different states, acknowledging the varying characteristics of each 
disease state may provide a more accurate picture of the nature of responses to MS.
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As Evers and Kamilowicz (1996) have suggested, this approach would 
undoubtedly benefit both doctors and patients to a greater extent.
1.10 Treatment and disease modification in multiple sclerosis
Although there remains no known cure for MS, there are a vast number of 
approaches to treatment of symptoms and rehabilitation. It is not the aim of the 
current review to give detailed analysis of primary and secondary symptomatic 
management, as this has been covered fully elsewhere (see Smith and Scheinberg,
1990). The following section instead provides an overview of different approaches 
which may be considered individually or utilised in combination to begin to 
alleviate many of the most troubling symptoms of MS.
al Dmg Treatment 
Immunosuppressants
Since it has been suggested that MS is an autoimmune disease, 
inununosuppressants such as ACTH and corticosteroids have been widely used in 
treatment. Their clinical benefit is thought to be linked to their anti-inflammatory 
effect (Cochrane, 1990). Both have been shown to improve the time to recovery 
from acute attacks (Rose et al, 1970; Tourtillotte et al, 1980), but there is still 
conflicting data on their effect on outcome and long term course. Chronic 
administration does not benefit patients, and in some cases may induce drug 
dependency. Azathioprine is also used and usually well tolerated, although there 
are associated risks of bone marrow suppression, hepatic suppression, infection, 
nausea and vomiting. Controlled trials have suggested, but do not confirm, that
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this dmg may slow down the disease course and reduce the rate of relapse (Mertin 
et aL, 1982).
Immunostimulants
As MS has been linked to diminished rather than increased immunity, treatments 
directed at stimulating the immune system have also been employed. In 1993, 
Food and Dmg Administration (FDA) approved Betaseron for the treatment of MS. 
To date, this is the only dmg approved by the FDA for the treatment of MS (Khan, 
1996). Other immunostimulants currently being tested include Interferon beta-1 a 
and Interferon-alfa, variations of which have shown a moderate decrease in the 
frequency of attacks in relapsing-remitting disease (Jacobs, Cookfair, Rudick and 
the Multiple Sclerosis Collaborative Research Group, 1994; Lubetzki, Dubard and 
Stankoff, 1996; Lynch, 1996). The use of interferon beta-la has also shown a 
significant reduction in the average number of active lesions present (Brod, 
Lindsey and Wolinsky, 1996).
Assessment of treatment effects on long-term disability in MS using prospective 
studies remains difficult, due to the gradual decline in cognitive functioning that 
accompanies the disease. High dropout rates on double-blind controlled studies 
have also confounded analyses to date (Prevention of Relapses and Disability by 
Interferon beta-la Subcutaneously in Multiple Sclerosis (PRISMS) Study Group, 
1998). The effective use of Interferon agents is therefore still being investigated, 
and with better designed research protocols slowly emerging, a greater 
understanding of the pathogenesis of demyelination, and the use of MRI, an 
increase in new treatments for MS now seems both realistic and plausible (Khan, 
1996). Many other new treatments that are designed to inhibit disease progression
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are currently in trials, including immunonoglobulin, copolymer-1, and bovine 
myelin (Smith and Darlington, 1999).
bl Nonpharmologic treatment
Drug treatments for multiple sclerosis are generally expensive, may cause side 
effects including injection-site reaction and flu like symptoms. The majority of 
patients are happy to continue with treatment despite such effects, even though the 
treatments already discussed have demonstrated no beneficial effects for cognitive 
deficits associated with the disease and offer no cure for MS (Fawcett, Sidney, 
Hanson and Riley-Lawless, 1994; Logan-Clubb and Stacy, 1995). Consequently, 
an increasing number of patients use complementary medicines.
One of the most commonly used is physical therapy, which can do much to 
alleviate many of the most troubling of MS symptoms, including disorders of gait, 
bladder and bowel, upper extremities, speech and deglutition. Such treatment 
requires “careful assessment of the patients neurological and other symptoms; 
knowledge of his or her intellectual, emotional and social skills and demands; and 
an understanding of the patients support network” (Smith and Scheinberg, 1990, 
p346). Because of the immense variation of individual symptoms and patient’s 
needs, the physician works closely many other professional in related fields, 
including speech, physical and occupational therapists; social workers and 
rehabilitation specialists.
Counselling, nutrition therapy, massage, acupuncture and removal of mercury alloy 
dental fillings (Fawcett et a l, 1994; Siblerud, 1992) are also frequently used, as are 
techniques involving yoga, evening primrose oil and planned approaches to rest or
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exercise (Fitzpatrick, Robinson and Scambler, 1993). A fairly recent, yet 
controversial approach to treatment is hyperbaric oxygen therapy (HBO). Very 
few controlled trials have been undertaken using this method, although some 
patients are said to have gained benefit from it (Wynne, 1989). A dramatic increase 
in the number of individuals being treated in this way has been witnessed, even 
though the controlled trials which have been published to date provide insufficient 
evidence to advocate its use (Barnes, Bates, Cartlidge, French and Shaw, 1985; 
Kleijen and Knipschild, 1995; Monks, 1988).
1.11 Measurement of physical disability and multiple sclerosis
Because the course of MS is so unpredictable many attempts have been made to 
quantify impairment and disability. This helps in making a prognosis, to select 
patients for research protocols, and to judge rehabilitative needs. One of the 
earliest measures devised was Steinbrocker’s Functional Grades in 1949. This 
consisted of four grades, from normal activity through diminished vocational or 
domestic work, to chair or bed ridden. This particular scale was never validated, a 
problem shared by many of the early scales of this kind (Liang, Larson, Cullen and 
Schwartz, 1985) and given the variety of measures which have since been 
developed, it is rarely used today.
The best known comprehensive scale used for MS is the Minimal Record of 
Disability (MRD), developed by the International Federation of Multiple Sclerosis 
Societies (1985). A more detailed description of its properties and content can be 
found in Table 1.1. It’s conceptual basis stems from the classification of 
dysfunction by the World Health Organisation (WHO) (1980) into three tiers. The
51
first is impairment, caused by the underlying organic disorder resulting in clinical 
signs and symptoms. The second is disability, reflecting the personal limitations 
imposed on the activities of daily living. The third tier is handicap, reflecting the 
environmental situation that limits the disabled person from achieving an optimal 
social role.
In summary, impairment is the primary deficit, while disability represents 
functional limitations. Finally, handicap refers to a social disadvantage. This 
system was devised in order to facilitate assessment of different dimensions of the 
consequences of disease. It has also assisted in clarifying previously confusing and 
overlapping terminology. Therefore many of the currently utilised functional 
assessment scales incorporate the WHO categories.
A vast number of scales are available for measurement of functional status in 
multiple sclerosis. Some are designed for use specifically with MS patients 
(‘disease-specific’), whilst others are intended for more general use (‘generic’). 
Some assess impairment, whilst others focus on disahility and handicap, or the 
social environment. Some methods are designed specifically for severely ill, 
institutionalised patients, whilst others are intended for less disabled patients living 
within the community. Many scales remain suitable for use with both populations.
For further clarification, McDowell and Newell (1996) draw on the useful 
distinction between Activities of Daily Living (ADL) scales and Instrumental 
Activities of Daily Living (lADL) scales. ADL scales cover physical functioning 
alone and are concerned with more severe levels of disability. They are therefore 
relevant mainly to institutionalised patients and the elderly, and consider
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functioning such as dressing, bathing, using the toilet and eating. lADL scales, on 
the other hand are more applied, considering problems more typically experienced 
by those living in the community (in other words reflecting the ‘handicap’ level of 
dysfunction outlined ahove). Issues such as mobility, difficulty in shopping, 
cooking, or managing money are therefore addressed.
The quantity of measures that have heen developed over the last 20 years or so 
(more than 50 ADL scales were previously identified by McDowell and Newell, 
1996) limits extensive review. However, Table 1.1 overleaf provides an attempt by 
the author to review 12 of the more widely used and tested ADL and lADL scales 
that are currently available and considered suitable for use with persons with MS.
Generally, very few authors declare what levels of correlation are to be taken as 
demonstrating adequate psychometric standards for both the validity and reliability 
of a given measure. It is acknowledged that the standards for adequate reliability 
and validity will depend largely on the type and consequences of decisions that will 
be made on the basis of results. However, several authors have specified different 
guidelines for use in the same situation. For example, coefficients of 0.50 (Caplan, 
Naidu and Tripathis, 1984), 0.60 (Nunnally, 1967) and 0.70 (Nunnally, 1978) have 
all been considered adequate for research purposes.
Pedhazur and Schmelkin (1994) suggest that the user must determine their own 
standards for psychometric adequacy, based on the amount of error they are willing 
to tolerate given the nature of the study conducted. On this basis, the standards 
used to evaluate the psychometric properties of the ADL and lADL measures in the 
present review are hased upon Nunally’s (1978) criterion of r=0.70 or above.
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As already stated, this is by no means an exhaustive compendium. There are many 
other functional disability scales which have been developed and are applicable to 
persons with MS. Those outlined above, however, are the most widely used.
As Table 1.1 demonstrates, 58% (N=7) of measures reviewed have obtained 
consistent adequate reliability coefficients of 0.70 or above. Seventy-one percent 
of these are generic measures, whereas only 29% are disease-specific measures. 
Forty-three percent are ADL measures, and 57% are lADL measures. By 
comparison, only 25% (N=3) of measures reviewed demonstrated consistent 
adequate validity coefficents of 0.70 or above. Of these assessment tools, 67% 
(N=2) are generic AIDL measures, and 33% (N=l) are disease specific ADL 
measures.
It is noteworthy that 75% (N=9) of measures reviewed have either no reported 
evidence, or only very basic evidence of reliability and/or validity testing to date.
In some cases where testing has been conducted, conflicting data concerning levels 
of reliability and validity has been obtained. The observation that considerably 
more measures demonstrated adequate levels of reliability than validity may in part 
stem from the fact that, at the time of writing, there is no ‘standard’ measure of 
physical disability for use with persons with MS. In other words, none of the 
existing disability measures demonstrate sufficient validity to be used as a 
comparison tool when testing the validity of newer measures of physical disability.
As is the case of many areas of assessment development, the expansion of 
functional disability measures over the last decade or so has been somewhat 
uncoordinated. Many scales have been derived without due consideration of the
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strengths and weaknesses of already existing measures, and very few have been 
evaluated formally for reliability, validity and responsiveness. The present review 
suggests that more focussed attention is required concerning the identification of 
valid and reliable measures of functional disability in multiple sclerosis. Further 
consideration should also be given to the feature of responsiveness to change. At 
the time of writing, the decision to test responsiveness to change appears to be a 
rather haphazard one across studies. However, given the progressive nature of MS, 
the ability of a chosen measure to detect changes in physical ability becomes an 
essential characteristic.
The present review also suggests that there is considerable work to be done in 
developing and refining disease-specific measures, if they are to meet the 
traditional psychometric criteria outlined by Nunally (1978). Of all disease-specific 
measures reviewed, the EDSS (Kurtzke, 1983) and the FIM (Hamilton et al, 1987) 
appear the most promising of measures from a psychometric viewpoint. However, 
given the number of studies of MS persons that have employed the EDSS to date, 
the relative paucity of psychometric data on the measure is surprising. On the basis 
of the data presently reviewed, both the EDSS and the FIM might benefit from 
further psychometric testing, in order to confirm their reliability, validity and 
responsiveness to changes in the physical disability of persons with MS.
Alongside consideration of the psychometric properties of each measure available 
for use, instruments should be selected according to the population to be tested. 
Degree of disability, disease course, environment (i.e. community or institution), 
and ability to communicate and attend are just some of the factors which might 
influence choice of assessment tool. It is thus recommended that ADL and lADL
60
measures are selected to correspond with such requirements (McDowell and 
Newell, 1996). Some of the health-based QoL measures reviewed in Section 2.8 
(pp. 109-110) are essentially no broader than many current lADL scales. The 
researcher should not therefore be discouraged from utilising them where 
considered more relevant or applicable.
1.12 Summary
Multiple sclerosis is the most widespread of the degenerative neurological diseases,
Cofsl
associated with demyelination of the brain, spinal e h r i  and optic nerves. It most 
commonly affects young adults in their 30's, with impediment most often occurring 
in the 4th and 5th life decades. The disease follows an unpredictable course of 
varying and unpredictable symptoms in which exacerbations and remissions cannot 
be controlled. With reference to these 'ups' and 'downs', the experience of having 
MS has been likened to living life "on a roller-coaster" (Barton, Magilvy and 
Quinn, 1994).
It has long been recognised that the prevalence of the disease varies according to 
georaphic location, being limited in temperate climates and higher in northern 
latitudes. This remains evident within countries; prevalence rates in the south of the 
UK are reported to be significantly lower than those in the Northern Scottish Isles. 
Non-Caucasians have a lower prevalence rate than Caucasians, and women also 
tend to be more susceptible than men.
The precipitating cause of MS remains unknown. Factors contributing to it's onset 
may include a genetic predisposition and environmental agents, probably of viral
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origin. However, many other suggestions have been put forward concerning the 
aetiology of MS, and at the current time there remains little conclusive evidence in 
any one direction. Theorists thus continue to consider it a disease of multifactorial 
origin.
As there are no formal diagnostic criteria for MS, diagnosis of the disease is largely 
based on clinical features which are characterised by multiplicity of CNS 
symptoms and signs over time. MS is a devastating diagnosis, and other diseases 
with similar symptoms must be ruled out before the clinically definite diagnosis is 
given. Laboratory techniques like computed tomography, cerebrospinal fluid 
analysis and evoked potential testing may assist in diagnosis and, although there is 
currently much emphasis on the use of magnetic resonance imaging (MRI) 
techniques, the most successful diagnostic outcomes rest upon a combination of 
these methods.
The clinical features of MS are widespread and vary between and within 
individuals. About 55% of people presented with more than one symptom at onset 
and the combination of symptoms becomes more complex as the disease 
progresses. Weakness in one or more limbs is the most common initial symptom 
present in approximately 40% of cases (MeAlpine, 1972). Other primary 
symptoms include fatigue, balance problems, bladder and bowel dysfunction, 
sensory disturbance, weakness, ataxia, dizziness, gait disturbances, changes in 
sexual functioning, spasms and spasticity.
Psychological features are just as diverse. Emotional lability, euphoria and 
depression are commonly reported, although it is not yet clear whether depression
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is related to the development of MS, or whether it remains a response to the disease 
itself. There has also been a great deal of research describing cognitive 
impairments associated with MS, concerning defecits of recent memory, attention, 
verbal fluency, conceptual reasoning and visual spatial perception. Cognitive 
capacities are interrelated, and about 55-65% of persons with MS are thought to 
experiences changes within such areas (Lyon-Caen et al., 1986).
At the time of writing, there remains no known cure for MS and no specific 
treatment that can influence the overall course of the illness. Researchers continue 
to explore the role of certain drugs in reducing relapses, treating chronic 
progression and decreasing the development of new central nervous system lesions. 
Several treatments are thought to show great promise in alleviating these problems, 
although, again, further investigation is needed. To date, the only drug which has 
been approved specifically for the treatment of MS, by Food and Drug 
Administration in 1993, is Betaseron (Khan, 1996).
Alternative treatments and therapies are also available for symptom management, 
and may include physiotherapy, relaxation techniques, complementary medicines 
and cognitive therapy. Client education, appropriate exercise and practice of 
positive health habits are also recommended (Shapiro, 1991). Treatment with 
hyperbaric oxygen has received increased attention over the last few years, 
although there remains insufficient evidence to advocate its use at the present time. 
A multidisciplinary approach to treatment is often recommended (Fawcett et ah, 
1994).
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In order to monitor progress within a rehabilitation programme or assess overall 
dependency, several scales have been developed over the last decade or so which 
quantify the patient’s degree of disability and/or measure the dependence on others 
in activities of daily living. Some scales are specifically designed for use with MS 
patients, whilst others are intended for a wider range of patient populations. Each 
scale has its limitations, as already outlined, and no one measure has yet been 
accepted as the ‘standard’ by which other measures may be evaluated. New 
measures are constantly being developed, and the researcher is advised to choose 
scales very carefully, with the specific requirements of their individual client 
population in mind (McDowell and Newell, 1996).
Although patient outcomes in multiple sclerosis have generally been measured 
using disability scales like the EDSS, broader measures which encompass “disease 
burden” may be used to provide a more overall picture of individual well-being. In 
Chapter 2, many of these broadly termed ‘quality of life’ measures are considered 
in greater depth. The remainder of the present chapter provides a brief overview of 
the neurological diagnoses other than MS that individuals have presented with 
across the present research.
1.13 Cerebral palsv
Cerebral palsy is a disorder of movement and posture that affects one or more parts
of the nervous system (Brett, 1991). Physical and cognitive characteristics
therefore vary from one case to the next. The disorder has pre-natal causes, such as
maternal infections and inheritance; peri-natal causes, including obstruction of the 
Cord
umbilical chgrd, resulting in lack of oxygen; and post-natal causes, such as
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meningitis or encephalitis (Quinn, 1994). The prevalence of cerebral palsy is 
currently rated at 2 per 1,000 live births (Lenti, 1996). There are several different 
forms of cerebral palsy, which are classified according to the part of the body 
affected, the type of motor disability and severity of overall disability (Evans and 
Alberman, 1985; Gans and Glenn, 1990). Ingram’s (1984) classification is often 
adopted, which consists of hemiplegia, bilateral hemiplegia, diplegia, ataxia, 
dyskinesia, and ‘other’.
In children, hemiplegia is generally a congenital disorder. It mainly affects the 
right side of the body, and especially the right arm. Alongside motor impairment, 
sensory, visual field, speech, and mental development disorders are also 
encountered (Lenti, 1996). In adulthood, hemiplegia may be caused by rupture of a 
congenital aneuryism, a tumour, or a head injury. The largest proportion of 
individuals with hemiplegia are the middle-aged to elderly, where the cause is 
usually due to hemorrhage occurring as a consequence of high blood pressure and a 
degenerative condition of the blood vessels (Kolb and Wishaw, 1990). In bilateral 
hemiplegia (tetraplegia) all four limbs are affected, the upper limbs being more 
severely spastic than the lower. The most frequent causes include fetal 
malformation, infection or vascular trouble, and perinatal distress. Mental 
retardation, epilepsy, bulbar muscle involvement and ocular defects are common 
(Lenti, 1996).
Ataxic cerebral palsy is characterised by motor impairment of cerebellar origin, 
which is associated with marked hypotonia. This is the main clinical feature in the 
first months of life, together with a delay in reaching the motor milestones. In most 
cases the condition is congenital, with no defined risk factors, although in a fraction
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of cases perinatal abnormalities are the cause. Intellectual impairment, speech 
disorders, ocular problems and epilepsy may occur (Lenti, 1996). Spastic diplegia 
affects all four limbs, although the upper limbs are the most severely affected, mere- 
the-^ppcr-lesG severely=than- the 4 ewer. The condition occurs most commonly 
among pre-term infants. Intelligence is less severely affected than in tetraplegia, 
and is generally within, or just below, normal limits. Epilepsy, ocular deficits and 
deafness are often associated with this form of cerebral palsy (Yokochi et al.,
1991). Dyskinetic cerebral palsy is usually caused by perinatal risk factors that are 
often preceded by fetal disturbances. Motor symptoms and typical extrapyramidal 
movements may only become evident many months after birth. Speech is very 
often impaired in such cases, while intelligence generally remains within the 
normal range (Lenti, 1996).
There is presently no cure for cerebral palsy, and, in cases of severe physical 
disabilities, a multi-disciplinary approach to treatment aimed at preventing 
worsening of symptoms is generally advocated (Quinn, 1994). For a thorough 
account of the classification and clinical features of cerebral palsy, the reader is 
referred to Lenti (1996). Quinn (1994) also provides an informative overview of 
the drugs that may be used to assist in treatment of cerebral palsy.
1.14 Dystonia
Dystonia is a disorder of movement that is characterised by prolonged muscle 
contractions that cause distorted postures of the affected body part(s) It is 
associated with excessive muscular tone, and may involve frequent involuntary 
repetitive twisting movements (Berardelli et al., 1998). Most lesions responsible
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for dystonia involve the basal ganglia or the thalamus (Marsden, Obeso , Zarranz 
and Lang, 1985; Pettigrew and Jankovic, 1985).
Fahn, Bressman and Marsden (1998) suggest that dystonia may be classified into 
four groups according to the underlying cause. Primary dystonia occurs in patients 
who have no signs of structural abnormality in the CNS. This is the commonest 
form, and recent research suggests it has a strong genetic origin (Benecke, 
Strumper and Weiss, 1992; Ozelius et al., 1997). Dystonia-plus syndromes occur 
when dystonia is combined with other pathological changes. Secondary dystonia is 
used to describe cases where there is a demonstrateable exogenous, structural or 
metabolic cause. Finally, heredodegenerative dystonia occurs when there is 
underlying brain degeneration.
1.15 Friedreich’s ataxia
Ataxia is a general term used to describe incoordination, usually of voluntary 
movements. Friedreich’s ataxia is the most common of all the spino-cerebellar 
ataxias. Although reasonably rare, it remains one of the most common of the 
hereditary disorders of the nervous system (Beaumont, 1996). An autosomal 
condition, the neuropathological abnormalities of Friedreich’s ataxia include 
axonal neuropathy and degeneration of spinal tracts, leading to spinal atrophy 
(Harding, 1981). Peripheral nerve damage also occurs, resulting in depressed 
tendon reflexes, and dorsal column degeneration leads to postural decline 
(Beaumont, 1996). Non-neurologic symptoms may include diabetes mellitus 
(Klockgether e/a/., 1998).
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Friedreich’s ataxia normally appears around the onset of puberty, and takes a 
progressive course that may lead to severe disability and premature death, usually 
before the age of 50 years (Klockgether et al., 1998). This condition may be 
accompanied by general intellectual impairment in some cases, and personality 
disturbances have also been noted, but it remains unclear whether these are a 
symptom or a consequence of the disease. A schizophrenia-like disturbance with 
paranoid delusions referred to as “Friedreich’s psychosis” has also been described, 
although it remains possible that this is an independent disorder in those affected 
(Beaumont, 1996).
1.16 Generalised epilepsy
Epilepsy is a condition characterised by recurrent fits, or seizures. During a partial 
seizure, the abnormal electrical discharge is limited to one area of the brain, 
whereas during a generalised seizure, it spreads rapidly to affect a much larger area 
of the brain. The effects of the seizure will depend on which part, and how much 
of the brain is affected. There are many known causes of seizures, including drug 
or alcohol withdrawal, prolonged hunger and extreme sleep deprivation. Flowever, 
if the seizure threshold of the brain is low, then factors such as drowsiness, low 
blood sugar and flickering lights may also trigger off the abnormal electrical 
discharge associated with seizure (Fenwick, 1996).
In some cases, seizures are triggered spontaneously, with no apparent precipitating 
factor. It is thought that brain excitability is probably inherited, determined by 
genes that have their strongest effect in childhood and thereafter become 
progressively weaker (Fenwick, 1996). Generally speaking, the chances of
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developing epilepsy are between 1 in 200. For someone with one parent with 
epilepsy, the chances of developing it rise to about 1 in 40 (Russell, 1996).
Generalised seizures affect both sides of the body equally, and may arise over a 
wide area of the brain. The best known and most common of these is the grand mal 
attack, during which the persons falls to the floor unconscious. This type of attack 
typically consists of three stages; a tonic stage, in which the arms and legs become 
straight and rigid, breathing becomes laboured and the mouth clenches tight; a 
clonic stage, during which the muscles of the body jerk in unison; and a post-tonic 
(or postictal) depression, in which the patient appears confused. Approximately 
50% of these seizures are proceeded by an aura (Kolb and Wishaw, 1990; Sander 
and Thompson, 1989). Some convulsions may consist of only the clonic phase; 
otherwise the extent of the tonic and clonic phases varies with each fit. Bowel and 
bladder control may be lost throughout the duration of the fit (Fenwick, 1996).
A second generalised seizure is the absence seizure, usually experienced by 
children, and characterised by a ‘blank’ period of up to about 30 seconds. During 
this time the individual remains unaware of anything that is happening to him or 
her, as if daydreaming or simply inattentive. Drop attacks affect all ages, and are 
characterised by a sudden loss of consciousness or muscle tone. Hence the term 
‘drop’ attack, as the person literally drops to the ground. Myoclonic attacks involve 
an uncontrollable jerking of the muscles on one or both sides of the body, without 
necessarily causing an unconsciousness or semi-conscious state. Infantile spasms 
occur only in approximately 1 in 7,000 cases, usually developing between the ages 
of 3 months and a year, and often result in permanent brain damage (Fenwick, 
1996). The reader is referred to Fenwick (1996) and Trimble and Thomspon
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(1986) for detailed reviews of the neuropsychological aspects of epilepsy, and the 
treatment strategies currently advocated.
1.17 Hydrocephalus
Hydrocephalus involves a progressive increase in volume of cerebrospinal fluid 
(CSF), due to a variety of pathological processes that cause over-production of, or 
obstruction of the passage of cerebrospinal fluid. Hydrocephalus affects both 
children and adults. In adult cases, it is most likely the result of cerebrovascular 
anomalies of the deep white matter (Dennis, 1996). Infant hydrocephalus occurs in 
as many as 27 of every 100,000 newborn babies, usually within the first few 
months of life (Kolb and Wishaw, 1990). Because the skull bones of the infant are 
not yet fused, the increase in CSF pressure leads to expansion of the head in all 
directions. If expansion damages the cortex, intelligence may be impaired as a 
result. If untreated, hydrocephalus causes death or severe mental or motor 
disabilities. However, the condition may now be treated with some degree of 
success, by draining excess CSF, although such treatment in children only partially 
reverses the neuropathological changes, and may not restore cognitive function 
(Dennis, 1996). Dennis (1996) provides an excellent overview of the effects of 
hyprocephalus on the brain, etiologies and treatment, and the neuropsychological 
aspects of the disorder.
1.18 Myasthenia gravis
Myasthenia gravis is a disorder of the motor system characterised by weakness and 
fatigue of voluntary muscles. The disorder is generalised in approximately 85% of 
cases, and confined to limb muscles in 15% of patients (Heitmiller, 1999). The
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onset of myasthenia gravis can occur at any age, but is twice as common in women 
as. in men, and frequently affects young women in their second and third decades 
of life (Batocchi et ah, 1999). Ten to twenty percent of infants bom to myasthenic 
women show signs of neonatal myasthenia gravis, caused by the passive transfer of 
antibodies from mother to child (Planche, 1983).
Initial symptoms may include diplopia (double vision), ptosis (drooping of the 
eyelid), weakness of voice, and difficulty in chewing and swallowing. Symptoms 
are usually most apparent at the end of the day, and are relieved after sleep. The 
severity of the disease varies from a mild unilateral ptosis in some people to an 
incapacitating generalised weakness with a threat of loss of life coming from 
respiratory paralysis in others. Muscular weakness is caused by a failure of normal 
neuromuscular transmission. It is now recognised that the enzyme acetylcholine 
(AchE) reduces symptoms and, as a result, few individuals with myasthenia gravis 
die as a direct result of the disorder (Kolb and Wishaw, 1990).
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CHAPTER 2
Quality of Life (QoL) : A Review of the Literature
72
2:1 General introduction
The concept of quality of life (QoL) is by no means a new phenomenon. Since the 
Ancient Greek time of Plato’s Republic (reflecting the quest of a high quality of life 
for the whole of society, rather than a chosen few) and Arisotoles Eudamonia (the 
understanding for the best way to live one’s life) QoL has been a much debated 
issue. Within the last 25 years or so, this interest has expanded to new heights and 
QoL now has meaning across many different disciplines, from geography, literature 
and philosophy to advertising, sociology and psychology.
Renewed interest in the topic has also contributed to a shift in paradigm within the 
field of health care. Emphasis was traditionally on the cure of disease and the relief 
of suffering but has now shifted to focus on the maintenance and enhancement of 
health. Consequently, the assessment of QoL now has many applications, 
including evaluation of existing therapeutic or environmental provisions and 
alternative forms of treatments. Measurement may also be used to provide 
information about the QoL of a specific population group, to analyse the 
relationship of QoL with other variables and evaluate the effects of specific policies 
and programmes.
The aim of the present chapter is to outline and discuss both the general problems 
associated with QoL research and those encountered in relation to assessment of 
persons with multiple sclerosis and other neurodegenerative diseases. Although 
clinicians and researchers have studied QoL in depth for the last 25 years or so, 
definitions of the concept remain inconsistent and disagreements concerning 
methods of assessment continue to dominate the literature. QoL has emerged as a
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more puzzling and complex construct to assess than many first anticipated, as the 
contents of the following chapter will demonstrate.
2.2 The concept of QoL
As Rogerson (1995) suggests, conceptualising QoL has proved to be “a difficult 
process... compounded by the multidimensionality of the term, and the degree to 
which this multidimensionality needs to be reflected in the concepts of life quality” 
(p. 1374). As a result, clarification of the QoL concept is usually avoided, the 
readers attention instead being diverted to the abstract nature of this issue (Sullivan, 
1992). Draper (1992) attributes such confusion to a traditional view that divides 
the body into a subjective mind and an objective body, one which can be traced 
back to Cartesian philosophies of the seventeenth century. From this basis, he 
continues the QoL concept has been split into isolated fragments of the human 
experience.
The ‘subject-object dichotomy’ Draper (1992) referred to has become a central 
issue in examination of a person’s QoL. According to Rogerson (1995) there are 
two fundamental components and processes that operate, those relating to an 
internal psycho-physiological mechanism and those external conditions which 
trigger the internal mechanism. And so very different ways of conceptualising QoL 
have emerged. Within these approaches, there are certain commonalties, but also 
distinct differences, especially in terms of comprehensiveness, level of specificity 
and theoretical rigour (Parmenter, 1994).
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Whilst the majority of researchers agree that QoL is multidimensional, by its very 
nature the construct is not directly observable. Views therefore conflict as to which 
phenomena should be chosen as its indicators, and how their choice can be 
justified. Furthermore, there are disputes as to whether life quality components 
vary from one individual to the next, or whether core features can he identified 
which are common to us all. As Andrews and Withey (1976) noted, the QoL 
concept could incorporate practically anything of interest to anybody.
In an attempt to understand the concept, QoL it has often been equated with 
theoretical explorations of happiness, dating from the work of early Greek 
philosophers to present day philosophy and social science (Andrews, 1981; 
Parducci, 1984; Veenhoven, 1991). Many recent studies isolate the dimension of 
general well-being in their definition of happiness, which has further been defined 
as “a thoughtful appraisal of quality of life as a whole, a judgement of satisfaction 
with life” (Argyle, 1987, p.4). At the very least, happiness is thought to affect the 
perceived QoL (Stones and Kozma, 1989), and in the health-care context the view 
that QoL can only be conceptualised as a feeling of general happiness has been 
advocated by many (e.g. Gill, 1984; Milbrath, 1979).
Similarly, QoL is often considered in terms of life satisfaction and morale. 
Homquist (1982) has argued that human needs are the foundation for QoL and that 
QoL is the degree of satisfaction with, for example, physical, psychological, social, 
activity, marital and structural requirements. This is somewhat akin to Maslow’s 
(1954) hierarchy of needs, incorporating psychological well being, safety and 
security, social well being and belonging, ego, status and self-esteem and self-
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actualisation. As of yet, however, there has been little attempt to examine these 
assumptions critically (Bowling, 1995).
Zautra and Goodhart (1984) described four models of psychological well being 
which may be used to subjectively evaluate life experience and provide an 
indication of QoL. The epidemiological model refers to factors in people’s lives 
that may increase the probability of disorder. The life-crises model is based on the 
notion that outcomes other than illness may follow from life experience. QoL is 
also thought to arise through competency, via experiences of self mastery, efficacy 
and competency. Finally, there is the adaptation level, based on the notion that 
people evaluate their experiences by comparing them to a baseline, consisting of 
their own previous experience and of comparisons made with others. This level is 
thought to affect the persons appraisal of their QoL by influencing the extent to 
which positive experiences contribute to life satisfaction and negative experiences 
to distress.
The underlying assumption of this approach is that the greater ones satisfaction 
with his or her resources, the greater the feelings of life satisfaction and well being. 
Perhaps the most often referred to advocates of this approach are Campbell, 
Converse and Rogers (1976), who have completed national studies of satisfaction 
and dissatisfaction in life domains such as family, work, leisure, health and social 
relations. They conclude that generally, greater satisfaction in such domains is 
related to a higher perceived QoL.
Felce and Perry (1996) have since argued that QoL is a person-centred 
phenomenon based on a 3-element model that incorporates personal values, life
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conditions, and personal satisfaction. Schalock (1996) also suggests that the 
perception of significant others, and interpretation of various life experiences may 
play a part in determining QoL. This idea is echoed by many other social scientists 
and gerontologists, such as Andrews (1974) who argued that QoL is related to the 
extent to which pleasure and satisfaction have been obtained.
Borthwick-Duffy (1992) presented a similar framework in emphasising three 
perspectives of QoL: (a) QoL defined as the quality of life condition, (b) QoL 
defined as satisfaction with life conditions and (c) QoL defined as a combination of 
both life conditions and satisfaction. Felce and Perry (1995) later added to the third 
perspective to provide a fourth dimension, emphasising the need to take account of 
personal values, aspirations and expectations.
Many theorists have been able to disentangle the terms QoL, life satisfaction, 
morale and happiness. Edgerton (1990) equates QoL with the conditions under 
which life is lived, suggesting that satisfaction with life is a separate and ultimately 
more important criterion of individual welfare. Horley (1984) considered 
subjective-well being (a term often used interchangeably with person-centred QoL) 
as a broad and abstract construct requiring more concrete, distinct indicators such 
as life satisfaction, happiness, and morale. To avoid conceptual confusion, he 
continued that subjective well-being should be broadly defined as “a self-perceived 
positive feeling or state” (pp. 126-7). He also referred to Stones and Kozma’s 
(1980) conceptual definition of morale in terms of “moral condition as regards 
discipline and confidence”; happiness as “an activity or state in the sphere of 
feelings”; and life satisfaction as “gratification of an appropriate proportion of the 
major desires of life” (p.270).
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On the basis of such conceptions, Holmes (1989) argues that QoL cannot be 
characterised only in terms of happiness and/or psychological well being. The QoL 
of the individual must be examined with acknowledgement of their social context 
and circumstance. This generally includes external, environmentally based 
conditions such as health, standard of living, education, neighbourhood, friendships 
and social welfare (Harwood, 1976; Wingo and Evans, 1978; Kaplan, Anderson 
and Ganiats, 1993).
Holland (1990) goes further to suggest that expressions of satisfaction alone fail to 
differentiate among a range of living environments. Moreover, if satisfaction is a 
measure of comparison, people whose circumstances and options to date may make 
them particularly prone to low expectations may be the most likely to report 
satisfaction in situations that the majority would find intolerable. Edgerton, 
Bollinger and Herr (1984) and Flynn (1989) are amongst those who have shown 
that individuals remain satisfied about the present and remarkably optimistic about 
the future despite the adverse conditions which they live (including victimisation, 
poverty, threats to health, experience of loss and social isolation).
As Campbell, Converse and Rogers (1976) argued, if we become accustomed to 
evaluating life’s quality in terms of material possessions, we overlook the fact that 
satisfaction is a psychological experience. Indeed, the quality of this experience 
may not necessarily correspond very closely to external conditions. Whilst social 
context and circumstance may provide useful indicators of QoL, their importance 
should not be overplayed in relation to the experience of the individual.
78
Many therefore believe the QoL concept is approachable at varying levels, which 
include the assessment of societal or community well being as well as the specific 
evaluation of the individual. There is a widespread view that the concept of QoL 
must therefore contain both person-centred and objective, health-based 
components. Rosenberg (1995), for example, suggests that although humans are 
biological organisms suitable for naturalistic studies, one should also take account 
of those features that constitute man as a person, such as understanding and 
interpretation.
In essence, there are many equally valid and competing conceptions of QoL, which 
cannot be rank-ordered unless one considers their applicability at the individual 
level. Many conceptual models have been proposed within the last 15 years which 
advocate a multidimensional approach (e.g. Brown and Bayer, 1992; Cummins, 
1992; O’Brien, 1987; Parmenter, 1988; Stark and Goldsbury, 1990) but beyond this 
the merits of particular formulation are not yet known. Exploration of the QoL 
concept does, however, appear to benefit from an integrated approach to 
conceptualisation, combining reflection on health and disease issues at an 
individual level with a psychometric tradition.
2.3 Definitions of QoL
Whilst it is generally recognised that QoL is a multidimensional construct, it is this 
very property which renders the concept so difficult to define. Joyce (1994, p.44) 
stated with regard to definition that almost every author defines QoL in his or her 
own way, each emphasising a different aspect of the construct. He also pointed out 
that many authors fail to define their terms at all. At the time of writing, this
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observation remains true. As Hunt (1997) observed, “QoL may appear as health 
status, physical functioning, perceived health status, subjective health, health 
perceptions, symptoms, need satisfaction, individual cognition, functional 
disability, psychiatric disturbance, well-being and, often, several of these at the 
same time” (p.206). On this basis, unsurprisingly, there are those who conclude 
that close definition (and measurement) of QoL is beyond the bounds of possibility 
(Sullivan, 1992).
Much of the underlying reason for this problem lies in the subjective 
mind/objective body problem aheady emphasised by Draper (1992). The health- 
based approach to QoL incorporates the view that QoL is made up of those factors 
that are necessary to sustain life; those enhancing or impairing the enjoyment of 
living (Ruta and Garratt, 1994). Schipper (1990), for example, suggested that QoL 
may be defined by four parameters; physical and occupational status, psychological 
state, social interaction, and somatic sensation. Spilker (1990) agreed on the notion 
of four domains, but instead defined these as physical status and functional ability; 
psychological status and well being; social interactions and economic status. 
Ferrans (1996), on the other hand, identified health and functioning, psychological 
and spiritual well being, social and economic factors and family as the four 
domains that represent QoL.
However, Felce and Perry (1995) reviewed 15 key QoL literature sources and 
grouped the majority of aspects mentioned on these sources into five domain 
headings; physical well being, material well being, social well being, development 
and activity and emotional well being. A similar conclusion was reached by 
Flanagan (1982) having surveyed 3,000 individuals, although domains were
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grouped as follows: physical and material well being; relations with other people; 
social, community and civic activities; personal development and fulfilment and 
recreation.
As Schipper (1990) concludes, the strategy behind QoL studies (when viewed 
objectively) is to “provide a numerical representation of patient function and track 
it over time” (p.55). The concept becomes fragmented into distinct sub-areas, so 
that each one can be analysed separately. There are many objections to this 
approach, mainly from subjectivists who maintain that focussing on what people 
can/cannot do, or have/do not have does not constitute a good or bad quality of life, 
at least not in the eyes of the individual concerned. By focussing on levels of 
physical and social behaviour, we do not ask for judgements, for experience of 
quality. In the words of Bergsma and Engel (1988, p.276) “quantities” of life may 
be closer to what is actually being observed.
Take, for example, the case of E. Power Biggs, a patient with rheumatoid arthritis 
discussed by Liang, Cullen and Larson (1982). They state that “throughout much 
of his later life, Biggs had inadequate hand function for his needs: that of a superb 
concert pianist. Even after excessive use of steroids and repeated 
metacarpoplasties, his hand span was never satisfactory for him” (p.776).
The point made by the authors is that in Biggs’ case, his inability to play the piano 
had a devastating effect on his QoL. For another patient, however, this effect may 
be negligible. External value systems fail to recognise that for most people, health 
is not the end to which they aspire, but merely a means of achieving the end. As 
O’Boyle, McGee and Joyce (1994) continue, the assumption that health is the
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major QoL component for patients remains unjustifiable. Perhaps then, if the QoL 
concept is to have true meaning and relevance, we should place less emphasis on 
those factors necessary to sustain life and concentrate more on those that make life 
worth living. As Ruta and Garratt (1994) state, “to define what a good or bad QoL 
is requires us to define exactly what it is that makes life worth living-its purpose” 
(p.139).
The person-centred approach to QoL therefore takes as its starting point the 
experience of individuals; their subjective interpretation of events and the meaning 
they are able to find in them. QoL thus becomes “dependent upon one’s 
conception of what constitutes a meaningful life” (De Jong and Batavia, 1989, p.2). 
Similarly, in a health care setting QoL has been defined as “that which the patient 
says it is” (Joyce, 1994, p.47).
As long as there are differing conceptions of QoL, there will continue to be a lack 
of consensus as to the definition of QoL. Although the objective, health-based 
approach was once an acceptable means by which to consider an individual’s QoL, 
there is increasingly a greater shift towards the person-centred stance. Many 
researchers now believe that if definitions and conceptions of QoL are to have any 
real meaning, then the individual’s perspective must be the primary focus. 
Although the investigation of person-centred experiences may provide several 
methodological challenges, attempting to define QoL in terms of externally derived 
health-based domains may distort it’s true meaning and render it a memingless 
concept.
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2.4 Health status. OoL and health-related QoL
Before considering the measurement of QoL, it may be useful to distinguish 
between these three terms, as they are often used interchangeably in the literature, 
and yet refer to very different entities.
Measures of health status are used to measure health outcome, and although there 
are few satisfactory definitions of this basic concept, the most widely used is that of 
total social, psychological and physical well-being (World Health Organistaion 
(WHO), 1947). Indices of health status tend to focus on illness, disease and 
negative concepts, and on the group rather than the individual. On this basis, much 
of the research referred to under QoL is actually measuring health status. It is also 
worth noting that much ‘QoL’ research has actually led to the development of 
measures representing health status (O’Boyle, McGee and Joyce, 1994).
The study of QoL in medicine has been largely concerned with matters relating to 
health; for example the areas of a persons life thought to be responsive to medical 
intervention (O’Boyle, McGee and Joyce, 1994). This has resulted in the 
construct of ‘health-related-quality-of-life’ (HRQoL); defined as “the value 
assigned to the duration of life as modified by the social opportunities, perceptions, 
functional states and impairments that are influenced by disease, injuries, 
treatments or policy” (Patrick and Erickson, 1988, p. 104). Most conceptualisations 
include the dimensions of physical, social and role functioning, as well as mental 
health and general health perceptions.
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The distinction between HRQoL and QoL rests on the former being based wholly 
on health domains that can be easily measured and quantified. QoL may consist of 
a much broader range of elements, many of which are generally un-related to the 
range of factors monitored by physicians and health-care systems. It remains 
imperative that the terms QoL, HRQoL and health status are used with more 
caution than has so far been witnessed. If the terms continue to be applied 
haphazardly, clarity of at least some of issues surrounding definition of QoL and its 
conceptual basis will remain unattainable.
2.5 The measurement of QoL
The measurement of QoL fits onto many levels of enquiry. Bergsma and Duff 
(1980) summarised this by identifying 4 distinct levels; macro, meso, personal and 
physical. The macro level refers to the meaning of life in society, where 
assessments of QoL play a part in political decisions on medical investments and 
decisions on issues such as euthanasia. The meso level refers to systems within 
society such as health care systems, which have their own internal structures but 
still have connections with the outside world. The personal level includes the 
frame and reference of the individual (both the patient and the doctor). Life’s 
quality is thus based on evaluative considerations of hope, individual wishes and 
personal knowledge of circumstances. Finally, the level o f physical activities by­
passes person-centred judgements and experience, referring instead to pure 
observable behaviour.
The majority of QoL research is concerned with the third and fourth levels only. 
Until recently, developed QoL measures focussed mainly on this fourth level.
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partly because the physical level remains more easily quantifiable than the personal 
level, and partly because quantifying quality (as defined at the personal level) 
appeared barely feasible. Within the last 10 years or so it has become the more 
widespread belief that when measurement is confined to the measurable in this 
way, it is not necessarily quality which is being measured (Bergma and Engel, 
1988). Many now adhere to the Rene Dubos’ view, that “the measurable drives out 
the important”(Liang, Cullen and Larson, 1982, p.777).
The methods by which QoL has been assessed have largely rested on theoretical 
perspectives regarding what constitutes QoL. A greater range of measures has 
therefore developed in line with a renewed interest in the nature of the QoL 
construct. This is not necessarily a positive chain of events. The desire to produce 
the ‘perfect’ QoL measure (which, it is now recognised, can never exist) has led to 
the frenzied production of new measures, in place of attempting to refine already 
existing measures. Alongside traditional questionnaire and interview techniques, 
assessment approaches now include, for example, QoL cards and computer based 
methodologies.
Whilst it is recognised that the development of new instruments may be warranted 
in certain research areas, Aaronson (1988) rightly states that “.. .if more effort were 
invested in the admittedly cumbersome task of searching for appropriate available 
instruments, the perceived need for undertaking the even more difficult task of 
instrument development would diminish” (p.221). The result of the current 
decision to constantly ‘return to the drawing board’ has been summarised by 
Cummins, McGabe, Gullone and Romeo (1994) who observed that not one of over
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eighty QoL measures recently identified had achieved a level of acceptance against 
which other scales could be validated.
The ‘cautionary note’ within Schalock’s (1990) book entitled ‘Quality o f Life: 
Perspectives and Issues ’ reads as follows; “We are just beginning to understand 
the concept of QoL and are probably not doing a very good job at this moment in 
time of measuring it” (p. 139). Nine years later, this statement still holds true, 
although it underestimates the control the researcher is able to exercise in selecting 
the most appropriate assessment tool for use with the population they are working 
with.
2.51 Patient ‘v’ ‘proxy’ QoL ratings
In cases where individuals are too cognitively impaired, or too ill and fi*ail to 
validly complete QoL assessments themselves, a member of nursing staff, a close 
fidend or a relative may complete the assessment on the patient’s behalf. These are 
generally referred to as ‘proxy’ ratings in the literature, where the rater attempts to 
judge the patient’s QoL fi"om the patients perspective (Coen, 1999).
However, the view that no individual can or should make judgements about 
another’s QoL has been has been argued by many researchers, and several studies 
have also demonstrated that priorities for patients, family and staff are quite 
different. To illustrate this point, Lomas, Piakard and Mohide (1987) and Oleson, 
Heading, McGlynn and Bistodeau (1994) studied the perceptions of QoL in 
language disabled adults and older persons living in long-stay institutions. In both 
reports, these formulations were compared to health care professional’s
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perspectives. Both claim that items generated by clients were more specific and 
concrete than those generated by health care professionals.
Of even greater concern are findings of Woodend, Nair and Tang (1997), who 
compiled a list of items based on the content all QoL measures constructed 
between the years of 1975 to 1989. This was administered in a survey format to 
physicians, allied health professionals, cardiac outpatients and family members, 
who were asked to rate the relative importance of each item to the patient’s QoL. 
Of the top ten items ranked by patients, only three items appeared on the staff top 
ten list, and five on the family members list. The patients, in contrast with staff and 
family, chose aspects of QoL that reflected the positive aspects of life.
This forms the basis of one of the main objections to proxy ratings of patient QoL, 
in that however poor a person’s QoL may seem from an external view point, the 
individual patient may still value their life and have their own sense of worth. We, 
as ‘outsiders’ remain ignorant of how some patients see themselves as having 
changed for the better rather than the worse. In the absence of reliable perceptions 
of QoL from the patient’s perspective, Emanuel (1998) rightly suggests that all the 
proxy can do is offer an unverifiable guess. The case against ’significant other’ 
ratings of QoL has been put forward by several comparison studies, the main 
outcome of which suggests that the patients feelings, opinions and perceptions 
cannot be assumed (Bowling, 1995).
Indeed, the majority of traditional assessment tools, by their very nature, suggest 
that as a disease progresses, the patient’s QoL will decrease accordingly. In a 
survey of 256 individuals with MS, Harper, Harper, Chambers, Cino and Singer
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(1986) confirm this, but only in relation to physical and social health scores (areas 
that are more easily observed from an external viewpoint). They found no 
correlation between QoL and measures of emotional health. Stuifbergen (1995) 
has since added to this assumption, suggesting that despite living with chronic 
disabling conditions (in this case MS), individuals generally report positive 
perceptions of their current health.
Coen (1999) suggests that consideration of the QoL values and preferences of the 
individual before, for example, cognitive deterioration occurs may assist proxy 
raters in producing more ‘accurate’ evaluations of patient QoL. However, this 
suggestion fails to account for the possibility that points of reference change over 
time, and thus individuals may change the standards by which they assess their 
QoL (see Section 2.7, pp. 104-106 for further discussion of the dynamic nature of 
QoL). On this basis, the strategy outlined by Coen (1999) may produce no more 
accuracy than that obtained in the studies already outlined by Lomas, Piakard and 
Mohide (1987), Oleson et al, (1994) and Woodend, Nair and Tang (1997).
If further information was obtained concerning the areas of greatest discrepancy 
between patients and proxy raters, this knowledge could be used to assist in 
decreasing future contradiction rates. Further studies are therefore required to 
evaluate the relationship between proxy and patient ratings using a variety of QoL 
measures, across a variety of patient groups, so that appropriate recommendations 
can be made concerning their utility in future research.
It is also important to recognise that, in some cases, it may be better to abandon the 
quest for knowledge of QoL altogether, in respect of the individual’s opinions and
perceptions, which may not be accurately represented using this approach. This is 
indeed a difficult scenario in which to judge the best way forward, and individual 
cases differ as to their degree of complexity. In such instances communication with 
all relevant parties is the key; and whether or not QoL assessment follows, respect 
for the needs and wishes of the individual concerned remain of greatest importance.
2.52 Generic ‘v’ disease-specific QoL measures
QoL measures generally fall into one of three categories. They are either generic 
(designed to be used across a wide range of disease types), domain-specific 
(instruments focussing on one particular disease but designed for use across 
different types of the disease, for example cancer populations) or disease-specific 
(designed for a specific population e.g. breast cancer patients, or specific treatment 
effects.). The major advantage of employing a generic measure is that they allow 
for comparison of results across disease groups and studies. As a consequence, 
there is far more information available concerning the psychometric properties of 
such instruments.
Generic measures like the Sickness Impact Profile (Bergner, Bobbit, Kessel, 
Pollard, Gibson and Morris, 1976) and the SF-36 Heath Survey (Ware and 
Sherboume, 1992) have become widely used across a number of research settings, 
whilst the development of disease-specific questionnaires has remained slow. One 
drawback of using generic instruments is that they cannot identify aspects of 
disease that are specific to a certain condition. Such aspects may be of great 
importance to the overall QoL judgements that are made (Hutchinson and Fowler,
1992), and thus disease-specific measures are often employed. This type of
89
measure is often more condensed, and avoids asking irrelevant questions of 
respondents.
Disease-specific measures have now been developed for all manner of illnesses, 
ranging from anaemia to HIV and AIDS, and including variations of cancer, 
cardivascular and rheumatological conditions (for a full list refer to Bowling, 1995, 
ch.8). However, this type of measure is often criticised for being too narrow in 
focus and not including outcome and modifying variables such as depression, self­
esteem, social support and coping strategies. Furthermore, disease-specific 
measures enable a greater degree of specificity, but often at the cost of 
generalisability. In order to obtain ‘the best of both worlds’, researchers may 
therefore use a generic instrument supplemented with a disease-specific measure. 
The SF-36 Health Survey (Ware and Sherboume, 1992) is becoming increasingly 
used for this purpose.
An alternative option is to supplement disease-specific scales with domain-specific 
measures (although these instruments are the least commonly used). Whilst no one 
study can hope to measure every relevant domain, the domain scales developed are 
generally very long. Bowling (1995) gives some valuable advice on this issue, 
stating that domain specific scales should be “.. .used when the area is of particular 
interest to the investigator, and the disease-specific (or generic) scale selected for 
use neglects that domain” (p. 16). Otherwise there is a danger of administering a 
battery that contains too many, and sometimes overlapping, items. In turn, this 
becomes tiresome for respondents and produces an overwhelming amount of data 
that may be more of a hindrance than a help.
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2.53 Health-based and person-centred measures of QoL
The differences between health-based and person-centred approaches to 
conceptualisation and definition of QoL have already been discussed in the 
appropriate sections. Likewise it has already been mentioned that these theoretical 
perspectives underpin the methods by which QoL is assessed. The purpose of the 
following section is to explore in greater depth many of the measures currently 
used to assess QoL in terms of their development, content and practicality.
The distinction between health-based and person-centred QoL measures in the 
following review is based upon how the measures have been used in previous 
research. There is often great overlap between the two entities. Generally speaking, 
health-based measures are derived from an external viewpoint and can be 
completed by somebody other than the patient if necessary. They tend to focus on 
areas of QoL which are easily observable, such as health and physical functioning.
Person-centred measures can only be completed by the individual whose QoL is 
being assessed. This may involve a semi-structured interview, where the individual 
nominates the areas by which their QoL is to be assessed. The measure should not 
be based upon pre-determined questions concerning pre-determined life areas, 
although as Table 2.2 demonstrates, some person-centred measures have been 
constructed in this way. Although person-centred reports of QoL have often 
incorporated assessments of mood, affect and happiness, scales purporting to 
measure these constructs without reference to QoL have been excluded from the 
present review, in the hope that some clarity may be retained.
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Many health status measures are included in the review, as they are often employed 
as objective, health-based QoL indicators (because of their focus on areas that are 
directly observable and important in the eyes of the external judge). Where 
measure are referred to that originated as health status measures, the abbreviation 
HS are incorporated. A guide to the number of studies using each measure is 
presented, and if the measure has been used within a neurological setting this is 
also indicated. The abbreviation NRU refers to measures that have no recorded use 
with a neurological population. Disease-specific measures have not been 
incorporated in the present review, although MS-specific QoL measures are 
evaluated in Table 2.4 (p.118).
The review that follows is by no means exhaustive, and the measures listed in 
Tables 2.1 and 2.2 are those which have been used in several published studies up 
to 1999, rather than in only one study. The QoL cards do not fulfil this assumption, 
and are included as they show promise for future application, providing that 
adequate psychometric standards are reached. The psychometric properties of 
each instrument reviewed are considered separately in Table 2.3
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As Table 2.1 demonstrates, health-based QoL measures are usually constructed on 
the basis of review of the existing literature, using the knowledge of the 
researcher/clinician involved, or on the basis of interviews or questionnaires 
regarding what constitutes a ‘good’ QoL. These interviews may be given to 
members of the general population, or to members of a targeted sub-group for 
whom the measure is intended. This method still generates an external framework 
around which responses are construed. Rather than being “what the patient says it 
is” (Joyce, 1994, p.47) QoL in this instance becomes what a group of persons other 
than the patient (but perhaps with the same medical condition) say it is. The 
variation among individuals still remains unaccounted for.
Fewer person-centred measures are included in the review in Table 2.2, reflecting 
their relatively recent development. At the time of the present review, no published 
reports were located that used any of these measures in a neurological setting. 
However, the selection of person-centred measures reviewed may be suitable for 
use with individuals with neurodegenerative diseases, and future QoL studies 
conducted in a neurological setting may benefit from utilising this approach to 
assessment.
2.6 Psychometric requirements of QoL measures
Whether one gathers health-based or person-centred QoL data, measurement tools 
should possess the characteristics of reliability and validity. Even though person- 
centred measures are not always amenable to the same methods of psychometric 
analysis as the more traditional measures available, due to their open-ended 
structure, this does not preclude the need for data to satisfy basic psychometric
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standards. One of the main problems in the QoL field of research is that very few 
instruments are tested adequately to meet such criteria. This problem has arisen in 
part from the sense of urgency surrounding development of new measures and in 
part from the fact that many measures are designed for use in one study. The end 
result is a plethora of scales claiming to measure QoL, few of which have been 
adequately tested. Many of the problems concerning the psychometric testing of 
established QoL instruments are now considered.
2.61 Reliability
Establishing the re-test reliability of QoL instruments (that is, the knowledge that 
they produce the same or very similar results on two or more occasions with the 
same respondents) is not an easy procedure. The very nature of the QoL construct 
means that it is often uncertain whether results obtained represent an unreliable 
measure, a real change in individual perception of QoL, or a combination of these 
two factors. This is even more of a problem with person-centred measures, as they 
focus on the individuals’ internal beliefs rather than external ratings of observable 
phenomena , so associated changes that occur are often undetectable. Because of 
this potential uncertainty, many believe this method of estimation to be of limited 
value, and advocate internal consistency analysis as an alternative (e.g. Aaronson, 
1988; Jenkinson, 1995).
However, as internal consistency analysis indicates the extent to which items on a 
scale are tapping an underlying construct, this method is impossible to use with 
person-centred measures, which do not possess an external framework. 
Furthermore, as this approach is based on assessment over a single session, it tells
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us nothing about the reliability of a test over time. Establishing internal reliability 
is not an acceptable alternative to establishing re-test reliability, and claims made 
about the reliability of a test should therefore be treated cautiously.
2.62 Validity
Establishing the validity of a QoL instrument is considered by many to be more 
complex than establishing its reliability (Aaronson, 1988). There are numerous 
published reports of QoL measures correlating highly with other ‘established’ 
measures and therefore being valid. However, the fact remains that even these 
established measures have limitations, which are often overlooked (Jenkinson, 
1995). The problem facing QoL researchers is that no instrument has yet reached 
the psychometric standard required of this criterion measure, so new measures are 
simply validated against existing measures that may not have been adequately 
tested themselves.
One alternative is to compare the measurement with other indices that it would be 
expected to correlate highly with, but the main problem with this approach is that 
few studies declare what levels of correlation are to he taken as demonstrating 
adequate validity. McDowell and Newell (1996) have suggested that the adequacy 
of validity and reliability coefficients may be determined by comparing them to 
typically observed values within the QoL literature. They suggest, for example, 
that convergent validity correlations between tests are low by general psychometric 
standards, typically falling between 0.40 and 0.60. However, when compared to 
standards generally obtained in the QoL literature, a correlation of 0.60 is relatively
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high. On the basis of this literature, they conclude that a correlation of 0.60 
between two QoL measures represents an extremely strong association.
If obtained correlations between QoL measures are generally between 0.40 and 
0.60, all this suggests is that the different measures are tapping into different 
constructs. This explanation seems plausible given the uncertainty surrounding 
definitions of QoL. Low correlations may also highlight the differences within 
groups, reflecting the individualised nature of QoL. To suggest that a generally 
low correlation coefficient becomes an extremely high association on the basis of 
values typically observed within the QoL literature does little for the scientific 
status of QoL research. It simply demonstrates that many of the QoL measures 
developed to date have not demonstrated sufficient validity to warrant their 
continued use.
Researchers all too frequently adopt a measure for use because of its psychometric 
performance in previous studies, where a different population and often a different 
disease group have been studied. What several researchers and clinicians fail to 
acknowledge is that the same instrument may be more or less valid (or more or less 
reliable, for that matter) depending on the variability of the population studied. 
The only relevant psychometric estimates are those that are obtained for the 
population being studied. The psychometric properties of any QoL assessment tool 
used for the first time in a given population should therefore be tested thoroughly 
before use, otherwise the credibility of results obtained remains uncertain. Tests of 
reliability and validity should begin with a justified statement of the type of 
variables that the QoL measure should logically be related to. The expected
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strength of correlation coefficients also be stated and justified before psychometric 
tests are conducted.
2.63 Responsiveness to change
Before discussing this issue, it should he noted that the term ‘sensitivity’ is often 
used in the QoL literature when describing the responsiveness of a measure. As the 
terms ‘specificity‘ and ‘sensitivity’ are often used in the medical literature to 
describe the validity and reliability of measures, in order to avoid potential 
conftision, the term ‘responsiveness’ will be used throughout the present and 
subsequent chapters to describe the stability of a variable across time.
For outcome measurements like QoL, responsiveness to change over time is an 
essential characteristic, although there is little consensus as to how this should be 
assessed. According to Jenkinson (1985), it is “a psychometric feature which has 
historically been relatively ignored” (p. 1399). In general, most of the emphasis has 
been on establishing reliability and validity. Ironically, as the QoL construct is 
sensitive to fluctuation in individual state and therefore not as stable as traits such 
as intellect, a measure that demonstrates high reliability may be a poor indicator of 
QoL as it will be unresponsive to changes over time. QoL measures should 
therefore demonstrate a high level of stability in unchanging situations and 
sensitivity to changing circumstances (Atkinson, 1982).
Utilising effect sizes is a simple method of expressing, in a standardised way, the 
amount of change detected by an instrument. Generally, the responsiveness of an 
instrument should be inversely related to the expected effect size; the smaller the
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effect size, the greater the required sensitivity and the larger the required sample 
size. Unfortunately, large sample sizes are rare in longitudinal research, especially 
in the clinical field where the majority of QoL research is conducted. Here, 
decreasing sample sizes are more common as a function of death or deterioration of 
medical condition, fatigue or simple loss of interest. As Aaronson (1988) points 
out, it is often difficult to estimate the expected effect size in QoL research, and 
consequently most available instruments do not provide data. “At present, he 
suggests, one must rely on a more subjective judgement of instrument 
responsiveness based on an examination of question wording, response scale levels 
and scale score variability” (p.226).
There are, however, alternative methods available for measuring this psychometric 
property, which remain under-utilised at the present time. In the absence of large 
clinical samples, self-reports of change may provide one of several means by which 
to assess the responsiveness of a QoL measure. Alternatively, Ziehland (1994) has 
suggested the use of global rating scales and multiple-item transition scales. Her 
detailed discussion of measuring change in health status provides an excellent 
account of the alternative methods that can be adopted, many of which are equally 
applicable to QoL assessment.
2.64 Instrument applicability
Although not a psychometric issue as such, it is worth noting instrument 
applicability; the selection of a suitable data collection method and assessment tool 
(or tools) (Feinstein, 1978). This primarily involves consideration of the amount of 
time and effort demanded by a measure in relation to the abilities and health of the
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target population. In longitudinal studies, this should also he considered in relation 
to expected changes or deterioration in health status over the course of the study. It 
is imperative that researchers determine apriori that the measure intended for use is 
appropriate for the population to be studied.
In order to establish this, Aaronson (1988) suggests that “balanced consideration 
should be given to the nature of the research question at hand, the possibilities and 
limitations inherent in the research setting, and the conceptual and methodological 
strengths and weaknesses of candidate measures” (p.228). In addition to this, the 
psychometric standards of candidate measures should also be considered, although 
the specific needs and requirements of the individuals involved remains of utmost 
importance.
2.7 The dynamic nature of QoL
As the research outlined in the previous section suggests, there are general 
limitations in establishing the re-test reliability of QoL instruments, as results 
obtained may reflect real changes in QoL perceptions rather than unreliable 
measures. When using QoL measures, it has generally been presumed that 
individual QoL perceptions remains stable. However, points of reference change 
over time and yet there have been few attempts to build into assessment study of 
the fluctuations of individual response. To date, the possibility that an individual 
may change the standards by the way they assess their QoL and the subsequent 
effects of this change upon valid QoL measurement have been largely ignored. 
Allison, Locker and Feine (1997) provide one of relatively few thoughtful accounts 
of what they term “within-subject QoL construct dynamism” (p.221).
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A simple example of construct dynamism can be extracted from life satisfaction 
research conducted by Campbell, Converse and Rogers (1976) and Rogers and 
Converse (1976). They suggest that life satisfaction ratings are less stable over a 
longer time period (8 months) than a shorter time span (3 days). The 
methodological philosophy behind Campbell, Converse and Rogers (1976) 
suggestion was that the 8-month period was long enough to permit change in real 
life circumstances and experience, so the stability of the measures would be higher 
over a shorter re-test period.
For this model to he accepted as underlying the QoL construct, QoL needs to be 
measured on a far more frequent basis than in the majority of research studies to 
date. Any QoL measure which is accepted as suitable in a given population also 
needs to demonstrate this pattern of stability over time, being high over days and 
moderate over months. Re-test coefficients will therefore decrease over time, as 
Campbell, Converse and Rogers (1976) demonstrated; 3 day coefficients of 0.80 
and above diminishing to between 0.43 and 0.56 eight months later. Additionally, 
Atkinson (1982) suggested that stability in unchanging situations and 
responsiveness to changing circumstances must be demonstrated if measures are to 
be useful indicators of QoL.
There are several challenges inherent in attempting to measure a construct like 
QoL, where perceptions change with little warning, for an infinite number of 
reasons, and for reasons that are likely to differ from one individual to the next. A 
singular assessment may only be accurate for a short time period, and this 
dynamism can only be acknowledged if measurement is taken on a more regular 
basis than the majority of studies conducted to date, using a responsive assessment
105
tool that focuses on the areas that are reported to change at assessment. Many of 
the factors that cause QoL perceptions to fluctuate will be unique to the individual, 
and collectively these will be far wider in scope than the content of the majority of 
established generic and disease-specific measures. For this reason, person-centred 
QoL measures may be more appropriate tools for investigation of QoL in dynamic 
terms.
2.8 Review of the psychometric properties of measures currently 
used to assess QoL
In Section 1.11 (p.53), it was pointed out that very few authors declare what levels 
of correlation are to he taken as demonstrating adequate psychometric standards for 
both the validity and reliability of a given measure. The advice of Pedhazur and 
Schmelkin (1994) was also noted, suggesting that researchers should formulate and 
justify their own standards for psychometric adequacy in future tests or reviews of 
the psychometric standards of measures.
As McDowell and Newell (1996) point out in relation to the QoL literature, many 
authors seem “pleased to arbitrarily interpret virtually any level of correlation as 
supporting the validity of their measure” (p.33). It is acknowledged that the 
standards for adequate reliability and validity will depend largely on the type and 
consequences of decisions that will be made on the basis of results. However, given 
the lack of consensus concerning the psychometric testing of QoL measures 
outlined by McDowell and Newell (1996), and the problems associated with 
measuring a concept like QoL which changes over time, the advice of Pedhazur 
and Schmelkin (1994) again seems appropriate. The psychometric standards used
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to evaluate the psychometric properties of the QoL measures in the review that 
follows have heen devised accordingly.
In light of the notion of QoL dynamism, one might expect the criterion required for 
QoL measures to be considered reliable and valid as slightly lower than 
requirements for more stable constructs, such as I.Q., reflecting this dynamism. On 
the basis of this theory, the present review assessed the psychometric standards of 
QoL measures using two separate criterion. The first of these was whether they 
reach an acceptable standard level of psychometric test-retest reliability, which the 
author considers generally to be at or over 0.70, in agreement with Nunally (1978). 
However, given the dynamic, ever-changing nature of QoL that has already been 
outlined, a second lower acceptable criterion of 0.60-0.69 has been introduced.
It is strongly advised that QoL researchers adopt a similar approach in future 
psychometric research, of formulating and justifying their own standards for 
psychometric adequacy. This process, when applied to the evaluation of QoL 
measures, might restore some of the scientific rigour that has been lost in the 
process of psychometric evaluation to date.
In Table 2.3, the health-based and person-centred measures that were introduced in 
Tables 2.1 and 2.2 are considered again, this time in relation to their established 
levels of reliability, validity and responsiveness to change. The accompanying key 
is as follows:
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0 = no numerical results reported in the literature reviewed 
* = weak reliability/validity indicated (less than r=0.60)
** = adequate reliahility/validity demonstated (r=0.60 to 0.69)
*** = excellent reliability/validity demonstrated (r=0.70 and above)
Where a combination of stars (ie */**) are displayed, different results reported 
range across these categories.
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As Table 2.3 demonstrates, 60% (N=9) of measures reviewed have reported 
reliability and/or validity coefficients ranging from below r=0.60 (weak) to 
between r=0.60 to 0.69 (adequate), making it difficult to draw firm conclusions 
regarding their psychometric quality. Of the remaining measures, only the 
SEIQoL-DW demonstrates adequate levels of reliability and validity, but since the 
measure has only recently been developed conclusions are again based on limited 
literature. Of all the measures reviewed, 53% (N=8) have either no reported testing 
of responsiveness to change in the literature (the SEIQoL-DW is included in this 
category), or associated claims that further evaluation is required before 
conclusions can be drawn. Of the measures that have been demonstrated to be 
responsive to change, none meet the requirements for adequate reliability and 
validity already discussed.
The measures presently reviewed are generally the most widely used throughout 
health-care settings, and yet the content of Table 2.3 raises several questions 
concerning the reliability and/or validity of many of these measures. The same 
questions are raised regarding some of the person-centred measures reviewed, 
although many have only recently been developed and further psychometric testing 
is required before informed conclusions can be drawn.
The present observations may partially explain why researchers are so keen to 
develop new QoL measures, rather than re-test existing measures for which there is 
insufficient and/or conflicting data concerning levels of reliability and validity. As 
previously discussed, one possible way forward is to re-focus psychometric 
expectations to reflect to a greater extent the dynamism of the QoL construct. This 
shift in emphasis may assist in explaining variability within and between individual
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scores, which may have contributed to the inconsistencies reported across studies 
of the psychometric properties of QoL measures to date.
2.9 OoL and neurodegenerative disease
To date, the uptake of QoL assessment and research in neurological settings has 
been slow, relative to the marked increase in QoL studies generally across the last 
25 years. This may he partially attributable to factors that make assessment of any 
kind difficult with these population groups, including problems associated with 
cognitive deficits, emotional state and communication difficulties. The application 
of QoL research and assessment in individuals with neurological illness holds 
many potential problems, and careful consideration of both the type of measure(s) 
employed and the nature of the population group to be studied are required. Many 
of the health-based and disease-specific measures used at the present time are 
unsuitable for individuals with moderate to severe neurological illness, due to their 
focus on physical status, and/or inadequate psychometric standards.
Engstrom and Nordeson (1995) investigated the perceived QoL of 169 patients 
with a range of progressive neurological diseases, including multiple sclerosis 
(N=55) and Parkinson’s disease (N=20). Patients were asked to express, in their 
own words, what they regarded as QoL. The authors identified four main 
categories of QoL from patients’ responses; living in a sense of affinity, being 
independent, living on one’s own terms, and feeling that life is meaningful. 
Engstrom and Nordeson (1995) acknowledge that the categorisation of answers 
should not be over-generalised. Indeed, of equal interest was the individual nature 
of responses obtained. For example, one individual defined QoL as “to be hopeful.
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to feel that you are a good enough person, to feel joy of life” (p.l81). A second 
respondent considered QoL was “...to be able to come and go as like, to manage 
without having people coming in to help in every situation...” (p. 180). These 
answers provide a concrete example of the individual nature of QoL, when viewed 
from the patients’ perspective.
An earlier study of QoL and neurological ilhiess conducted by Stensman (1985) 
suggested that alterations in a person’s value system are also likely to occur during 
the process of adaptation to severe disability. Stensman (1985) compared the QoL 
reported by 36 severely mobility-disabled individuals with that of 36 non-disabled 
control participants matched according to age, gender, country of birth and 
geographical area. The 36 individuals with severe disability had a range of
Cord
diagnoses; the most common were cerebral palsy (N=13); spinal ehord injury with 
quadreplegia (N=6); and multiple sclerosis (N=5). Behaviours such as going to the 
toilet alone, taking a hath by oneself or feeding oneself were rated as significantly 
less important by people with disabilities than able-bodied people, particularly 
those lacking the function in question.
Aside from these studies, at the time of writing there are few reported 
investigations of QoL in population groups with a range of neurodegenerative 
diseases. The vast majority of QoL research that has been conducted within a 
neurological setting has focussed on persons with disabilities relating to MS, 
epilepsy, or stroke. At the present time, there are far fewer published papers on 
QoL and, for example, Parkinson’s disease and cerebral palsy, and no recorded 
assessment of QoL in patients with rarer neurological conditions such as 
Friedreich’s ataxia and hydrocephalus. However, for chronic conditions like these,
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where there is no known cure, increased knowledge concerning how to maximise 
QoL becomes especially important. It also has considerable significance for the 
care and management of individual patients; clinical audit of care and therapeutic 
interventions, and assessment and improvement of clinical services.
It remains beyond the scope of the present chapter to review the available literature 
on QoL in persons with epilepsy, stroke and MS, as the literature associated with 
each condition has increased considerably across the past 5 years. As the majority 
of persons involved in the present research on QoL and severe neurological 
disability are diagnosed with MS, there follows an overview of studies conducted 
to assess QoL within this context. Individuals with a specific interest in QoL and 
epilepsy are encouraged to read Trimble and Edwin Dodson’s (1994) edited book 
entitled ‘Epilepsy and QoL’, which provides a comprehensive discussion of several 
QoL issues relating specifically to this population.
2.10 OoL and MS
The features of MS make the assessment of QoL in this patient group even more 
complex than the conceptual and methodological obstacles associated with QoL 
research in general. Through physical and mental disahilities, many have limited 
means of expressing their opinions and feelings. Fatigue and limited concentration 
may also influence the nature and length of assessments that can be conducted. 
Cognitive deterioration may also impair patients’ ability validly to perceive their 
own QoL (Beatty, 1993). Indeed the validity of statements can be difficult to 
judge, especially when QoL is viewed as “that which the patient says it is” (Joyce, 
1994, p.47).
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Some form of cognitive assessment is therefore recommended within the tests 
administered, if formal knowledge concerning cognitive ability is not already 
available. Whilst it is recognised that individuals with such cognitive deficits 
should not he exempt from QoL assessment, it remains impossible validly to assess 
their QoL with the measures that are currently available for use. The development 
of an appropriate assessment technique is an arduous task, but one which is 
undoubtedly recognised as necessary.
As the majority of QoL measures focus on functional ability and health, individuals 
with disabling conditions like MS are likely to achieve very low QoL scores. 
Lintem, Beaumont, Kenealy and Murrell (1999) compared scores obtained using 
the SF-36 (a health-based measure) and the PGI (a person-centred measure) in a 
group of 30 MS patients with a relatively high level of physical disability as
measured by the EDSS (X=8.4, range=7.5 to 9.0). There were significant 
differences between the scores obtained on the two measures, reflecting their 
different conceptual approaches to QoL. Results obtained suggested that aspects 
other than physical and health based entities play a significant role in QoL 
perceptions. Weinburg (1984) similarly suggested that degree of physical disability 
is unrelated to life satisfaction.
Rothwell, McDowell, Wong and Dorman (1997) asked 42 MS patients, with
varying degrees of disability as measured by the EDSS (X=5.5, range=l to 8), 
which domains on the SF-36 were most important to them. These judgements were 
compared with proxy ratings obtained from clinicians. The authors suggested that 
the clinicians were significantly more likely than the patients to rate physical
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functioning and physical role limitations as important, and significantly less likely 
to be concerned with mental health and emotional role limitations. Given these 
findings, the ‘mis-match’ between person-centred QoL perceptions and the content 
of traditional health-based QoL measures becomes most apparent. The QoL 
measures used with MS patients, or any population with physical disabilities 
should therefore he selected vary carefully.
To date, studies of QoL and MS have suggested that contact with healthy people 
(Maybury and Brewin, 1984), perceived support from family and friends (Mclvor, 
Riklan and Reznikoff, 1984) and engagement in health promoting behaviours 
(Petajan et al., 1996; Stuifbergen, 1995) facilitate better psychosocial adaptation 
and QoL. Garden (1991) suggested that QoL might also be improved through 
rehabilitation programmes that address issues of sexuality and the incidence of 
sexual dysfunction associated with the disease. Poorer QoL as a whole is thought to 
be most strongly related to increased interference with social activities (Aaronson, 
1997).
Despite these indicators, important predictors of QoL and their paths of influence 
remain largely unclear. This lack of knowledge may he partially attributed to the 
fact that so few QoL measures have been developed specifically for use with 
persons with MS. In a recent review of the generic instruments currently available 
for measuring QoL in MS, the majority were deemed unsuitable for use due to their 
poor psychometric properties and lack of relevance (Galen Research, 1996). Of 
those that have been developed, few have been used by researchers other than the 
authors. These instruments are evaluated in Table 2.4.
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As Table 2.4 demonstrates, the QoL measures that have been developed for 
persons with MS are generally health-related and/or have yet to reach adequate 
psychometric standards. These measures are unsuitable for individuals with 
moderate to severe neurological illness, due to their focus on physical status. 
Furthermore, each instrument evaluated has only one or two published reports 
associated with the testing of its psychometric properties. Thus further, more 
extensive testing is generally required. A greater emphasis on the use of person- 
centred measures may provide a logical ‘next step’ forward, as many of these 
assessment tools provide detailed information on the areas of life that are important 
to each individual assessed. It is precisely this information that will enhance our 
understanding of QoL in persons with MS and other neurodegenerative diseases.
2.11 Summary
Interest in the QoL concept has increased substantially over the past 25 years and 
yet clinicians and researchers continue to debate the meaning of the term and 
approaches to its measurement. No definitive answer to either of these questions 
has emerged. Confusion surrounding definition and measurement of QoL stems 
partly from the interchangeable use of the terms health status, HRQoL and QoL. 
The vast difference between these concepts is often overlooked when QoL studies 
are conducted, and on this basis future QoL assessment may benefit from increased 
use of the person-centred/health-based distinction.
Whilst a plethora of health-based measures has been developed, the person-centred 
approach is only now becoming recognised, having long been considered as 
lacking scientific rigour for its focus on unobservable, individualised perceptions.
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Production of traditional measures has been fast and continuous, and assessment 
tools have often been developed for use with a specific population. The 
consequence, a multitude of measures, barely used and rarely tested for their 
psychometric quality, is now becoming evident.
Given the confusion surrounding adequate psychometric standards for QoL 
measures, the present review encourages researchers and clinicians to reach their 
own conclusions regarding the coefficients that are acceptable for each individual 
study conducted, based on the nature of the study at hand and the dynamic nature 
of the QoL construct. Although little attention has been paid to QoL dynamism to 
date, more frequent assessments, incorporating person-centred measures and 
assessment of life changes may contribute to a greater understanding of the 
dynamic nature of QoL.
The application of QoL holds many potential problems, as individuals will often 
have complex and profound disahilities that make routine assessment both 
challenging and complex. Careful consideration of hoth the type of measures 
employed and the nature of the population group to be studied are therefore 
required. The requirements of the individual should guide the choice of 
measurement tool, a point highlighted within sections 2.9 and 2.10 in relation to 
persons with MS and other neurological illnesses. At the present time, important 
predictors of QoL and their paths of influence within this context remain largely 
unclear. For individuals with neurodegenerative disease, where there is no 
available cure, the goals of health care focus on maximised comfort, function and 
satisfaction. A valid means of monitoring QoL in neurological settings has yet to 
be achieved and yet remains imperative.
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CHAPTERS
Psychometric Evaluation of Two QoL Instruments
STUDY 1 (Parts 1 and 2)
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3.1 Introduction
The number of theoretical writings on the reliability, validity and responsiveness of 
QoL measures has increased alongside the growing number of assessment studies 
that have been conducted. However, as Section 2.8 outlined, the psychometric 
standards of the majority of QoL measures do not match the criteria that were 
established earlier in this thesis.
QoL assessment has the potential to positively influence medical care and if 
conducted without due consideration of psychometric issues this could have 
"drastic effects, not least of inaccurate or inappropriate data" (Jenkinson, 1995, 
p. 1395). Whilst assessment tools need to be selected in accordance with the nature 
of the research to be conducted and the specific population being studied, it has 
already been noted that the assessment of QoL in persons with severe neurological 
disability poses a number of significant problems, and that a feasible means of 
measuring QoL in persons with MS has not yet been established.
3.2 Study 1: Part 1
As outlined in Section 2.61, there are general limitations in establishing the re-test 
reliability of QoL instruments, as results obtained may reflect real changes in 
perceived QoL rather than unreliable measures. When assessing the psychometric 
properties of a QoL measure, deciding to examine the re-test reliability of a test 
instrument carries with it the assumption that the QoL construct remains stable 
across time. However, points of reference change over time and yet there are few 
published papers that acknowledge the fluctuations in individual QoL that are 
likely to occur. The notion of QoL dynamism (i.e. an individual changing the
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standards by which they assess their QoL) was outlined in Section 2.7 (p.104-106). 
As Allison, Locker and Feine (1997) state, the possibility of QoL dynamism and its 
subsequent effects upon valid QoL measurement has been largely ignored. 
Edgerton (1990) argues that where longitudinal research has been conducted to 
address these issues, the research has suffered from serious flaws of research 
design, such as sampling weaknesses, too hrief time spans between tests, or too few 
points of measurement.
Allison, Locker and Feine (1997) also suggest that different aspects of a QoL 
instrument may demonstrate differing levels of responsiveness to change. On this 
basis, one might expect the physical aspects of many health-based measures to 
remain more stable over time than person-centred perceptions of QoL, as physical 
entities are less likely to reflect life changes that occur across time. Although there 
have heen few published comparisons of the responsiveness of health-based and 
person-centred QoL measures, there are reports of person-centred measures 
reflecting changing life circumstance. Campbell, Converse and Rogers (1976) and 
Rogers and Converse (1976) suggested that person-centred life satisfaction ratings 
are less stable over a longer time period (8 months) than a shorter time span (3 
days). The methodological philosophy behind that study was that the 8-month 
period was long enough to permit change in real life circumstances and experience, 
so the stability of the measures would be higher over a shorter re-test period.
This theory may be taken one stage further, as in its present state it fails to account 
for the effect of fluctuations in perceived QoL that occur on a day-to day basis. On 
the one hand, QoL perceptions may appear less stable across a longer time span 
than a shorter time span, due to the real life changes highlighted by Campbell,
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Rogers and Converse (1976) and Rogers and Converse (1976). However, QoL 
perceptions may also fluctuate throughout and across each day, thus appearing less 
stable across a shorter time span than Campbell, Rogers and Converse (1976) and 
Rogers and Converse (1976) suggest.
When considered from this dynamic perspective, stability and fluctuations in 
perceived QoL may be likened to the tonic and phasic effects associated with 
physiological responses such as galvanic skin response (GSR). The effects of short­
term, 'phasic' changes on QoL may be smoothed across a longer time span to 
provide an averaged indication of long-term perceived QoL. Within the present 
population, for example, factors such as a cancelled visit by a relative or friend, or 
a postponed outing may serve to lower present QoL perceptions. Similarly, a trip 
to the hairdressers, a birthday celebration, or time spent in company may enhance 
present QoL perceptions. However, none of these factors are likely to have any 
long-lasting effect on perceived QoL. In fact, positive and negative fluctuations 
may balance each other out across an extended time period, as the incidents that 
cause QoL to fluctuate are likely to be relatively short-lived.
If this is the case, then where no long-term, 'tonic' life changes are reported to 
occur, perceived QoL may appear relatively stable across an 8-month period, after 
the data has been smoothed to remove the effects of short-term, phasic changes. 
Figure 3.1 overleaf provides an indication of how long-term perceived QoL may 
appear after this process of averaging has been conducted. It is noteworthy that, in 
Figure 3.1, perceived QoL across a longer time span does increase slightly, even 
with the process of smoothing. This reflects the notion already discussed, that
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perceived QoL will shift more subtly across time reflecting changing points of 
reference.
By comparison, perceived QoL across an 8-day duration of this 8-month period 
may appear less stable (see Figure 3.2 overleaf). Without the process of smoothing, 
the 8-month period would show the same characteristics as the 8-day period, 
simply extended across a longer time frame.
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Figure 1: The dynamic nature of OoL across an eight month duration, where
no significant life changes have occurred, after smoothing
QoL change
+1
0
-1
1 2 3 4 5 6 7 8
Months
Figure 2: The dynamic nature of OoL across eight-davs of an eight month 
duration
QoL Change
+1
0
1
6 83 4 5 721
Days
Life change key: -1 = Negative change, 0 = No change, +1 = Positive change
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Individuals may experience fluctuations in perceived QoL on a day-to-day basis 
that are not significant enough to be caused by a life change, but that cause QoL to 
appear unstable nonetheless. Researchers should at least be aware of the potential 
effects of significant life changes and day-to-day circumstances and events on 
perceived QoL, in order that they may be controlled for in future QoL assessment.
For this dynamic model to be accepted as underlying the QoL construct, QoL needs 
to be measured on a far more frequent basis than in the majority of research studies 
to date. Any QoL measure which is accepted as suitable in a given population also 
needs to demonstrate a pattern of general stability over time, being high over days 
where no significant events and circumstances influence perceptions, and less 
stable over months where significant life changes may occur. If this is the case, re­
test coefficients will decrease over time, as Campbell, Rogers and Converse (1976) 
demonstrated; three-day coefficients of 0.80 and above diminishing to between
0.43 and 0.56 eight months later.
To date there remains no such established criterion against which to compare QoL 
coefficients, which makes establishing the reliability and validity of measures even 
more difficult. This problem was discussed in Section 2.8 (pp. 106-107), where it 
was suggested that one might expect the criterion required for QoL measures to be 
considered reliable as slightly lower than requirements for more stable constructs, 
such as I.Q, reflecting the dynamic nature of the QoL construct.
On this basis, and given the present theory of 'tonic' and 'phasic' QoL components, 
the present investigation assessed the re-test reliability of QoL measures using the 
criteria previously adopted in Sections 2.8 and 2.9 (p.108). The first of these was
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whether the measures reach an acceptable standard level of re-test reliability, 
considered generally to be at or over 0.70 (Nunnally, 1978). The second lower 
criterion of 0.60-0.69 acknowledged the possibility that perceived QoL would 
remain relatively unstable across a shorter time span, reflecting the construct 
dynamism discussed above. It was also anticipated that the correlation between 
end QoL points and starting QoL points would be lower than QoL points with a 
shorter time duration intervening, once the influence of life changes and 
pleasant/unpleasant events and circumstances were accounted for. This suggestion 
builds upon the previous findings of Campbell, Converse and Rogers (1976) and 
Rogers and Converse (1976), and incorporates the notion of shifting points of 
reference across time.
The present study examined the psychometric properties of two QoL measures; the 
SEIQoL-DW (the direct weighting version of the SEIQoL) and the SF-36 (see 
Section 2.53 for full details of both measures). The re-test reliability of the 
Hospital Anxiety and Depression scale (HADS; Zigmond and Snaith, 1983), a 
measure of emotional functioning, was also tested as it has been recommended for 
additional use in QoL studies (Slevin, 1992). All three measures had been 
administered within the current population, in a preliminary QoL study conducted 
10 months previously (Murrell, 1996). Results from this study provided a baseline 
measure for the current study, enabling anticipated changes in patient QoL over an 
extended time period to be examined in greater depth. The data already collected 
also provided an opportunity to compare QoL perceptions across extended and 
shorter time periods; examining the notion of QoL as a dynamic construct.
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In summary, the aims of the present investigation were as follows:
1. To compare the current QoL scores of 30 individuals with those obtained from 
the same residents 10 months previously.
2. To examine the re-test reliability of the QoL measures employed.
3. To establish the applicability of employing a longitudinal approach to QoL 
measurement, and to demonstrate its use in providing a broader understanding 
of the emergent nature of individual QoL perceptions.
3.21 Hypothesis
In order to address these aims, the following hypothesis was tested:
1. Residents' perceptions of QoL will vary more when measured over an extended 
time period (10 months) than over a short time span (every 2 weeks for a 
10-week period).
By testing this hypothesis, the dynamic nature of QoL could be examined across an 
extended time period. The data collected to address this hypothesis would also be 
analysed to examine the 2-week re-test reliability of each measure across a 10- 
week period. The theoretical model behind the rationale presented here was 
outlined in Section 3.1 (beginning on p.122).
3.22 Method
3.22.1 Participants
Thirty residents from the Royal Hospital for Neuro-disability, Putney took part in 
QoL assessments in 1996. Twenty-seven of these individuals were invited to take 
part in the current studies; two of the original participants had died and one had 
been transferred to another hospital. Residents were initially selected according to
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the following criteria: having a diagnosis of MS; having communication ability 
sufficient to complete the assessment instruments (with assistance); and being 
between the ages of 20 and 65. Within this population, care had been taken to 
include a range of levels of severity of disability and duration of illness (see Table 
3.3, p.136). Levels of severity of disability (EDSS ratings) were independently 
rated prior to the study commencing.
The cognitive abilities of 2 of the 27 individuals approached had deteriorated 
significantly since the baseline tests of 1996 were conducted. They were 
considered to have insufficient ability to complete the current tests and so were not 
assessed. Twenty-five individuals agreed to take part, three of these voluntarily 
withdrew from the study during the course of the assessments. Their reasons for 
doing so included being too busy, finding the assessment situation stressful and 
being involved in other research projects. Full data sets were therefore collected 
for 22 of the original 30 participants. Participants ranged in age fi-om 32 to 66 years 
( y =52.8, S.D.=10.6). Eleven respondents were women (50%) and eleven were 
men (50%).
3.22.2 Measures
1) The SF-36 Health Survey
The SF-36 (see Appendix 3.1) consists of 36 items, which measure the domains 
listed in Table 3.1 (adapted fi-om Ware, Snow, Kosinski and Gandek, 1993). 
Numbers in brackets refer to the number of items used to measure each construct.
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Table 3.1: Summary information for each SF-36 domain (UK version)
SF-36
Domain
Definition of highest and lowest scores
Lowest possible (Floor) Highest Possible (Ceiling)
Bodily Pain 
(2 )
Very severe and extremely limiting 
pain
No pain or limitations due to 
pain
General 
Health (5)
Evaluates personal health as poor 
and believes it is likely to get worse
Evaluates personal health as 
excellent
Mental 
Health (5)
Feels nervous and depressed all the 
time
Feels peaceful, happy and 
calm all of the time
Physical
Functioning
(10)
Limited a lot in performing all 
physical activities including 
bathing or dressing due to health
Performs all types of physical 
activities including the most 
vigorous without limitations 
due to health
Role
Emotional
(3)
Problems with work or other daily 
activities as a result of emotional 
problems
No problems with work or 
other daily activities as a 
result of emotional problems
Role
Physical (4)
Problems with work or other daily 
activities as a result of physical 
health
No problems with work or 
other daily activities as a 
result of physical health
Social
Functioning
(2)
Extreme and frequent interference 
with normal social activities due to 
physical or emotional problems
Performs normal social 
activities without interference 
due to physical or emotional 
problems
Vitality (4) Feels tired and worn out all of the 
time
Feels full of life and energy 
all of the time
A health transition item is also included. The score from this item does not 
contribute to scaled scores, but provides an evaluation of current health compared 
to one year ago. Item scores are summed and transformed into a scaled score 
ranging from 0 to 100 for each domain, using procedures devised by Ware et al 
(1993). Further information on the structure and psychometric properties of the 
SF-36 has been summarised previously in Tables 2.1 and 2.2 (beginning on pp.93 
and 96).
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2) The Schedule for the Evaluation of Individual Quality of Life -  Direct 
Weighting Method (SEIQoL-DW) (O’Boyle a/., 1997)
Information on the overall properties of the SEIQoL-DW (see Appendix 3.2) has 
been presented previously in Tables 2.2 and 2.3 (pp.96-97 and 109-111). The 
three stages within the SEIQoL-DW are as follows. In Stage 1 the interviewer 
elicits the five areas of life that are most important to the individual (called ’cues'). 
In Stage 2 patients are asked to rate their current status (cue levels) using scale 
ranging from 0 ('worst possible') to 100 ('best possible') with five intervening 
descriptors. These are 'very bad', 'neither bad nor good', 'good' and 'very good'. 
Individuals are then asked to rate their current QoL using a horizontal visual 
analogue scale (VAS), that ranges from 0 ('the worst life imaginable') to 100 (the 
best life imaginable').
In the final stage of the SEIQoL-DW, individuals weight the relative importance of 
each nominated life area. Patients are asked to divide a circle into five segments, 
the size of each segment reflecting the relative importance of each cue to overall 
QoL (see Appendix 3.3). If the respondent nominates fewer than five life areas 
(they may, for example, only be able to think of three), the system allows for the 
corresponding number of segments to be produced. A full account of instructions 
for calculating a SEIQoL-DW index score is provided within the SEIQoL-DW 
manual (O'Boyle, Browne, Hickey, McGee and Joyce, 1996).
The direct weighting instrument has been adapted for use with individuals in the 
current study, to a form demonstrated to be suitable for MS patients (Parker and 
Pimm, 1995). The original apparatus consists of five interlocking laminated 
circular disks, which are rotated around a central point to form a type of pie chart.
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These disks are mounted on a larger backing disk that displays a scale from 0-100, 
enabling the relative size of each coloured segment to be calculated. Although 
colourful and tactile, this apparatus is too small and complex for individuals with 
MS, where symptoms may include blurred vision, tremor and uncoordinated, 
limited arm movements. Therefore a singular white disk was constructed of a 
much larger size, with five thick coloured strips of perspex rotating around the 
central point similar to hands of a clockface (see Appendix 3.3). With a 0-100 scale 
printed on the reverse side, the relative weight of each segment could still be 
determined, and the resulting instrument was much easier for individuals to 
understand and manipulate.
3) The Hospital Depression and Anxiety Scale (HADS) (Zigmond & Snaith, 
1983)
The HADS (see Appendix 3.4) is a brief assessment of anxiety and depression, 
consisting of 14 items divided into two sub-scales (Anxiety and Depression). The 
HADS specifically assesses emotional state over the last two weeks. Further 
information on the properties of the scale is presented in Table 3.2. Here, the 
responsiveness of each scale has been classified according to percentage of 
correctly identified psychiatric or medically ill patients with the presence of 
depression and/or anxiety, where * = below 60%, ** = 60-79% and *** = 80% or 
above.
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3.22.3 Design and analysis
The study was essentially a factorial design, using repeated measures analysis of 
variance and Pearson product moment correlation coefficients to investigate the data. 
The design of this study attempted to control for the effect of three variables: years 
since diagnosis, extent of physical disability, and extent of therapeutic intervention (in 
preparation for Part 2 of Study 1). Participants were selected on this basis to fill the 
cells in each group of Table 3.3. The figures below represent the 22 participants who 
completed all 5 assessments, rather than the 30 who were initially invited to take part 
in assessments.
Table 3.3: The a-priori design constructed for years since diagnosis, extent of 
disability and extent of therapeutic intervention variables
Years since diagnosis Disability score (EDSS) Extent of therapeutic 
Intervention (per week)
22 >22 8.0 8.5 9.0 3 hours >3 hours
N =ll N =ll N=10 N=8 N=4 N =ll N =ll
It was important to control for the years since diagnosis variable because MS is a 
progressive disease that generally involves gradual deterioration over a long period of 
time. Twenty-two years was the median time since diagnosis of the population as a 
whole, and so formed the cut-off point for the two groups. Concerning degree of 
disability, it should also be noted that the rating scale of the EDSS ranges from 0 
(normal) to 10 (death from MS). A score of 8 indicates the individual is perambulated 
in a wheelchair, although able to perform many self-care functions. A score of 9 
indicates "a helpless bed patient who can communicate and eat" (Kurtzke, 1983, 
p. 1452).
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As the scores documented in Table 3.3 demonstrate, the current client population has 
an extremely high level of disability. The relatively small number of participants with 
EDDS ratings of 9 is also acknowledged. This reflects the greater difficulties in 
communication and/or higher levels of cognitive impairment encountered within this 
group, which prevented several residents from participating. Whilst the current study 
could not address this issue, it is recognised as an area which requires fiirther 
attention.
The following independent variables were measured in Study 1: length of time 
between assessments (an extended time period of 10 months and fortnightly time 
span); severity of disability; duration of illness; emotional functioning (Part 1 
analyses) and extent of therapeutic intervention (Part 2 analyses). The dependent 
variable was QoL derived from the standardised scaled scores of the SF-36 and the 
SEIQoL-DW. Analyses were also conducted in relation to Anxiety and Depression 
(HADS) scaled scores, which were transformed to a 0-100 scale for this purpose.
In order to examine the re-test reliability of the SF-36, the SEIQoL-DW and the 
HADS, each measure was administered fortnightly to participants. Assessments were 
conducted over a period of 10 weeks, as the Time Plan in Table 3.4 demonstrates.
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Table 3.4: Time-plan for reliability assessments
Re-Test Week Measures Administered to
1 1 Group 1 (SF-36, SEIQoL-DW, HADS)
2 Group 2 (SF-36, SEIQoL-DW, HADS)
2 3 Group 1 (SF-36, SEIQoL-DW, HADS)
4 Group 2 (SF-36, SEIQoL-DW, HADS)
3 5 Group 1 (SF-36, SEIQoL-DW, HADS)
6 Group 2 (SF-36, SEIQoL-DW, HADS)
4 7 Group 1 (SF-36, SEIQoL-DW, HADS)
8 Group 2 (SF-36, SEIQoL-DW, HADS)
5 9 Group 1 (SF-36, SEIQoL-DW, HADS)
10 Group 2 (SF-36, SEIQoL-DW, HADS)
Key to Table 3.4 
Group 1= 15 residents Group 2=15 residents
3.22.4 Ethical considerations
The main ethical concern in Study 1 was the amount of assessment to be conducted 
with each individual. Whilst initial assessment of the psychometric properties of the 
measures employed was required, of greatest importance was the well being of the 
individuals involved. The administration time for the SF-36, the SEIQoL-DW and the 
HADS totals approximately 40 minutes (based on previous assessment with the 
current population). It was recognised that this quantity of assessment should not 
become stressful for the resident and must remain justifiable. The assessment period 
was considered to be justified by the information that would be gained, and every care 
was taken to break the tasks down into shorter periods of assessment that were 
tolerable for the participants.
Throughout the course of Study 1 it was ensured that these periods did not interfere 
with any other clinical or social activities of the individuals concerned, unless they 
specified this as their wish. It was anticipated that these assessments would provide
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an interesting, enjoyable social activity for participants. Bearing in mind the overall 
length of the study to be conducted, it was made clear throughout Study 1 that, should 
an individual wish to discontinue their involvement in the study, they were free to do 
so at any point in time. Studies 1 to 6 were granted ethical approval from the 
Riverside HA Ethics Committee (December 1996) and the Medical Research 
Advisory Committee of the Royal Hospital for Neuro-disability (February 1997).
3.22.5 Procedure
Residents were invited to participate in the present study. Each interested resident 
was briefed on the nature of the overall investigation, and more specifically as to the 
aims of the study, using both an information sheet (see Appendix 3.5) and personal 
explanation. Of the total invited, all agreed to participate. Informed consent was then 
obtained according to Hospital guidelines (see Appendix 3.6). Following this, a series 
of individual appointments were made with each of the residents' wards in order to 
conduct the required number of interviews.
The three measures employed, the SF-36, the SEIQoL-DW and the HADS, were each 
administered using an interview format so that account could be taken of the 
communication difficulties of the participants. In preparation for analyses relating to 
Part 2 of the present study, QoL 'generally' ratings and information concerning 
reported life changes and events was obtained from participants on each of the five 
assessments conducted. QoL 'today' ratings were obtained on the second and 
subsequent re-test assessments (see Section 3.32.1, pp.163-164 for further details of 
these ratings).
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Medical and demographic data had already been collected from Hospital records and 
through the Department of Clinical Psychology (March 1996), which also provided 
EDSS scores (a measure of neurological impairment) for each participant. All 
interviews were conducted within a quiet area. One hundred and five were conducted 
on the residents ward, one was conducted at the individual's home, and four were 
conducted within the Department of Clinical Psychology. Each resident completed 
scales in the following order, the SF-36, the HADS, and finally the SEIQoL-DW. Of 
the 22 individuals who took part in all 5 re-tests, four wished to complete all 3 
questionnaires within one sitting on each occasion. For the remainder, each re-test 
was split into two or three smaller assessment sessions, with one questionnaire per 
session, either to overcome problems of fatigue and poor concentration or because of 
busy patient schedules. In total, approximately 140 hours were spent interviewing 
residents.
3.23 Results
Individual scores obtained on each of the SF-36 re-tests were re-coded, using the
scoring algorithms documented within the SF-36 Health Survey Manual and
Interpretation Guide (Ware et al, 1993). Using the same manual, scaled scores were
obtained and transformed to a 0-100 scale. A global QoL score was derived from the
SEIQoL-DW data using procedures outlined by O'Boyle et al (1996). All other
measures were scored according to the methods described in Section 3.22.2 (pp. 130-
134). Means and standard deviations obtained for each variable are shown in Table
3.5. The corresponding key is as follows:
B -  Baseline Measure (1996) 4 -  Re-test 4 (1997)
1 -  Re-test 1 (1997) 5 -  Re-test 5 Q 997)
2 -Re-test 2 (1997)
3 -Re-test 3 (1997)
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Table 3.5: Means and standard deviations obtained for each variable (N=22)
Variable Mean S.D. Variable Mean S.D.
EDSS (1996 rating) &30 0.48 EDSS (1997 rating) 832 0.48
Therapy (hours per 
week)
3.59 1.63 Duration of illness 
(years)
22.41 10.61
P]ERSON-CENTRED QoL SCORES
SEIQoL-DW (B) 61.69 15^3 SEIQoL-DW (1) 74.16 17.59
SEIQoL-DW (2) 73.24 2225 SEIQoL-DW (3) 66.59 22.92
SEIQoL-DW (4) 78.45 22.40 SEIQoL-DW (5) 75.49 16.64
QoL ‘generally’ (B) 60.00 19.26 QoL ‘generally’ (1) 56.70 23.52
QoL ‘generally’ (2) 61.93 25.44 QoL ‘generally’ (3) 59.84 25.73
QoL ‘generally’ (4) 71.02 30.04 QoL ‘generally’ (5) 66.68 25.03
QoL ‘today’ (2) 61.86 25.79 QoL ‘today’ (3) 60.45 20.52
QoL ‘today’ (4) 74.30 2288 QoL ‘today’ (5) 69.16 25.45
SF-36 DOMAIN SCORES
Bodily Pain (B) 90.14 18.54 Bodily Pain (1) 89.50 21.10
Bodily Pain (2) 81.82 25.69 Bodily Pain (3) 8286 26.76
Bodily Pain (4) 82.27 24.63 Bodily Pain (5) 84.59 23.28
General Health (B) 70.27 21.73 General Health (1) 67.55 21.35
General Health (2) 6&32 19.86 General Health (3) 64.00 2632
General Health (4) 70.64 2266 General Health (5) 69.73 24.08
Mental Health (B) 76.55 16.98 Mental Health (1) 74.36 16.55
Mental Health (2) 74.18 19.89 Mental Health (3) 74.91 21.95
Mental Health (4) 80.18 18.54 Mental Health (5) 82.00 20.35
Physical Functioning (B) 10.91 22.55 Physical Functioning(l) 8.41 21.95
Physical Functioning (2) 6.59 18.41 Physical Functioning(3) 268 16.13
Physical Functioning (4) 4.77 14.76 Physical Functioning(5) 223 16.44
Role Emotional (B) 8L82 36.70 Role Emotional (1) 77.27 33.15
Role Emotional (2) 77.27 33.15 Role Emotional (3) 68.18 36.34
Role Emotional (4) 87.88 21.93 Role Emotional (5) 8636 28.47
Role Physical (B) 55.68 32.67 Role Physical (1) 60.23 31.49
Role Physical (2) 67.05 35.68 Role Physical (3) 64.77 36.73
Role Physical (4) 64.32 33.60 Role Physical (5) 77.27 28.77
Social Functioning (B) 82.25 22.10 Social Functioning (1) 75.00 27.28
Social Functioning (2) 76.14 23.44 Social Functioning (3) 76.14 30.11
Social Functioning (4) 81.82 26.65 Social Functioning (5) 88.07 20.59
Vitality (B) 62.05 22.40 Vitality (1) 63.64 23.96
Vitality (2) 61.59 21.40 Vitality (3) 59.77 25.93
Vitality (4) 67.27 2279 Vitality (5) 70.23 22.55
Anxiety (B) 25.11 19.00 Anxiety (1) 21.65 14.89
Anxiety (2) 22.29 15.79 Anxiety (3) 26.41 2 2 A2
Anxiety (4) 21.65 20.72 Anxiety (5) 18.18 17.30
Depression (B) 21.00 16.60 Depression (1) 2273 14.91
Depression (2) 25.32 23.94 Depression (3) 27.27 23.75
Depression (4) 21.21 23.77 Depression (5) 17.75 20.11
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From observation of the position of the mean in relation to minimum and 
maximum scores, the shape of the distribution of several variables appeared highly 
skewed. These observations were confirmed by calculating descriptive statistics 
for skewness, 32 of the 87 variables showing skews greater than 1 or less than -1, 
as Table 3.6 demonstrates.
Table 3.6: Selected variables observed as asymmetrical and their degree of 
skewness before (11 and after (2) transformation
Variable Skew 1 Skew 2 Variable Skew 1 Skew 2
PERSON-CENTRIDD QoL SCORES
QoL ‘generally’(4) -1.05 -0.13 (Ar)
SF-36 DOMAIN SCORES
Bodily Pain (B) -1.73 -1.36 (Ar)# Bodily Pain (1) -1.85 -1.55 (Ar)#
Bodily Pain (2) -1.26 -0.70 (Ar) Bodily Pain (3) -1.52 -0.92 (Ar)
Bodily Pain (5) -1.72 -0.84 (Ar)
Mental Health (B) -1.15 -0.70 (Ar) Mental Health (3) -1.13 -0.12 (Ar)
Mental Health (4) -1.75 -0.18 (Ar) Mental Health (5) -1.57 -0.38 (Ar)
Physical 
Functioning (B)
2.08 1.57 (Sq)# Physical 
Functioning (1)
2.93 2.22 (Sq)#
Physical 
Functioning (2)
3.14 2.44 (Sq)# Physical 
Functioning (3)
2.95 2.52 (Sq)#
Physical 
Functioning (4)
3.09 2.84 (Sq)# Physical 
Functioning (5)
3.23 2.90 (Sq)
Role Emotional (B) -1.76 -1.58 (Ar)# Role Emotional 
(2 )
-1.04 -0.78 (Ar)
Role Emotional (1) -1.36 -0.79 (Ar) Role Emotional
(4)
-1.66 -1.28 (Ar)#
Role Emotional (5) -Z08 -1.67 (Ar)#
Role Physical (5) -1.22 -0.47 (Ar)
Social Functioning 
(B)
-1.17 -0.41 (Ar) Social
Functioning (3)
-1.33 -0.52 (Ar)
Social Functioning
(4)
-1.71 -0.80 (Ar) Social
Functioning (5)
-2.19 -1.15 (Ar)#
HADS S(CORES
Anxiety (3) 1.02 -0.32 (Sq) Anxiety (4) 1.27 0.02 (Sq)
Depression (B) 1.01 -0.04 (Sq) Depression (2) 1.62 0.39 (Sq)
Depression (4) 1.19 0.18 (Sq) Depression (5) 1.07 0.27 (Sq)
(Ar) -  Transformed using ARCSIN function 
(Sq) -  Transformed using SQ RT function
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A number of transformations were conducted, including square root and arcsin 
which removed the skewness from 20 of the variables. None of the transformation 
procedures were sufficient to remove the skew from the remaining variables, 
marked # in Table 3.6. In this situation the robustness of ANOVA to departures 
from normality must be trusted to yield valid results (Winer, 1971).
It was hypothesised that the skewed distributions observed largely resulted from 
the severity of disease and disability within this particular population, which would 
serve to group scores at either the high or low end of each scale (as in, for example, 
the Physical Functioning sub-scale of the SF-36, where scores were generally at the 
bottom of the scale). As many individuals with MS lack insight into their condition 
this could also contribute to the present findings (as in, for example, low overall 
scores on the Depression and Anxiety scales). The generally high scores obtained 
on the social functioning variable are likely to reflect the busy day to day schedule 
of the majority of patients at the Royal Hospital for Neuro-disability.
Following inspection of the data, analyses were carried out in order to test the 
hypothesis stated in Section 3.2. The results of Parts 1 and 2 of the present study 
are summarised in Section 3.33.4 (beginning on p. 185).
3.24 Analysis of results: Part 1
3.24.1 Re-test reliability
The five fortnightly re-tests conducted in relation to Hypothesis 1 enabled the re­
test reliability of the SEIQOL-DW, the SF-36 and the HADS within the present 
population to be examined. Reliability analyses are presented before analyses
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relating to Hypothesis 1, which are discussed independently for the SEIQoL-DW 
and the SF-36, beginning on p. 150.
The SEIOoL-DW
Means and standard deviations for SEIQoL-DW scores on each test occasion are 
presented in Table 3.5. Before examining the re-test reliability of the SEIQoL- 
DW, scores for the 3rd re-test were examined in greater detail as the mean score 
obtained was somewhat lower than the other SEIQoL-DW re-test means. As the 
sample size was small, it was thought that this might be due to individual 
variability in scores. One outlying case was identified and removed from the data 
set. This case reported a negative life change occurring between re-tests 2 and 3, 
which may explain the inconsistent SEIQoL-DW scores obtained. Having 
removed this case from the data set, the mean SEIQoL-DW score for re-test 3 rose 
to 68 .86 . However, all 22 cases were retained for the current analyses in order to 
remain true to the dataset.
In order to assess the re-test reliability of the SEIQoL-DW, Pearson product 
moment coefficients were calculated. Results are summarised in Table 3.7. The re­
test assessments (column one) in bold type refer to those conducted with a two 
week interval between them.
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Table 3.7: Correlations among mean SEIOoL-DW scores across re-test
occasion (N=22)
Re-tests r value
1 and 2 0.51*
1 and 3 0.54**
1 and 4 0.55**
1 and 5 0.30
2 and 3 0.32
2 and 4 0.45*
2 and 5 0.49*
3 and 4 0.53**
3 and 5 0.54**
4 and 5 0.54**
* = p < 0 . 0 5 — /7<0.01
Although significant relationships were demonstrated between the majority of re­
test mean scores, the obtained r coefficients for comparisons across a 2-week 
interval did not reach the lower reliability criterion set in Section 3.1 (0.60-0.69). 
The averaged correlation coefficient, calculated using Fisher's z transformation, 
was r=0.51. Whilst this finding suggested there was a significant relationship 
between re-test means (p<0.05), it also indicated that the SEIQoL-DW was not 
sufficiently reliable to use in the current research situation. However, this 
relatively low coefficient may also reflect the focus of the SEIQOL-DW on aspects 
of QoL that may vary extensively on a day-to-day basis. This finding is discussed 
within Section 3.34 (beginning on p. 194).
It is interesting to observe that there was no significant relationship between re­
tests 2 and 3 , which seems surprising as the these tests were conducted with only a 
fortnight between them. However, once the outlying score from the 3rd re-test was 
again excluded fi-om the data set and this analysis was repeated, a significant
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relationship was demonstrated (r=0.48, /><0.05). Although no significant 
relationship was observed among the first and last re-tests, these assessment points 
were 2 months apart. This suggests that person-centred QoL ratings do change 
across time, a notion that is discussed further in relation to analyses conducted to 
examine Hypothesis 1.
The SF-36
Means and standard deviations for SF-36 domain scores on each test occasion are 
presented in Table 3.5. Before considering the re-test reliability of each SF-36 
domain, individual scores obtained on the General Health, Role Emotional and 
Role Physical scales were examined in greater detail, as means were not as 
consistent over time as was anticipated. Similarly to the SEIQoL-DW, the majority 
of individual scores remained fairly consistent over time, with the exception of one 
or two participants, whose scores were more wide ranging on these scales. For the 
General Health scale, this pattern was consistent with reported life changes taking 
place between assessments. Collectively, these findings give some indication of 
the effect of individual scores on the original mean scores obtained (which were 
retained for all subsequent analyses).
In order to assess the re-test reliability of each SF-36 domain, Pearson product 
moment correlation coefficients were calculated, the results of which are 
summarised in Table 3.8. The re-test assessments (column one) in bold type refer 
to those conducted with a two week interval between them. Averaged correlations 
calculated for each domain using Fisher’s z transformation are shown in Table 3.9.
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Table 3.8: Correlations among mean totals across test occasion for each
domain of the SF-36 (N=22)
SF-36: Bodily Pain SF-36: General Health SF-36: Mental Health
Re-tests r value r value r value
1 and 2 0.20 0.59** 0.57**
1 and 3 0.37 0.39 0.39
1 and 4 0.51* 0.63** 0.59**
1 and 5 0.32 0.65** 0.57**
2 and 3 0.85** 0.73** 0.59**
2 and 4 0.39 0.72** 0.75**
2 and 5 0.49* 0.73** 0.57**
3 and 4 0.51* 0.59** 0.61**
3 and 5 0.59** 0.60** 0.63**
4 and 5 0.63** 0.84** 0.70**
SF-36: Physical Functioning SF-36: Role Emotional
Re-tests r value r value
1 and 2 0.92** 0.33
1 and 3 0.98** 0.51*
1 and 4 0.97** 0.77**
1 and 5 0.95** 0.67**
2 and 3 0.96** 0.43*
2 and 4 0.95** 0.62**
2 and 5 0.97** 0.49*
3 and 4 0.98** 0.68**
3 and 5 0.97** 0.69**
4 and 5 0.99** 0.91**
SF-36: Role Physical SF-36: Social Functioning SF-36: Vitality
Re-tests r value r value r value
1 and 2 0.57** 0.64** 0.59**
1 and 3 0.42* 0.41 0.65**
1 and 4 0.45* 0.46* 0.78**
1 and 5 0.66** 0.19 0.60**
2 and 3 0.53** 0.63** 0.70**
2 and 4 0.74** 0.53** 0.79**
2 and 5 0.54** 0.41 0.73**
3 and 4 0.45** 0.40 0.69**
3 and 5 0.67** 0.47* 0.45*
4 and 5 0.53** 0.14 0.78**
* == p < 0 . 0 5 =p<0.01
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Table 3.9: Averaged correlations for re-test means for each SF-36 domain
SF-36 Domain Averaged 
r value
SF-36 Domain Averaged 
r value
Bodily Pain 0.61** General Health 0.70**
Mental Health 0.62** Physical Functioning 0.98**
Role Emotional 0.66** Role Physical 0.51*
Social Functioning 0.47* Vitality 0.70**
» == p < 0 . 0 5 % = /> < 0.01
The reliability of the Role Physical and Social Functioning scales for use with the 
current population remained uncertain, as the lower criterion set for established re­
test reliability has not been met in each case. By contrast, the re-test coefficients 
for the Bodily Pain, Mental Health and Role Emotional scales suggested that they 
are sufficiently reliable to use within the current population, although they did not 
reach the level required for psychometric reliability. The coefficients calculated for 
the General Health, Physical Functioning and Vitality domains indicate that these 
scales of the SF-36 are reliable and consistent measures, achieving a particularly 
high standard of re-test reliability. Given the severity of disability within the 
present population the stability of Physical Functioning scores across time was 
largely to be expected.
The Hospital Anxiety and Depression Scale (HADS)
Table 3.10 summarises the number of participants in each scoring band of the 
HADS following interpretation of untransformed anxiety and depression scores. 
The number of individuals in each scoring band remained fairly consistent across 
test occasion. Using a cut off point of 10 (suggested by Zigmond and Snaith, 
1983), the mean percentage of individuals with a high probability of suffering from 
(a) anxiety disorder was 10.60%, and (b) depression was 15.15%.
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Table 3.10: Number of participants in HADS scoring band across test occasion
Re-test ANXIETY
Normal (0-7) Mild (8-10) Moderate (11-14) Severe (15-21)
N N1 N2 N N1 N2 N N1 N2 N N1 N2
1 17 4 1 0
2 17 16 16 3 2 2 1 0 0 0 0 -
3 15 15 14 3 3 1 2 0 - 1 0 -
4 16 14 13 3 3 1 1 1 - 1 1 -
5 19 16 13 1 1 0 1 0 - 0 0 -
DEPRESSION
Normal (0-7) Mild (8-10) Moderate (11-14) Severe (15-21)
N N1 N2 N N1 N2 N N1 N2 N N1 N2
1 19 1 2 0
2 16 15 15 2 0 0 3 2 2 1 0 -
3 17 14 13 1 0 - 2 1 1 2 0 -
4 17 15 13 2 0 - 2 1 1 1 0 -
5 18 17 13 2 1 - 2 1 0 0 0 -
Key to Table 3.10:
N = Number of participants within scoring band
N1 = Number of participants in the same scoring band across two week re-test 
duration (i.e. across re-tests 2-1, 3-2, 4-3 and 5-4)
N2 = Number of participants in the same scoring band since Re-test 1
Mean Anxiety and Depression scores across test occasion are presented in Table
3.5. Generally, means appeared relatively consistent across the 10-week retest 
duration, although Anxiety scores on Re-test 3 were slightly higher than the other 
test results. Closer examination of individual scores confirmed two participants 
with outlying scores had influenced the original mean total obtained. Both scores 
were retained for subsequent analyses in order to remain true to the data.
In order to test the re-test reliability of the HADS, Pearson product moment 
correlation coefficients were calculated, results of which are presented below in 
Table 3.11. The re-test assessments (column one) in bold type refer to those
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conducted with a two-week interval between them. Averaged coeffients calculated 
for each domain using Fisher's z transformation are shown in Table 3.12.
Table 3.11: Correlations among mean scores across test occasion for each 
HADS domain (N=22)
HADS: Anxiety SF-36: Depression
Re-tests r value r value
1 and 2 0.80** 0.58**
1 and 3 0.53** 0.39
1 and 4 0.60** 0.55**
1 and 5 0.41 0.65**
2 and 3 0.74** 0.45*
2 and 4 0.76** 0.77**
2 and 5 0.73** 0.83**
3 and 4 0.75** 0.55**
3 and 5 0.73** 0.56**
4 and 5 0.79** 0.91**
=p<0.05 = /7<0.01
Table 3.12: Averaged correlations for comparisons among re-test means for 
each HADS domain
HADS Domain Averaged r value
Anxiety 0.77**
Depression 0.66**
* = /><0.05 ** =/><0.01
Generally, there seemed to be a strong relationship between Anxiety and 
Depression scores obtained across all assessments. Re-test reliability across a 2- 
week duration was high for both scales, although only the Anxiety domain reached 
an acceptable level of psychometric reliability by traditional re-test standards. The
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Depression scale reached the lower criterion set for suitability for research within 
the present population.
3.24.2 Hypothesis 1
Hypothesis 1 states that residents' perceptions of QoL will vary more when 
measured over an extended time period (10 months) than over a short time span (10 
weeks). The rationale for this hypothesis was stated in Section 3.1, where the 
notion of QoL dynamism was discussed. In essence, it was considered that a time 
span of 10 months between QoL assessments introduces the likelihood that a 
greater number of individual life changes will occur within the population studied, 
the effects of which are demonstrated via the weaker relationship between tl and t2 
QoL mean scores. By comparison, when tl and t2 assessments are conducted with 
a duration of weeks rather than months between them, fewer individual life 
changes will occur within the population studied. Although circumstances and 
events specific to the individual may influence perceived QoL within a shorter 
time-span, their effects on QoL are likely to remain short-lived. Therefore the 
relationship between tl and t2 QoL scores would generally be stronger across a 
duration of weeks than a duration of months.
The SEIOoL-DW
In order for Hypothesis 1 to be supported there should be a greater relationship 
between SEIQoL-DW scores that are obtained within re-tests 1-5 (Comparison B), 
in comparison to the relationship between baseline and re-test scores (Comparison 
A). Pearson product moment correlation coefficients among baseline and re-test 
means are presented in Table 3.13.
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Table 3.13: Correlations among mean SEIOoL-DW totals across baseline and
re-test occasions (N=22)
SEIQoL-DW
Baseline mean correlates with:
Re-test 1 mean 0.23
Re-test 2 mean -0.08
Re-test 3 mean 0.35
Re-test 4 mean &38
Re-test 5 mean 0.10
Averaged r value: 0.30
Averaged r value (Comparison E(): 0.51*
* ==/><0.05 = /? < 0.01
No significant relationships were demonstrated among the baseline mean and 
mean re-test scores. Comparison of averaged r values suggested there was a 
significant relationship among SEIQOL-DW re-test means (Comparison B) but not 
between the 1996 baseline and 1997 re-test SEIQoL-DW means (Comparison A). 
With the critical value of the standard error of the difference between Fisher's z's at
0.34, the difference between the two averaged r's was significant. It is 
acknowledged that correlations obtained in the current study are not entirely 
independent and that this formula is usually used with uncorrelated r's derived from 
different and un-matched samples. However, this was the most appropriate of tests 
of difference between population r's to employ.
These analyses suggested there was significantly greater variation between the 
baseline measure and re-test scores than between the re-test scores alone. To 
examine the effect within participants’ ratings across test occasion a repeated 
measures ANOVA was conducted (see Appendix 3.7). F  values suggested a 
significant effect when the baseline and re-test means were compared
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(F(5, 105)=3.57, j9<0.01). When only re-test means were compared no significant 
effect was obtained (F(4, 84)= 1.89, N.S.). This indicated that a longer time span 
(10 months) resulted in significantly greater variation in individuals' perceived QoL 
than that recorded across a shorter time span of 10 weeks.
Post-hoc comparisons using the Tukey multiple-comparison test established more 
precisely that significant differences were only found between the baseline test of 
1996 and re-test 4, and the baseline test and re-test 5 (/?<0.05), the assessments with 
the longest duration of time between them. On the basis of these analyses. 
Hypothesis 1 was therefore accepted; participants' perceptions of QoL as measured 
by the SEIQoL-DW varied more over an extended time period than over a shorter 
time span.
The SF-36 Health Survey
In order for Hypothesis 1 to be supported there should be a greater relationship 
between SF-36 domain scores that are obtained within re-tests 1-5 (Comparison B), 
in comparison to the relationship between baseline and re-test scores (Comparison 
A). Pearson product moment correlation coefficients among baseline and re-test 
means are presented in Table 3.14.
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Table 3.14: Correlations among mean SF-36 domain scores across baseline
and re-test occasions (N=22)
SF-36: BODILY PAIN SF-36: GENERAL HEALTH
Baseline mean correlates with: Baseline mean correlates with
Re-test 1 mean 0.61** Re-test 1 mean 0.41
Re-test 2 mean 0.65** Re-test 2 mean 0.61**
Re-test 3 mean 0.62** Re-test 3 mean 0.79**
Re-test 4 mean 0.25 Re-test 4 mean 0.44*
Re-test 5 mean 0.19 Re-test 5 mean 0.46*
Averaged r value: 0.49* Averaged r value: 0.59**
Averaged r value (Comparison E,): 0.61** Averaged r value (Comparison B,): 0.70**
SF-36: MENTAL HEALTH SF-36: PHYSICAL FUNCTIONING
Baseline mean correlates with Baseline mean correlates with
Re-test 1 mean 0.52* Re-test 1 mean 0.83**
Re-test 2 mean 0.56* Re-test 2 mean 0.89**
Re-test 3 mean 0.37 Re-test 3 mean 0.87**
Re-test 4 mean 0.43* Re-test 4 mean 0.81**
Re-test 5 mean 0.36 Re-test 5 mean 0.81**
Averaged r value: 0.45* Averaged r value: 0.85**
Averaged r value (Comparison E;): 0.62** Averaged r value (Comparison E1): 0.98**
SF-36: ROLE EMOTIONAL SF-36: ROLE PHYSICAL
Baseline mean correlates with Baseline mean correlates with
Re-test 1 mean 0.55** Re-test 1 mean 0.29
Re-test 2 mean -0.05 Re-test 2 mean 0.29
Re-test 3 mean 0.22 Re-test 3 mean 0.39
Re-test 4 mean 0.23 Re-test 4 mean 0.00
Re-test 5 mean 0.31 Re-test 5 mean 0.08
Averaged r value: 0.27 Averaged r value: 0.21
Averaged r value (Comparison E(): 0.66** Averaged r value (Comparison E0:0.51*
SF-36: SOCIAL FUNCTIONING SF-36: VITALITY
Baseline mean correlates with Baseline mean correlates with
Re-test 1 mean 0.73** Re-test 1 mean 0.60**
Re-test 2 mean 0.50* Re-test 2 mean 0.53*
Re-test 3 mean 0.20 Re-test 3 mean 0.51*
Re-test 4 mean 0.43* Re-test 4 mean 0.62*
Re-test 5 mean 0.04 Re-test 5 mean 0.31
Averaged r value: 0.42* Averaged r value: 0.57*
Averaged r value (Comparison E1): 0.47* Averaged r value (Comparison E0: 0.70**
* = p < 0 . 0 5 * *  —= /> < 0.01
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Coefficients obtained for the Bodily Pain, General Health, Mental Health, Physical 
Functioning, Social Functioning and Vitality variables suggested there were 
significant relationships within both comparison groups (i.e. significant 
relationships between re-test means, and between the baseline measure and re-test 
means for each domain), although significance levels were generally higher for 
Comparison B. When the standard error of the difference between Fishers z's for 
each domain was calculated, there were significant differences between all but the 
Social Functioning mean average. Therefore Hypothesis 1 was rejected for these 
domains, as there was no greater relationship between scores obtained within 
re-tests 1-5, in comparison to the relationship between baseline and re-test scores.
Further analysis using one-way repeated measures ANOVAs were conducted on 
the remaining SF-36 scales (See Appendix 3.8), as correlations obtained suggested 
there were weaker relationships between the baseline measure and re-test means 
then re-test means alone, as predicted by the first hypothesis. Results obtained are 
summarised in Table 3.15.
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Table 3.15: Comparisons among baseline and re-test means for selected
domains of the SF-36 (N=22)
SF-36 Domain F  value d f Sig. level
Bodily Pain (H) a) 0.86 (5,17) N.S.
b) 0.59 (418) N.S.
General Health a) 0.65 (5,105) N.S.
b) 0.75 (4, 84) N.S.
Mental Health a) 2.04 (5,105) N.S.
b) 1.92 (4, 84) N.S.
Physical Functioning (H) a) 1.25 (5,17) N.S.
b) 1.13 0418) N.S.
Role Emotional (H) a) 4.44 (5,17) J9<0.01
b) 5.03 (418) f<0.01
Role Physical a) L89 (5,105) N.S.
b) 2.06 (4, 84) N.S.
Vitality a) 1.64 (5,105) N.S.
b) 2.17 (4, 84) N.S.
Key to Table 3.15
(H) = Hotellings multivariate test was used, as sphericity test results were 
significant (so correlations between, for example, the role emotional 
variables were not all roughly the same).
a) = Results for Comparison A (among baseline measure and re-test means)
b) = Results for Comparison B (among re-test means)
As Table 3.15 demonstrates, there were no significant effects within participants' 
SF-36 scores across test occasion, with the exception of the Role Emotional 
domain. Here, significant effects were demonstrated within both comparison 
groups. Again, this was not in the predicted direction and suggested there was 
slightly more within-participant variation over a shorter time span than over a 
longer time span. Collectively, results demonstrated that Hypothesis 1, which 
stated that there would he greater variation in patient QoL over an extended time 
period than over a short time span, does not hold true for the domains of the SF-36.
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A summary of results obtained in Part 1 of the present study may be found in Table 
3.34 of Section 3.33.4 (pp.187-188).
3.25 Discussion
Hypothesis 1 tested the re-test reliability of the SEIQoL-DW, the SF-36 and the 
HADS in order that the feasibility of using these tools within a severely disabled 
population of MS patients could be established. Bearing in mind the uncertainty 
surrounding the psychometric requirements of QoL measures in general and the 
implications of assessing the QoL of persons with MS (see Sections 2.6 and 2.7) it 
was considered essential to establish the working value of these assessment tools 
before further assessment commenced.
three.
The Depression scale of the HADS and of the eight SF-36 scales reached the 
lower criterion set for adequate re-test reliability (0.60 to 0.69). Only the Anxiety 
scale of the HADS and the General Health, Physical Functioning and Vitality 
domains of the SF-36 reached the required 0.70 or above criterion accepted as the 
traditional standard for reliability to be met. It was expected that the Physical 
Functioning scores would be more stable across time than other domains of the 
SF-36, as the construct being measured is less flexible in severely disabled 
individuals than domains like Emotional Functioning. Furthermore, individuals 
within the present study were generally in the latter stages of progressive MS, 
which is characterised by a gradual deterioration across a number of years. On this 
basis, one might not expect General Health and Vitality scores to fluctuate 
significantly across a ten month duration. As the theoretical model in the
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Introduction (pp. 123-127) stated, less dynamic constructs should produce higher 
reliability coefficients across re-test occasions.
Although a lower coefficient was therefore expected to reflect the reliability of the 
SEIQoL-DW, the person-centred QoL measure, it was not anticipated that it would 
fail to reach the lower criterion set of 0.60 to 0.69. With hindsight, perhaps two 
week intervals between tests was too long a duration for a measure designed to 
reflect individual perceptions rather than stable health constructs. For example, in 
one of the few published studies to test the reliability of person-centred QoL 
measures, Campbell, Converse and Rogers (1976) used 3-day test intervals (which 
produced coefficients of 0.80 and above). Within this shorter time period one might 
expect fewer significant changes to be reported, and fewer fluctuations in perceived 
QoL as a result of circumstances and events that are specific to the individual.
An alternative suggestion for assessing the re-test reliability of person-centred QoL 
measures draws upon the theoretical model of QoL dynamism presented in Figures
3.1 and 3.2 (p.126). Ideally, one would assess QoL four times daily, once every 
two months across, for example, a six-month duration. One would then smooth the 
data collected across each daily assessment to obtain three averaged QoL scores (as 
daily assessments were conducted, in this hypothetical case, with a two-month 
duration between them). This technique would reduce the problems associated 
with within-subject variability after the data had been smoothed, and might also 
enhance our understanding of the factors that influence day-to-day fluctuations in 
perceived QoL.
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Although this shorter time span between person-centred QoL assessments might 
make it more feasible to demonstrate a good level of measurement reliability, 
practice effects would almost certainly influence outcomes in some cases. Within 
the present population, this might partially depend on level of cognitive 
functioning. Clearly some balance is required and intervals must be fine tuned in 
order to capture the dynamic nature of QoL, without participants becoming over 
familiar with the test tools employed or bored and frustrated with test content and 
participation.
This problem highlights both the underdeveloped state of knowledge concerning 
psychometric testing of QoL measures and the importance of further research with 
already existing measures, rather than continued development of new alternatives. 
Present findings also support the argument put forward by Aaronson (1988) and 
Jenkinson (1995), that the focus of person-centred measures on internal beliefs 
render the estimation of reliability via the re-test method of little value. As 
Kirshner and Guyatt (1985) suggest, it is possible that small changes within 
individuals may result in poor between-person reliability, making the magnitude of 
within person variance of more importance.
Although the re-test reliability of the SEIQoL-DW within the present population 
remains undemonstrated, correlations between re-tests were generally significant, 
and the one incident where this did not occur was explained by a single individual 
outlying score. The fact that averaged SEIQoL-DW scores were not significantly 
related over a period of 10 months or 2 months (the first and last re-test conducted), 
but were significantly related over 2 weeks follows the pattern proposed by 
Campbell, Converse and Rogers (1976), of a decrease in stability over time. As
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Atkinson (1981) suggests, stability coefficients for such measures decline more 
quickly than general indicators as the time period increases. He continues that, 
"rather than reducing the attractiveness of specific measures, this feature and 
marked differences between Change and No Change groups, recommends them as 
reliable and sensitive measures" (p.121). The differences between Change and No 
Change groups' QoL scores is addressed in Part 2 of the present study, beginning 
on p. 160.
In relation to the theoretical QoL model presented in Section 3.1, it was considered 
that perceived QoL across a longer time span should increase or decrease slightly, 
even when the process of smoothing has heen conducted. This reflects the notion 
that points of reference change across time. Collectively, results of Hypothesis 1 
suggested that the scales of the SF-36 did not reflect this dynamic nature of the 
QoL construct, perhaps not surprisingly considering the health-based structure of 
each scale.
Several authors have previously reported 'ceiling' and 'floor' effects in using the SF- 
36 (e.g. Anderson, Aaronson and Wilkin, 1993; Kurtin et ah, 1992). As Table 3.6 
(p. 141) demonstrates, the problem of floor effects was also identified in the present 
study and again indicates the potential problems of using the measure with this 
patient population. A final problem identified with the SF-36 concerns its basis on 
self-reports of events "during the past 4 weeks". In light of some of the cognitive 
deficits of the present population this poses particular problems, as many 
individuals are unable to remember the information required. The accuracy of 
responses obtained therefore remains questionable in some cases.
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3.3 Study 1; Part 2
Alongside the need to obtain a reliable means of QoL assessment within the present 
population, it is also necessary to find QoL measures that are responsive to change, 
so that potential improvement and deterioration in individual QoL can be 
monitored. Atkinson (1981) is among the few researchers who have considered 
this notion, through examination of the aspects of QoL which remain relatively 
stable in relation to reported life change. In his study, the correlation of measures 
in the group reporting no life change provided a fair indication of the stability of 
measures in absolute terms, and their responsiveness to changing conditions could 
also be examined. He suggested that stability in unchanging situations and 
responsiveness to changing circumstances must be demonstrated if measures are to 
be useful indicators of QoL. This again indicates that QoL is a dynamic construct, 
"not as labile as mood or as stable as personality" (McCauley and Bremer, 1991, 
p.381).
The present study also assessed the responsiveness of each test instrument by 
comparing results to individuals’ reported life changes across assessments. 
Although the difference in responsiveness between person-centred and health- 
based approaches has not been directly studied, it was thought that person-centred 
QoL measures would reflect changing life circumstances to a greater extent than 
health-based measures. Health-based domains should remain fairly stable 
regardless of life changes, which may have a greater impact on internal based 
domains.
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For the present study, demonstration of the concurrent validity of QoL measures 
was not conducted using previously developed QoL assessment tools, as the pitfalls 
of such an exercise have already been demonstrated in Section 2.62. The advice of 
McDowell^nd-NewelL(T996) was-instead-adhered to, in considering the types of 
variable with which QoL should be logically related in persons with MS. Among 
the research outlined in Section 2.10 (beginning on p. 115), it was suggested that 
contact with healthy people (Maybury and Brewin, 1984) and engagement in 
health-promoting behaviours (Stuifbergen, 1995) facilitated a higher QoL. In 
response to a questionnaire concerning alternative experiences of therapy, Fawcett 
et al (1994) also found that 44% of individuals surveyed, all of whom had MS, 
thought participation had increased their QoL. Occupational, physical and aquatic 
therapies were among those activities listed. However, the averaged years since 
diagnosis for this population was only 8.19 years. It remains uncertain whether 
extent of physical disability influences the benefits gained from therapy, and 
further testing was therefore required with a more severely disabled sample of MS 
patients before these findings could be generalised to a wider population.
On the basis of the limited existing literature, participation in health-promoting 
behaviours was considered the most accessible means of assessing the concurrent 
validity of the SF-36 and the SEIQoL-DW within the current population. Many of 
the activities listed by Fawcett et al (1994) were among those in which individuals 
in the present study participated (further details of which are found within Section 
3.32.2, pp.164-165). Due to the physical orientation of the SF-36, it was thought 
that scores obtained would correlate to a greater extent with therapeutic 
intervention undertaken than the person-centred SEIQoL-DW, which focuses upon 
a wider range of personal, QoL-related issues.
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In summary, the aims of the present investigation were as follows:
1. To examine the effects of perceived life changes in relation to health-based and 
person-centred QoL scores.
2. To examine the obtained measurements of QoL in relation to extent of 
therapeutic intervention.
3. Through points 1 and 2, to examine the responsiveness to change and 
concurrent validity of the QoL measures employed.
3.31 Hypotheses
In order to address these aims, the following hypotheses were tested:
1. Where changes occur that may enhance or decrease QoL (i.e. changes in course 
of therapy, major outings or a family illness) scores obtained will reflect this. 
Where no significant life changes take place the correlation between sets of 
scores will be higher than when changes have occurred.
By testing this hypothesis, the responsiveness of each test instrument to perceived 
life change could be examined.
2. Extent of therapeutic intervention may improve QoL as measured by the health- 
based SF-36 and person-centred quality of life scores (the SEIQoL-DW).
By testing this hypothesis, the concurrent validity of each test instrument could be 
examined, as scores should correlate with factors known to be related to QoL. The 
theoretical model behind each rationale presented here has been outlined in Section 
3.3 (beginning on p. 160).
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3.32 Method
Details of participants, measures, study design, analysis and ethical considerations 
have already been presented in Section 3.22 (beginning on p. 129). Additional 
information relating to Part 2 of Study 1 is presented below.
3.32.1 Measures
For information on the overall properties of the SF-36 Health Survey, the SEIQoL- 
DW and the HADS, the reader is directed to Section 3.22.2 (beginning on p. 130). 
The following ratings were also obtained on each test occasion (unless otherwise 
stated):
II OoL ’generally’
The second stage of the SEIQoL-DW incorporates a horizontal visual analogue 
scale (VAS) previously outlined in Section 3.22.2 (p. 132). Individuals are asked to 
rate their current QoL using the range of 'the worst life imaginable' (0) to 'the best 
life imaginable' (100).
In the present study, individuals were asked to rate their QoL 'generally' using the 
same range of worst life imaginable (0) to best life imaginable (100) (see Appendix
3.2). Individuals are asked to indicate where along this line they would put a mark 
to represent their QoL 'generally'. Where patients were able to hold a pen and 
write, they drew this line for themselves; otherwise the researcher would draw the 
line with full guidance from the individual concerned.
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21 QoL 'today'
From the second re-test onwards (i.e. the second test of the later series), individuals 
were also asked to rate their QoL on the day of each assessment conducted, using 
the same visual analogue scale rating as for QoL 'generally' ratings (see Appendix
3.2). QoL 'generally' and 'today' ratings were calculated by measuring across the 
10cm Likert scales on which responses were made. A score ranging from 0 (worst 
QoL imaginable) to 100 (best QoL imaginable) was obtained for each participant 
by multiplying the point of the response (cm) by 10.
31 Life change measure
From the second re-test onwards, participants were asked if any significant positive 
or negative changes had taken place which might have affected the way they saw 
their QoL since the last assessment. Participants were also asked if any 
circumstances or events had occurred on the day of, or across the days preceding 
assessment, that may affect their present QoL perceptions. This addressed the 
notion of day-to-day fluctuations in perceived QoL, introduced in Section 3.1 
(pp.123-127). One of three options, positive, negative or no change was recorded 
on each test occasion.
3.32.2 Procedure
Whilst assessments were being conducted, physiotherapists, occupational 
therapists, the speech and language and music therapy departments within the 
Royal Hospital provided information concerning extent of therapeutic intervention, 
collected via questionnaire (see Appendix 3.9). All departments responded, and 
the following activities were listed as constituting 'therapeutic intervention':
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Physiotherapy, Hydrotherapy, Gym, Art Therapy, Computing, Relaxation, Group 
Occupational Therapy (O.T.) sessions (i.e. Gardening, Journal Group, News and 
Views and Cookery), Speech and Language Therapy and Music Therapy (both 
group and individual sessions).
3.33 Analysis of results: Part 2
Means and standard deviations for each variable may be found in Table 3.5 
(p. 140).
3.33.1 Hypothesis 1
Hypothesis 1 stated that when measured every two weeks there would be the least 
difference between sets of scores where no significant changes take place. Where 
individuals reported positive or negative life changes to occur between tests, QoL 
scores obtained should reflect this. By testing this hypothesis, the responsiveness of 
each test instrument to perceived life change could be examined.
To test this assumption, mean totals of each re-test were firstly summarised by 
three levels of recorded change (i.e. positive, negative or no change) for each 
measure. The differences between re-test scores (i.e. 1 and 2, 2 and 3, 3 and 4, 4 
and 5) for each individual in each change/no change group were firstly calculated. 
These scores were then summed to give three difference scores, which were 
ordered in terms of corresponding level of change. The total mean difference was 
then calculated for each of the three levels of the life change variable. The use of 
difference scores was considered justified on the basis that scores generally
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appeared to have a linear distribution. Results obtained for each measure are now 
considered in turn.
The SEIOoL-DW
The total mean differences obtained for each level of the change variable are shown 
in Table 3.16.
Table 3.16: The total mean difference among SEIOoL-DW re-test scores for 
participants reporting positive, negative and no significant life changes 
between assessments
Type of change reported Mean difference between tests S.D.
Positive change (N=9) +10.43 12.93
Negative change (N=8) -17.87 26.76
No change (N=22) +1.99 10.36
Means were in the predicted direction, demonstrating that the greatest increase in 
SEIQoL-DW scores from one assessment to the next occurred when people 
experienced positive life changes between test occasions. Conversely, the greatest 
decreases occurred for those who had experienced negative life changes between 
test occasions. Means also indicated that, in comparison to the life change groups, 
there was very little overall difference between test totals for those who do not 
experience life changes between SEIQoL-DW tests.
In order to test whether the differences observed were significant a one-way 
unrelated ANOVA was conducted (see Appendix 3.10). Results confirmed the 
significant difference observed between levels of the change variable
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(F(2, 36)=7.57,j9<0.01), and so Hypothesis 1 was accepted. Post-hoc comparisons 
were made using Tukey's multiple comparison test, which demonstrated that the 
means for the negative and no change, and the negative and positive change groups 
were significantly different. This suggested that the SEIQoL-DW is not only 
responsive to change, but responsive to the direction of change (i.e. positive or 
negative). The SEIQoL-DW was therefore concluded to be responsive to reported 
life change within the present population.
The SF-36
Table 3.17 overleaf shows the mean difference between sets of scores for each 
condition of the life change variable on each SF-36 domain.
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Table 3.17; The total mean difference among scores on each SF-36 domain for 
participants reporting positive, negative, and no life changes between 
assessments
SF-36 Type of life change Mean difference S.D.
Domain reported between tests
Bodily Pain Positive change (N=9) +14.67 33.26
Negative change (N=8) +10.63 10.63
No change (N=22) -7.96 16.32
General Positive change (N=9) +11.39 27.46
Health Negative change (N=8) -12.43 23.35
No change (N=22) -0.67 15.89
Mental Positive change (N=9) +9.33 23.69
Health Negative change (N=8) -10.25 25.73
No change (N=22) +1.56 6.48
Physical Positive change (N=9) -1.67 3.54
Functioning Negative change (N=8) -5.63 12.37
No change (N=22) -0.45 1.31
Role Positive change (N=9) +14.81 37.67
Emotional Negative change (N=8) -2.08 55.23
No change (N=22) +1.89 15.22
Role Physical Positive change (N=9) +13.89 39.74
Negative change (N=8) -10.93 52.37
No change (N=22) +5.49 14.29
Social Positive change (N=9) +11.11 32.14
Functioning Negative change (N=8) +4.68 43.27
No change (N=22) +3.50 7.98
Vitality Positive change (N=9) +13.61 29.64
Negative change (N=8) -13.75 22.36
No change (N=22) +1.84 6.07
Means obtained for the Bodily Pain and Social Functioning variables suggested 
that scores increased where positive or negative life changes were reported. 
Conversely, Physical Functioning means decreased when positive or negative life 
changes were reported to occur. The scales did not appear responsive to changes 
when they occurred, and did not distinguish between positive and negative changes 
as expected. No further analyses were conducted with these domains and it was 
concluded that the Bodily Pain, Physical Functioning and Social Functioning
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domains of the SF-36 could not distinguish between positive and negative changes. 
In all of the scales tested, the mean difference for those who reported no life change 
occurring between tests remained stable, adding further credibility to the re-test 
reliability of each scale.
For the remaining SF-36 variables, means obtained were in the predicted direction. 
The greatest increase in scores occurred when positive changes were reported to 
have occurred between assessments, and the greatest decrease in scores was seen 
when negative changes were reported to have occurred between assessments. 
Finally, where no changes took place, there was very little overall difference 
between test mean totals. In order to test whether there was a significant effect of 
life change on QoL (SF-36 domain scores), one-way unrelated ANOVAs were 
conducted (see Appendix 3.11). Results obtained are presented in Table 3.18.
Table 3.18: Comparisons among mean differences for each life change group, 
for selected domains of the SF-36 (N=22)
SF-36 Domain F  value d f Sig. level
General Health 3.71 (2, 36) p<0.05
Mental Health 2.96 (2, 36) N.S.
Role Emotional 0.69 (2, 36) N.S.
Role Physical 2.19 (2, 36) N.S.
Vitality 5.07 (2, 36) p<0.05
Although mean differences had been in the predicted direction, F  values obtained 
for the Mental Health, Role Emotional and Role Physical scales did not support 
Hypothesis 1. None of the scales was able to distinguish sufficiently between 
different types of reported life change, and the responsiveness of each thus remains 
undemonstrated.
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There was a significant difference between the three General Health and Vitality 
means. Post-hoc comparisons using Tukey's multiple comparison test indicated that 
the significant difference lay between the positive and negative change groups in 
both cases (p<0.05). No significant differences were found involving the no change 
group, due to the extent of variance within this condition. Collectively these 
findings supported Hypothesis 1, as General Health and Vitality scores reflected 
positive and negative changes that took place between assessments. Where no 
changes took place between test occasions, scores remained consistent. The 
Vitality and General Health scales were therefore concluded as the only SF-36 
domains to be responsive to reported life change within the present population.
The Hospital Anxiety and Depression Scale (HADS)
Within the scoring system of the HADS, a higher score on each domain indicates a 
higher degree of generalised anxiety or depression (Zigmond and Snaith, 1983). If 
HADS scores obtained reflected reported life change, supporting Hypothesis 1, 
scores should decrease the most where positive changes are reported (reflecting 
lower levels of anxiety/depression), and increase the most where negative changes 
are reported (reflecting higher levels of anxiety/depression). For both scales, means 
differences obtained were in the predicted direction and suggested stability among 
test results where no changes were reported to occur, as demonstrated in Table 
3.19.
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Table 3.19: The total mean difference among scores on each HADS domain for 
participants reporting positive, negative, and no significant life changes 
between assessments
HADS
Domain
Type of life change 
reported
Mean difference 
between tests
S.D.
Anxiety Positive change (N=9) -5.38 12.40
Negative change (N=8) 5.15 8.72
No change (N=22) -1.65 3.38
Depression Positive change (N=9) -7.32 13.93
Negative change (N=8) 6.37 11.28
No change (N=22) -1.42 3.59
Despite these indications, results of one way analyses confirmed there were no 
significant differences among the mean differences obtained by the life change 
groups on either the Anxiety scale (F(2, 36)=0.82, N.S.) or the Depression scale 
(F(2, 36)=1.81, N.S.) (see Appendix 3.12). On this basis. Hypothesis 1 was not 
supported, and it was concluded that the HADS scales were not fully responsive to 
reported life changes within the present population.
3.33.2 Hypothesis 2
Hypothesis 2 stated that extent of therapeutic intervention (i.e Physiotherapy, 
Speech and Language Therapy, Art Therapy and Music Therapy) may improve 
QoL as measured by the SF-36 and the SEIQoL-DW. The theoretical basis of this 
prediction is discussed within Section 3.1. Results obtained for each test instrument 
will now be considered in turn.
The SEIOoL-DW
If extent of therapeutic intervention improved QoL as measured by the SEIQoL- 
DW, there should be a relationship between scores whereby the greater the number
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of hours spent in therapy per week, the higher the SEIQoL-DW score. In order to 
test this hypothesis, QoL means were firstly summarised by each level of the 
therapy variable (equal to/less than 3 hours and greater than 3 hours). No uniform 
pattern emerged from this process, as Table 3.20 demonstrates.
Table 3.20; Overall mean SEIOoL-DW scores for each Therapy group across 
re-test occasions
Mean score across test 
occasion for Therapy group 1 
(N=ll)
S.D. Mean score across test 
occasion for Therapy group
2(N=11)
S.D.
73.20 15.44 73.98 16.48
Key to Table 3.20:
Group 1 = < 3 hours therapeutic intervention per week 
Group 2 = greater than 3 hours therapeutic intervention per week
Results suggested that higher levels of therapeutic intervention did not result in 
higher QoL scores, in fact there was very little difference between the therapy 
groups' QoL scores. The effects of test occasion and Therapy group on QoL were 
examined using a 5 x 2 mixed factorial design (see Appendix 5.13). The obtained 
F  value confirmed there was no significant effect of Therapy group on QoL scores 
(F(l, 20)=0.01, N.S.). On this basis. Hypothesis 2 was rejected. Extent of 
therapeutic intervention did not improve QoL as measured by the SEIQoL-DW.
The SF-36
If extent of therapeutic intervention improved QoL as measured by the SF-36, then 
a greater number of hours spent in therapy per week would result in higher scores 
on each SF-36 domain. This relationship might be stronger for some domains than
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others, reflecting the individual constructs measured within the SF-36. In order to 
examine this hypothesis in greater detail, overall mean scores across re-test 
occasion were summarised for both Therapy groups on each SF-36 domain, as 
shown below in Table 3.21.
Table 3.21: Overall SF-36 means for each Therapy group across re-test 
occasions
SF-36 Domain Mean score across 
test occasion for 
Therapy group 1
(N=ll)
S.D. Mean score across 
test occasion for 
Therapy group 2
(N=ll)
S.D.
Bodily Pain 84.89 18.43 83.53 23.12
General Health 66.13 19.66 69.96 19.81
Mental Health 73.38 20.14 80.87 10.21
Physical Functioning 11.00 23.85 1.27 0.74
Role Emotional 69.09 28.79 89.70 15.88
Role Physical 64.55 29.02 68.91 25.46
Social Functioning 75.68 18.61 83.18 19.62
Vitality 62.36 24.03 66.64 16.55
Means suggested that there was very little difference between group scores 
obtained for the Bodily Pain, General Health, Role Physical, Social Functioning 
and Vitality scales. However, greater differences were observed between Mental 
Health, Physical Functioning, Role Emotional and Social Functioning means. 
Forming a 5 x 2 mixed factorial design, the effects of test occasion and therapy 
group on QoL scores were examined using two-way ANOVAs (see Appendix 
3.14). Results are summarised in Table 3.22.
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Table 3.22: Comparison of OoL (SF-36I scores across re-test occasion by 
Therapy group
SF-36 Domain F  value d f Sig.level
Bodily Pain 0.21 (1,20) N.S.
General Health 0.21 (1,20) N.S.
Mental Health 1.53 (1,20) N.S.
Physical Functioning 1.07 (1,20) N.S.
Role Emotional 4.64 (1,20) /)<0.05
Role Physical 0.65 (1,20) N.S.
Social Functioning 0.91 (1,20) N.S.
Vitality 0.26 (1,20) N.S.
The only main effect demonstrated for therapy group was on the Role Emotional 
scale. For the remainder of SF-36 domains, results suggested that the variance 
within groups was greater than the variance between groups. However, by 
violating the assumption of repeated measures and treating scores as though from 
independent measures, t-tests conducted produced significant results for the Mental 
Health, Physical Functioning and Role Emotional domains, as Table 3.23 
demonstrates.
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Table 3.23; Independent samples based comparisons of SF-36 domain means 
for Therapy groups 1 and 2
Variable Mean S.D. ^-value 4 f 2-Tail Sig
Bodily Pain Grp 1 
Grp 2
84.89
83.53
26.45
21.69
0.29 108 N.S.
General Health G rpl 
Grp 2
66.13
69.96
2189
21.39
0.03 108 N.S.
Mental Health G rpl 
Grp 2
73J8
80.87
2133
13.85
2.05# 87.86 /><0.05
Physical
Functioning
G rpl 
Grp 2
11.00
1.27
23.51
3.49
3.03# 56.39 p<0.01
Role Emotional Grp 1 
Grp 2
69.09
89^8
34.46
23.89
3.64# 96.17 J9<0.01
Role Physical Grp 1 
Grp 2
64.54
68.91
35.51
30.93
-0.69 108 N.S.
Social Functioning Grp 1 
Grp 2
75.68
83.18
26.73
24.55
1.53 108 N.S.
Vitality Grpl 
Grp 2
62.36
66.63
27.13
19.10
-0.95 108 N.S.
# The separate variance estimate was used to calculate the t-value, rather than the 
pooled estimate, as Levene’s test was significant (p<0.05).
Although the method used to obtain the effect was not fully justified in statistical 
terms, it does suggest that a sample with greater statistical power might have 
produced significant results. The implications of this finding are discussed in 
greater depth in Section 3.34.
The significant effect of therapy group on Role Emotional scores (F(l, 20)=4.64, 
/><0.05) (see Appendix 3.14) suggested that those receiving a greater amount of 
therapeutic intervention per week reported fewer problems encountered with daily 
activities due to emotional problems. Post-hoc comparisons were conducted using 
Tukey’s multiple comparison test to establish more precisely where the differences 
between Therapy groups lay. Significant differences were found between groups 
on each test occasion. Hypothesis 2, which stated that extent of therapeutic
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intervention may improve QoL as measured by the SF-36 was therefore supported 
for the Role Emotional domain, the only SF-36 scale to show a significant effect of 
extent of therapeutic intervention.
3.33.3 Further exploratorv analyses
Further analyses were conducted to test the concurrent validity of the SEIQoL-DW, 
the SF-36 and the HADS, the results of which are reported below.
The SEIOoL-DW
It was anticipated that if the SEIQoL-DW were measuring the QoL construct from 
the participants’ perspective, scores would be closely related to participant's ratings 
of their QoL 'generally' and their QoL 'today' (i.e. on the day the assessment was 
conducted). In order to explore this notion, means were firstly calculated for each 
variable, as shown in Table 3.24.
Table 3.24; Mean SEIOoL-DW scores, and mean OoL ‘today’ and generally’ 
ratings across test occasion
Mean QoL Rating
Test occasion The SEIQoL-DW QoL ‘today’ QoL ‘generally’
Baseline 61.69 60.00
Re-Test 1 74.16 56.70
Re-Test 2 73.24 61.86 61.93.
Re-Test 3 66.59 60.45 59.84
Re-Test 4 78.45 74.30 71.02
Re-Test 5 75.49 69.16 66.68
SEIQoL-DW mean scores were generally higher than the means for QoL 'today' 
and 'generally' ratings, which were clustered fairly closely together. To determine
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whether there were significant relationships among these means, Pearson product 
moment correlation coefficients were calculated. Findings are summarised in Table 
3.25, and averaged correlations using Fisher's z transformation are presented in 
Table 3.26.
Table 3.25: Relationships among SEIOoL-DW scores and OoL 'today* and 
'generally' ratings across test occasion (N=221
TEST OCCASION
VARIABLES B 1 2 3 4 5
SEIQoL-DW 
QoL ‘today’
0.52* 0.70** 0.47* 0.28
SEIQoL-DW 
QoL ‘generally’
0.21 0.33 0.58** 0.59** 0.71** 0.55**
QoL ‘today’ 
QoL ‘generally’
0.69** 0.80** 0.63** 0.21
^  ==/><0.05 ;?<0.01
Table 3.26: Averaged correlations among SEIOoL-DW scores and OoL 
'today' and 'generally' ratings across test occasion (N=22)
Variables Averaged r value
SEIQoL-DW/QoL 'today' 0.52*
SEIQoL-DW/QoL 'generally' 0.52*
QoL 'today'/QoL 'generally' 0.62**
*  == p<0.05 ** = j9<0.01
Results suggested there were significant relationships among QoL as measured by 
the SEIQoL-DW, and QoL 'today' and 'generally' ratings. Stronger relationships 
were identified however between the latter two variables. This indicates that the
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SEIQoL-DW is measuring something similar to the QoL construct as viewed from 
the participants’ perspective.
The SF-36
Scores from the Physical Functioning scale of the SF-36 were compared to EDSS 
ratings obtained at the beginning of the 1997 assessments. It was considered that 
they should be related, as the EDSS evaluates level of disability. More specifically, 
it was considered that participants with a lower EDSS rating (i.e. a lower level of 
disability) should obtain higher Physical Functioning scores (reflecting less 
limitation in performing physical activities due to health). Physical Functioning 
means were therefore summarised by levels of the EDSS variable, results of which 
are presented in Table 3.27.
Table 3.27; Physical Functioning scores obtained across test occasion (1997) 
by levels of the EDSS
Physical Functioning (SF-36) Mean
Test Occasion EDSS Group 1 (<8) EDSS Group 2 EDSS Group 3 (9)
(N=9) (8.5) (N=9) (N=4)
Mean S.D. Mean S.D. Mean S.D.
Re-Test 1 17.22 32.89 222 5.07 2.50 5.00
Re-Test 2 13.89 27.25 0.00 0.00 5.00 10.00
Re-Test 3 12.22 24.25 0.00 0.00 0.00 0.00
Re-Test 4 11.67 21.93 0.00 0.00 0.00 0.00
Re-Test 5 12.77 24.51 0.00 0.00 0.00 0.00
Means suggested that those who were rated as having lowest levels of disability 
obtained highest mean Physical Functioning scores, although the large variation 
either side of Group 1 mean scores is acknowledged. Physical Functioning scores 
were slightly higher for those with the highest disability level when compared to
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the middle group, however. Correlation coefficients suggested significant negative 
relationships among collective EDSS ratings and Physical Functioning scores of 
1997, as shown in Table 3.28
Table 3.28: Relationships between the EDSS rating of 1997 and Physical 
Functioning (SF-36) scores obtained (N=221
PHYSICAL FUNCTIONING (SF-36)
Re-Test 1 Re-Test 2 Re-Test 3 Re-Test 4 Re-Test 5
EDSS (1997) -0.53* -0.47* -0.51* -0.58** -0.57**
*  == /?<0.05 ** = /?<0.01
These results provided further support for the notion that participants with a lower 
EDSS rating would obtain higher Physical Functioning scores. In order to 
determine whether there were significant differences between these groups. 
Physical Functioning scores obtained across each test occasion (N=22) were 
summed for each individual. Table 3.29 below shows the distribution of these 
scores in the three disability (EDSS) groups.
Table 3.29: Physical Functioning means across test occasion for each level of 
the EDSS variable
EDSS Group Overall Physical Functioning Mean S.D.
1 g 8 ) 11.51 22.01
2 (8.50) 0.55 1.13
3 (9) 2.00 4.00
Means suggested that a lower level of disability (as rated by the EDSS) was 
associated with a higher overall level of Physical Functioning (SF-36). Of the six
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individuals within EDSS Group 1 who obtained EDSS ratings of 8.0, five obtained 
overall Physical Functioning scores of zero, and the remaining individual obtained 
an overall score of one. Of the three individuals within EDSS Group 1 who 
obtained EDSS ratings of 7.5, one obtained an overall Physical Functioning score 
of 3, whilst the remaining two individuals obtained overall scores of 54.00 and 
64.00. This explained the large variance observed either side of the Group 1 mean 
score in Table 3.29. Given the small number of individuals within the present 
population who obtained EDSS ratings of 7.5, it was initially considered most 
appropriate to collapse these two groups before analyses were conducted. One 
alternative option, of eliminating individuals with EDSS ratings of 7.5 from the 
data set, is explored below.
Although the means in Table 3.29 suggested that the Physical Functioning domain 
was responsive to different levels of disability within the current population, results 
of a one way repeated measures ANOVA confirmed there was no significant effect 
of level of disability (EDSS rating) on Physical Functioning (SF-36) scores (F(2, 
19)=1.43, N.S.) (see Appendix 3.15A). It is worth noting that this finding was 
unchanged when the three cases who obtained ratings of 7.5 on the EDSS were 
eliminated from the data set, and the analysis was repeated (F(2, 17)=0.76, N.S.) 
(see Appendix 3.15B). This suggested that eliminating the cases that had caused 
the large variation either side of the Physical Functioning mean observed in Table 
3.29 made no significant difference to this finding.
This test suggests that the Physical Functioning scale has a poor level of concurrent 
validity, although the problem of insufficient power size was again demonstrated 
here. By violating the assumption of individual scores (see Section 3.34 for
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discussion) a significant effect occurred (F(2, 107)=7.41, /><0.01) (see Appendix 
3.16). Post-hoc comparisons using a Tukey multiple comparison test confirmed 
that individuals with a lower level of disability obtained significantly higher 
physical functioning scores than individuals with a moderate level of disability. 
Although the method used to obtain the effect was not fully justified in statistical 
terms, it suggests again that a sample with greater statistical power might have 
produced significant results. The relationship between EDSS ratings and Physical 
Functioning scores might therefore benefit from further testing before conclusions 
are made concerning the concurrent validity of the Physical Functioning (SF-36) 
scale.
The HADS
The first post-hoc analysis conducted was a test of concurrent validity, to determine 
whether the Anxiety and Depression scales of the HADS were measuring different 
constructs on each re-test occasion. In order to investigate this possibility, Pearson 
product moment coefficients were calculated, as demonstrated in Table 3.30.
Table 3.30: Correlations between the Anxiety (A) and Depression (D) scales of 
the HADS for Re-tests 1-5 (N=22)
Test Occasion Mean
(A)
S.D.
(A)
Mean
(D)
S.D.
(D)
Anxiety/Depression
Coefficient
Re-Test 1 21.65 14.89 22.73 14.91 0.19
Re-Test 2 22.29 15.79 25.32 23.94 0.48*
Re-Test 3 26.41 22.42 27.27 23.75 0.67**
Re-Test 4 21.65 20.72 21.21 23.77 0.61**
Re-Test 5 18.18 17.30 17.75 20.11 0.70**
=/?<0.05 = /7<0.01
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As four of the five coefficients were significant, the averaged r value was 
calculated using Fisher’s z transformation procedure. A coefficient of r=0.55 
(p<0.01) was obtained, suggesting that overall there was a significant relationship 
between the scores obtained on the Anxiety and Depressions scales. The sum of 
individual scores obtained across re-test occasion for the Depression and Anxiety 
scales were calculated. Overall means are shown in Table 3.31.
Table 3.31: Overall mean scores obtained across test occasion for the 
Depression and Anxietv scales of the HADS (N=22)
Overall Anxiety 
Mean Total
Overall S.D. Overall Depression 
Mean Total
Overall S.D.
4.63 3.33 4.80 3.76
Although a significant relationship was demonstrated between scores on the 
Anxiety and Depression scales, suggesting that they measuring similar constructs, 
means were not expected to be so similar. The validation of the HADS (Snaith and 
Zigmond, 1994) claims to measure Anxiety and Depression as separate constructs
i.e. differentiates between them. This analysis suggests one of two things; either the 
HADS does not measure two separate constructs within the present population, or 
the individuals who obtained ‘normal’ range depression scores within the present 
study also obtained ‘normal’ range Anxiety scores.
It was noted that, across test occasion, between 59% and 81% of individuals with 
‘normal’ range depressions scores also obtained ‘normal’ range Anxiety scores. By 
comparison, between 4% and 31% of individuals rated themselves as either 
anxious with ‘normal’ range Depression scores, or depressed with ‘normal’ range
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Anxiety scores. This suggests that the similar means presented in Table 3.31 were 
at least partly due to a relationship between the presence/absence of Anxiety and 
Depression within the present population, although the relatively large variation in 
percentages across test occasion is acknowledged.
Analyses were also conducted to establish whether Anxiety and Depression scores 
were related to the Role Emotional and Mental Health scales of the SF-36. As each 
scale purports to measure a construct relating to emotional well being, significant 
relationships between Anxiety/Depression scores and Role Emotional/Mental 
Health scores would suggest a good level of concurrent validity for each measure 
concerned. In order to examine this possibility, Pearson product moment 
correlation coefficients were first calculated, summaries of which are presented in 
Table 3.32.
Table 3.32: Relationships among Anxietv and Depression (HADS) scores and 
the Mental Health/Role Emotional SF-36 domain scores (N=22)
Test Occasion HADS scale Correlates with
Mental Health (SF-36) Role Emotional (SF-36)
Re-test 1 Anxiety -0.35 -0.24
Depression -0.30 -0.13
Re-test 2 Anxiety -0.61** -0.56**
Depression -0.51* -0.15
Re-test 3 Anxiety -0.83** -0.59**
Depression -0.75** -0.43*
Re-test 4 Anxiety -0.77** -0.53*
Depression -0.59** -0.29
Re-test 5 Anxiety -0.75** -0.57**
Depression -0.71** -0.35
= p < 0 . 0 5 =j9<0.01
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No significant correlations were observed among the measures in re-test 1. 
Although several significant relationships were demonstrated elsewhere these were 
not uniform. The coefficients obtained were averaged so that conclusion could be 
made, as demonstrated in Table 3.33.
Table 3.33: Averaged correlations for comparisons among Anxietv and 
Depression scores and Mental Health and Role Emotional scores (SF-36)
Paired Variables Averaged r value
Anxiety/Mental Health -0.69**
Anxiety/Role Emotional -0.50**
Depression/Mental Health -0.59*
Depression/Role Emotional -0.26
* =/)<0.05 ** —
Results obtained demonstrated significant negative relationships between Anxiety 
and Depression scores and scores obtained on the Mental Health scale of the SF- 
36. Thus individuals reporting a higher level of generalised anxiety or depression 
(as measured by the HADS) also seemed to report more feelings of nervousness 
and depression (indicated by a lower score on the Mental Health scale). Likewise, 
the significant, albeit slightly weaker negative relationship between Anxiety scores 
and Role Emotional scores suggested that individuals with higher levels of 
generalised anxiety also reported having more problems with daily activities due to 
physical or emotional problems (indicated by a lower score on the Role Emotional 
scale).
Through these suggested relationships, a good level of concurrent validity has been 
indicated for each scale, although results should be treated with some caution as no
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causal patterns can be inferred from correlation. It was interesting to note that 
Anxiety scores were significantly related to Role Emotional scores obtained, and 
depression scores were not. A stronger relationship was also inferred for Anxiety 
and Mental Health scores. These and other findings obtained within the current 
section are discussed in greater detail in Section 3.34, following a summary of 
results obtained across Parts 1 and 2 of the present study.
3.33.4 Summary of results 
Part 1 : Hypothesis 1
Hypothesis 1 stated that residents' perceptions of QoL would vary more when 
measured over an extended time period (10 months) than over a short time span 
(10 weeks). By testing this hypothesis, the dynamic nature of QoL could be 
examined across an extended time period. The data collected to address this 
hypothesis was also analysed to examine the 2-week re-test reliability of each 
measure across a 10-week period. Table 3.34 overleaf summarises findings 
obtained. The accompanying key is printed below.
Key to Table 3.34:
* = p<0.05 ** = /7<0.01
c = ceiling effect obtained / =  floor effect obtained
Comparison A = Comparison among the baseline measure of 1996 and the 
fortnightly re-tests of 1997 
Comparison B = Comparison among the fortnightly re-tests of 1997
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Part 2: Hypothesis 1
Hypothesis 1 stated that when measured every 2 weeks, the correlation between 
sets of scores would remain greatest where no significant life changes took place. 
Where changes occurred that may enhance or decrease QoL (i.e. changes in a 
course of therapy, major outings or a family illness) it was anticipated that scores 
obtained would reflect this. By testing this hypothesis, the responsiveness of each 
test instrument to change would be examined. Table 3.35 overleaf summarises 
findings obtained.
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Part 2: Hypothesis 2
Hypothesis 2 stated that extent of therapeutic intervention (i.e Physiotherapy, 
Speech and Language Therapy, Art Therapy and Music Therapy) may improve 
QoL as measured by the SF-36 and the SEIQoL-DW. The theoretical basis of this 
prediction is discussed within Section 3.3 (p.l61). Results obtained for both QoL 
measures are depicted in Table 3.36. The accompanying key is as follows:
Key to Table 3.36:
Therapy Group 1 - receive equal to or less than 3 hours therapeutic intervention 
per week
Therapy Group 2 - receive greater than 3 hours therapeutic intervention per 
week
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3.34 Discussion
Hypothesis 1 tested the responsiveness of the SEIQoL-DW, the SF-36 and the 
HADS in order that the feasibility of using these tools within a severely disabled 
population of MS patients could be established. Bearing in mind the uncertainty 
surrounding the psychometric requirements of QoL measures in general and the 
implications of assessing the QoL of persons with MS (see Sections 2.6 and 2.7) it 
was considered essential to establish the working value of these assessment tools 
before further assessment commences.
The demonstrated responsiveness of the SEIQoL-DW to individual reports of life 
change between assessments and the stability of scores where no changes were 
reported are perhaps more indicative of a reliable person-centred QoL measure 
within the present population. The magnitude of within-person change may have 
rendered the SEIQoL-DW unreliable by traditional standards, but suggests the need 
for an alternative criterion for reliability that takes account of the individual nature 
of responses obtained when assessing person-centred QoL.
When considered from this less traditional perspective, there seem adequate 
grounds for the continued use of the SEIQoL-DW within the current population. 
For individuals whose disease has no known cure, where the goals of health-care 
are to improve QoL, the most important feature of measures employed are their 
ability to monitor changes in QoL so that individual requirements may be met by 
health carers. The present findings suggest that the SEIQoL-DW is capable of 
meeting these demands.
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Previous assessment in the present sample has also produced encouraging findings 
for the SEIQOL-DW in comparison to the PGI, a person-centred QoL measure 
concluded as unsuitable for use due to it's dependency on physical ability (Lintem 
et a l, 1999). Lintem et al (1999) also suggest that data derived from the SEIQoL- 
DW may be related to feelings of satisfaction and well being, a finding 
demonstrated in the present study through the high correlations found between 
SEIQoL-DW scores and QoL 'today' and 'generally' ratings. They also reported a 
markedly normal distribution of SEIQoL-DW scores and analyses which suggest 
that SEIQoL-DW scores were influenced more by internal disposition than external 
circumstance. On the basis of these findings the SEIQoL-DW seems an adequate 
person-centred indicator of QoL and is therefore recommended for use with the 
present population. Testing in other samples of individuals with severe disability 
and/or MS are required before more generalised recommendations can be made.
The majority of SF-36 scales (with the exception of the General Health and Vitality 
scales) were demonstrated as unresponsive to reported changes within the present 
population. These findings are concurrent with previous findings that the SF-36 
may not be able to detect deterioration in some conditions and may also be too 
cmde to detect improvements (Bowling, 1995). Alongside the objective-health 
basis of the SF-36 this limits its value in assessing the QoL of persons with severe 
disability associated with MS.
Although the Anxiety scale of the HADS demonstrated an acceptable level of 
reliability by traditional re-test standards in Part 1 of the present study, neither the 
Anxiety or Depression scales of the HADS were significantly responsive to 
reported life changes (although means were in the predicted direction). Part 1
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analyses also suggested that responses obtained on the Anxiety scale correlated to a 
greater extent with the Mental Health and Role Emotional constructs of the SF-36 
than the Depression scale.
Despite these suggested differences between the Depression and Anxiety scales 
overall mean scores remained similar, as a relatively large proportion of individuals 
obtained ‘normal’ range Depression and Anxiety ratings across test occasion. This 
made it difficult to evaluate the validity of the HADS, which remains inconclusive 
in the present population. As conditions of anxiety and depression may not be so 
dynamic as person-centred QoL on the whole, responsiveness to change may not be 
as important a factor as re-test reliability. Responsiveness to factors known to 
influence depression or anxiety in persons with MS, such as marital and disease 
adjustment (Devins and Seland, 1987) may be more important in determining the 
usefulness of the HADS.
Although the current research did not address this issue specifically, previous 
research with the current population has suggested an association between duration 
of illness and depression, whereby the less time spent since diagnosis, the greater 
the level of depression (Kenealy et al., 1999). This relationship has been postulated 
by many other researchers and is congruent with the stages of adaptation to MS 
described by Matson and Brooks (1977) (see Section 1.9, pp.46-47 for further 
details). On the basis of the high levels of re-test reliability demonstrated in the 
current study, it may be productive to continue using the HADS in addition to QoL 
measures within the present population, at least until further research is 
accumulated to suggest otherwise.
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Hypothesis 2 stated that QoL would be affected by extent of therapeutic 
intervention, on the basis of previous research conducted by Fawcett et al (1994) 
and Stuifbergen (1995) (see Section 3.3, p.l61). The only relationship 
demonstrated in the present study was between extent of therapeutic intervention 
and the Role Emotional scale of the SF-36, suggesting that those receiving more 
than 3 hours of therapeutic intervention each week encountered fewer problems 
with daily activities due to emotional problems. On the basis of the literature 
examined, which suggested that participation in health-promoting behaviours 
increased QoL, it was anticipated that a greater number of relationships would have 
been demonstrated with the QoL measures.
There are many potential reasons why these effects were not found, the first of 
which was mentioned in Section 3.33.2 (p. 175) in relation to insufficient statistical 
power. Small and often shrinking sample sizes continue to pose a problem when 
working with clinical samples, especially in longitudinal investigations. There are 
currently few methods of data analysis available that yield satisfactory solutions to 
this problem and the majority of statistical procedures still assume that sample 
sizes are fairly large (Collins & Horn, 1991; Elias & Robbins, 1991). Whilst there 
is little the researcher can do to control small and decreasing sample sizes, the 
implications introduced should not be overlooked.
Alongside insufficient statistical power, small sample sizes often introduce the 
problem of individual outlying scores, which become more influential to mean 
scores and in some cases overall results obtained. There is also a greater likelihood 
that skewed distributions will occur. Both of these problems were encountered 
within the current set of analyses. Much of the skewed data was transformed
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successfully, and for the variables that were too skewed to remedy using this 
process the robustness of ANOVA was trusted to yield valid results. There is very 
little that can be done to control this problem, or the problem of individual outlying 
scores influencing results obtained, short of eliminating data. In this event the 
remaining data becomes artificial in some respects. Whether or not the original 
data set is retained for the purpose of analyses (as was the case in the present 
investigation in order to remain true to the data set), the potential consequences of 
small sample sizes continue to pose problems for the researcher.
There are several other factors that may have influenced the outcomes of the 
present study. Health-promoting behaviours and beliefs such as philosophy and 
attitude to life (Fawcett et al., 1994) and self-efficacy (Stuifbergen, 1995) are also 
thought to contribute to QoL perceptions in persons with MS. However, it was 
thought these factors would prove difficult to measure within the present 
population, as in many ways they mirror the complexities of the QoL construct. 
The notion of extent of therapeutic intervention as an independent variable seemed 
to overcome this problem at the outset, but may have been too broad with 
hindsight. Perhaps of more importance to QoL in the current setting are issues 
such as the reasons for participating in therapy and perceived improvement as a 
result of therapy. Type of therapy (i.e. one-to-one sessions versus socially 
interactive group sessions) may also be an important contributing factor. Simply 
assessing time spent in therapy emphasises quantity rather than quality, and future 
study in this area would benefit from more careful consideration of these issues.
Although previous research suggests that participation in therapy enhances QoL 
(Fawcett et al., 1994), there is no suggestion that extent of participation has the
198
same effect. To illustrate this point, one might consider the notion that physical 
exercise promotes psychological well being. The emphasis here is on exercise 
versus no exercise, rather than a little versus a lot. The original intention of the 
current study was to compare persons receiving no therapy in relation to the two 
groups established (less than/equal to 3 hours per week and greater than 3 hours), 
but no individuals were eligible to take part who fitted this description. Although 
accepting violation of the assumption of repeated measures was able to 
demonstrate further differences between the two established groups, the 
introduction of a 'no therapy' group would have provided a more satisfactory design 
and may have generated different findings.
3.35 General summary; Parts 1 and 2
The purpose of the present study was to assess the feasibility of using health-based 
(SF-36) and person-centred (SEIQoL-DW) QoL measures in a population of 
severely disabled individuals with MS, before further research commenced on the 
nature of QoL in this population. Collectively, results obtained suggest that the 
SEIQoL-DW is more suited to the purposes of the current research than the SF-36, 
having reflected the dynamic nature of QoL to a greater extent than the health- 
based SF-36. The person-centred approach was also more responsive to individual 
life changes and fluctuations, reflecting in part the emphasis of the SEIQoL-DW on 
the individual. The SF-36 is not recommended as an appropriate tool with severely 
disabled individuals, due to floor and ceiling effects obtained. In addition it lacked 
responsiveness to life change, a feature that many regard as the most important 
indicator of a psychometrically sound QoL assessment tool.
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The clear difference in outcomes obtained for the two approaches suggests that 
researchers may need to consider more carefully the aspects of QoL that are to be 
studied. If, for example, individual change is to be monitored, and/or longitudinal 
assessments are to be conducted, then person-centred measures may prove more 
useful, as their structure appears to he more responsive to both long and short-term 
changes. On the other hand, health-based measures may prove more useful in their 
intended role, of functional assessment of health-related issues (so long as an 
objective, external viewpoint is required).
In the past, QoL has been considered too broad to be meaningful, its measurement 
beyond the bounds of possibility (Sullivan, 1992). The present study suggests that 
this is not the case if the objectives of research are fully defined before 
measurement commences. Assessment tools and techniques need to be tailored 
precisely to the needs of the population at hand and several measures may need to 
be piloted before a tool can be found which demonstrates psychometric quality 
with these individuals. Having completed this process in the present study, a 
number of recommendations for future QoL assessment in persons with severe 
disability associated with MS are made below.
3.36 Recommendations
In general it is recommended that measures should be thoroughly tested before use 
with MS and other patients with severe neurological disability to determine their 
responsiveness to perceived life changes, especially if a longitudinal investigation 
follows. Given the unpredictable course of the disease responsiveness to change 
becomes an essential feature of the measures employed. Studies may also benefit
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from additional assessment using the HADS, which is relevant to MS persons in 
hospital settings and generates useful additional information relating to individual 
perceptions of QoL.
Verification of the validity of the SEIQoL-DW can be obtained by simply asking 
respondents how they feel about their QoL, as was done in the present study. If a 
person-centred measure is used, then quantification of physical disability using a 
measure like the EDSS may also be useful. Although some manipulation of the 
SEIQoL-DW may be required in order to meet the needs of individuals concerned, 
the direct weighting version may also provide a valid means of assessing 
individuals in other disease categories whose QoL is poorly represented by 
traditional measures.
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CHAPTER 4
The Relationship between Cognitive Impairment, Social 
Comparison Processes and QoL Judgements
STUDY 2
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4.1 Introduction
Having found a QoL measure that is suitable for use within the current population, 
exploration of the QoL construct itself can now begin. Previous research with the 
present population has already identified several factors that are related to QoL, 
such as duration of illness, cognitive dysfunction and depression (Kenealy et al., 
1999). However, it has yet to be established how individual QoL perceptions are 
constructed. The next stage of the research therefore examines the psychosocial 
processes that are used to make these judgements.
There has been little research conducted on how people reach conclusions 
regarding the quality of their life, as QoL assessment has usually focused on the 
contents of a hypothetically good QoL. There is some agreement however that 
social comparisons are involved. Sartorius (1987) theorised that illness facilitates 
comparisons in three ways. According to Sartorius (1987), on an intrapersonal 
(individual) level people may compare their QoL to how they might ideally like to 
be, how they were at important times of their illness and before it began, and how 
they were at their very best at any time. On an interpersonal level, individual QoL 
is compared with others fiom different social groups. This may include fiiends, 
work colleagues and acquaintances of the same age and/or sex. Comparisons are 
also made with others with the same or a different disease. At the sociocultural 
level, Sartorius suggests people’s condition may be compared with society’s 
expectation of how they should be.
The existing literature also suggests that downward comparisons are often made by 
individuals with serious medical problems (Affleck and Tennen, 1991; Blalock,
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DeVellis and DeVellis, 1989; DeVellis et al., 1990). Downward comparisons 
(comparisons with people less fortunate than oneself) are generally thought to 
enable people to intensify their feelings of subjective well being, whereas upward 
comparisons are thought to result in negative feelings of failure, inadequacy, 
relative deprivation and resentment (Hemphill and Lehman, 1991; Wills, 1981).
However, these findings are not always consistent, and several researchers have 
suggested that the affective consequences of social comparisons may depend less 
on comparison direction and more on the context of comparison judgements (e.g. 
Buunk, Collins, Taylor, VanYperen and Dakof, 1990; Taylor and Lobel, 1989; 
Tessser, 1988). As Lyubomirsky and Ross (1997) point out, cancer patients may be 
comforted from comparisons with others whose symptoms or circumstances they 
perceive to be worse than their own (Wood, Taylor and Lichtman, 1985), but they 
may also be inspired by ‘upward’ comparisons with good copers and long-term 
survivors (e.g. Buunk et ah, 1990; Taylor, Aspinall, Giuliano, Dakof and Reardon, 
1993). It has also been suggested that comparisons can occur unintentionally and 
without any of the consequences outlined above (Gilbert, Giesler and Morris, 
1995).
Social comparisons have been suggested as playing an important role in coping 
with chronic illness (Wood, Taylor and Lichtman, 1985). Both Wills (1981) and 
Wood, Taylor and Lichtman (1985) have suggested that downward comparisons 
may be strongest early On in the process of adaptation to a negative event but may 
be less urgent after long-term adaptation to the negative event has occurred. This 
notion lies parallel to the proposed stages of coping and adaptation that occur 
within individuals with MS. Although adjustment is a continual response to the
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changing disease process, longitudinal studies suggest that most adjustment takes 
place in the early stages after diagnosis (Matson and Brooks, 1982), the point at 
which Wills (1981) and Wood, Taylor and Lichtman (1985) suggest the frequency 
of social comparison information obtained is at its greatest. On this basis, 
acknowledgement of the varying characteristics of each disease stage may provide 
a more detailed picture of the processes involved in constructing QoL judgements 
in persons with MS.
The relation between social comparison information and depression has also been 
explored by researchers. Several studies have suggested that non-depressed persons 
make significantly fewer comparisons than mildly depressed persons (Swallow and 
Kuiper, 1990, 1992). Some researchers have also reported a focus on negative 
(upward) comparisons, which contribute to the depression itself (Beck, Rush, Shaw 
and Emery, 1979; Swallow and Kuiper, 1992; Wood, 1996). However, there is 
also evidence to suggest depressed people are less likely to seek out social 
comparison information, due to the potential effects of discomfort (Brickman and 
Buhnan, 1977; Flett, Vredenburg, Pliner and Krames, 1987) and the fact that 
depressed people exhibit more negative outcome expectancies (Strack, Blaney, 
Ganellen and Coyne, 1985).
The majority of health-related studies have not yet addressed the use of social 
comparisons in the context of QoL judgements. Skevington (1994) is among the 
few researchers to address these issues. Her aim was to look at whether social 
comparisons are made in assessing QoL and what types of comparisons might be 
used in a sample of 31 patients with chronic arthritis. Results suggested that 
downward comparisons were used more frequently than upward comparisons.
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although in line with previous findings, they did not consistently produce an 
improvement in well-heing. Similarly, upward comparisons did not always 
produce a decline in well-being.
Skevington’s findings also supported the three levels proposed by Sartorius (1987). 
Most comparisons were interpersonal, and comparisons with people who were very 
much older, especially if they were fit and healthy, were particularly salient in 
evaluating QoL. Individuals sometimes combined different types of comparison to 
explain how they evaluated their QoL, for example considering their condition at a 
previous time (intrapersonal), comparing it with that of others (interpersonal) and 
then using this past knowledge to make inferences about the future.
Skevington (1994) concluded that the study of social comparisons with reference to 
quality of life seemed appropriate. This was also the patient’s conclusion, as the 
majority believed there was no objective basis for defining what a good QoL might 
be. The present study also adopts this view, in considering the evaluation strategies 
that are made in relation to the QoL judgements of individuals with severe 
neurological disability.
Again, there has been very little research conducted concerning social comparison 
processes and persons with neurological disability. Hemphill and Lehman (1991) 
considered the relations between comparison dimension and affective 
consequences from social comparisons in a sample of 151 MS patients. They 
anticipated that as MS is a chronic illness which involves deterioration, comparing 
downward on the dimension of physical condition would make people feel worse 
as they have little control over their physical condition. Despite these suggestions.
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individuals reported feeling better more of the time when comparing downward on 
the physical condition as compared to a coping dimension. The authors concluded 
that both fear and comfort might be the result of making comparisons with those 
who are physically worse off.
Respondents in the study above had been diagnosed with MS an average of five 
years earlier, whilst the averaged years since diagnosis was 22 in the previous study 
conducted with the present population. As respondents in the current study are in 
the more advanced stages of neurological disease, several additional factors require 
attention in studying social comparisons in the context of QoL assessment, most 
notably that of memory deficits.
To date, few published reports have examined the role of autobiographical memory 
in neurologically disabled patients or its effect on QoL, let alone its effect on social 
comparison processes. Many researchers agree that QoL is dependent on an 
individual's past experience, present life style and future ambitions. In 
Skevington’s (1994) report, she states the most frequent theme arising from 
intrapersonal comparisons involved past accounts. However, Kenealy et al. (1999) 
studied 30 individuals with MS who took part in QoL assessments at the Royal 
Hospital for Neuro-disability in 1996, 60% of whom had some form of 
autobiographical memory deficit. Patients with normal autobiographical memory 
had the highest levels of depression (HADS) and the lowest QoL scores (as 
measured by SF-36 Role Physical scale). This effect also interacted with duration 
of illness; individuals with impaired autobiographical memory and a longer 
duration of illness reported higher QoL ratings than groups defined by only one or 
neither of these characteristics.
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They concluded that, as an aspect of the progression of MS, autobiographical 
memory deficits become more likely and more severe when present. 
Consequently, information regarding the individual’s own QoL status before 
disease onset becomes increasingly difficult to access, because individuals have 
simply forgotten what life was like before they were ill. As individuals are unable 
to make valid comparative judgements one of two alternative processes might 
occur, either invalid judgements are made or an alternative comparison strategy is 
adopted. In either case, Kenealy et al. (1999) propose that higher QoL judgements 
will be obtained than those based upon comparisons with autobiographical pre­
illness status, as individuals who cannot remember their pre-illness status may be 
more satisfied generally with their present QoL.
This study forms an important basis for the present investigation. Although 
Kenealy et al. (1999) measured QoL fi*om a health-based perspective, on the basis 
of these findings one might also expect autobiographical memory to influence 
person-centred QoL ratings, and the processes used to construct these ratings. With 
such a high level of autobiographical memory deficits in the present population the 
need for establishing a more precise understanding of perceptions of QoL and the 
use of social comparison processes remains essential in order to understand the 
nature of QoL in persons with severe neurological disability.
4.2 Hypotheses
Having identified several aspects of QoL and social comparisons that required 
further investigation in individuals with severe neurological disability, the 
following hypotheses were constructed:
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1. The presence of autobiographical memory deficits will effect perceptions of 
QoL; individuals with autobiographical memory deficits will rate their QoL as 
higher than individuals with intact autobiographical memory.
2. Cognitive functioning will effect the processes used to evaluate QoL; 
individuals with cognitive deficits affecting ability to make comparisons will be 
less likely to use social comparisons when rating their QoL than individuals 
without such cognitive deficits.
3. There will be a significant effect of evaluation strategy on QoL ratings; 
individuals who make comparative judgements when evaluating their present 
QoL will produce significantly lower QoL ratings than individuals who 
evaluate their QoL without the use of comparison processes.
Hypotheses 1 and 2 enabled exploration of the relationship between cognitive 
impairment and social comparison processes involved in constructing QoL 
judgements. In order to examine the second hypothesis, the cognitive ability to 
make comparisons was assessed using cut-off points derived from the Similarities 
sub-test of the WAIS-R (Wechsler, 1986) and the Pyramids and Palm Trees 
(Howard and Patterson, 1992). Comparative processes are required in order to 
successfully complete both tests, which are described in greater detail in Section 
4.32. Through examination of Hypothesis 3, the relationship between social 
comparisons and QoL as measured by the SEIQoL-DW and QoL visual analogue 
scales could also be examined (see Section 4.32).
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4.3 Method
4.31 Participants
Thirty-one residents were invited to take part in the assessments, including the 22 
residents with MS who participated in Studies 1 and 2. In order to obtain a 
representative number of participants, individuals with disabilities relating to 
several other neurological illnesses were also invited to take part in the study. The 
range of diagnoses included in this sample is presented below in Table 4.1. Figures 
represent the 24 individuals who completed all assessments, rather than the 31 who 
were initially invited to take part.
Table 4.1: The range of diagnoses of individuals taking part in Study 2
Diagnosis N (%)
Multiple sclerosis 17 70.83
Cerebral palsy 2 8J4
Dystonia 1 4.17
Generalised epilepsy 1 4.17
Left hemiplegia 1 4.17
Myasthenia gravis 1 4.17
Right and partial left hemiplegia 1 4.17
It is acknowledged that disease category may influence the nature of scores 
obtained but given that MS is such a variable individualised disease additional 
variation between individuals as a result of disease groups was not expected.
The cognitive abilities of 3 the 22 individuals who had taken part in Study 1 had 
deteriorated significantly since this time (Spring 1997, nine months previously). 
They were considered to have insufficient ability to complete the current tests and 
so were not assessed. One of the 31 individuals did not wish to participate when 
initially asked and another patient, although willing to take part was on holiday for
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the duration of the study. Of the remaining 26 individuals, one voluntarily 
withdrew from the study after the first session and one presented behavioural 
problems that made assessment both difficult and potentially invalid. Full data sets 
were therefore collected for 24 individuals.
4.32 Measures
Medical and demographic data and scores from the EDSS (measuring extent of 
physical disability) were made available from hospital records or supplied by the 
Department of Clinical Psychology. Information concerning significant life changes 
continued to be collected, as it formed an important context for the assessments 
conducted.
1) Cognitive Functioning
Information collected from cognitive assessments provided further information 
concerning the aspects of function that are implicated in the process of 
comparisons, and the effects of cognitive impairment on comparison strategies. 
Three cognitive tests were administered prior to assessment to establish whether 
each participant has the cognitive ability to make general comparative judgements, 
an important control needed in order to investigate how individuals QoL 
perceptions are constructed. A fourth test, assessing ability to perceive and think 
clearly, was administered 3 weeks after the QoL/Social Comparison assessments 
were completed, in order to reduce the amount of assessment to be conducted at 
any one time and thus lessen the problem of over-taxing participants. A description 
of each cognitive test administered now follows.
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Pyramids and Palm Trees (Howard and Patterson, 1992)
The Pyramids and Palm Trees test was designed to determine the degree to which 
an individual can access meaning from words and pictures. It is a brief and easily 
administered test consisting of 52 triads in which a given item has to be matched to 
a target, on the basis of their being some property or association involved. A 
choice must be made between the target and a distracter in each case (an example 
triad is presented in Appendix 4.1 A). Items can be presented as words or pictures, 
depending on the needs of the individual client group being assessed.
Three practice triads and twenty of the 52 trials in the Pyramids and Palm Trees 
test were administered to the participants in the present study, to reduce the 
problems caused by fatigue and limited concentration span. The pictures were 
enlarged to accommodate the visual disturbances that are often encountered as a 
result of neurological illness. Individuals were also presented with 5 triads at the 
outset where the distracter had been replaced with a second target picture, identical 
to the first (see Appendix 4. IB). In each case, individuals were asked which of the 
two given items was the same as the target picture, so that individuals who could 
not make comparisons would be identified before the main test commenced. Only 
those who successfully completed this process then completed the remainder of the 
test. Further information on the psychometric properties of the Pyramids and Palm 
Trees test may be found in the accompanying test manual (Howard and Patterson, 
1992).
The Similarities sub-test of the WAIS-R (Wechsler, 1986)
The Similarities sub-test (see Appendix 4.2) is a test of verbal concept formation, 
where individuals have to explain what each of a pair of words has in common (i.e.
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orange-banana). There are 15 comparisons in total, which gradually get harder as 
the test progresses. The test is discontinued after four consecutive failures. The 
Similarities sub-test has been noted as an excellent test of general intellectual 
ability; virtually independent of any memory component. Of all the WAIS-R sub­
tests this is considered to be the one least affected by background and experience. 
It does not depend on academic skills and is relatively independent of social and 
educational background (Lezak, 1995).
The Digit Span sub-test of the WAIS-R (Wechsler, 1986)
The Digit Span test of the WAIS-R (see Appendix 4.3) is one of the most 
commonly used tests of immediate verbal recall. It comprises of two different 
tests. Digits Forward and Digits Backward. Both tests consist of seven pairs of 
random number sequences that get progressively longer. Each sequence is read 
aloud by the investigator at the rate of one digit per second. In the Forward test, 
individuals are asked to repeat each sequence exactly as it is given. In the 
Backward test individuals are asked to repeat the sequence backwards so that the 
sequence 4,2, for example, is repeated as 2, 4. On both tests, when a sequence is 
repeated correctly, the investigator reads the next longer sequence of numbers, until 
the patient either fails both pairs in a sequence or completes the final nine-digit test 
correctly. Both tests involve auditory attention and depend upon a short-term 
retention capacity. The two digit span scores are combined to obtain one score. 
Further details concerning psychometric properties of both the Digit Span and 
Similarités sub-tests may be found in the WAIS-R manual (Wechsler, 1986).
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The Autobiographical Memory Interview (AMI) (Kopelman, Wilson and 
Baddeley, 1990)
The Autobiographical Memory Interview (AMI) (see Appendix 4.4) is a frequently 
used assessment of autobiographical memory, consisting of a semi-structured 
interview designed to access two components of autobiographical memory. The 
personal semantic (PS) element assesses patients recall of facts from their personal 
past life (i.e. where they have lived, their previous occupation etc.). There is also 
an autobiographical incidents element (AIS) which assesses patients recall of 
specific events or incidents in their past life (i.e. something that happened at 
school). Each element assesses memory across three broad time spans: childhood, 
early adult life and recent life. Responses may be verified by talking to relatives, 
friends and nursing staff, checking hospital records and noting inconsistencies in 
response.
Correlations for inter-rater reliability in the AMI have reported coefficients of 
between 0.83 and 0.86 (Kopelman, 1989; Kopelman, Wilson and Baddeley, 1989). 
The validity of the AMI has been established in a number of different areas, for 
further details see Kopelman, Wilson and Baddeley (1990).
Coloured Progressive Matrices (CPM) (Raven, Court and Raven, 1995)
The CPM is a standard neuropsychological test designed specifically for use with 
young children, less able adults, or clinically with people who are intellectually 
subnomal or who have deteriorated. It is used in cases where intellectual activity 
has become impaired, in order to establish the ability to perceive and think clearly. 
The instrument consists of three sets of 12 items of increasing difficulty, which can 
normally be completed by children under 11 years of age. The problems are
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represented as a series of pictures that have a section of the picture missing. 
Patients are required to select the missing piece of the picture from a choice of six 
possible pieces (an example is presented in Appendix 4.5).
Results of psychometric evaluations vary with populations studied, although almost 
all factor-analytic studies conducted in clinical settings report that the CPM has a 
high loading on General Intelligence. In a study to assess the progressive 
impairment of 60 MS outpatients, Halligan, Reznikoff, Friedman and La Rocca 
(1988) suggested that CPM scores decline progressively with the disease process. 
For further details the test manual cites numerous studies of reliability and validity 
(Raven, Court and Raven, 1995).
2) Emotional Functioning
Emotional state was assessed using the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond and Snaith, 1983), further details of which can be found on 
pp. 133-134 of Section 3.22.2.
3) Social Comparisons
A Social Comparisons/QoL structured interview was constructed for the present 
study (see Appendix 4.6), incorporating a linear analogue format that enables direct 
comparisons with sections of the SEIQoL-DW (O’Boyle et al., 1996). The 
interview content has been influenced by discussions with a healthy adult 
population (see Section 4.4 for details of Pilot Study) and also by research 
conducted on social comparisons and the subjective well-being of cancer patients 
(VanderZee et al., 1996).
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The interview consisted of three sections. In the first of these sections individuals 
rate their QoL ‘generally’ on a visual analogue scale and explain how they made 
this judgement (i.e. were comparisons made and if so did they involve the 
individuals own past {intrapersonal) or comparisons with other people 
{interpersonal). In the second stage, individuals are asked to respond on a Likert 
scale (where 0 is the ‘worst possible’ or ‘not at all’ and 7 is the ‘best possible’ or 
‘all the time’) to 3 questions regarding their views about their future; their QoL in 
relation to others with the same illness; and the extent to which they feel they need 
information about other people’s experience of the same illness. A fourth question 
considers the extent to which individuals compare themselves with people they 
consider to be both worse and better off than themselves. Section 3 asks 
individuals whether if given the hypothetical option, they would rather know about 
people who have scored higher or lower than themselves, or neither. Responses 
from Section 1 allow individuals to be grouped in the following way:
Group 1 = individuals who state they make comparisons when rating their QoL 
generally
Group 2 = individuals who state they do not make comparisons when rating their 
QoL generally
Sections 2 and 3 are intended to provide additional information on the relationship 
between QoL judgements and social comparisons.
4) OoL
QoL was assessed using the SEIQoL-DW and QoL ‘today’ and ‘generally’ ratings. 
Information concerning the content, administration and scoring of each measure is 
presented in Section 3.22.2 (pp.132-133) and Section 3.32.1 (pp.163-164).
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4.33 Procedure
Residents were invited to participate after consultation with the chartered clinical 
psychologist responsible for their care. In each case, the study was explained using 
both an information sheet (see Appendix 4.7) and hy personal explanation. 
Informed consent was then obtained according to hospital guidelines (see Appendix 
4.8). The procedures outlined in Study 1 concerning making and conducting 
appointments continued to apply in the current study (see Section 3.22.5, pp. 138- 
139).
The SEIQoL-DW, QoL ‘today’ and ‘generally’ ratings. Social Comparison/QoL 
Interview and the HADS were administered after cognitive assessments had been 
conducted, as demonstrated below in Table 4.2.
Table 4.2: Time-plan for assessments in Study 2
Week Measures Administered
1-2 Autobiographical Memory Interview
3-4 Similarities (WAIS-R)/Pyramids and Palm Trees
5-6 SEIQoL-DW/HADS
5-6 Social Comparison/QoL Interview
7/8/9
10-11 Coloured Progressive Matrices
4.34 Design and analysis
Hypotheses were explored using questionnaires, administered in an interview 
format so that the communication difficulties of the participants was accounted for. 
The self-report technique that was used is the only available method outlined in the 
literature that accommodates the nature of the disabilities of the present population. 
This was demonstrated to he feasible in Study 1 where individuals with MS were
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asked to rate their QoL ‘today’ and ‘generally’.
Years since diagnosis was controlled for using the same procedure as in Study 1 (see 
Section 3.22.3, p.l35). Autohiographical Memory Interview (AMI) scores were also 
controlled for, using the cut-off points stated within the AMI test manual (Kopelman, 
Wilson and Baddeley, 1990), which are based on the performance of 34 healthy 
controls. Population norms for the Similarities sub-test of the WAIS-R were drawn 
from the WAIS-R test manual and are based on healthy normal functioning persons of 
the same age group. Cut off points are based on the relation of scaled scores to 
deviations from the mean, as presented in Table 22, p.l51 of the WAIS-R Manual 
(Wechsler, 1986). Cut off points for the Pyramids and Palm Trees test were drawn 
from the test’s manual, formed on the basis that patients scoring 90% or above do not 
have a clinically significant impairment in the task at hand.
The following independent variables were measured: ability to make comparative 
judgements, autobiographical memory and presence/absence of comparisons made 
when evaluating QoL. The dependent variable was person-centred QoL, as 
measured by the SEIQoL-DW and QoL ‘today’ and ‘generally’ ratings. The study 
was essentially a factorial design, and the data was investigated using ANOVA. 
Additional analyses were conducted using Pearson product moment correlation 
coefficients, a chi-square test and K-means cluster analysis.
4.35 Ethical Considerations
The ethical concerns of Study 2 mirror those of Study 1, namely the amount of 
assessment to be conducted with each individual. This issue was discussed in full 
on pages 137-138. The administration time for the QoL measures, social
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comparison/QoL interview, cognitive measures and the HADS totals 
approximately two hours. Every care was taken to break the tasks down into 
shorter periods of assessment that were tolerable for the participants. Ethical 
procedures concerning informed consent, termination of testing and confidentiality 
of course continued to apply.
4.4 Social Comparisons/QoL Pilot Study
Before the study commenced, a pilot study was conducted using the social 
comparison/QoL interview with a population of 10 healthy adults working within a 
neurological setting. The aim of the pilot study was to identify potential problems 
such as ambiguity of terms or over-complexity of items, permitting further scale 
refinement. Ideally, a second population of neurologically disabled individuals 
fi*om the Royal Hospital for Neuro-disability would have been approached at this 
stage, in order that more direct generalisations could be made in adapting the scale 
where necessary to the needs of the current population. However, as all persons 
meeting the criteria for selection of participants stated in Section 4.31 had already 
been approached to take part in the main study, this was not a possible option.
The adults who were approached were therefore asked to fill in the interview from 
the perspective of a severely neurologically disabled patient. Of these ten 
individuals, six were currently working within the clinical psychology department 
at the Royal Hospital for Neuro-disability, two had recently completed research 
posts there and the remaining two were honorary neuropsychologists at the Royal 
Hospital for Neuro-disability and full time lecturers at Roehampton Institute 
London. It was considered that the feedback from this group provided the most
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valid basis for scale refinement, as all individuals who took part had considerable 
experience and knowledge of the day to day lives of the individuals for whom the 
questionnaire was intended. As the items within the social comparison/QoL 
interview represent several different constructs, rather than several aspects of a 
singular construct, analysis of internal consistency was not considered a viable 
basis for refining the interview format.
4.41 Revisions and related structured interview developments
Item 2 of the Social Comparison/QoL structured interview was re-written to 
incorporate the fact that 70% of individuals in the pilot study used both 
interpersonal and intrapersonal methods of comparison when considering their 
QoL, rather than just one of these methods as was anticipated. Item 3 was also re­
written to emphasise the value of, rather than need for, information regarding other 
people’s experience of illness. The final version of the structured interview is 
shown in Appendix 4.6. The pilot study was followed by the main study, the 
results of which are presented below.
4.5 Results
Individuals scores obtained on the WAIS-R subscales were transformed to scaled 
scores using procedures outlined in the WAIS-R manual (Wechsler, 1986). Scores 
on the AMI, the SEIQoL-DW and the Coloured Progressive Matrices were also 
transformed to single summary scores (see corresponding manuals for full details).
A number of observations were made on inspection of the social comparisons/QoL 
interview data. When making judgements on their QoL ‘generally’ (Section 1),
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only one individual (4% of total asked) said that her QoL rating was based on 
comparisons with other people and this comparison involved people she considered 
to be better off (an upward comparison) rather than worse off than herself. A 
further 38% of individuals (N=9) stated their rating was based on comparisons with 
other times in their lives, but the remaining 58% (N=14) made no comparisons at 
all in their evaluations. In order to reduce potential variability within groups 
formed for statistical analyses, the comparison with ‘other’ case was omitted from 
the data set and two groups, the ‘comparison with self and the ‘no comparison’ 
group were retained.
One individual (4%) reported a positive life change occurring at the time of QoL 
assessments; five individuals (22%) reported a negative life change occurring at the 
time of QoL assessments; and seventeen (74%) individuals reported no life change 
occurring at the time of assessments. For the purpose of the present analyses, the 
‘positive’ and ‘negative’ life change groups were combined to form a ‘life change 
experienced’ group. This was considered justified on the basis that neither group 
would be experiencing the stable QoL that is reported when no life changes occur 
within the present population. Means and standard deviations obtained for each 
variable are shown in Table 4.3.
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Table 4.3: Means and standard deviations obtained for each variable (N=23)
Variable Mean S.D.
Duration of illness 25.61 14.27
Years since admission 9.39 5.58
Pyramids and Palm Trees 17.78 3.13
Similarities (WAIS-R) (scaled score) 7.35 3.66
Digit Span Forward (WAIS-R) 6.39 2.25
Digit Span Backward (WAIS-R) 4.09 2.19
Digit Span: Total (scaled score) 10.48 3.99
Autobiographical Incidents Scale (AMI): Childhood 3.73 2.71
Early adult life 4.00 2.89
Recent adult life 4.21 3.05
Autobiographical Incidents Scale Total 11.95 7.95
Personal Semantics Scale (AMI): Childhood 14.46 4.97
Early adult life 13.59 5.18
Recent adult life 13.07 6.65
Personal Semantics Scale Total 41.20 15.10
HADS: Anxiety 4.96 2.90
Depression 4.70 3.23
SEIQoL-DW 70.67 17.81
QoL ‘today’ 69.74 25.03
QoL ‘generally’ 70.78 23.85
QoL ‘generally’ (2) 68.09 22.78
Coloured Progressive Matrices: Set A 7.95 2.75
Set AB 7.32 3.75
SetB 6.73 3.65
Coloured Progressive Matrices Total 22.00 9.52
N.B. The QoL ‘generally’ (2) rating was obtained at the time of the social 
comparison/QoL interview and shall be referred to using this label from this point 
forward.
From observation of the mean in relation to minimum and maximum scores, the 
shape of the distribution of the majority of scores appeared normal. This was 
confirmed when descriptive statistics for skewness were calculated, although the 
Pyramids and Palm Trees variable showed a skew less than -1 (-1.83). The skewed 
distribution observed was largely due to the fact that most individuals scored at the 
higher end of the scale. However, the cut-off point for a clinically significant 
impairment on the task at hand is 90% (anything below 18/20 in this instance), so
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even people who score highly in relation to minimum and maximum scores may 
actually perform poorly.
An arcsin transformation was conducted on Pyramids and Palm Trees scores, but 
this was not sufficient to remove the skew. In this situation the robustness of 
ANOVA to departures fi*om normality must be trusted to yield valid results (Winer, 
1971).
4.6 Analysis of results
4.61 Hypothesis 1
Hypothesis 1 stated that the presence of autobiographical memory deficits would 
affect perceptions of QoL; individuals with autobiographical memory deficits 
would rate their present QoL as higher than individuals with intact 
autobiographical memory. This was based on Kenealy et al. ’s (1999) proposal that 
information regarding the individual’s own QoL status before disease onset 
becomes increasingly difficult to access where autobiographical memory deficits 
are present. Perceptions of QoL will therefore be higher for individuals who 
cannot remember their pre-illness status, as they may be more satisfied generally 
with their present QoL than individuals with normal autobiographical memory 
functioning who can remember their pre-illness status.
In order to test this hypothesis, SEIQoL-DW, QoL ‘today’ and QoL ‘generally’ 
means were firstly summarised for individuals with and without deficits on the 
Autobiographical Incidents scale of the AML Results obtained are presented below 
in Table 4.4. This scale shall be referred to using the ‘AIS’ abbreviation from this
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point forward.
Table 4.4: Mean SEIOoL-DW and OoL ‘today’ and ‘generally’ scores for each 
Autobiographical Memory group (N=23)
Autobiographical Memory Functioning
Deficits (N=14) No Deficits (N=9)
QoL Variable Mean S.D. Mean S.D.
SEIQoL-DW 74.78 18.23 64.27 16.00
QoL’Today’ 74.79 21.05 61.89 29.82
QoL ‘Generally’ 73.07 25.26 67.22 22.45
QoL ‘Generally’ (2) 67.64 25.13 68.77 19.98
As Table 4.4 demonstrates, QoL mean scores were generally higher for individuals 
with abnormal autohiographical memory than individuals with normal 
autobiographical memory. This was in the direction of the predicted hypothesis. 
Four univariate ANOVAs were conducted in order to examine whether 
autohiographical memory functioning had a significant effect on QoL (SEIQoL- 
DW, QoL ‘today’, QoL ‘generally’ and QoL ‘generally (2), see Appendix 
Appendix 4.9). F  values confirmed that there were no significant effects of 
autobiographical memory on QoL, a finding that was also replicated when only 
individuals reporting no significant life changes at the time of assessment were 
considered independently (see Appendix 4.10).
However, descriptive statistics showed there was substantial variation either side of 
QoL mean scores for both autobiographical memory functioning groups. When 
individual scores obtained on the AIS and the SEIQoL-DW were examined in 
greater detail, two outlying scores were identified. Participants 7 and 19 both had 
autobiographical memory deficits and scored 40.15 and 43.99 on the SEIQoL-DW,
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much lower than the deficit group’s mean SEIQoL-DW score of 74.78. When 
these two cases were removed from the data set, the mean SEIQoL-DW score rose 
from 74.48 to 80.23, increasing the mean difference between the deficit/no deficit 
groups’ scores. The F  value obtained using univariate analysis of variance was 
significant (F(l, 19)=6.44,/?<0.05) (see Appendix 4.11). There was a significant 
effect of autobiographical memory functioning on person-centred QoL. The 
influence of cognitive functioning on QoL therefore remained open to question.
To further examine the relationship between autobiographical memory functioning 
and QoL, AIS scores were broken down by time period (memory for childhood, 
young adult and recent incidents). QoL mean scores were then summarised by each 
AIS subgroup, for individuals with and without deficits in autobiographical 
memory, on the basis of cut-off points within the AMI test manual. Mean QoL 
scores are presented in Table 4.5.
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Table 4.5: Mean OoL scores by deficit/no deficit groups for childhood, young 
adult and recent snbscales of the AIS
Memory for childhood incidents
QoL Variable Cases Mean S.D.
SEIQoL-DW Deficit (N=15) 75.27 17.67
No Deficit (N=8) 62.04 15.55
QoL ‘Today’ Deficit (N=15) 76.47 21.30
No Deficit (N=8) 57.12 27.99
QoL ‘Generally’ Deficit (N=15) 74.87 25.31
No Deficit (N=8) 63.12 20.09
QoL ‘Generally’ 2 Deficit (N=15) 68.13 24.29
No Deficit (N=8) 68.00 21.21
Memory for young adult incidents
QoL Variable Cases Mean S.D.
SEIQoL-DW Deficit (N=ll) 72.64 17.38
No Deficit (N=12) 6&85 18.75
QoL ‘Today’ Deficit (N=ll) 74.45 20.99
No Deficit (N=12) 65.41 28.46
QoL ‘Generally’ Deficit (N=ll) 69J6 28.50
No Deficit (N=12) 72.08 19.89
QoL ‘Generally’ 2 Deficit (N=ll) 66.63 28.69
No Deficit (N=12) 69.41 16.88
Memory for recent incidents
QoL Variable Cases Mean S.D.
SEIQoL-DW Deficit (N=13) 76.16 15.22
No Deficit (N=10) 63.52 19.12
QoL ‘Today’ Deficit (N=13) 83J3 17.97
No Deficit (N=10) 52.20 22.27
QoL ‘Generally’ Deficit (N=13) 75.38 26^#
No Deficit (N=10) 64.70 18.76
QoL ‘Generally’ 2 Deficit (N=l 3) 7269 27.59
No Deficit (N=10) 62.10 13.51
The mean scores suggested there was little difference between the QoL perceptions 
of individuals with and without memory deficits for incidents in young adult life. 
However, individuals with autobiographical memory deficits for childhood or 
recent incidents obtained higher mean QoL scores than individuals without these 
deficits. This was in the direction of Hypothesis 1. In order to examine whether 
there were significant effects of autobiographical memory functioning for
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childhood, young adult and recent life incidents on QoL (SEIQoL-DW, QoL 
‘today’, QoL ‘generally’ and QoL ‘generally’ 2), twelve univariate ANOVAs were 
conducted (see Appendix 4.12). Results are summarised below in Table 4.6.
Table 4.6: The effects of autobiographical memory deficits for childhood, 
young adult and recent incidents on QoL scores
Memory for childhood incidents
QoL Variable F  value d f Sig. level
SEIQoL-DW 3.15 (1.21) N.S.
QoL ‘Today’ 3.46 N.S.
QoL ‘Generally’ L28 N.S.
QoL ‘Generally’ (2) 0.00 N.S.
Memory for young adult incidents
QoL Variable F  value d f Sig. level
SEIQoL-DW 0.25 (1,21) N.S.
QoL ‘Today’ 0.73 N.S.
QoL ‘Generally’ 0.07 N.S.
QoL ‘Generally’ (2) 0.08 N.S.
Memory nr recent incidents
QoL Variable F  value d f Sig. level
SEIQoL-DW 3.11 (1,21) N.S.
QoL ‘Today’ 13.69 /7<0.01
QoL ‘Generally’ 1.11 N.S.
QoL ‘Generally’ (2) 1.23 N.S.
With the number of non-significant findings obtained within this set of analyses, the 
increased chance of Type II errors occurring here is acknowledged. However, it is 
worth noting that the possibility of a Type II error is raised when a particularly 
stringent alpha level is set. A lenient alpha level lowers the chance of a Type II error, 
but increases the chance of a Type I error (Reber, 1985). With the alpha level set at 
0.05 in the present analyses, it therefore seemed more likely that a true hypothesis 
would be erroneously rejected, than a false hypothesis wrongfully accepted. On this 
basis it is noteworthy that the F  values representing the effect of autobiographical
227
memory for childhood incidents on SEIQoL-DW and QoL ‘today’ scores, and the F  
value representing the effect of autobiographical memory for recent incidents on 
SEIQoL-DW scores, just failed to reach significance (p<0.05).
F  ratios confirmed that there were no significant effects of autobiographical 
memory deficits for childhood or young adult incidents on QoL scores obtained. 
However, there was a significant effect of autobiographical memory deficit for 
recent incidents on QoL ‘today’ ratings; individuals with a deficit for recent 
incidents obtained significantly higher QoL ‘today’ scores than individuals with 
intact memory for recent incidents (F(l, 21)=13.69, j9<0.01). This finding was in 
the direction of the predicted hypothesis, and on this basis Hypothesis 1 was 
accepted. The presence of autobiographical memory deficits did affect perceptions 
of QoL when memory for recent incidents was considered independently. It is also 
worth noting that this effect was relatively unchanged when immediate memory 
(Digit Span subscale of the WAIS-R) was entered as a covariate (F(l, 21)=14.03, 
/><0.01) (see Appendix 4.13), suggesting that the effect was not just a consequence 
of poor immediate memory.
4.62 Hypothesis 2
Hypothesis 2 stated that cognitive functioning would affect the processes used to 
evaluate QoL; individuals with deficits affecting ability to make comparisons 
would be less likely to use social comparisons when rating their QoL than 
individuals without deficits relating to ability to make comparisons. In order to 
examine this hypothesis, the frequency of individuals with and without deficits on 
each cognitive test administered was firstly obtained for both comparison groups. 
Results are presented in Table 4.7.
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Table 4.7: The frequency of individuals with and without deficits on the 
Pyramids and Palm Trees. Similarities and AIS. for both comparison groups
Cognitive Functioning
Pyramids and Palm 
Trees
Similarities Autobiographical
Memory
Comparison
group
Deficits
(<=17)
No
Deficits
(>=18)
Deficits
(<=4)
No
Deficits
(>=5)
Deficits
(<=15)
No
Deficits
(>=16)
1 N=3 N=6 N=2 N=7 N=5 N=4
2 N=4 N=10 N=4 N=10 N=9 N=5
Key to Table 4.7:
Group 1= individuals making comparisons with their own past life in order to 
evaluate their present QoL 
Group 2= individuals evaluating their present QoL without using comparison 
processes
The frequency distributions suggested that individuals with low scores on one 
cognitive test did not always obtain low scores on the other cognitive tests. 
However, significant relationships were demonstrated among the tests when 
Pearson product moment correlation coefficients were calculated, as Table 4.8 
demonstrates.
Table 4.8: Correlations observed among Pyramids and Palm Trees. 
Similarities and AIS scores (N=23)
AIS Pyramids and Palm Trees Similarities
AIS 0.66** 0.61**
Pyramids and Palm Trees 0.66** 0.64**
Similarities 0.61** 0.64**
*=p<0.05 **=p<0.01
In order to clarify groupings within the cognitive data before further analyses were
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conducted AIS, Pyramids and Palm Trees and Similarities scores were analysed 
using K-means cluster analysis. Three and four-cluster solutions were obtained, 
but the three-cluster solution (using 5 iterations) was retained as it provided more 
logical case groupings than the four-cluster solution. Table 4.9 presents the means 
for the subgroups identified.
Table 4.9; Final cluster centres identified for AIS. Pyramids and Palm Trees 
and Similarities scores (N=23)
Cluster
1(N=9) 2(N=8) 3(N=6)
Cognitive
Variable
Mean S.D. Mean S.D. Mean S.D.
AIS 19.78 2.81 11.38 3.29 1.17 1.16
Pyramids and 
Palm Trees
19.33 0.87 18.88 2.10 14.00 3.52
Similarities &89 3.44 7.13 2.74 3.83 1.72
From inspection of means in relation to ‘normal’ and ‘abnormal’ ranges for each 
cognitive test, cluster group 1 can be said to represent the 'normal functioning’ 
individuals; who obtain ‘normal’ range scores on all three cognitive tests. Cluster 
group 2 seems representative of ‘mid-rangefunctioning’ m6iyià\xdXs\ who generally 
obtain ‘abnormal’ range scores on the AIS but ‘normal’ range scores on Pyramids 
and Palm Trees and Similarities tests. Finally, cluster group 3 appears 
representative of ‘abnormal functioning’ individuals; who obtain abnormal range 
scores on all three cognitive tests.
As Table 4.10 demonstrates, a one-way unrelated ANOVA suggested that there 
were significant differences among cluster groups’ scores on all three of the
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cognitive tests, the greatest difference observed on the AIS (see Appendix 4.14).
Table 4.10: Significant differences observed among AIS. Pyramids and Palm 
Trees and Similarities mean scores for each cluster group identified (N=23I
Cognitive
Variable
Cluster Group Means F  value d f Sig.
LevelCluster 1 Cluster 2 Cluster 3
AIS 19.78 11.38 1.17 8258 (2, 20) j9<0.01
Pyramids and 
Palm Trees
18.88 19.33 14.00 11.83 (2,20) j9<0.01
Similarities &89 7.13 283 8.15 (2, 20) j9<0.01
Post-hoc comparisons using Tukey’s multiple comparison test confirmed 
significant differences between all three cluster groups on the AIS (p<0.01); 
between groups 1 and 3 (p<0.01) and 2 and 3 (p<0.01) on the Pyramids and Palm 
Trees; and between groups 1 and 3 (p<0.01) on the Similarities test.
Having identified three distinct cognitive groups, the frequency of social 
comparisons made within each group was examined in order to address Hypothesis 
2. As Figure 4.1 overleaf demonstrates, 55% (N=5) of individuals with normal 
autobiographical memory (cluster group 1) made social comparisons in order to 
evaluate their QoL. For this group, the ability to choose between making or not 
making comparisons remains an option. However, only one individual (12.5%) 
with autobiographical memory deficits (cluster group 2) made comparative 
evaluations and in this case a significant life change was also reported at the time 
of assessment (see Section 4.64).
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Fifty percent (N=3) of the individuals with abnormal cognitive functioning (Cluster
3) stated they made comparisons, even though they did not appear to have the 
cognitive capacity to do so. Further analysis using a one-way unrelated ANOVA 
confirmed this group also had significantly lower Digit Span scores than groups 1 
and 2 (Appendix 4.15) (F(2, 20)=8.27, /><0.01), confirming they had abnormal 
immediate memory functioning. This group may not have remembered rating their 
QoL, therefore producing invalid responses when asked whether or not they had 
made comparisons in order to make this rating. This would provide an explanation 
for the frequency of comparisons made within Cluster 3, a possibility that is 
discussed in greater detail in Section 4.7.
A modified Pearson chi-square test using Yates correction for continuity was 
applied in order to determine whether the observed frequencies for comparisons 
within clusters 1 and 2 were significantly different from those to be expected if 
there was no association between comparison strategy and cognitive functioning. 
Using dj=l, the obtained chi-square value of 1.79 was not significant. Results 
confirmed that there was no significant difference between the frequency of social 
comparisons made by individuals with and without deficits affecting ability to 
make comparative judgements. Hypothesis 2 was therefore not supported. It is also 
interesting to note that there was no significant difference among the frequency of 
social comparisons made by individuals with and without autobiographical 
memory deficits for childhood (X^=0.10, df=\, N.S.), young adult (X^=1.89, df=\, 
N.S.) or recent incidents (X^=0.39, df=\, N.S.). This suggests that the social 
comparisons that were made were not typically associated with any one specific 
life phase, but were drawn from across the life span of the individuals concerned.
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4.63 Hypothesis 3
Hypothesis 3 stated that there would be a significant effect of evaluation strategy 
on QoL ratings; individuals who made comparative judgements when rating their 
present QoL would obtain significantly lower QoL ratings than individuals who 
evaluated their QoL without the use of comparative processes. The theoretical 
basis for this prediction is discussed within Section 4.1. In order to test this 
hypothesis mean QoL ‘generally’ (2) scores were obtained for both comparison 
groups; for all cases and independently for those reporting no significant life 
changes occurring at the time of the assessment. Results are presented in Table 
4.11.
Table 4.11: Mean OoL ‘generally’ (21 ratings obtained for both comparison 
groups; for all cases (N=23) and those reporting no significant life changes 
occurring at the time of the assessments (N=17)
Social Comparisons Groups
ALL CASES
GROUP 1 (N=9) 
(Comparisons)
GROUP 2 (N=14) 
(No Comparisons)
Mean S.D. Mean S.D.
54.89 17.22 76.57 22.30
‘NO CHANGE’ CASES OHLY
GROUP 1 (N=5) 
(Comparisons)
GROUP 2 (N=12) 
(No Comparisons)
Mean S.D. Mean S.D.
43.40 13.15 81.17 17.94
The mean QoL ‘generally’ (2) score was much higher for individuals who had not 
made comparative judgements than individuals who had used a comparative 
process in or order to rate their QoL. The difference between group’s means also 
increased when individuals reporting no significant life changes were considered
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independently. In order to examine whether there was a significant effect of 
evaluation strategy on QoL ‘generally’ (2) ratings, one-way unrelated ANOVAs 
were conducted (see Appendix 4.16). Results are summarised in Table 4.12.
Table 4.12: Analysis of the difference in OoL ‘generally’ (2) between Groups 1 
and 2
Variable Cases F  value d f Sig. level
QoL ‘generally’ (2) All cases 6.11 (1.21) p<0.05
QoL ‘generally’ (2) No change only 17.85 (1,15) p<0.01
F  values obtained confirmed there was a significant effect of evaluation strategy on 
QoL ratings; individuals who made comparative judgements with their own past 
when rating their QoL ‘generally’ produced significantly lower QoL ratings than 
individuals who evaluated their QoL ‘generally’ using no comparative process. 
Hypothesis 3 was therefore supported. It is also worth noting that these effects were 
relatively unchanged when depression (HADS) was entered as a covariate, (see 
Appendix 4.17), suggesting that depression had not influenced the effect of 
evaluation strategy on QoL ‘generally’ (2) ratings.
4.64 Further exploratory analyses
Extent of autobiographical memory deficit and OoL
Analyses were conducted to determine whether extent of autobiographical memory 
deficit had an effect on QoL scores. Individuals were grouped in the following 
way, according the number of ‘abnormal’ range scores they obtained on the 
childhood, young adult and recent life AIS subscales:
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Group 1 = normal autobiographical memory functioning (‘normal’ range scores 
on all three subscales)
Group 2 = moderate autobiographical memory deficits (one/two ‘abnormal’ 
range scores)
Group 3 = severe autobiographical memory deficits (three ‘abnormal’ range 
scores)
QoL means were then obtained for each of these groups (see Table 4.13).
Table 4.13: Mean QoL scores for each AIS deficit’ group
AIS deficit group
Group 1 (N=5) Group 2 (N=9) Group 3 (N=9)
QoL Variable Mean S.D. Mean S.D. Mean S.D.
SEIQoL-DW 60.51 17.83 71.34 18.06 75.64 17.15
QoL ‘today’ 41.40 11.39 75.33 25.24 7&89 19.19
QoL ‘generally’ 56.20 15.30 79.00 16.71 70.67 30.97
QoL ‘generally’ 2 61.00 16.71 72.55 15.74 67.55 31.39
Mean QoL scores suggested that individuals with ‘normal’ autobiographical 
memory functioning (Group 1) obtained lower QoL scores than individuals with 
moderate (Group 2) and severe (Group 3) autobiographical memory deficits. 
However, the relatively small number of cases within Group 1 is acknowledged, 
and is thought to reflect the fact that cognitive skills are impaired to some extent in 
the majority of individuals with late-stage neurological illness.
A one-way umelated ANOVA was performed to examine whether the differences 
observed among QoL scores for each deficit group were significant (see Appendix 
4.18). Results are summarised in Table 4.14.
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Table 4.14: Analysis of the difference in OoL between AIS groups
QoL Variable d f F  ratio Sig. level
SEIQoL-DW (2,20) 1.19 N.S.
QoL ‘Today’ (2,20) 6.10 7?<0.01
QoL ‘Generally’ (2,20) 1.54 N.S.
QoL ‘Generally’ 2 (2,20) 0.39 N.S.
F  values suggested there was a significant effect of extent of AIS deficit on QoL 
‘today’ ratings (F(2, 20)=6.10, /><0.01). Post-hoc comparisons using Tukey’s 
multiple comparison test confirmed that individuals with ‘normal’ autobiographical 
memory functioning obtained significantly lower QoL ‘today’ ratings than 
individuals with moderate autobiographical memory deficits (p<0.05) and severe 
autobiographical memory deficits (p<0.01). There were no significant differences 
between the QoL ‘today’ ratings of individuals with moderate and severe deficits. 
These findings provide further support for Hypothesis 1, and are discussed in 
Section 4.7
General cognitive functioning and OoL
Having established a relationship between recent memory deficits and QoL, the 
three cluster groups identified in analysis of Hypothesis 2 were utilised to examine 
level of general cognitive functioning and its effects on QoL. Mean QoL scores 
obtained for each of the three cognitive groups, for all cases and ‘no significant life 
change’ cases only, are presented below in Table 4.15.
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Table 4.15: Mean QoL scores obtained for general cognitive functioning 
groups; for all cases (N=23) and only those reporting no significant life 
changes occurring at the time of OoL assessments (N=17)
Cognitive Functioning Groups
ALL CASES
GROUP 1 (N=8) GROUP 2 (N=9) GROUP 3 (N=6)
QoL Variable Mean S.D. Mean S.D. Mean S.D.
QoL ‘Generally’ 65.00 19.62 71.50 29.17 78.50 23.75
QoL ‘Today’ 59.67 27.26 73.50 21.57 79.83 24.27
SEIQoL-DW 60.79 17.57 76.67 16.67 77.47 14.94
QoL ‘Generally’ (2) 63.89 16.46 71.00 21.63 70.50 33.79
‘NO CHANGE’ CASES CINLY
GROUP 1 (N=6) GROUP 2 (N=5) GROUP 3 (N=6)
QoL Variable Mean S.D. Mean S.D. Mean S.D.
QoL ‘Generally’ 65.33 23.27 85.40 9.53 78.50 23.75
QoL ‘Today’ 69.67 27.29 80.60 19.15 79.83 24.26
SEIQoL-DW 55.55 17.73 81.61 10.70 77.47 14.94
QoL ‘Generally’ (2) 59.67 18.79 82.00 10.37 70.50 33.71
Note: Group 1 -  'normal functioning/comparisons \ Normal range cognitive test 
scores (AIS included). Mixed comparative strategies employed 
Group 2 -  'mid-range functioning/no comparisons \ Abnormal AIS scores 
only, generally no comparisons made.
Group 3 - ‘abnormal functioning/comparisons \ Abnormal range cognitive 
test scores, mixed comparative strategies employed.
When all cases were considered, means suggested the abnormal cognitive 
functioning group generally obtained the highest QoL scores, the normal and mid­
range groups obtaining lower QoL means. There were further distinctions between 
mid-range and normal cognitive functioning groups on SEIQoL-DW and QoL 
‘today’ mean ratings, suggesting the normal cognitive functioning group generally 
obtained the lowest QoL scores. However, one-way unrelated ANOVAs indicated 
that there was no significant effect of general cognitive functioning on QoL 
perceptions (see Appendix 4.19).
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When ‘no significant life change’ cases were considered independently, there was a 
greater distance between the QoL mean scores obtained by cluster groups 1 and 2 
(see Table 4.16). One-way unrelated ANOVAs (see Appendix 4.20) suggested that 
there was a significant effect of cognitive functioning on SEIQoL-DW scores 
obtained (F(2, 14)=4.99, p<0.05 ). A post-hoc analysis using Tukey’s multiple 
comparison test confirmed these differences lay between groups 1 and 2 (p<0.05). 
Therefore where no significant life changes were reported at the time of 
assessment, individuals with ‘mid-range’ cognitive functioning (abnormal AIS 
scores only) had significantly higher QoL ratings than individuals with ‘normal’ 
cognitive functioning, a finding that provides further support for Hypothesis 1.
Life change, evaluation strategy and OoL
Whilst conducting analyses relating to Hypothesis 3, it was noted that 66% (N=4) 
of individuals reporting significant life changes to have occurred during the week 
before assessments were individuals who had made comparisons with their past in 
order to evaluate their present QoL. Although a small proportion of the overall 
population, this suggested the occurrence of life changes might be a determining 
factor in whether or not social comparisons are made. It has already been 
established that individuals who are able to make comparisons may or may not do 
so, but the underlying reasons for this remain unknown. In order to investigate the 
possibility that life changes are involved, a 2 x 2 unrelated ANOVA was performed 
so that the effects of life change and evaluation strategy on QoL ‘generally’ (2) 
scores could be examined. Results of the two-way ANOVA conducted (see 
Appendix 4.21) are summarised below in Figure 4.2.
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Figure 4.2: The interaction effect observed between evaluation strategy and 
life change on OoL ‘generally’ (2) ratings
No life change reported Life change reported 
Reported life change
Comparison made ■ No comparison made
There was a significant interaction between evaluation strategy and life change on 
QoL ‘generally’ (2) ratings {F{\, 19)=11.09,/?<0.01), although no significant main 
effects were found. The interaction effect suggests that when life changes are not 
reported to occur at the time of assessment, individuals who make comparisons 
with their own past in order to evaluate their present QoL report significantly lower 
QoL (QoL ‘generally’ X=43.40) than individuals who refrain from using this 
evaluation strategy (QoL ‘generally’ Y=81.17). However, when life changes are 
reported to occur, individuals who make comparisons with their own past in order 
to evaluate their present QoL report significantly higher QoL (QoL ‘generally’ X= 
69.25) than individuals who refrain from using this evaluation strategy (QoL 
‘generally’ X =49.00).
This finding was unexpected, as the no comparison/life change group who reported
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a lower perceived QoL ‘generally’ included one individual who experienced a 
positive life event at the time of assessment. One would assume that this individual 
would report a high level of QoL ‘generally’, given the positive life event of an 
unexpected visitor. However, this positive event may have had some negative 
repercussions. Events that are beyond the individuals’ control, whether they are 
negative or positive events, may create anxiety, stress and uncertainty. This type of 
response may be especially evident in persons with MS, where an unpredictable 
disease course may increase the individuals’ perceived need for stability in all other 
life areas.
It remains important not to over-interpret this data, as only one positive life change 
was reported in the present study. However, this individual did have a diagnosis of 
MS. Therefore, on the basis of the suggestion outlined above, a second 2 x 2  
unrelated ANOVA was conducted to examine the same interaction effect when 
persons with MS (N=16) were considered independently of those with other 
neurological diagnoses (N=7) (see Appendix 4.22). The interaction effect between 
evaluation strategy and life change on QoL ‘generally’ (2) ratings remained 
significant, albeit slightly weaker (F(l, 12)=5.74, /><0.05). This suggests that 
uncertainty, stress and anxiety may be associated with uncontrollable positive and 
negative life events in persons with MS and other neurodegenerative diseases. 
This set of analyses is discussed in greater depth in Section 4.7.
Memory for recent events, significant life change and OoL
Previous research with the present population has suggested that life changes that 
occur around the time of assessment play an important role in subsequent QoL 
judgements (see Section 3.31). However, if one cannot remember recent incidents
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in great detail, then life changes that occur around the time of assessment may be 
less important in determining present QoL.
On this basis, a 2x2 ANOVA was conducted to examine the effects of life change 
(Factor 1) and memory deficits for recent incidents (Factor 2) on QoL (see 
Appendix 4.23). Factor 1 had two levels (change/no change) and Factor 2 had 2 
levels (deficit/no deficit). Results are summarised in Figure 4.3.
Figure 4.3: The interaction effect observed between life change and 
autobiographical memory deficit for recent incidents on SEIOoL-DW scores
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Life change reported No life change reported 
Life change
Deficit ■ No deficit
There was a significant interaction between life change, autobiographical memory
deficit for recent incidents and SEIQoL-DW scores (F(l, 19)=9.33, /?<0.01),
although no main effects for life change were found on this occasion. The
interaction effect suggests that when life changes are not reported to occur at the
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time of assessment, individuals with an autobiographical memory deficit for recent 
events report significantly higher QoL (SEIQoL-DW X=79.71) than individuals 
without this deficit (SEIQoL-DW X  =54.85). However, when life changes are 
reported to occur, individuals with an autobiographical memory deficit for recent 
events report significantly lower QoL (SEIQoL-DW X=56.69) than individuals 
with intact autobiographical memory for recent events (SEIQoL-DW Y =76.51).
Given the interaction effect of evaluation strategy and life change on QoL 
‘generally’ (2) ratings (see p.240), it is interesting to note that the individuals with 
deficits for recent events who reported life changes occurring did not make use of 
comparative strategies and reported relatively low SEIQoL-DW scores. It is also 
noteworthy that this interaction effect suggested the opposite to findings in relation 
to Hypothesis 1, where individuals with an autobiographical memory deficit 
reported significantly higher perceived QoL than those with normal 
autobiographical memory functioning.
4.7 Discussion
Hypothesis 1 stated that the presence of autobiographical memory deficits would 
affect perceptions of QoL; individuals with autobiographical memory deficits 
would rate their QoL as higher than individuals with intact autobiographical 
memory. This was based on previous research by Kenealy et al (1999), who 
demonstrated that individuals with autobiographical memory deficits were more 
satisfied with their present QoL than individuals with normal autobiographical 
memory functioning, as they could not remember their pre-illness status. Although 
Kenealy et al (1999) adopted a health-based approach to QoL measurement using
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the SF-36 Health Survey, it was anticipated that autobiographical memory 
functioning would also affect evaluations of person-centred QoL.
Hypothesis 1 was supported when the AIS scale was broken down by life phase, 
analyses confirming that individuals in the present population with 
autobiographical memory deficits for recent incidents obtained significantly higher 
QoL ‘today’ scores than individuals without this deficit. The ‘recent life’ subscale 
of the AIS focuses on, for example, incidents that have occurred at the individual’s 
present hospital, and incidents involving family within the last year. The present 
findings suggest that individuals are more satisfied with their present QoL when 
they cannot remember such events.
This may be because their deficit prevents them from obtaining a full 
understanding of the impact that disease progression has had across recent years of 
their lives. For example, individuals who now receive fewer visits from relatives, 
or get out less frequently than they used to, may be happier without knowledge of 
this impact. By comparison, individuals who are able to remember such details 
about their recent life may rate their present QoL as significantly lower.
Initially, analyses in the present study suggested there was no effect of 
autobiographical memory deficits on QoL. However, when two individual outlying 
scores were removed, a significant effect of autobiographical memory functioning 
on SEIQoL-DW scores was demonstrated; individuals with intact autobiographical 
memory functioning obtained significantly lower SEIQoL-DW scores than 
individuals with ‘abnormal’ autobiographical memory functioning.
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Within exploratory analyses, a similar effect on SEIQoL-DW scores (where no 
significant life changes were reported) was obtained when the autobiographical 
memory groups were substituted by the cognitive cluster groups identified in 
analysis of Hypothesis 2. Furthermore, when extent of autobiographical memory 
deficit was examined, individuals with ‘normal’ autobiographical memory 
functioning obtained significantly lower QoL ‘today’ ratings than individuals with 
both ‘moderate’ and ‘severe’ autobiographical memory deficits. Each of these 
latter findings support previous research conducted by Kenealy et al. (1999), who 
stated individuals who cannot remember their pre-illness status may be more 
satisfied generally with their present QoL.
The influence of individual outlying scores on QoL means in the present study may 
have obscured results obtained in the first analysis, given that the latter analyses 
supported Hypothesis 1. The problem of individual outlying scores and their 
influences has already discussed within Section 3.34 of Study 1. This is, however a 
feature of the data that is acknowledged to pose problems with small sample sizes. 
On this basis, further research is required before conclusions are drawn concerning 
the effects of autobiographical memory deficits on person-centred QoL.
The role of cognitive functioning on QoL scores was also investigated in 
Hypothesis 2, which stated that individuals with cognitive deficits affecting ability 
to make comparisons would be less likely to use social comparisons when rating 
their QoL than individuals without such cognitive deficits. Given the small sample 
size in the present study, the highly significant differences obtained on cognitive 
test scores among cluster groups confirmed three very different cognitive profiles 
within the present population. This finding also supports previous research by
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Beatty et al (1996), who suggested that with respect to memory performance there 
are at least three ‘clusters’ of MS patients based on degree of impairment.
Although results of frequency analyses were not significant, some interesting 
observations emerged from observed frequencies. Fifty percent of the ‘abnormal 
functioning’ group stated they made comparisons with their past in order to 
evaluate their present QoL. In light of their severe cognitive impairments, 
particularly their short-term and autobiographical memory deficits, it was 
concluded that their responses on the Social Comparisons/QoL Structured 
Interview were probably invalid. Kenealy et aVs (1999) suggestion that cognitive 
deficits make the process of comparisons in order to evaluate QoL increasingly 
prone to error, or inaccessible, provides a logical explanation for the patterns 
observed within this group.
Hypothesis 3 stated there would be a significant effect of evaluation strategy on 
QoL ratings; individuals who made comparative judgements when evaluating their 
present QoL would produce significantly lower QoL ratings than individuals who 
evaluated their QoL without the use of comparison processes. This was partially 
based on previous research by Skevington (1994), who concluded that the study of 
social comparisons seemed appropriate when considering QoL; the same 
conclusion independently put forward by patients involved in the study.
QoL ‘generally’ (2) scores (obtained at the time of the QoL/Social Comparisons 
Structured Interview) were significantly higher for individuals who did not make 
comparisons, confirming that comparison strategy had a significant effect on 
person-centred QoL. Individuals who made comparisons with own past generally
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had lower perceptions of their present QoL; a finding that was even more 
pronounced when ‘no change’ cases were considered independently.
Comparison strategy had no effect on reported SEIQoL-DW scores, a possible 
advantage of using this measure in order to assess individual QoL. Perhaps the 
structure of the SEIQoL-DW does not invite comparisons so readily as the visual 
analogue scales, as questions are less direct and the term QoL is not actually 
mentioned. The fact that SEIQoL-DW scores are not influenced by comparison 
strategies employed provides further justification for use of the SEIQoL-DW in 
assessing person-centred QoL in a severely disabled neurological population, as 
scores obtained remains unaffected by different judgement strategies employed.
None of the individuals in the present study made the ‘downward’ comparisons that 
are said to occur most frequently in persons with serious medical problems 
(Affleck and Tennen, 1991; Blalock, DeVellis and DeVellis, 1989; DeVellis et al., 
1990; Skevington, 1994). In fact, in all but one case individuals made comparisons 
with their own past, the type of comparison that Sartorius (1987) refers to as 
‘intrapersonaT.
One plausible explanation for this stems from the findings of Wood, Taylor and 
Lichtman (1985). They suggest that the frequency of downward comparisons is 
strongest early on in the process of adaptation to illness. If social comparisons play 
an important role in coping with chronic illness, then the need for upward and 
downward comparisons may be less urgent after long-term adaptation to illness has 
occurred. As the averaged years since diagnosis was 26 years within the present 
sample, this might explain the absence of such comparisons in the present study.
247
Perhaps if the study was replicated using individuals with an average disease 
duration of say, 5 years, upward and downward comparison strategies would have 
been encountered. Several studies have suggested that non-depressed persons 
make significantly fewer comparisons than mildly depressed persons (Swallow and 
Kuiper, 1990, 1992). This may be another reason why few comparisons were 
made, as only 2 individuals within the present population showed signs of 
depression on the HADS.
The present study also demonstrated that significant life changes reported to occur 
at the time of assessment and comparison strategy interact with person-centred 
QoL. However, it was unexpected that the ‘no comparison/life change’ group who 
reported a lower perceived QoL ’generally’ included one individual who reported a 
positive life event at the time of assessment. Although one might expect a higher 
reported QoL in cases where positive life changes are experienced, it was 
considered that events that are beyond the individuals’ control, whether positive or 
negative, may create anxiety, stress and uncertainty.
It was also suggested that the unpredictable disease course associated with MS 
might increase the desire for stability in all other life areas within the present 
population. An additional analysis indicated that this perceived need for stability 
might not be unique to persons with MS, and might also apply to persons with 
other neurodegenerative diseases within the present population.
Evers and Kamilowicz (1996) conducted a study of patient attitude as a function of 
disease type in 108 MS patient in remission, and 135 patients with a chronic 
progressive disease course. The authors did not present information concerning the
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extent of physical disability or range of illness duration within this sample. 
However, they suggested that persons with chronic progressive MS perceived 
several life areas with significantly greater negativity than persons with relapsing- 
remitting MS. For example, the chronic-progressive group experienced greater 
frustration with regard to completing daily activities; held more negative 
perceptions concerning their ability to cope with the symptoms of MS; and held 
more pessimistic beliefs with respect to their own abilities.
Perhaps persons with chronic-progressive MS also perceive positive events with a 
degree of negativity, believing, for example, that there must be a negative event 
soon to follow. This would provide an alternative explanation to the lower 
perceived QoL reported by the individual experiencing a positive life change 
within the present study. If individuals with chronic-progressive MS hold negative 
perceptions of their ability to cope with MS-related symptoms, this might also 
increase their perceived need for stability that has aheady been discussed. 
However, it remains essential not to over-generalise when interpreting this finding, 
as only one individual within the present population experienced a positive life 
change at the time of assessment. Whilst the present finding provides interesting 
and unexpected information concerning the affect of positive life changes on 
perceived QoL, all interpretations relating to this effect remain purely speculative.
Aside from the plausible explanations for this finding, the associated interaction 
effect suggested that making comparisons with ones’ past life is not detrimental to 
present QoL perceptions if life changes are being experienced at the time of 
assessment. On the contrary, individuals who are experiencing life changes and 
make comparisons report significantly higher QoL evaluations than individuals
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who are experiencing life changes but refrain from making comparisons. On the 
other hand, when life changes are not reported to occur at the time of assessment, 
individuals who make comparisons with their own past in order to evaluate their 
present QoL report significantly lower QoL than individuals who refrain from 
making such comparisons.
If the experience of negative or positive changes increases anxiety, stress and 
uncertainly in some persons with MS and other neurodegenerative diseases, then 
the process of making comparisons with ones’ own past life may alleviate some of 
this stress. The comparisons that individuals in the present population made served 
a positive frmction in some cases, producing higher QoL perceptions in cases 
where uncontrollable, potentially threatening changes were experienced and had 
the potential to produce more negative QoL perceptions.
In such cases, comparisons made may have been with other times of significant 
change or life events, providing the individual with concrete examples of how they 
have previously faced periods of uncertainty successfully. With this knowledge, 
even though these individuals may have been experiencing potential anxiety, stress 
and uncertainty, their present QoL ratings were higher than some of the individuals 
not experiencing such changes. The process of comparisons with ones’ own past 
may also be used to demonstrate that positive life events previously experienced 
are not necessarily followed by negative life events, although this notion remains 
speculative as no ‘positive change’ cases used a comparative process in order to 
evaluate their QoL within the present study.
Exploratory analyses also demonstrated a significant interaction between life
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change, memory deficit for recent incidents and SEIQoL-DW scores. Where no life 
changes were reported to occur at the time of assessment, individuals with memory 
deficits for recent incidents obtained significantly higher SEIQoL-DW scores than 
individuals without such deficits, a relationship supporting earlier findings obtained 
in relation to Hypothesis 1. However, when life changes were reported to occur, 
individuals with memory deficits for recent events obtained significantly lower 
scores than individuals with intact memory for recent events. This finding suggests 
that persons with an autobiographical memory deficit are not so homogenous in 
terms of the way they perceive their QoL as initial findings suggested.
It has already been suggested that increased anxiety, stress and uncertainty may 
accompany the presence of positive or negative life changes that individuals 
perceive to be beyond their control. Comparisons with similar times in ones’ own 
past may alleviate some of these feelings, and thus increase perceived QoL. On this 
basis, it is possible that a greater degree of increased uncertainty and anxiety may 
accompany the experience of life change for individuals who remain unable to 
sufficiently draw from their own past experiences involving life change.
With incomplete knowledge regarding their own ability to work through times of 
change, these individuals may find the experience of life change far more 
unsettling than individuals who have the cognitive abilities to draw from their past 
experience in this situation. It is interesting to note that neither of the individuals 
with deficits for recent incidents who reported life changes occurring at the time of 
assessment made comparisons with their own past in order to rate their present 
QoL. Although a small minority of the overall population, the fact that they 
obtained low QoL scores adds further support to the notion that social comparisons
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may play an important mediating role when life changes are being experienced.
Skevington (1994) concluded that the study of social comparisons with reference to 
QoL in individuals with rheumatoid arthritis seemed appropriate. Findings from 
the present study support the association between QoL and social comparisons, but 
also highlight the influence that cognitive functioning and life change can have on 
the evaluation strategies and QoL perceptions of individuals with severe 
neurological disability. Further research is now required concerning these 
relationships, perhaps with individuals with less severe neurological disability, and 
certainly with a greater number of persons experiencing positive and negative life 
changes at the time of assessment, in order to determine with greater certainty 
precisely how these factors influence QoL.
Present findings support the view that evaluations of QoL are in part dependent 
upon one’s ability to remember one’s past experiences. In the present study, any 
loss of knowledge about one’s past seemed to result in changes to these 
perceptions, as Kenealy et al. (1999) suggest. In light of these findings, an 
enhanced understanding of person-centred QoL in individuals with severe 
neurological disability could be gained through assessment of autobiographical 
memory functioning before person-centred QoL assessments are conducted. 
Immediate memory testing is also advised before QoL assessments are conducted, 
perhaps alongside more general cognitive tests in order to build up cognitive 
profiles. This information provided a useful basis in the present study for 
indicating where potentially invalid responses lay, and could provide similar 
information in QoL assessments with other severely neurologically impaired 
populations.
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Alongside the role of cognitive functioning, the presence of significant life changes 
and comparison strategy adapted also play significant and interacting roles in the 
QoL perceptions of individuals with severe neurological disability. These factors 
should also be monitored in future QoL assessments within similar client groups, as 
their identification provides a starting point for establishing a more precise 
understanding of QoL perceptions in individuals with severe neurological 
disability.
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CHAPTERS
An Assessment of Interventions to Improve the QoL Perceptions of 
Individuals with Severe Neurological Disability
STUDIES 3 and 4
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5.1 Introduction: Studies 3 and 4
■»
Quality of life is often assessed as the outcome variable of intervention studies, 
which enable the effects of a new treatment, drug or therapy to be evaluated at the 
group level. However, the effect of practical interventions that can be applied on a 
day-to-day basis to improve individual QoL is rarely the focus of such studies. 
Through Studies 1 and 2, information has already been obtained concerning factors 
that influence perceptions of QoL in the present population, and a QoL measure 
has been found that is suitable to use with severely disabled individuals. It is now 
therefore possible to explore practical ways of improving perceptions of QoL of 
individuals with severe neurological disability and to assess these interventions.
Stuifbergen (1995) examined the relationship between the practice of health- 
promoting behaviours and QoL in 61 individuals with MS. Six percent (N=4) of 
this sample rated themselves as mostly or totally requiring help with personal 
assistance. The Health Promoting Lifestyle Profile (HPLP; Walker, Sechrist and 
Pender, 1987) was administered to assess the frequency with which individuals 
reported taking part in activities directed toward increasing level of exercise, 
nutrition, interpersonal support, stress management, health responsibility and self 
actualisation.
Stuifbergen (1995) suggested there was a significant relationship between the 
practice of health-promoting behaviours and perceived QoL, as measured by the 
Quality of Life index (QLI; Ferrans and Powers, 1985), in persons with MS. 
However, one might expect significant correlations between the health-promoting 
behaviours outlined above and the QLI, which assesses factors such as physical
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health, mobility, psychological functioning, achieving personal goals and family 
relationships. These findings shed little light on the factors that improve 
perceptions of person-centred QoL in persons with MS. Given that several studies 
have highlighted the differences between health status and individual QoL (i.e. 
Joyce, 1994; Lintem et ah, 1999; Murrell et al., 1999; O’Boyle, McGee and Joyce, 
1994) it would be interesting to examine the extent to which health-promoting 
behaviours relate to person-centred perceptions of QoL.
Stuifbergen (1995) also stated that participants used physical exercise as the most 
frequent strategy for coping with the demands of the illness. However, individuals 
often had great difficulty completing tasks related to physical activity and exercise 
due to their physical limitations. This finding reinforces the fact that practical 
interventions designed to enhance the QoL of persons with severe physical and 
cognitive impairments must be targeted at the level of abilities of the individuals 
concerned. When the strategies employed to improve QoL are designed from the 
patient’s perspective, they may be far more effective in enhancing QoL perceptions 
at both individual and group levels.
Although there is a large body of research on the effects of clinical and medical 
intervention on QoL in persons with neurological illness, there are relatively few 
published papers that evaluate practical interventions aimed to improve patient 
QoL. The studies that have been conducted with other patient groups on this basis 
have generally used every-day ward life as a basis for intervention. For example, 
Favell, Realon and Sutton (1996) suggested that simple social interactions with 
staff dramatically increased levels of happiness in some individuals with profound 
mental retardation. Powell-Lawton, Moss and Duhamel (1995) have also
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suggested that family and professionals could enhance the QoL of elderly impaired 
relatives living at home through better use of TV, diversionary activities, social 
stimulation and environmental variety. These individuals had a relatively low level 
of variety in activities, social and environmental context, and spent a large 
proportion of their time in passive activities such as viewing TV, listening to the 
radio and receiving assistance from a caregiver.
The majority of patient-based intervention studies conducted to date have involved 
older persons living in long-term care settings. Many of these studies have not 
actually evaluated the effectiveness of their intervention on QoL. Indeed, there 
appears to be an underlying assumption that increased interaction with others 
(Davies and Snaith, 1980), engagement in recreational activity (Jenkins, Felce, 
Lunt and Powell, 1977), and a change of environment (Harwood and Ebrahim, 
1992) are associated with increased QoL.
Few researchers define what they mean by QoL, and those who do generally use 
level of interaction and engagement as their QoL indicator (i.e. Allen and Turner, 
1991; McFayden, Prior, and Kindness, 1982). Although QoL outcomes have been 
assessed using observation techniques (i.e. Davies and Snaith, 1980; Jenkins et al., 
1977), there remains a paucity of literature assessing intervention outcome using 
quantitative assessment of health-based or person-centred QoL. Patient-based 
interventions may provide an accessible means for improving patient QoL, but 
without valid measurement of QoL outcomes, the short and long-term benefits of 
interventions remain largely unknown.
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5.2 STUDY 3
Improving patient QoL remains an important component of care in any care-giving 
environment where patients may have reduced opportunities for participation and 
choice. The studies outlined on pp.255-257 have attempted to improve patient QoL 
through simple interventions, assuming that resulting changes in interaction and 
engagement levels were indicators of improved QoL. However, this assumption is 
based on the common but unproven theory that high interaction levels are related to 
improved QoL.
Having reviewed the available literature on simple intervention studies conducted 
in a gerontological setting, Allen (1993) designed a programme that used a number 
of interventions assumed in other studies to be beneficial, and evaluated their 
effects on interaction levels in 19 elderly women on a continuing care ward. The 
interventions included a staff-training programme, and several ward activities such 
as movement to music, bingo, beauty therapy, ward concerts, group activities and 
trips out of the hospital. Findings derived from observational study suggested there 
was no change in overall level of activity or interaction post-intervention. It was 
also found that patients were more likely to spend time alone, be involved in fewer 
interactions, and obtain fewer responses from others in the post-intervention phase 
of the study.
Although Allen (1993) presumed that interaction levels are synonymous with 
patient QoL, he raised some interesting points regarding the design of intervention 
studies for use with older people. These points are relevant to the present study, 
and other intervention studies that are designed to improve QoL in different patient
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groups. Allen (1993) concluded that activities need to be better tailored to the 
individual, as activities that individuals are motivated by and interested in may 
produce greater interaction levels. Indeed, interactions that are tailored to the 
individual may also improve patient QoL outcomes. He also stated that further 
work is necessary to identify the most effective interventions, and warned that 
achieving the aim of enhancing patient QoL is not as straightforward a task as 
previous research has suggested.
Knowledge of the factors that are important to individuals with severe neurological 
disability may therefore assist in designing an intervention study to improve QoL 
within the present population. This information has already been obtained using 
the SEIQoL-DW in Studies 1 and 2, where individuals frequently nominate 
‘getting out and about’, ‘going out’ and ‘contact with the outside world’ as 
important areas of their lives (see Table 5.1 overleaf). From this point forward, 
these terms are collectively referred to as ‘going out’.
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Table 5.1; The most frequently elicited life areas considered important in 
Studies 1 and 2 using the SEIOoL-DW
No. of times considered 
3'^ 4*** and 5'^  
most important life area
Total no. of 
times
Mentioned
% of
participants 
nominating area
Assessment 1 (N=22)
Life area r n^ci r^ü 4m 5'" %
Going out 2 0 2 4 4 12 54
Hobbies 2 2 3 2 3 12 54
Family/Going home 5 3 3 0 0 11 50
Assessment 2 (N=22)
Family/Going home 9 4 3 1 0 77
Going out 4 3 2 1 0 45
Friends 1 3 1 1 0 27
Assessment 3 (N=22)
Family/Going home 6 5 2 1 0 14 63
Going out 3 3 3 1 0 10 45
Therapy
Communication
0 1 2 3 0 6 27
1 0 4 1 0 6 27
Assessment 4 (N=22)
Family/Going home 7 3 1 2 0 13 58.5
Going out 2 7 3 1 0 13
Mixing with others 3 0 1 1 1 6 26
Assessment 5 (N=22)
Family/Going home 10 4 1 1 0 16 72
Going out 3 1 2 2 1 9 40.5
Mixing with others 0 2 3 1 0 6 26
Assessment 6 (N=22)
Family/Going home 8 5 2 0 1 16 72
Going out 3 4 1 1 0 9 40.5
Friends 0 2 5 0 0 7 31.5
Assessment 7 (N=24)
Family/Going home 6 7 3 3 1 20 83
Going out 3 2 3 4 1 13 54
Quality of care 2 1 2 2 0 6 29
‘Going out’ was considered the second most important life area in 5 of the 7 
assessments conducted to date. In the remaining two assessments, it was rated as 
the most important area, together with hobbies and family.
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If it can be demonstrated that ‘going out’ enhances the QoL of individuals in long­
term care, then simple inexpensive adaptations to daily routine can be made 
accordingly. Potentially, increased environmental variety as an intervention holds 
great benefits for hospital management sectors, staff nurses and carers and 
ultimately the patients themselves.
On this basis, the present study investigated the effects a simple intervention (time 
spent outside, accompanied) have on perceptions of person-centred QoL. It was 
anticipated that results obtained from this pilot study would form the basis for 
further experimental research concerning the effects of time spent outside on 
person-centred QoL in persons with severe neurological disability. It was also 
anticipated that the current study would provide greater clarity concerning the QoL 
construct, through an enhanced understanding of the factors that influence transient 
and long-term QoL perceptions.
Previous research with the present population suggests that the presence and 
direction of life changes reported at the time of assessment affect perceived QoL. 
Generally, where positive life changes are reported, individuals report a higher 
perceived QoL, and where negative life changes are reported at assessment, 
individuals report a lower perceived QoL (see Section 3.33.1, pp.165-167). It 
should be noted, however, that the effect of negative life changes may he mediated 
through the use of comparison strategies with one’s own past when evaluating 
present QoL (see Section 4.64, pp.239-241).
Where no life changes are reported at assessment, perceived QoL within the 
present population appears relatively stable across time (see Section 3.31, pp.165-
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167). On this basis, one might expect the QoL ratings of persons experiencing no 
life changes to reflect the outcomes of intervention most clearly. It was therefore 
considered important to assess the effects of life change when examining the 
benefits of time spent outside in the present study, in order to obtain an enhanced 
understanding of related QoL outcomes.
Although individuals within the present population have a relatively high level of 
disability, some patients are more physically dependent than others. This is 
reflected by the EDSS scores obtained in previous studies, which have generally 
ranged from 7.5 (full use of upper limbs, so able to wheel oneself in a wheelchair 
for a limited time) to 9 (no use of upper limbs, so unable to wheel oneself in a 
wheelchair) on the 10-point rating scale.
Given that individuals with a lower level of physical disability are able to wheel 
their own wheelchairs, they may go outside more regularly than individuals with a 
higher level of disability, who are dependent on staff or visitors to take them 
outside. Individuals who generally spend a fair amount of time outdoors may gain 
less from the intervention than individuals who generally spend less time outside, 
especially if this is due to restricted mobility or requiring medical assistance to go 
outside. It was considered important to assess the influence of time normally spent 
outside on the outcomes of intervention, and to determine whether time spent 
outside is dependent on extent of disability, in order to determine whether this 
intervention is beneficial to QoL in persons with severe neurological disability.
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In summary, the aims of the present study were as follows:
1. To examine whether time spent outside enhances perceptions of QoL in 
individuals with severe neurological disability.
2. To examine whether individuals who go outside less frequently experience 
greater benefits from spending time outside than individuals who go outside 
more often.
3. To examine whether individuals who go outside less often have a higher level 
of disability than individuals who go outside more frequently.
4. To begin to establish whether spending time outside is a practical and 
accessible way in which to improve individual QoL in persons with severe 
neurological disability.
5.21 Hypothesis
The following hypothesis was tested:
QoL scores obtained immediately after intervention (individuals spending time 
outside, accompanied) (t2) will be significantly higher than scores obtained one 
week before this intervention takes place (tl).
5.22 Method
5.22.1 Participants
Thirty-three individuals were identified as able take part in the present study, 
including the 24 individuals who agreed to participate in Study 2. One of these 
individuals had died since the last study was conducted. The cognitive abilities of 
two other patients who had taken part in Study 2 had deteriorated significantly. 
They were not invited to take part in the present study, as they were considered to
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have insufficient abilities to complete the tests. Of the remaining 30 individuals, 
two were unable to participate due to medical reasons (hay fever and a visual 
intolerance to sunlight) and one did not wish to participate when initially asked. 
Consent procedures were completed for 27 individuals, one of whom was unable to 
grasp the concepts and methods associated with the SEIQOL-DW.
Full data sets were therefore completed for 26 participants, whose ages ranged 
from 31-74 years (^=54 years, S.D.=10.87). Eleven participants were men (42%) 
and 15 participants were women (58%). The range of diagnoses included in this 
sample are presented in Table 5.2.
Table 5.2: The range of diagnoses of the 26 individuals taking part in Study 3
Diagnosis N (%)
MS 17 65.38
Cerebral palsy 2 7.69
Dystonia 1 3.85
Friedreich’s ataxia 1 3.85
Generalised epilepsy 1 3.85
Hydrocephalus 1 3.85
Left hemiplegia 1 3.85
Myasthenia gravis 1 3.85
Right and partial left hemiplegia 1 3.85
5.22.2 Intervention
The intervention employed was operationally defined as 20 minutes spent outside 
(accompanied) within the hospital grounds on a warm day. Each individual was 
administered QoL assessments one week before the intervention {tl), and 
immediately after the intervention {t2).
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5.22.3 Design and analysis
The design of the study attempted to control for the effects of extent of disability. 
Participants were initially selected on this basis to fill the cells in each group of 
Table 5.3. The figures below represent the 26 participants who completed tl and t2 
assessments.
Table 5.3: The a-priori design constructed for Extent of disability
Disability score (EDSS)
<=8.0 >&0
N=14 N=12
The rationale for controlling for extent of disability was presented in Section 5.2 
(p.262). The rating scale of the EDSS ranges from 0 (normal) to 10 (death from 
MS); a score of 8 indicates the individual is perambulated in a wheelchair, although 
able to perform many self-care functions. A score of 9 indicates “a helpless bed 
patient who can communicate and eat” (Kurtzke, 1983, p. 1452).
Previous studies with the present population have noted the relatively small number 
of participants with EDDS ratings of 9, reflecting to the greater difficulties in 
communication and/or higher levels of cognitive impairment encountered within 
this group, which prevent several residents from participating (see Section 3.22.3, 
pp.135-136). The design of the present study acknowledges this problem by 
attempting to control for two, rather than three levels of disability. For the purpose 
of analyses in the present study, ratings of less than/equal to 8 reflected a lower 
level of disability for the present population, and ratings that were greater than 8 
reflected a higher level of disability within the present population.
265
The present study employed a mixed factorial design; the within-subjects factor 
was test occasion, the between-subjects factor was life change, and the dependent 
variable was perceived QoL. The effects of time spent outdoors were analysed 
using analysis of variance and covariance.
5.22.4 Measures
11 Background information
Data concerning the number of outings in the week between tl and t2 assessments 
was collected from ward diaries and members of hospital staff for each participant. 
Before tl  assessments commenced, individuals were asked to rate how frequently 
they felt they generally went outside, using a Likert scale ranging from 1 (Never) to 
7 (Very often) (see Appendix 5.1). EDSS ratings were obtained for each 
participant, in order to assess level of physical ftmctioning. Before t2 assessments 
commenced, individuals were asked to report whether they had experienced any 
significant life changes or events since the tl assessments conducted one week 
beforehand.
21 OoL
The SEIQoL-DW, and QoL ‘today’ and ‘generally’ ratings were used to assess 
QoL perceptions (see Section 3.22.2, pp.132-133, and Section 3.32.1, pp.163-164, 
for a full description of these measures).
5.22.5 Procedure
Residents were invited to participate after consultation with the chartered clinical 
psychologist responsible for their care. In each case, the study was explained using 
both an information sheet (see Appendix 5.2) and by personal explanation.
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Informed consent was then obtained, according to Hospital guidelines (see 
Appendix 5.3). The procedures outlined in Study 1 concerning making and 
conducting appointments continued to apply in the current study.
The SEIQoL-DW was administered a week before the planned intervention and 
immediately after the intervention took place. QoL ‘today’ and ‘generally’ ratings 
and information concerning significant life changes were also obtained on each 
occasion, as demonstrated in Table 5.4.
Table 5.4: Time plan for assessments in Study 3
TIME Measures Administered
tl Baseline: SEIQoL-DW, QoL today and generally ratings
INTERVENTION
t2 Assessment of Intervention: SEIQoL-DW, QoL today and generally 
ratings
All assessments were conducted on the ward, in the privacy of the individuals own 
room. The hypothesis was explored using questionnaires, administered in an 
interview format. The self-report technique used in previous studies with the 
present population was also retained for the present study. Both of these 
techniques accommodate the communication difficulties, visual disturbances and 
limited physical abilities of the individuals concerned.
5.22.6 Ethical Cousideratious
One of the main ethical concerns of the present study concerns the problem of 
Uhthoff s phenomenon that can occur in individuals with MS. It is associated with 
increased body temperature through physical exercise or heat and typically causes a
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transient worsening of symptoms. As the present intervention was conducted 
outside on warm days, assessments were scheduled to avoid the hottest ‘midday’ 
sun. Every care was taken to avoid prolonged exposure to the sun and individuals 
remained in shaded areas of the hospital grounds whenever possible. Immediately 
before each intervention took place, individuals were made aware that they could 
return indoors at any point during the intervention.
All individuals were consulted about the intervention activity in the pre test phase 
of assessment which occurred the week beforehand, in order to reduce potential 
feelings of lack of exercised control over environment and to re-establish that 
individuals were happy to be taken outside. A member of nursing staff 
accompanied individuals who required medical surveillance during off-ward 
activities.
The other main ethical concern involves quantity of assessment, as the QoL 
measures were to be completed at tl and t2 assessments. The" measures used for 
the present study were purposefully selected for their brevity. The total 
administration time for the SEIQoL-DW and QoL ‘today’ and ‘generally’ ratings is 
approximately 30 minutes. Every care was taken to ensure that this period of 
assessment was not too stressful or tiring for the participants concerned.
It was ensured that assessments did not interfere with any other clinical or social 
activities of the individuals concerned, unless they specified this as their wish, or 
unless arrangements were agreed with all relevant nursing staff and patients 
beforehand. It was anticipated that these assessments would provide an interesting, 
enjoyable social activity for participants. Throughout the course of Study 3 it was
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made clear that, should an individual wish to discontinue their involvement in the 
study, they were free to do so at any point in time. Ethical procedures concerning 
termination of testing and confidentiality of course continued to apply.
5.23 Results
SEIQoL-DW scores were transformed to single summary scores using procedures 
outlined by O’Boyle et al (1996). One individual reported a positive life change 
occurring between tl and t2 assessments, their t2 QoL ratings increasing 
accordingly. This case was omitted from the data set, in order to reduce potential 
bias within the data. For the remaining 25 participants, six (24%) reported a 
negative life change occurring between tl and t2 assessments, and nineteen (76%) 
reported no life change occurring between tl and t2 assessments. Means and 
standard deviations obtained for each variable are shown in Table 5.5.
Table 5.5 Means and standard deviations obtained for each variable (N=25)
VARIABLE Mean S.D.
Duration of illness 2936 14.83
Years since admission 10.88 635
PRE-TEST POST-TEST
Mean S.D. Mean S.D.
SEIQoL-DW 69.01 15.91 71.02 15.51
QoL ‘Today’ 68.40 20.49 72.64 19.57
QoL ‘Generally’ 66.26 2Z83 65.04 19.39
Observation of mean scores in relation to minimum and maximum scores 
suggested that the distribution of scores was relatively normal. This was confirmed 
when descriptive statistics for skewness were run, all scores showing skews less 
than +1 and greater than -1.
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5.24 Analysis of results
The hypothesis stated that QoL scores obtained immediately after intervention 
(individuals spending time outside accompanied) {t2) would be significantly higher 
than scores obtained one week before this intervention took place {tl). In order to 
determine the effects of intervention, mean tl and t2 QoL scores were firstly 
obtained for all cases, and independently for those reporting no significant life 
changes occurring at the t2 assessments.
Table 5.6: Mean tl  and t2 QoL ratings, for all cases (N=25). and 'no change* 
cases independently (N=19)
Variable Cases Test occasion Mean S.D.
SEIQoL-DW All cases tl 69.00 15.91
t2 71.02 15.51
No change only tl 69.15 16.81
t2 72.70 16.84
QoL ‘today’ All cases tl 68.40 20.50
t2 72.64 19.57
No change only tl 66.94 22.77
t2 78.73 17.46
QoL ‘generally’ All cases tl 66.26 2283
t2 65.04 19.40
No change only tl 65.29 24.81
t2 67.89 20.61
With the exception of QoL 'generally' mean scores, when all cases were considered 
QoL means increased slightly after individuals had spent time outside. All t2 QoL 
means were higher than their tl equivalent when 'no change' cases were considered 
independently.
In order to test whether the effects of intervention were significant, three 2x2 
mixed ANOVAs were conducted to examine the effects of test occasion (Factor 1)
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and life change (Factor 2) on QoL (‘today’, ‘generally’ and SEIQoL-DW, see 
Appendix 5.4). Factor 1 had two levels (pre and post-test) and Factor 2 had 2 
levels (‘negative life change’ and ‘no life change’). No significant main effects or 
interactions were demonstrated for SEIQoL-DW and QoL ‘generally’, and no main 
effects were demonstrated for QoL ‘today’. There was a significant interaction 
between test occasion, life change, and QoL ‘today’ scores (F(l, 23)=12.49, 
/7<0 .01), as shown in Figure 5.1.
Figure 5.1: The interaction effect observed between test occasion and life 
change on OoL ‘today’ ratings
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Reported life change
No life change □  Negative life change
The interaction effect suggested that individuals experiencing no life changes
between t l  and t2 assessments reported significantly higher QoL ‘today’ after
having spent time outside (%=78.73) compared to that reported one week before
intervention (A=66.94). However, individuals experiencing negative life changes
between tl  and t2 assessments at the time of assessment reported significantly
271
lower QoL ‘today’ after having spent time outside ( =53.33), compared to that
reported one week before intervention =73.00). In order to investigate whether 
the amount of time usually spent outside influenced this finding, three 2 x 2 
ANCOVAs with time usually spent outside as the covariate were conducted on 
QoL (‘today’, ‘generally’ and SEIQoL-DW). It is noteworthy that these effects 
were unchanged when the frequency of time normally spent outside was accounted 
for, suggesting that this finding was not simply a consequence of the amount of 
time generally spent outside (see Appendix 5.5).
Results of an independent t-test also suggested that there was no significant 
difference between the amount of time that individuals with a lower or higher level 
of disability (EDSS) generally spent outside (/=0.29, dj=23, N.S.). This suggests 
that medical supervision or physical assistance, which are often required by 
individuals with a higher level of disability in order to go outside, may not prevent 
these individuals from getting out as frequently as those with a lower level of 
disability.
5.25 Discussion
The primary aim of the present study was to begin to determine whether time spent 
outside (accompanied) improves the QoL perceptions of individuals with severe 
neurological disability. Findings from the present study suggest that, regardless of 
the amount of time normally spent outside, individuals experiencing no life 
changes at the time of assessment report a higher perceived QoL after having 
spending time outside. However, where negative life changes occurred between 
assessments and intervention, individuals reported significantly lower QoL after 
spending time outside, compared to that reported one week before intervention.
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Previous research with the present population suggests that that negative life 
changes experienced around the time of assessment lower subsequent QoL 
perceptions (see Section 3.33.1, pp. 165-167). The present finding suggests that 
time spent outside in the hospital grounds may not alleviate the experience of 
negative life changes experienced at the time of intervention. Perhaps this is not 
surprising, if the benefits of time spent outside are relatively short-lived, as 
suggested in the present study by the affect on perceived QoL ‘today’ rather than 
perceived QoL ratings’. Although one must be careful not to over-interpret this 
preliminary data, the present finding does highlight the importance of recording 
reported life changes when assessing QoL outcomes, in order to obtain a more 
precise understanding of the benefits of intervention.
An organised trip outside of the hospital grounds might improve perceived QoL on 
a transient level for persons experiencing no change and negative changes at the 
time of assessment. Perhaps this latter group would benefit more from an 
intervention that takes them away from their usual surroundings. For the purpose 
of the present study, 'getting out and about', 'going out' and 'contact with the outside 
world' were grouped under the heading of 'going out'. These items clearly include 
organised outings like trips to the theatre and concerts, which involve not only a 
change of environment, but also time away from the hospital and increased contact 
with the outside world. Such activities might help distract individuals from the 
period of uncertainty or unhappiness that they face at the time of negative life 
changes or events, thus producing a more effective basis for intervention.
In Section 5.2, it was noted that ‘going out’ was considered the second most 
important life area in 5 of the 7 assessments conducted with the present population
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to date. In the remaining two assessments, it was rated as the most important area, 
together with hobbies and family. On this basis, it was interesting to note that time 
spent outside had no significant effect on SEIQoL-DW scores in the present study. 
This may be because ‘going out’ is generally one of four or five areas mentioned 
when individuals within the present population complete the SEIQoL-DW. Thus 
time spent outside may not influence total SEIQoL-DW scores significantly, as it 
remains one of several components that are judged and rated to produce overall 
QoL estimates.
Findings from the present study suggest that time spent outside (accompanied) 
increases perceived QoL ‘today’ ratings, where no life changes are reported at the 
time of assessment. This provides support for previous research by Stuifbergen 
(1995), who suggests a relationship between health-promoting behaviours (i.e. 
activities directed toward increasing the well being of the individual) and QoL in 
individuals with less severe disability associated with MS. The present findings 
also support research by Powell-Lawton et al (1995), who suggest that perceived 
QoL (of elderly impaired relatives living at home) may be improved through 
environmental variety. This suggests that, in agreement with Harwood and 
Ebrahim (1992), efforts to improve QoL in long-term care need not be dependent 
on provision of expensive new facilities.
Previous research suggests that QoL and Happiness may be increased by simple 
interventions such as increased social interaction (Favell et al, 1996). Although 
the present study focussed only on QoL outcomes, it remains possible that a short 
amount of time spent outside also increases level of reported Happiness, especially 
given that the benefits of intervention are likely to be transient rather than long
274
term. Further study might therefore benefit from assessing QoL and Happiness pre 
and-post intervention, in order examine this possibility.
It has already been recognised that the potential benefits of increased 
environmental variety hold implications for hospital management sectors, staff 
nurses and carers, as well as the patients themselves. However, in order to 
establish that time spent outside is a practical and accessible way in which to 
improve QoL within the present population, further research is now required. It 
remains essential to determine that the demonstrated increase in QoL ‘today’ 
ratings obtained in the present study was due to time spent outside, and not, for 
example, the additional one-to-one company inherent in this type of intervention.
‘Communication’ and ‘mixing with others’ are also life areas that have been 
mentioned as important when individuals within the present population complete 
the SEIQoL-DW (see Table 5.1, p.260). Furthermore, studies have suggested that 
a greater level of social interaction may increase Happiness and QoL in persons 
with profound mental retardation (Favell et al., 1996), and in impaired elderly 
relatives who live at home (Powell-Lawton, Moss and Duhamel, 1995). Once the 
effect obtained in the present study has been attributed to time spent outside, 
fiirther analyses may be conducted to determine which individuals benefit from 
spending time outside, and whether this type of intervention represents a practical 
means of improving QoL in persons with severe neurological disability. Until such 
time, conclusions remain unwarranted concerning the benefits of time spent outside 
within the present population.
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5.3 STUDY 4
Results obtained in Study 3 suggested that, where no significant life changes were 
reported at assessment, time spent outside had a significant effect on QoL ‘today’ 
ratings. T2 QoL ‘today’ ratings (i.e. on the day of intervention) increased 
significantly after having spent time outside in comparison to tl QoL ‘today’ 
ratings obtained one week beforehand. However, it remains uncertain whether the 
effects obtained were due to time spent outside, or due to the extended time period 
of one-to-one company that accompanied this outing. As there was a one-week 
interval between tl and t2 assessments, several other uncontrolled factors may have 
influenced this finding.
Study 3 was conducted during the summer months, when the weather was 
generally warm. The present study was conducted through September and 
October, when the outside temperature had dropped and the weather was unsettled, 
and it was felt that a greater understanding of the effects of time spent outside on 
QoL would be gained by recording the outside temperature during each 
intervention phase. If the previously demonstrated effects of time spent outside on 
QoL were partially due to warm weather at the time of intervention, it was 
important to establish this in the present study.
A greater knowledge of the effects of environmental variety on QoL perceptions 
may also be obtained though consideration of the cognitive disabilities of the 
present population. Analyses in relation to Study 2 confirmed there was a 
significant effect of cognitive functioning on QoL scores (where no life changes 
were reported at the time of assessment); individuals with ‘mid-range’ cognitive
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functioning obtained significantly higher QoL ratings than individuals with 
‘normal’ cognitive functioning (see pp.237-239). On the basis of these findings 
one might also expect cognitive functioning to influence the effect of interventions 
on QoL scores obtained. It was therefore felt that further research should be 
carried out before time spent outside could be concluded as beneficial to the QoL 
perceptions of individuals with severe neurological disability.
In the discussion of Study 3 it was noted that a short amount of time spent outside 
might increase level of reported Happiness as well as perceptions of QoL, given 
that the benefits are likely to be transient rather than long term. Other than 
research already outlined by Favell et al. (1996), studies that examine the effects of 
simple interventions such as environmental variety rarely consider the outcomes on 
QoL and Happiness. This may be partly because, as outlined in Section 2.2 (pp.77- 
78), disentangling the two terms can prove difficult.
QoL has often been equated with theoretical explorations of Happiness in an 
attempt to enhance our understanding of the construct. Furthermore, several 
studies isolate the dimension of QoL in their definition of Happiness. Argyle 
(1987) for example, defines Happiness as “a thoughtfiil appraisal of quality of life 
as a whole, a judgement of satisfaction with life” (p.4), whilst Beckmann and 
Ditlev (1992) go so far as to state that “quality of life must be defined through the 
difficult concept of happiness” (p. 133). At the very least. Happiness is thought to 
affect the perceived QoL, (Stones & Kozma, 1989) and in the health-care context, 
the view that QoL can only be conceptualised as a feeling of general Happiness has 
been advocated by many (see also Gill, 1984; Milbrath, 1979).
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On the other hand, several theorists have attempted to disentangle the terms QoL 
and Happiness, as the review of the QoL concept in Chapter 2 demonstrated. 
Horley (1984) considered subjective-well being (a term often used to refer to 
patient-QoL) as a broad, abstract construct, requiring more concrete, distinct 
indicators such as Happiness. To avoid conceptual confusion, he continued that 
subjective well-being should be broadly defined as “a self-perceived positive 
feeling or state” (pp. 126-7). He also referred to Stones and Kozma’s (1980) 
conceptual definition of Happiness as “an activity or state in the sphere of feelings” 
(p.270). On the basis of such conceptions. Holmes (1989) argues that QoL cannot 
be characterised only in terms of Happiness.
Having reviewed the literature on the conceptual bases of the QoL and Happiness 
constructs in Chapter 2, it seems evident that there are distinctions between the 
QoL and Happiness constructs. Happiness may represent short-term, transient 
feelings of well-being, based upon the ‘here and now’. QoL, on the other hand, 
may represent an evaluation of the frequency and importance of positive and 
negative events across a longer time-span. In fact, the major difference between the 
Happiness and QoL constructs may not be the factors that comprise each concept, 
but the time span across which both judgements are made. Present Happiness may 
interact with perceived QoL, and the external factors that influence perceived QoL 
(i.e. life changes, social comparisons, comparisons with one’s own past) may also 
influence Happiness judgements, although there is a paucity of research literature 
examining these notions.
The idea that QoL and Happiness are separate, albeit related, concepts has gained 
recent support through the development of the WHOQOL-100, a QoL measure
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developed by the WHOQOL Group (1998b). Skevington, MacArther and 
Somerset (1997) conducted focus groups with patients, health professionals and 
community members, in order to obtain information concerning the ways in which 
British people represent facets of their QoL relating to health. The relevance, 
importance and comprehensiveness of 33 QoL facets was largely confirmed. 
Rankings demonstrated that Happiness was the most important aspect of QoL. 
This finding suggests that, whilst QoL may be affected by level of reported 
Happiness, Happiness is only one of several factors that influence QoL perceptions.
In relation to the number of theorists who have attempted to separate the QoL and 
Happiness concepts through definition and philosophy, there have been relatively 
few published empirical investigations concerning the similarities and differences 
between the two constructs. If QoL and Happiness are separate, though related, 
entities, this holds important implications for studies of person-centred QoL, as 
knowledge of the level of reported Happiness at the time of assessment may 
enhance understanding of individual QoL perceptions.
Research is now required that focuses on the relationships between these two 
constructs, rather than their differences, in order that an informed decision can be 
made regarding the assessment of Happiness in parallel with future assessments of 
QoL within the present population. Whilst the SEIQoL-DW does not assess 
Happiness in parallel with person-centred QoL, in its adapted form this measure 
has demonstrated its suitability for use within the present population. It therefore 
seems more practical to assess Happiness alongside QoL within the present 
population, rather than incorporating a measure of Happiness within the SEIQoL- 
DW. The conceptual foundations for ratings of QoL ‘today’ and QoL ‘generally’,
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which have been obtained in the present research conducted to date, are also
uncertain and further clarification of these terms is therefore warranted.
The aims of the present study, which was a partial replication of Study 3, were as
follows:
1. To determine whether time spent outside enhances QoL perceptions and level 
of reported Happiness in individuals with severe neurological disability.
2. To determine whether one-to-one company enhances QoL perceptions and 
level of reported Happiness in individuals with severe neurological disability.
3. To clarify relationships among perceived QoL and level of reported Happiness 
ratings in individuals with severe neurological disability.
4. To examine whether outside temperature increases the QoL benefits of time 
spent outside in individuals with severe neurological disability.
5. To examine whether level of cognitive functioning affects the QoL benefits of 
time spent outside in individuals with severe neurological disability.
6 . To establish whether spending time outside is a practical and accessible way in 
which to improve individual QoL in persons with severe neurological 
disability.
5.31 Hypotheses
On the basis of these aims, the following hypotheses were tested:
1. There will be a significant effect of environmental setting on QoL and
Happiness ratings. Ratings will be significantly higher after participants have 
spent 20 minutes outside accompanied than after having spent (a) 20 minutes 
on the ward, in one-to-one company and (b) 20  minutes on the ward.
280
unaccompanied.
By testing this hypothesis, it was possible to determine whether the effect of time 
spent outside on QoL ‘today’ ratings obtained in Study 3 was due to time spent 
outside or the time spent in one-to-one company that accompanied the intervention. 
The control condition (20 minutes spent on the ward unaccompanied) provided a 
baseline with which to compare the effects of interventions.
2. There will be significant positive relationships among QoL and Happiness 
‘today’ and ‘generally’ ratings.
It was anticipated that testing this hypothesis would enhance our conceptual 
understanding of the similarities and differences between the QoL and Happiness 
constructs.
5.32 Method
5.32.1 Design and analysis
A repeated measures pre-test post-test design was used to determine whether the 
effect of time spent outside on QoL ‘today’ ratings demonstrated in Study 3 was 
due to time spent outside or increased time spent in one-to-one company. The 
independent variable in the present study was environmental setting, which had 
three levels: outside within the hospital grounds (accompanied); on the ward in 
one-to-one company; and on the ward unaccompanied.
Three experimental conditions were used in order to assess the effect of 
environmental setting on post-test QoL and Happiness ratings. In Condition A, 
individuals were taken outside for 20 minutes between pre-and post-tests. In 
Condition B, individuals spent 20 minutes in one-to one company between pre-and
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post-tests. In Condition C, individuals were left unaccompanied on the ward for 20 
minutes between pre-and post-tests. Before assessments commenced, participants 
were randomly assigned to one of six experimental groups, and the order of 
intervention was then counterbalanced, as shown in Table 5.7.
Table 5.7: Counterbalanced order of intervention for Study 4
Group 1 
(N=4)
Group 2 
(N=4)
Group 3 
(N=4)
Group 4 
(N=4)
Group 5 
(N=4)
Group 6 
(N=4)
BCA CBA CAB BAG ACB ABC
The effects of time spent outside and one-to-one company were analysed using 
ANOVA. Additional analyses were conducted using ANCOVA, K-means cluster 
analysis, and Pearson’s product moment correlation coefficient.
5.32.2 Participants
Twenty-four of the twenty-six individuals who completed assessments in Study 3 
were randomly selected to take part in the present study, in order to complete the 
cells in Table 5.7. The remaining two individuals were reserve participants; both 
were required during the assessment phase due to participant illness and a patient 
timetable that precluded assessment at the necessary regular intervals. Participants’ 
ages ranged from 31 to 74 (j^54.87 years, S.D.=11.02), the mean duration of 
illness was 27.25 years (S.D.=15.05) and the mean years since admission was 
10.91 years (S.D.=6.54). Ten participants were men (42%) and 14 were women 
(58%). The range of diagnoses within this sample are presented in Table 5.8.
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Table 5.8: The diagnoses of the 24 individuals who took part in Study 4
Diagnosis N (%)
MS 15 62.50
Cerebral palsy 2 833
Dystonia 1 4.16
Friedreich’s ataxia 1 4.16
Generalised epilepsy 1 4.16
Hydrocephalus 1 4.16
Left hemiplegia 1 4.16
Myasthenia gravis 1 4.16
Right and partial left hemiplegia 1 4.16
5.32.3 Measures
1) Background information
Information concerning significant life changes and frequency of time normally 
spent outside continued to be collected. EDSS ratings obtained in Study 3 were 
retained for use in the present study. It was considered that the presence/absence of 
life change, frequency of time normally spent outside and extent of physical 
disability (EDSS) formed an important context for the assessments conducted.
D Cognitive assessment
Cognitive assessments using the AMI, the Similarities sub-test of the WAJS-R and 
the Pyramids and Palm Trees test were conducted 8 months previously, in Study 2, 
with 19 (79%) individuals from the present sample. Before the present QoL 
assessments commenced, these measures were administered to the 5 (21%) 
individuals who had not taken part in Study 2, in order to complete cognitive 
cluster information.
These measures were chosen for use in this study on the basis of previous research
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with the present population, which has identified three distinct cognitive groupings 
on the basis of autobiographical memory functioning (AMI) and the ability to make 
comparisons (Pyramids and Palm Trees test and the Similarities sub-test of the 
WAIS-R; see Section 4.62, pp.228-231). The Digit Span sub-test of the WAJS-R 
was also administered in order to assess immediate memory. These cognitive 
measures are described in greater depth on pp.211-214 of Section 4.32.
3) OoL
The administration time for the SEIQoL-DW when used with the present 
population varies between 15 and 40 minutes. The present study required brief 
assessment tools in order to conduct pre-and-post tests either side of each planned 
intervention. Therefore the SEIQoL-DW was not administered in the present study. 
QoL ‘today’ and ‘generally’ ratings were used to assess QoL perceptions, using 
visual analogue rating scales ranging from 0 (‘worst life imaginable’) to 100 (‘best 
life imaginable’) Pages 163-164 of Section 3.32.1 provide a full description of 
these assessment tools.
41 Happiness
Happiness ‘generally’ and ‘today’ (i.e. on the day of assessment) were assessed 
using two visual analogue scales, both ranging from 0 (extremely unhappy) to 100 
(extremely happy) (see Appendix 5.6). These were based on the QoL ‘today’ and 
generally’ scales outlined above and used in previous studies with the present 
population, and on the Delighted-Terrible Faces scale (Andrews and Withey, 
1974). The Faces scale is a five minute task to administer and through it’s 
simplicity it is reported to have a good level of acceptance by stroke patients 
(Anderson, 1998) and the elderly (Bowling, Farquhar, Grundy and Formby, 1993).
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It consists of seven faces, ranging from a wide smiling face (‘delighted’) at one end 
of the scale to a face with a turned down mouth (‘terrible’) at the other end of the 
scale. Item responses can either be summed or analysed independently.
The Delighted-Terrible Faces Scale has been adapted for use in several studies, 
including evaluation of counselling in primary care (Harvey et ah, 1998) and 
studies of QoL in patients with Hanson’s disease (Kataoka et ah, 1995) and 
multiple sclerosis (Vickrey et al., 1995). In the latter study, Vickrey et al. (1995) 
report a 4-week test-retest reliability coefficient of 0.75. Bowling and Browne 
(1991) have also reported reliability coefficients of around 0.80. There are 
generally few reports on the psychometric properties of the original or adapted 
versions of the scale as it is not frequently used as an assessment tool.
For the purpose of the present study, the ‘delighted’ and ‘terrible’ faces of the scale 
were enlarged to a size suitable for individuals with visual disturbances, and 
placed at either end of two 0-100 visual analogue scales. Individuals are asked to 
indicate where along a 10cm line they would put a mark to represent their 
happiness ‘today’ (Scale 1), and their happiness ‘generally’ (Scale 2). Where 
patients were able to hold a pen and write, they drew this line for themselves; 
otherwise the researcher would draw the line with full guidance from the individual 
concerned. Happiness ‘generally’ and ‘today’ ratings were calculated by 
measuring across the 10cm scale on which responses were made.
5.32.4 Procedure
Residents were invited to participate after consultation with the chartered clinical 
psychologist responsible for their care. In each case, the study was explained using
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both an information sheet (see Appendix 5.7) and by personal explanation. The 
procedures outlined in Study 1 concerning making and conducting appointments 
continued to apply in the current study (see Section 3.22.5, pp.138-139). 
Immediately before each intervention took place, pre-test QoL and Happiness 
‘today’ and ‘generally’ ratings were obtained.
In Condition A, individuals were then asked to rate how frequently they felt they 
normally went outside, using the Likert scale previously described in Section
5.22.4 (p.266). Individuals then spent 20 minutes outside, underneath a veranda 
overlooking the main garden on the hospital. As the weather was more unsettled 
than in Study 3, this reduced the likelihood that wind or rain would postpone 
interventions. The outside temperature was taken 10 minutes into the intervention, 
which began once participants had reached the veranda. After 20 minutes had 
passed, participants were taken back to the ward, and post-test assessments were 
conducted.
In Condition B, the interviewer stayed with each participant following pre tests, in 
the individuals own room or, in the case of Day Hospital clients, in a room of the 
training disabled flat within the Hospital. The following 20 minutes were spent in 
social conversation, and then post-tests were conducted. In Condition C, 
individuals were asked to remain on the ward for 20 minutes following pre-tests. 
The interviewer then left, and returned 20 minutes later to conduct post-test 
assessments. It should be noted that whilst methodological problems associated 
with the use of participants as their own controls are acknowledged, the severity of 
neurological disability within the present population rendered the use of matched 
participants across each experimental condition of the present study impractical.
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Information concerning significant life changes was obtained at the start of each 
pre test session. In Condition C, where participants remained on the ward for 20 
minutes between pre and post-test sessions, individuals were also asked about any 
changes that had occurred during this intervention period. A member of nursing 
staff accompanied individuals outside who required medical surveillance during 
off-ward activities. The time plan for assessments is presented below in Table 5.9.
Table 5.9: Time plan for assessments in Study 4
WEEK DAY Experimental Group 1 Experimental Group 2
1 1-2 Condition B (company) Condition C (control)
1 4-5 Condition C (control) Condition B (company)
2 1-2 Condition A (outside) Condition A (outside)
Experimental Group 3 Experimental Group 4
2 4-5 Condition C (control) Condition B (company)
3 1-2 Condition A (outside) Condition A (outside)
3 4-5 Condition B (company) Condition C (control)
Experimental Group 5 Experimental Group 6
4 1-2 Condition A (outside) Condition A (outside)
4 4-5 Condition B (company) Condition C (control)
5 1-2 Condition C (control) Condition B (company)
A three to four-day interval was left between each phase of the study. Given that 
participants were completing pre and post-measures within the same half-hour, 
hypotheses were explored using visual analogue scales. This format enabled 
information to be gathered without causing unnecessary fatigue to participants. 
The self-report technique used in previous studies with the present population was 
also retained for the present study. Both of these methods accommodate the 
communication difficulties, visual disturbances and limited physical abilities of the 
present population.
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5.32.5 Ethical Considerations
The main ethical concerns of the present study concern the frequency of 
assessment and the time spent outside during unsettled weather conditions. All 
outside interventions were conducted under the shelter of a veranda, and a large 
blanket was made available on each occasion, to keep participants warm where 
necessary. As some of the individuals in the present study may be more 
susceptible to chills than most, medical approval was obtained from each ward 
sister before individuals were asked to take part in assessments. Furthermore, when 
individuals were taken outside, staff nurses were made aware beforehand so that 
they could dress individuals appropriately.
The potential problem of such frequent assessments was minimised through use of 
visual analogue scales. The total time for each assessment session (including the 20 
minute intervention) was approximately half an hour. This was no longer than QoL 
assessment sessions conducted in previous studies with the present population. 
Every care was taken to ensure that assessments were not too stressful or tiring for 
the participants concerned.
It was also ensured that assessments did not interfere with any other clinical or 
social activities of the individuals concerned, unless they specified this as their 
wish, or arrangements were discussed with all relevant nursing staff and patients 
beforehand. It was anticipated that these assessments would provide an interesting, 
enjoyable social activity for participants. Throughout the course of Study 4 it was 
made clear that, should an individual wish to discontinue their involvement in the 
study, they were free to do so at any point in time. Ethical procedures concerning 
termination of testing and confidentiality continued to apply.
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5.33 Results
Digit Span and Similarities (WAIS-R) scores were transformed to scaled scores 
using procedures outlined in the WAIS-R manual (Wechsler, 1986). SEIQoL-DW 
scores were transformed to single summary scores using procedures outlined ^  by 
O’Boyle et al (1996). Total scores for the AMI were calculated using procedures 
outlined in the AMI manual (Kopelman, Wilson and Baddeley, 1990), and 
Pyramids and Palm Trees scores were obtained using the procedures outlined on 
p.212 of Section 4.32. Means and standard deviations obtained for each variable 
are shown in Table 5.10.
Table 5.10: Means and standard deviations obtained for each variable (N=24)
Variable Mean S.D.
Pyramids and Palm Trees 17.71 2.34
Similarities (WAIS-R) 7.50 3.79
Digit Span Total (WAIS-R) 6.95 3.05
Autobiographical Incidents Total (AMI) 12.08 7.79
Personal Semantics Total (AMI) 40.85 17.05
PRE-TEST 1 P(3ST-TEST
CONDITION A -2 0  MINUTES SPENT OUTSIDE
Mean S.D. Mean S.D.
QoL ‘Today’ 61.45 21.18 66.58 22.03
QoL ‘Generally’ 60.58 21.55 60.71 23.61
Happiness ‘Today’ 65.29 23.95 71.58 21.57
Happiness ‘Generally’ 69.08 22.49 69.62 21.27
CONDITION B -  20 MINUT]ES SPENT IN ONE-TO-ONE COMPANY
Mean S.D. Mean S.D.
QoL ‘Today’ 60.04 24.07 62.12 20.83
QoL ‘Generally’ 59.63 23.58 64.95 19.74
Happiness ‘Today’ 60.95 26.14 65.54 23.75
Happiness ‘Generally’ 68.83 23.27 65.45 23.45
CONDTnONC-CONTROL
Mean S.D. Mean S.D.
QoL ‘Today’ 65.37 19.63 57.67 22.49
QoL ‘Generally’ 64.25 21.83 60.37 19.33
Happiness ‘Today’ 63.96 24.15 62.41 17.85
Happiness ‘Generally’ 62.08 24.12 61.54 20.25
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From observation of the mean in relation to minimum and maximum scores, the 
distribution of scores appeared relatively normal. This was confirmed when 
descriptive statistics for skewness were conducted, all scores showing skews less 
than +1 and greater than -1.
5.34 Analysis of results
5.34.1 Hypothesis 1
Hypothesis 1 stated that there would be a significant effect of environmental setting 
on QoL and Happiness ratings. Ratings would be significantly higher after 
participants had spent 20 minutes outside accompanied than after having spent (a) 
20 minutes on the ward, in one-to-one company and (b) 20 minutes on the ward, 
unaccompanied. It was anticipated that results obtained in relation to this 
hypothesis would clarify whether the effect of time spent outside on QoL obtained 
in Study 3 was due to time spent outside, or the time spent in one-to-one company 
that accompanied the intervention.
In order to test this hypothesis, mean pre and post-test QoL and Happiness ratings 
were firstly obtained, as shown previously in Table 5.10. Means suggested that 
after individuals had spent time outside, or spent time in company, QoL and 
Happiness ‘today’ ratings increased slightly. However, the greatest difference 
between pre and post-test means occurred when individuals remained on the ward 
unaccompanied for 20 minutes, suggesting that post-test QoL ‘today’ ratings 
decreased. These observations were in the direction of the first hypothesis.
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In order to test whether the effect of interventions were significant, four 3 x 2  
repeated measures ANOVAs were conducted to examine the effect of test occasion 
(Factor 1) and experimental condition (Factor 2) on perceived QoL (‘today’ and 
‘generally’) and Happiness (‘today’ and ‘generally’, see Appendix 5.8). F  values 
confirmed there were so significant main effects for test occasion and experimental 
condition, and no significant interactions between test occasion and experimental 
condition on QoL and Happiness ratings. Thus interventions did not significantly 
affect post-test QoL and Happiness ratings compared to their pre-test equivalent on 
any of the experimental conditions tested.
Analyses were also conducted to determine whether the presence/absence of life 
changes influenced the effect of interventions. Two life change groups were 
formed; Group 1 (N=15) reported no life changes across experimental conditions, 
whereas Group 2 (N=9) reported either a positive or negative change on one or 
more test occasions. Four 3 x 2 x 2  mixed ANOVAs were conducted to examine 
the effects of experimental condition, test occasion and life change on perceived 
QoL (‘today’ and ‘generally’) and Happiness (today’ and generally’, see Appendix 
5.9).
No significant main effects or interactions were demonstrated, and on this basis 
Hypothesis 1 was rejected. Although means were in the predicted direction, there 
was no significant effect of environmental setting on QoL or Happiness ratings; 
ratings were not significantly higher after participants had spent 20 minutes outside 
(accompanied) than after having spent (a) 20 minutes on the ward in one-to-one 
company and (b) 20 minutes on the ward, unaccompanied. This finding is
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discussed in Section 5.35, and further analyses relating to this hypothesis are 
presented in Section 5.34.3.
5.34.2 Hypothesis 2
Hypothesis 2 stated that there would be significant relationships among QoL and 
Happiness ‘today’ and ‘generally’ ratings. It was anticipated that testing this 
hypothesis would enhance our conceptual understanding of the similarities and 
differences between the QoL and Happiness constructs.
In order to test this hypothesis, Pearson product moment correlation coefficients 
were calculated for all cases, and independently for cases where no life change had 
occurred at the time of assessment. Results are summarised in Table 5.11.
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Table 5.11: Correlations among OoL and Happiness ‘today’ and ‘generally’ 
baseline ratings across experimental condition
CONDITION A
ALL CASES (N=24) ‘NO CHANGE’ CASES (N=14)
VARIABLES r value VARIABLES r value
QoL ‘todayVQoL ‘generally’ 0.89** QoL ‘today’/QoL ‘generally’ 0.99**
QoL ‘today’/Happiness ‘today’ 0.63** QoL ‘today’/Happiness ‘today’ 0.88**
QoL ‘today’/Happiness 
‘generally’ 0.75**
QoL ‘today’/Happiness 
‘generally’ 0.85**
QoL ‘generally’/Happiness 
‘today’ 0.77**
QoL ‘ generally’/Happiness 
‘today’ 0.87**
QoL ‘generally’/Happiness 
‘generally’ 0.85**
QoL ‘generally’/Happiness 
‘generally’ 0.88**
Happiness ‘today’/Happiness 
‘generally’ 0.83**
Happiness ‘today’/Happiness 
‘generally’ 0.92**
CONDITION B
ALL CASES (N=24) NO CHANGE’ CASES (N=14)
QoL ‘today’/QoL ‘generally’ 0.47* QoL ‘today’/QoL ‘generally’ 0.96*
QoL ‘today’/Happiness ‘today’ 0.65** QoL ‘today’/Happiness ‘today’ 0.65**
QoL ‘today’/Happiness 
‘generally’ 0.53**
QoL ‘today’/Happiness 
‘generally’ 0.79**
QoL ‘generally’/Happiness 
‘today’ 0.53**
QoL ‘generally’/Happiness 
‘today’ 0.45*
QoL ‘ generally’/Happiness 
‘generally’ 0.65**
QoL ‘generally’/Happiness 
‘generally’ 0.60**
Happiness ‘today’/Happiness 
‘generally’ 0.41*
Happiness ‘today’/Happiness 
‘generally’ 0.88**
CONDITION C
ALL CASES (N=24) ‘NO CHANGE’ CASES (N=20)
QoL ‘today’/QoL ‘generally’ 0.56** QoL ‘today’/QoL ‘generally’ 0.88**
QoL ‘today’/Happiness ‘today’ 0.61** QoL ‘today’/Happiness ‘today’ 0.81**
QoL ‘today’/Happiness 
‘generally’ 0.45*
QoL ‘today’/Happiness 
‘generally’ 0.69**
QoL ‘ generally’/Happiness 
‘today’ 0.45*
QoL ‘generally’/Happiness 
‘today’ 0.70**
QoL ‘generally’/Happiness 
‘generally’ 0.61**
QoL ‘ generally’/Happiness 
‘generally’ 0.83**
Happiness ‘today’/Happiness 
‘generally’ 0.87**
Happiness ‘today’/Happiness 
‘generally’ 0.86**
= p<0.05 **=p<0.01
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As three pre-tests had been conducted with each measure, correlation coefficients 
were averaged using Fisher’s z transformation, in order that inferences could be 
made concerning the relationships among QoL and happiness measures. Table 
5.12 presents the averaged correlations obtained. For the ‘no change’ group, the 
mean degrees of freedom, 6^14, was used to obtain significance levels reported 
below.
Table 5.12: Averaged coefficients obtained for comparisons among OoL and 
Happiness ‘today’ and ‘generally’ pre-test ratings
ALL CASES (N=24)
VARIABLE Correlates with Averaged r value
QoL ‘today’ QoL ‘generally’ 0.69**
Happiness ‘today’ 0.63**
Happiness ‘generally’ 0.59**
QoL ‘generally’ Happiness ‘today’ 0.61**
Happiness ‘generally’ 0.52**
Happiness ‘today’ Happiness ‘generally’ 0.75**
‘NO CHANGE’ CASES ONLY
QoL ‘today’ QoL ‘generally’ 0.96**
Happiness ‘today’ 0.79**
Happiness ‘generally’ 0.78**
QoL ‘generally’ Happiness ‘today’ 0.71**
Happiness ‘generally’ 0.78**
Happiness ‘today’ Happiness ‘generally’ 0.89**
* -= p < 0 . 0 5 =J9<0.01
Averaged correlations suggested that, when all cases were considered, the strongest 
relationship observed was between Happiness ‘today’ and ‘generally’ ratings. The 
second strongest relationship occurred between QoL ‘today’ and ‘generally’ 
ratings. When ‘no change’ cases were considered independently, the relationship 
between QoL ‘today’ and ‘generally‘ ratings was greater than that for Happiness
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‘today’ and ‘generally’ ratings, the r value of 0.97 demonstrating an extremely 
strong positive relationship between QoL ‘today’ and ‘generally’ ratings.
Averaged correlations also suggested there were significant relationships among 
QoL and Happiness ratings, although the relationships between (a) QoL ‘today’ 
and ‘generally’ ratings and (b) Happiness ‘today’ and ‘generally’ ratings were 
stronger. On this basis. Hypothesis 2 was accepted. There were significant 
relationships among QoL and Happiness ratings, suggesting that the two concepts 
are related. However, the stronger relationships observed between QoL variables 
and between Happiness variables suggests there are also distinctions between the 
two constructs, a notion that is discussed in Section 5.35 (p.314).
Further support for this hypothesis was obtained when the QoL and Happiness 
ratings obtained on each test occasion were analysed using K-means cluster 
analysis. Two, three and four-cluster solutions were obtained; two cluster solutions 
were retained as they provided the most logical case groupings. Final cluster 
solutions are presented in Table 5.13.
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Table 5.13; Final cluster solutions identified for QoL and Happiness ‘today’ 
and ‘generally’ ratings (N=24)
CONDITION A F  value
VARIABLE Cluster 1 (N=13) Cluster 2 (N=l 1)
Mean S.D. Mean S.D.
QoL ‘today’ 46.23 13.20 79.45 12.84 38.67**
QoL ‘generally’ 43.53 9.29 80.73 11.87 74.07**
Happiness ‘today’ 47.85 15.34 85.91 13.19 41.61**
Happiness ‘generally’ 53.46 16.65 87.55 11.78 32.30**
CONDITION B
Cluster 1 (N=15) Cluster 2 (N=9)
QoL ‘today’ 47.53 19.31 80.89 15.19 19.47**
QoL ‘generally’ 49.53 18.18 76.44 22.61 10.27**
Happiness ‘today’ 45.27 18.14 87.11 12.54 36.93**
Happiness ‘generally’ 58.00 21.63 86.89 12.30 13.31**
CONDITION C
Cluster 1 (N=15) Cluster 2 (N=9)
QoL ‘today’ 56.93 16.84 79.44 15.99 10.42**
QoL ‘generally’ 51.93 15.47 84.77 13.86 27.31**
Happiness ‘today’ 50.40 18.63 86.55 12.25 26.69**
Happiness ‘generally’ 47.40 15.94 86.55 12.25 39.86**
J9<0.01
For each condition, cluster group 1 appeared to represent individuals who reported 
a relatively low level of QoL and Happiness in comparison to cluster group 2. 
Cluster group 2 individuals appeared to report high levels of QoL and Happiness. 
One way ANOVAs confirmed there were large differences at group level in 
perceived QoL and Happiness, although the extent of this difference varied across 
variable and experimental condition (see Appendix 5.10). This finding adds further 
support to the notion that QoL and Happiness constructs are, to a certain extent, 
related. However, the moderate to large variances either side of mean ratings in 
Table 5.13 indicate that the dynamics of this relationship may be more complex 
than the present analysis suggests.
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5.34.3 Further exploratory analyses
Outside temperature and the benefits of time spent outside
Analyses relating to Hypothesis 1 suggested that there was no significant effect of 
interventions on QoL and Happiness ratings within the present population. As 
Condition A interventions (time spent outside) were conducted in colder weather 
conditions than in Study 3, it was considered that the outside temperature at the 
time of intervention may have influenced QoL outcomes in this case.
In order to test this possibility, four 3 x 2  repeated measures ANCOVAs were 
conducted, to examine the effects of experimental condition and test occasion on 
perceived QoL (‘today’ and ‘generally’) and Happiness (‘today’ and ‘generally’) 
once the influence of outside temperature had been accounted for (see Appendix
5.11). No significant main effects or interaction effects were demonstrated, 
suggesting that the effects of intervention were not partially dependent on the 
outside temperature at the time of intervention. The colder weather conditions 
associated with the present study did not appear to have affected intervention 
outcomes. Further analysis were conducted to examine whether another third factor 
was influencing the non-significant effect of interventions on QoL and Happiness 
within the present study.
Level of cognitive functioning and the effect of interventions 
In order to examine whether the effect of interventions on QoL and Happiness 
ratings was affected by level of cognitive functioning. Autobiographical Incident 
Scale scores (AIS), Pyramids and Palm Trees, and Similarities scores (WAIS-R) 
were analysed using K-means cluster analysis. This method of analysis was used 
previously in Study 2 (see Section 4.62, pp.229-231), demonstrating that three
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distinct cognitive groupings existed within the population studied. In keeping with 
Study 2, a three-cluster solution (using 3 iterations) was obtained in the present 
analysis. It is interesting to note that although 6 new participants had been 
recruited for this study, and 5 of the participants in Study 4 had not taken part in 
Study 2, the same pattern of cognitive functioning emerged, as Table 5.14 
demonstrates.
Table 5.14: Final cluster centres identified for AIS. Pyramids and Palm Trees 
and Similarities scores (N=24)
Cluster
^(N=9) 2(N=8) 3(N=7)
Cognitive
Variable
Mean S.D. Mean S.D. Mean S.D.
AIS 19.78 2.81 12.37 2.24 1.85 2.II
Pyramids and 
Palm Trees
19.33 0.71 18.00 2.32 15.29 1.79
Similarities 11.00 3.12 6.37 2.50 4.29 1.60
Cluster group 1 represented the 'normal functioning’ individuals; who obtained 
‘normal’ range scores on all three cognitive tests (N=9). Cluster group 2 seemed 
representative of ‘mid-range functioning’ individuals; who generally obtained 
‘abnormal’ range scores on the AIS but ‘normal’ range scores on Pyramids and 
Palm Trees and Similarities tests (N=8). Cluster group 3 appeared representative 
of ‘abnormal functioning ’ individuals; who obtained abnormal range scores on all 
three cognitive tests (N=7).
One-way unrelated ANOVAs confirmed that there were significant differences 
among cluster groups’ scores on all three of the cognitive tests (p<0.01), the
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greatest difference observed on the AIS {F(2, 21)=100.45,/?<0.01) (see Appendix
5.12). This suggested there were vast differences at group level in the ability to 
recall specific personal incidents or events from the past. It is noteworthy that 
there were also vast differences among cluster groups’ Personal Semantic (PS) 
scores, which reflect the ability to recall specific personal facts from the past (F(2, 
21)=19.66,/><0.01) (see Appendix 5.12).
Although 62.5% of the present population are persons with MS, the remaining 
37.5% have other neurological diagnoses (the reader is referred to Table 5.8, which 
lists the range of diagnoses within the present population). It was considered that 
one or more of the individuals with neurological conditions other than MS may 
have contributed to the seemingly large difference among autobiographical incident 
scores, as the pattern and severity of cognitive deficits varies within and between 
the different neurological diagnoses of the present population.
In order to examine this possibility, individuals’ AIS scores were examined in 
greater detail. Two individuals in the ‘abnormal’ cognitive cluster group obtained 
AIS scores of zero in the present study; their diagnoses were generalised epilepsy 
and hydrocephalus. It was considered that these two scores may have lowered the 
AIS mean for the ‘abnormal’ cognitive cluster group, thus increasing the difference 
between groups AIS scores. In order to test this assumption, both cases were 
removed from the data set and the K-means cluster analysis was repeated.
The same pattern of ‘abnormal’, ‘mid-range’ and ‘normal’ cognitive functioning 
emerged (see Appendix 5.13), the AIS mean for the ‘abnormal’ cognitive cluster 
group only rising from 2.11 to 2.60. When the effect of cluster grouping on AIS
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scores was re-examined, a slightly lower F  value was obtained (F(2, 19)=89.63, 
j9<0 .01). Whilst this suggests that the two outlying cases contributed to the 
magnitude of difference previously observed, the present F  value confirmed there 
was still vast differences among groups’ AIS scores. This finding supports the 
notion that three very different cognitive groupings exist within the present 
population, a suggestion that is discussed in greater depth in Section 5.35.
Having identified three distinct cognitive groups, mean pre and post-test QoL and 
Happiness ratings were obtained for each group, as Table 5.15 demonstrates.
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Table 5.15: Mean pre and post-test OoL and Happiness ratings for each 
cognitive cluster group
Experimental
Condition
Variable Pre-test Post-test
Mean S.D. Mean S.D.
COGNITIVE CLUSTER GROUP 1 (N=9)
A QoL ‘today’ 53.44 19.97 61.22 18.01
QoL ‘generally’ 50.22 17.73 60.11 16.44
Happiness ‘today’ 58.00 20.27 63.44 17.26
Happiness ‘generally’ 5933 19.03 62.55 17.08
B QoL ‘today’ 53.77 1839 53.77 13.35
QoL ‘generally’ 54.77 14.05 59.89 19.07
Happiness ‘today’ 56.55 12.23 62.00 18.42
Happiness ‘generally’ 58 j# 14.17 63.11 7.25
C QoL ‘today’ 55.67 16.39 56.44 14.27
QoL ‘generally’ 51.67 14.98 56.44 13.62
Happiness ‘today’ 61.11 15.89 57.55 15.55
Happiness ‘generally’ 5833 17.03 58.00 15.08
COGNITIVE CLUSTER GROUP 2 (N=8)
A QoL ‘today’ 56.00 19.71 59.37 21.34
QoL ‘generally’ 61.12 22.09 58.12 21.26
Happiness ‘today’ 65.63 25.08 65.75 25.13
Happiness ‘generally’ 65.13 2639 63.87 27.10
B QoL ‘today’ 55.63 31.89 66.75 24.61
QoL ‘generally’ 65.62 28.09 67.25 22.42
Happiness ‘today’ 67.75 31.99 59.25 31.62
Happiness ‘generally’ 72.50 33.03 60.50 33.60
C QoL ‘today’ 63.75 20.40 56.00 2239
QoL ‘generally’ 68.25 20.65 63.12 21.59
Happiness ‘today’ 63.50 29.21 63.12 16.62
Happiness ‘generally’ 64.13 26.63 64.62 16.97
COGNITIVE CLUSTER GROUP 3 (N=7)
A QoL ‘today’ 78.00 16.72 81.71 22.71
QoL ‘generally’ 73.29 21.05 64.43 34.99
Happiness ‘today’ 74.29 27.25 88.71 12.79
Happiness ‘generally’ 86.14 11.32 85J# 9.14
B QoL ‘today’ 73.14 16.53 67.57 23.46
QoL ‘generally’ 59.00 29.41 68.85 18.94
Happiness ‘today’ 5835 33.61 77.29 17.65
Happiness ‘generally’ 64.57 31.35 74.14 16.29
C QoL ‘today’ 79.71 15.77 61.14 3259
QoL ‘generally’ 7535 24.76 62.29 24.57
Happiness ‘today’ 68.14 29.50 67.85 22.49
Happiness ‘generally’ 64.57 31.35 62.57 2299
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Means suggested that individuals with intact cognitive functioning (cluster group
1) generally benefited more from spending time outside than from spending time 
on the ward in one-to one company or on the ward unaccompanied. Individuals 
with mid-range cognitive functioning (cluster group 2) appeared to benefit more 
from spending time on the ward in one-to-one company judging from QoL ‘today’ 
ratings, although Happiness ‘today’ ratings decreased on this condition. On the 
basis of QoL ‘generally’, and Happiness ‘today’ and ‘generally’ ratings, 
individuals with abnormal range cognitive functioning (cluster group 3) also 
appeared to benefit most from time on the ward in one-to-one company. Happiness 
‘today’ and QoL ‘generally’ mean ratings decreased after this group bad spent 20 
minutes unaccompanied on the ward.
Four 3 x 3 x 2  mixed ANOVAs were therefore conducted to examine the effects of 
experimental condition, test occasion and general cognitive functioning on QoL 
(‘today’ and ‘generally’) and Happiness (‘today’ and ‘generally’) ratings (see 
Appendix 5.14). No main effects for experimental condition, general cognitive 
functioning, or test occasion were demonstrated, and no two-way or three-way 
interactions were obtained. These findings suggest that intervention outcomes 
were not affected by level of general cognitive functioning.
Although level of general cognitive functioning did not seem to influence 
intervention outcomes, it was considered that autobiographical memory and 
immediate memory might influence outcomes. Individuals with immediate 
memory deficits, for example, may have forgotten they bad just been outside by the 
time they returned to the ward in order to complete post-test assessments. If this 
was the case, these individuals might obtain similar pre and post-test QoL and
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Happiness ratings, when compared to individuals who remembered having spent 
time outside.
Furthermore, individuals with an autobiographical memory deficit may not be able 
to recall recent events that involve going out, or spending time outside. In this 
case, they may enjoy what they perceive to be the ‘novelty’ of spending time 
outside. On this basis, one might expect their post-test QoL and Happiness scores 
to increase, in relation to the post-test scores of individuals with normal 
autobiographical memory.
To test this possibility, a series of four 3 x 2  repeated measures ANCOVAs were 
conducted to examine the effects of test occasion and experimental condition on 
QoL (‘today’ and ‘generally’) and Happiness (‘today’ and ‘generally’), once the 
influence of autobiographical memory and immediate memory functioning were 
accounted for (see Appendices 5.15-5.17). Although no significant main effects 
were found relating to the hypothesis, once the influence of ability to remember 
facts from one’s past life (PS) was accounted for, two significant interactions were 
demonstrated for QoL ‘today’ and QoL ‘generally’. The first interaction effect is 
presented overleaf in Figure 5.2.
With the number of non-significant findings obtained within this set of analyses, 
the increased chance of Type II errors occurring here is acknowledged. However, a 
lenient alpha level lowers the chance of a Type II error, but increases the chance of 
a Type I error (Reber, 1985). With the alpha level set at 0.05 in the present 
analyses, it therefore seems more likely that a true hypothesis will be erroneously 
rejected, than a false hypothesis wrongfully accepted.
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Figure 5.2: The interaction effect observed between experimental condition 
and test occasion on OoL ‘today’ ratings, with autobiographical memory (PS) 
covaried
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The interaction between experimental condition and test occasion suggests that 
individuals reported lower perceived QoL ‘today’ after having spent time on the 
ward unaccompanied, than that reported before intervention. By comparison, 
spending time in one-to-one company and time spent outside appear to increase 
post-test QoL today’ ratings (F(2, 44)=5.17, /7<0.05). Engaging in either activity 
may therefore be preferable to spending time alone on the ward, which may be 
detrimental to perceived QoL within the present population.
Whilst this finding enhanced understanding of the effect of interventions in the
present study, the precise influence of autobiographical memory on QoL after
individuals had spent time alone on the ward remained unclear. It was considered
that individuals with intact autobiographical memory may have reported a lower
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perceived QoL having spent 20 minutes on the ward unaccompanied, due to the 
temporary decline in social activity that accompanied this experimental condition. 
This seems plausible given the busy daily schedules of most participants within the 
present population. However, as individuals with autobiographical memory 
deficits are less able to recall how they generally spend their time, they may be less 
concerned by this decline in social activity. To test this assumption, Pearson 
product moment correlation coefficients were obtained in order to examine the 
relationship between autobiographical memory and Condition C QoL ‘today’ 
difference scores.
The obtained r value suggested a significant positive relationship between 
autobiographical memory and QoL ‘today’ difference scores (r=0.59, /?<0.01). 
Thus a higher level of autobiographical memory functioning was related to larger 
difference scores. Larger difference scores on Condition C reflected a smaller 
overall decrease in post-test QoL ‘today’ ratings. Thus, after having spent time on 
the ward unaccompanied, the decrease in perceived QoL ‘today’ was greater for 
individuals with autobiographical memory deficits. This finding was contrary to 
the suggested outcome that was outlined in Section 4.61 (pp.223-228), where 
individuals with an autobiographical memory deficit for recent events obtained 
significantly higher QoL ‘today’ ratings than individuals with intact memory for 
recent events. Possible explanations for this are discussed in Section 5.35. There 
were no significant relationships between autobiographical memory and QoL 
‘today’ differences scores for Condition A (r=0.04, N.S.) or Condition B (r=-0.07, 
N.S.). This suggested that the QoL benefits associated with time spent outside and 
time spent in one-to-one company were similar for individuals with and without 
autobiographical memory deficits.
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The second interaction effect between experimental condition and test occasion for 
QoL ‘generally’, when the influence of ability to remember facts from one’s past 
life (PS) was accounted for, is presented in Figure 5.3.
Figure 5.3: The interaction effect observed between experimental condition 
and test occasion on OoL ‘generallv’ ratings, with autobiographical memorv 
(PSl covaried
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The second interaction effect suggests that time spent outside made little difference 
to perceived QoL; time spent on the ward unaccompanied resulted in a lower 
perceived QoL; and time in one-to-one company resulted in a higher perceived 
QoL (F(2, 44)=5.57,/?<0.05).
The relationship between autobiographical memory scores and QoL ‘generally’ 
difference scores on Conditions B and C were examined using Pearson product
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moment correlation coefficients, in order to establish the role of autobiographical 
memory in this context. Correlation coefficient (r) values suggested there was a 
significant positive relationship between autobiographical memory and Condition 
B difference scores (r=0.45, ^<0.05). Thus individuals with a higher level of 
autobiographical memory functioning obtained larger difference scores on 
Condition B. Larger difference scores on Condition B reflected a greater overall 
increase in post-test QoL ‘generally’ ratings. Thus, after having spent time in one- 
to-one company, the increase in perceived QoL ‘generally’ was greater for 
individuals with normal autobiographical memory functioning.
A significant positive relationship between autobiographical memory and 
Condition C difference scores was also demonstrated (r=0.43, /><0.05). Thus 
individuals with a higher level of autobiographical memory functioning obtained 
larger difference scores on Condition C. Larger difference scores on Condition C 
reflected a smaller overall decrease in post-test QoL ‘generally’ ratings. Thus, after 
having spent time on the ward, unaccompanied, the decrease in perceived QoL 
‘generally’ was greater for individuals with autobiographical memory deficits. This 
finding replicated results presented in Figure 5.2, and is discussed in Section 5.35.
The importance attributed to time snent outside and the effect of interventions 
Analyses in relation to Hypothesis 1 suggested that there was no significant effect 
of time spent outside (accompanied) on QoL. This finding was unexpected, as 
‘going out’ was considered the second most important life area in 5 of the 7 
SEIQoL-DW assessments conducted to date with the present population, and the 
joint most important life area in the remaining two assessments.
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Having established that autobiographical memory influenced the QoL outcomes of 
time spent in one-to-one company, and time on the ward, unaccompanied, further 
analyses were conducted to determine whether a third factor had influenced the 
effect of time spent outside on QoL, which had not yet been demonstrated.
It was considered that the importance attributed to time spent outside might 
influence the outcomes of this intervention. This information has already been 
collected using the SEIQOL-DW with the present population, which asks 
individuals to nominate up to five life areas that they consider important. On this 
basis, it was possible to determine whether the importance attributed to spending 
time outside influenced the QoL benefits associated with this intervention. In order 
to examine this possibility, participants were grouped according to their SEIQoL- 
DW responses on tl assessment of Study 3. Group 1 (N=14) nominated ‘going 
out’ as an important life area, whilst Group 2 (N=10) did not.
Four 3 x 2 x 2  mixed ANOVAs were conducted to examine the effects of 
experimental condition, test occasion and the importance attributed to spending 
time outside on perceived QoL (‘today’ and ‘generally’) and Happiness (‘today’ 
and ‘generally’, see Appendix 5.18). F  values confirmed that there were no 
significant main effects or interactions between these variables. This finding 
suggests that the outcome of interventions were not affected by the importance 
attributed to ‘going out’, a finding that is discussed in Section 5.35.
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Frequency of time normally spent outside and the effect of interventions 
The final exploratory analysis conducted was to examine whether the frequency of 
time normally spent outside influenced the effect of interventions in the present 
study. Results of four 3 x 2  repeated measures ANCOVAs confirmed there were 
no significant main effects with respect to the hypothesis, and no significant 
interactions between experimental condition and test occasion on perceived QoL 
(‘today’ and ‘generally’) and Happiness (today’ and ‘generally’), with the influence 
of time generally spent outside covaried (see Appendix 5.19). This finding, and the 
analyses conducted in Section 5.24 of Study 3 (pp.270-272), suggested that the 
amount of time generally spent outside did not affect the outcome of interventions 
in the present investigation.
5.35 Discussion
The primary aim of the present study was to determine whether time spent outside, 
or time spent in one-to-one company, affected QoL and Happiness ratings within 
the present population. Although means were in the predicted direction, analyses 
relating to Hypothesis 1 suggested that neither of these variables had a significant 
effect on perceived QoL and Happiness, and that the presence/absence of life 
changes made no difference to the effect of interventions.
This finding was surprising, given the interaction effect between test occasion and 
life change that was previously demonstrated in relation to Study 3. The 
discrepancy between findings suggested that the week-long interval between tl and 
t2 assessments in Study 3, alongside the absence of ‘company’ and ‘control’ 
conditions, may have influenced this initial finding. Furthermore, in Study 3
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individuals were taken around the hospital grounds once they were outside. In the 
present study, because of the unsettled weather conditions, individuals remained 
underneath the veranda overlooking the hospital grounds once they were outside. 
Whether this contributed to the difference between results obtained remains 
uncertain, and a second experimental study conducted in the warmer summer 
months would be necessary in order to examine this possibility.
Before Study 4 was conducted, it was anticipated that the lower outside 
temperatures during the present study would at least reduce the effect of time spent 
outside on perceived QoL and Happiness. However, exploratory analyses 
suggested that even though outside temperatures had dropped for the present study, 
this did not appear to affect intervention outcomes. It was also surprising to find 
that the effects of intervention did not differ as a function of cognitive cluster 
groups, especially as previous research with the present population has suggested 
significant differences among the perceived QoL of individuals with ‘normal’ and 
‘mid-range’ cognitive functioning (see Section 4.64, pp.237-239). A large variance 
within post-test sores was observed across these analyses, and once these variables 
were accounted for, the variance within groups remained greater than the variance 
between groups.
However, results of exploratory analyses did suggest that autobiographical memory 
influenced the effect of interventions. Once the ability to recall facts from one’s 
personal past life were accounted for, there were significant interactions between 
experimental condition and test occasion on QoL ‘today’ and QoL ‘generally’ 
ratings. Further analyses suggested that, having spent time on the ward, 
unaccompanied, individuals with autobiographical memory deficits obtained a
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larger overall decrease in perceived QoL ‘today’ and ‘generally’ than individuals 
with normal autobiographical memory. Spending time in one-to-one company and 
spending time outside accompanied resulted in similar increases in perceived QoL 
‘today’ for individuals with normal autobiographical memory and individuals with 
autobiographical memory deficits. This set of findings is particularly important as 
it suggests that time spent in one-to-one company and time spent outside may hold 
positive benefits for persons with severe neurological disability. Remaining on the 
ward without an activity to engage in may be detrimental to perceived QoL within 
the present population, especially for persons with autobiographical memory 
deficits.
Many of the individuals with such deficits have reasonably severe and widespread 
cognitive impairments, which reflect the latter-stages of many of the progressive 
neurological illnesses within the present population. On this basis, they are likely to 
have deficits associated with attention, conceptualisation and problem solving 
skills, information processing, the ability to perceive and think clearly, and verbal 
fluency (Thornton and Raz, 1997). Given the busy schedules of participants in the 
present study, individuals may welcome the opportunity to spend time alone. For 
persons with intact autobiographical memory functioning, this provides them with 
the opportunity to reflect on events that have taken place, think about personal 
matters, initiate conversations with others, think about things that they might want 
to do across the next few days, and so on. However, each of these activities 
requires one or more of the cognitive functions outlined above, which individuals 
with widespread cognitive deficits may not possess.
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Given this same opportunity to spend time unaccompanied, individuals with 
autobiographical memory deficits may not be able to spend time in this way. The 
activities that individuals with cognitive impairment would have taken part in 
during this 20 minute duration may have included watching TV, sitting on the ward 
among other patients, or sitting in their room, alone. As the investigator was not 
present during this time, these suggestions remain purely speculative. Perhaps, in 
some cases, these individuals felt confused about why they had been asked to 
remain on the ward, or uncertain about would be happening next. Perhaps these 
factors contributed to the decreased QoL ‘today’ and ‘generally’ perceptions 
obtained in the present study.
Although spending time in one-to-one company led to a similar increase in 
perceived QoL ‘today’ for both memory groups, those with intact autobiographical 
memory reported higher QoL ‘generally’ post-intervention than those with an 
autobiographical memory deficit. Time in one-to-one company appears to have a 
greater overall impact on the perceived QoL of individuals with normal 
autobiographical memory. If these individuals talked about recent personal events 
such as going on holiday or on outings, or being visited by friends or relatives 
when they spent time in one-to-one company, this might explain this finding. As 
the content of each social conversation was not recorded at the time of intervention, 
this suggestion remains purely speculative. However, it seems plausible that talking 
about events like a holiday would generally make one feel good about one’s overall 
QoL.
Verbal fluency deficits might also have contributed to the lower increase in 
perceived QoL on Condition B for individuals with autobiographical memory
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deficits. Indeed, it was observed at the time of intervention that some of the 
individuals with reduced cognitive functioning also had difficulties initiating 
spontaneous conversation. The topic and depth of conversation was more limited in 
these cases, whereas individuals with normal cognitive functioning had the 
opportunity to talk on a fairly philosophical level. One individual with normal 
cognitive functioning did comment during this intervention that they welcomed the 
opportunity to hold a thought-provoking conversation with someone. These 
observations may have contributed to the present finding, that time spent in one-to- 
one company resulted in a greater increase in perceived QoL ‘generally’ for 
persons with normal autobiographical memory.
Collectively, these findings suggest that future evaluation of intervention outcomes 
in a neurological setting may benefit from more detailed background information 
concerning level of cognitive functioning. In summary, the present findings suggest 
that time spent outside may is beneficial to perceived QoL ‘today’ within the 
present population. Time spent in one-to-one company may also be beneficial to 
perceived QoL, and time spent on the ward unaccompanied may he detrimental to 
perceived QoL. These findings hold important potential implications concerning 
efforts to maximise QoL in long-term care settings, indicating that increased social 
activity and interaction may contribute to achieving this aim. Further research is 
now required to delineate more clearly the characteristics of those who benefit 
from time spent outside and from time spent in one-to-one company, and those 
who respond poorly to time spent on the ward, unaccompanied. This knowledge 
may then be applied to assist in improving the perceived QoL of persons with 
severe neurological disability.
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Analyses in relation to Hypothesis 2 suggested that there were significant 
relationships among QoL and Happiness ratings. More specifically, the
relationships between (a) QoL ‘today’ and ‘generally’ ratings and (b) Happiness 
‘today’ and ‘generally’ ratings were stronger than the relationships among QoL and 
Happiness ratings. This suggests that, whilst Happiness and QoL are related 
constructs, they are distinguishable fi*om one another. Furthermore, it challenges 
the notion that QoL can only be conceptualised and defined through the concept of 
Happiness (Gill, 1984; Milbrath, 1979; Beckmann and Ditlev, 1992). The present 
findings, together with those of Study 3 (see Section 5.24.3), suggest that 
Happiness affects rather than determines QoL. Further research is now required to 
isolate the factors that mediate the relationship between perceived QoL and 
Happiness, so that an enhanced understanding of this complex relationship can be 
obtained. This would also further our understanding of the factors that influence 
perceptions of QoL within the present population.
Exploratory analyses conducted provided further insight concerning the clustering 
of cognitive function within the present population. The three distinct cognitive 
groupings identified were identical in structure to the cognitive clusters identified 
within Study 2 (see Section 4.62, pp.229-231), and, again, there were significant 
differences among cluster groups’ cognitive test scores. It is important to note that 
82% of the individuals in the present study had also taken part in Study 2, but 
interesting to note the remarkable difference observed among group AIS scores. 
The magnitude of effect here is noteworthy considering the relatively small number 
of individual taking part in the present study. This finding suggests that there are 
vast differences at group level in the ability to remember autobiographical incidents
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from one’s past life.
The identification of distinct cognitive cluster groups also suggests that there may 
be relatively uniform patterns of cognitive deficits within the present population. 
This finding supports previous research conducted by Beatty et al (1996), who 
suggested that, with respect to memory performance, there are at least three 
‘clusters’ of MS patients. The present findings, alongside those of Study 2, suggest 
that this pattern may extend to other types of cognitive deficit, and to individuals 
with severe disability resulting from other neurological illnesses. Further research 
using a representative sample of individuals with different neurological diagnoses 
is now required in order to test this assumption.
As outlined in Section 5.2 (pp.259-261), previous research using the SEIQoL-DW 
with the present population has demonstrated that ‘getting out and about’, ‘going 
out’ and ‘contact with the outside world’ are frequently nominated as important 
areas of individuals’ lives. However, exploratory analyses demonstrated that the 
importance attributed to ‘going out’ on the SEIQoL-DW had no significant 
influence on the effects of intervention. This suggests that the QoL benefits of 
spending time outside are not dependent on whether the individual feels that ‘going 
out’ is important to them. Present analyses relating to level of general cognitive 
functioning and immediate memory also suggest that the benefits of spending time 
outside are not dependent on whether the individual can remember taking part in 
the ‘outside’ intervention.
Across all studies conducted, the number of individuals nominating ‘going out’ as 
an important life area ranges from 40.5% to 58.5% (see Table 5.1). The only life
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area that has been consistently rated as more important than going out within the 
present population is ‘family/going home’, which 50-83% of individuals have rated 
as important across studies conducted to date. This variable may have provided a 
suitable foundation for an intervention study within the present population. 
However, some of the residents have no contact with their family, and in other 
cases family members live abroad. Although the present study indicates that time 
spent outside and time spent in one-to-one company are both beneficial to 
perceived QoL, it would be interesting to measure the effects of, for example, 
increased family contact on perceived QoL and Happiness within the present 
population.
As noted in discussion of Study 3 (p.273), it would he interesting to investigate the 
effects of a ‘going out’ intervention that involved spending time away from the 
Hospital. Time spent outside may have a greater effect on QoL and Happiness 
ratings when individuals spend time away from their usual surroundings and 
experience greater contact with the outside world. Unfortunately it was not 
possible to examine this hypothesis within the constraints of the present research, 
although this is an area that warrants further attention.
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CHAPTER 6
Assessing QoL in Persons with Severe Neurological Disability using
the WHOQOL-BREF
STUDY 5
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6.1 Introduction
The WHOQOL-BREF was developed by the World Health Organisation Quality of 
Life (WHOQOL) Group, who define QoL as “individual’s perceptions of their 
position in life in the context of the culture and value systems in which they live 
and in relation to their goals, expectations, standards and concerns” (The 
WHOQOL Group, 1998a, p.551). This definition is based on the view that QoL 
refers to a person-centred evaluation of life, and in this respect the conceptual 
foundations of the WHOQOL-BREF appear similar to those of the SEIQoL-DW.
The WHOQOL-BREF was derived from the WHOQOL-100, an assessment tool 
developed by the WHOQOL Group in 15 international field centres 
simultaneously, with the aim of developing a QoL measure that could be used 
cross-culturally. The WHOQOL-100 encompasses 24 facets universally regarded 
by all 15 field centres as important in assessing QoL, and four general questions 
that assess overall QoL and health. These facets are grouped into four domains; 
Environment, Physical, Psychological and Social Relationships. From each of the 
24 facets, the item that correlated most highly with the total score (the mean of all 
facets) was included in the WHOQOL-BREF. (For further details of the 
development of the WHOQOL-BREF, the reader is referred to the WHOQOL 
Group, 1998a).
The WHOQOL-BREF is substantially shorter than the WHOQOL-100, and 
therefore considered suitable for large epidemiological studies, routine clinical 
assessment, and for use with populations where more lengthy assessment remains 
unfeasible. Although the WHOQOL-BREF is a relatively recent development, the
318
WHOQOL Group suggest it is capable of assessing domains relevant to QoL in 
different cultures worldwide. Early psychometric testing suggests that the 
WHOQOL-BREF has adequate internal consistency (Cronbach’s alphas ranging 
from 0.66-0.80), and is able to discriminate between ‘ill’ and ‘healthy’ participants. 
At the time of writing there is little data available concerning the re-test reliability, 
concurrent validity and responsiveness to change of the WHOQOL-BREF, 
although further psychometric testing is soon to be completed (The WHOQOL 
Group, 1998a).
As the WHOQOL-BREF has only recently been developed, there are presently no 
published investigations concerning relationships among the WHOQOL-BREF and 
other QoL measures. However, the WHOQOL Group (1998a) suggest there are 
significant relationships between domain scores based on the WHOQOL-100 and 
domain scores calculated using items included in the WHOQOL-BREF, Pearson 
correlation coefficients ranging from 0.89 to 0.95. The authors stress the 
importance of individual domains in assessing QoL, but continue that the 
WHOQOL-BREF does not allow assessment of individuality within these facets. 
The extent to which the WHOQOL-BREF measures person-centred QoL therefore 
remains uncertain.
It is likely that the use of the WHOQOL-BREF for research purposes will increase 
considerably within the next five years, providing a cross-cultural QoL tool that 
will be useful for comparing QoL across disease category and within disease 
groups internationally. Within the present population of individuals with severe 
neurological disability, the WHOQOL-BREF could also provide a valid alternative
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to the SEIQoL-DW in cases where individuals lack the cognitive abilities required 
to complete this measure.
However, given that the WHOQOL-BREF includes assessment of physical 
functioning and overall health, floor effects may be encountered on some domains 
when used with a severely neurologically disabled population. Furthermore, many 
of the areas assessed (i.e. mobility, energy, esteem, finances, relationships) are 
likely to change as a function of disease duration and extent of disability. The 
effects of cognitive functioning, particularly autobiographical memory, and life 
changes have already been demonstrated to have an effect on person-centred QoL 
perceptions in the present population (see Section 4.6). The extent to which these 
factors influence WHOQOL-BREF scores requires careful consideration before the 
feasibility of using the WHOQOL-BREF with the present population can be 
established.
On this basis, the aims of the current study were:
1. To determine whether domain scores on the WHOQOL-BREF are related to 
person-centred QoL, as measured by the SEIQoL-DW and QoL ‘today’ and 
‘generally’ ratings.
The SEIQoL-DW, and QoL ‘today’ and ‘generally’ ratings continued to be used 
within the present study, on the basis of previous research conducted across Studies 
1 to 4. Findings to date have demonstrated that these measures are reliable, valid 
and responsive to life changes reported at the time of assessment. These assessment 
tools also appear to measure aspects of person-centred QoL, rather than health- 
based functioning. Furthermore, persons with reduced physical and/or cognitive
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functioning are generally able to understand and complete each measure with 
assistance.
2. To determine the effect of years since diagnosis and extent of disability on 
WHOQOL-BREF domain scores
3. To determine the effect of autobiographical memory on WHOQOL-BREF 
domain scores.
Results obtained in relation to Study 2 suggest that individuals with a recent deficit 
for autobiographical incidents (AIS) obtain significantly higher QoL ‘today’ ratings 
than individuals with intact memory for recent autobiographical incidents. 
Individuals with ‘normal’ autobiographical memory also obtain lower QoL ‘today’ 
ratings than individuals with moderate and severe deficits. Previous research with 
the present population also suggests that life change and autobiographical memory 
interact to affect QoL; when no life changes are reported individuals with an 
autobiographical memory deficit for recent events report significantly higher QoL 
(SEIQoL-DW) than individuals without this deficit. However, when life changes 
are reported to occur, individuals with an autobiographical memory deficit for 
recent events report significantly lower QoL than individuals with intact 
autobiographical memory for recent events (see Section 4.61, pp.223-228; Section 
4.64; pp.235-237, 241-243).
It was anticipated that similar findings might be obtained for the WHOQOL-BREF, 
if it were assessing person-centred QoL. The effect of autobiographical memory 
deficits across each time span of the AMI on person-centred QoL also warrants 
further attention, as previous research suggests the effect is only demonstrated once 
outlying scores are removed from the dataset (see Section 4.61, pp.224-225).
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The present study also enabled further exploration of factors that influence the use 
of social comparisons when evaluating present QoL. Although Study 2 identified 
many of the consequences of social comparisons when used to evaluate QoL in the 
present population, relatively few factors were identified that increased the 
likelihood that social comparisons would be made. Gilbert, Price and Allan (1995) 
suggest that the process of social comparisons is spontaneous, effortless and 
unintentional. However, as Gibbons and Buunk (1999) point out, circumstances 
and situations vary in the extent to which they promote a need for social 
comparison. For example, Molleman, Pruyn and van Knippenberg (1986) suggest 
that periods of stress and uncertainty may increase the use of social comparisons in 
persons with cancer.
Exploratory analysis relating to Study 2 suggested that individuals experiencing 
positive or negative life changes at the time of assessment report significantly 
higher QoL ‘generally’ when they make comparisons with their own past in order 
to evaluate their present QoL. This finding was explained by the increased 
uncertainty and instability that may accompany periods of change within the 
present population. As only one individual reported a ‘positive change’ at the time 
of assessment this subsequent interpretation remained speculative, and it was 
anticipated that the present study would provide an opportunity to re-examine this 
finding.
The relationship between depression and social comparison information was 
outlined on p.205 of Section 4.1. In summary, several researchers have 
demonstrated that depressed individuals make more social comparisons than non­
depressed individuals (i.e. Swallow and Kuiper, 1990, 1992; Beck, Rush, Shaw and
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Emery, 1979; Wood, 1996). Low self esteem has also been related to the tendency 
to compare oneself with less fortunate others (i.e. DeVellis et al., 1990; Taylor, 
Wood and Lichtman, 1983; Wood, Giordano-Beech, Taylor, Michela and Gaus, 
1994), and is thought to increase people’s reliance on social comparisons for self- 
evaluations (i.e. Brickman and Bulman, 1977; Wayment and Taylor, 1995).
With relatively few individuals in the present sample showing signs of even mild 
depression on the HADS to date, it has so far been impossible to test the 
hypothesised relationship between depression and social comparison information. 
However, a greater number of individuals in the present population report levels of 
unhappiness using happiness ‘today’ and ‘generally’ visual analogue scales (see 
Section 5.32.3, pp.284-285). If mild depression, low self-esteem, and periods of 
uncertainty are related to a greater number of social comparisons, then diminished 
levels of happiness and, indeed, extent of life satisfaction might also be associated 
with this psychosocial process. On this basis, it might be interesting to examine 
whether unhappy individuals make more social comparisons than happy 
individuals.
To date, there have been few published papers that examine social comparison 
processes among happy and unhappy individuals. However, Lyubomirsky and 
Ross (1997) suggest that individual differences in enduring levels of happiness are 
associated with a tendency for people to compare themselves with less fortunate 
others. They studied the social comparisons made by 25 self-rated happy, and 25 
self-rated unhappy undergraduate female psychology students. Participants took 
part in a 20-minute anagram-solving task alongside a supposed peer, who was
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actually an experimental confederate. The confederate monitored the participant’s 
pace and completed approximately 50% more or 50% fewer anagrams.
Baseline and post-performance mood were assessed using a 9-point Likert scale, 
which asked how good, happy and depressed participants currently felt. Pre and 
post-test assessments of anagram solving ability were completed by each 
participant. Results demonstrated that unhappy participants who saw their peer 
solve anagrams faster than they themselves did expressed greater doubts about their 
own ability at the task and showed a greater tendency to depress their positive 
mood. Happy participants, by contrast, showed no such tendency to respond 
negatively to the unfavourable social comparison provided by their faster peer. On 
this basis, Lyubomirsky and Ross (1997) suggest that happy individuals may not 
take into account negative social comparison information when evaluating 
themselves, but may instead use internal standards or objective criteria as a basis 
for self-evaluations. Happy individuals may also be particularly successful at 
ignoring or otherwise defending themselves against the potentially negative 
hedonic consequences of unfavourable comparisons.
One of the problems with this and many other social comparison studies to date 
concerns their reliance on artificial laboratory conditions that are far removed from 
the realities of the social world in which we live in. In everyday life, people may 
not be explicitly alerted to another’s performance as participants were in the study 
outlined above. Furthermore, this study only examines the relationship between 
level of reported happiness and comparisons with others. The relationship between 
current happiness and other types of comparisons, such as those with one’s own 
past or ideal future, remain uncertain.
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The present study therefore examined the relationships among level of reported
happiness, extent of life satisfaction and evaluation strategy when judging person-
centred QoL. On this basis, the final aim of the present study was:
4. To determine whether level of reported happiness and extent of life satisfaction 
are related to the use of social comparisons processes when evaluating present 
QoL.
6.2 Hypotheses
In relation to these aims, the following hypotheses were tested:
1. There will be significant relationships among the SEIQoL-DW, QoL and 
Happiness ‘today’ and ‘generally’ ratings and WHOQOL-BREF 
Environment, Psychological and Social Relationships scores, reflecting their 
orientation towards person-centred QoL.
2. There will be a significant effect of duration of illness and extent of disability 
on WHOQOL-BREF Physical scores, reflecting this domains orientation 
towards health-based QoL.
3. There will be a significant effect of autobiographical memory on SEIQoL-DW, 
WHOQOL-BREF and QoL ‘today’ and ‘generally’ scores; individuals with 
autobiographical memory deficits will obtain significantly higher QoL scores 
than individuals without autobiographical memory deficits.
4. Self-rated unhappy individuals will be more likely to use social comparisons 
when evaluating their present QoL than self-rated happy individuals, as 
indicated by Happiness ‘today’ and ‘generally’ visual analogue scale ratings.
5. Individuals who are generally unsatisfied with their life will be more likely to 
use social comparisons when evaluating their present QoL than individuals who
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are generally satisfied with their life.
It was anticipated that testing Hypotheses 1 and 2 would establish the feasibility of 
using the WHOQOL-BREF as a person-centred QoL measure within a population 
of individuals with severe neurological disability. The results obtained would also 
clarify the theoretical basis of the measure and provide further recommendations 
concerning the utility of the WHOQOL-BREF within the present population. 
Hypotheses 2 and 3 would provide further information concerning the factors that 
influence scores on the WHOQOL-BREF. Hypothesis 3 provided an opportunity 
to re-examine the extent to which autobiographical memory functioning influences 
person-centred QoL, as previous research with the present population suggests that 
this relationship warrants further attention. Finally, it was anticipated that a test of 
Hypotheses 4 and 5 would assist in enhancing our understanding of the 
psychosocial processes that occur when QoL judgements are made, and increase 
knowledge of the factors that influence the use of social comparisons. In turn, this 
information would assist in further development of a psychosocial model of QoL 
developed on the basis of previous literature and from findings obtained in Study 2.
6.3 Method
6.31 Participants
Twenty-eight residents were identified as able to take part in the assessments, 
including the 2fr individuals who participated in Study if. Two of these individuals 
had died since the last study was conducted, and one individual was no longer 
attending the day hospital. Consent procedures were completed for 25 individuals, 
one of whom was unable to grasp the concepts and methods associated with the
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SEIQoL-DW due to cognitive deterioration. Full data sets were therefore 
completed for 24 participants, whose ages ranged from 30-75 years (x=56  years, 
SD=11.31). Eleven participants were men (46%) and 13 participants were women 
(54%). The range of diagnoses in this sample is presented in Table 6.1.
Table 6.1: The range of diagnoses of the 24 individuals taking part in Study 5
Diagnosis N (%)
MS 17 70.83
Cerebral palsy 2 4.16
Dystonia 1 4.16
Friedreich’s ataxia 1 4.16
Hydrocephalus 1 4.16
Left hemiplegia 1 4.16
Myasthenia gravis 1 4.16
6.32 Measures
Medical and demographic data and extent of disability (EDSS) ratings were made 
available from hospital records or supplied by the Department of Clinical 
Psychology. Information concerning significant life changes continued to be 
collected in the same manner as in the previous studies with the present population 
(see Section 3.32.1, p. 164).
II The Autobiographical Memory Interview (AMI) (Kopelman. Wilson and 
Baddelev. 1990)
Details concerning the content and scoring of the AMI (see Appendix 4.4) are 
presented on p.214 of Section 4.32. The cut-off points used in the present study are 
documented within the AMI test manual (Kopelman, Wilson and Baddeley, 1990).
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2) Happiness
Happiness ‘today’ and ‘generally’ were assessed using the visual analogue scales 
introduced in Study 5 (see pp.284-285 of Section 5.32.3 and Appendix 5.6 for full 
details). The scales range from 0 (‘extremely unhappy’) to 100 (‘extremely 
happy’). Cut-off points were initially determined using median scores, which 
ranged between 66 and 74.5 on the 0-100 scales. These relatively high cut-off 
points support Lyubomirsky and Ross’ (1997) observation that people tend to show 
overall means that are on the high end of measures of current or long-term well­
being and life satisfaction. It was considered that these relatively high cut-off 
points did not reflect ‘unhappy’ participants in the present data, and on this basis 
K-means cluster analyses were used to determine ‘happy’ and ‘unhappy’ 
groupings.
3) Life Satisfaction
Life satisfaction was assessed using a visual analogue scale (VAS) ranging from 0 
(‘extremely dissatisfied’) to 100 (‘extremely satisfied’) (see Appendix 6.1). Again, 
the relatively high median cut-off point obtained of 70 supported Lyubomirsky and 
Ross’s (1997) observation that people tend to show overall means that are on the 
high end of measures of life satisfaction (see discussion above relating to 
Happiness measure). On this basis, A K-means cluster analysis was used to 
determine ‘unsatisfied’ and ‘satisfied’ groupings.
4) Social Comparisons/GoL Interview
Section 1 of the Social Comparisons/QoL Interview developed in Study 2 was used 
in the present study (see pp.215-216 of Section 4.32 and Appendix 4.6 for full 
details). Individuals were therefore asked to rate their QoL ‘generally’ on a visual
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analogue scale, and explain how they made this judgement (i.e. were comparisons 
made and if so were they comparisons with one’s own past, or comparisons with 
other people). Responses allow individuals to be grouped in the following way: 
Group 1: individuals who state they make comparisons when rating their QoL 
‘generally’
Group 2: individuals who state they do not make comparisons when rating their 
QoL ‘generally’
5) OoL
The SEIOoL-DW and OoL ‘generally’ and ‘today’ ratings (see Appendix 3.2) 
continued to be used in the present study, and are described in full detail in Section 
3.22.2 (pp.132-133) and Section 3.32.1 (pp.163-164).
The WHOQOL-BREF (see Appendix 6.2) encompasses 24 facets universally 
regarded by all 15 field centres as important in assessing QoL. These facets are 
grouped into four domains; Environment, Physical, Psychological and Social 
Relationships (see Table 6.2 overleaf).
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Table 6.2: WHOQOL-BREF facets and domains
DOMAIN FACETS INCORPORATED WITHIN DOMAIN
ENVIRONMENT Freedom, physical safety and security
Home environment
Financial resources
Health and social care: accessibility and quality
Opportunities for acquiring new information and skills
Participation in and opportunities for recreation/leisure 
activities
Physical environment (pollution/noise/traffic/climate)
Transport
PHYSICAL Pain and discomfort
Sleep and rest
Energy and fatigue
Mobility
Activities of daily living
Dependence on medicinal substances and mental aids
Work capacity
PSYCHOLOGICAL Positive feelings
Thinking, learning, memory and concentration
Self-esteem
Bodily image and appearance
Negative feelings
Spirituality/religion/personal beliefs
SOCIAL
RELATIONSHIPS
Personal relationships
Social support
Sexual activity
WHOQOL-BREF domain scores are calculated by multiplying the mean of all 
items included within the domain by four. Potential scores for each domain 
therefore range from 4 to 20. The psychometric properties of the WHOQOL-BREF 
are outlined on pp.318-319 of Section 6 .1.
6.33 Design and analysis
The design of this study attempted to control for the effects of years since diagnosis 
and extent of disability. Participants were initially selected on this basis to fill the
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cells in each group of Table 6.3. The figures below represent the 24 participants 
who completed all assessments.
Table 6.3: The a-priori design constructed for years since diagnosis and extent 
of disability
Years since diagnosis Disability score (EDSS)
<=28 >28 <=8.0 >8.0
N=12 N=12 N=14 N=10
It was important to control for the years since diagnosis variable because MS is a 
progressive disease that generally involves gradual deterioration over a long period 
of time. Furthermore, the WHOQOL-BREF focuses on several life areas that 
might be expected to change with disease progression, such as relationships, 
finances and environment. Twenty-eight years was the median time since diagnosis 
of the population as a whole, and so formed the cut-off point for the two groups.
It was important to control for extent of disability, because the WHOQOL-BREF 
also focuses on several areas relating to physical health and mobility. It should also 
be noted that the rating scale of the EDSS ranges from 0 (normal) to 10 (death from 
MS). A score of 8 indicates the individual is perambulated in a wheelchair, 
although able to perform many self-care functions. A score of 9 indicates “a 
helpless bed patient who can communicate and eat” (Kurtzke, 1983, p.1452).
Previous studies with the present population have noted the relatively small number 
of participants with EDDS ratings of 9, reflecting the greater difficulties in 
communication and/or higher levels of cognitive impairment encountered within
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this group, which prevent several residents from participating (see Section 3.22.3). 
The design of the present study acknowledges this problem by attempting to 
control for two, rather than three levels of disability. Group 1 obtained ratings of 
less than or equal to 8 (representing a lower level of disability for the present 
population) and Group 2 obtained ratings that were greater than 8 (representing a 
higher level of disability within the present population).
The independent variables in the present study were autobiographical memory, 
duration of illness, extent of disability, level of reported happiness, life satisfaction 
and the presence/absence of social comparisons. The dependent variables were 
QoL as measured by the SEIQoL-DW, the WHOQOL-BREF and QoL ‘today’ and 
generally’ ratings. Analyses were also conducted in relation to significant life 
changes reported to occur at the time of assessment.
Before QoL assessments commenced, participants were randomly assigned to one 
of three groups, and the order of assessment was then counterbalanced as shown in 
Table 6.4.
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Table 6.4: Counterbalanced order of assessment and time plan for Study
Group 1 (N=8) Group 2 (N=8) Group 3 (N=8)
Week 1 Autobiographical Memory Interview
Week 2
Session 1
SEIQoL-DW 
QoL today/generally
WHOQOL-BREF 
QoL today/generally 
Happiness today/ 
generally
Life Satisfaction 
Happiness today/ 
generally
QoL/Social Comparisons
Session 2 Life Satisfaction 
Happiness today/ 
generally 
QoL/Social 
Comparisons
SEIQoL-DW 
QoL today/generally
WHOQOL-BREF 
QoL today/generally 
Happiness 
today/generally
W eeks WHOQOL-BREF 
QoL today/generally 
Happiness today/ 
generally
Life Satisfaction 
Happiness today/ 
generally 
QoL/Social 
Comparisons
SEIQoL-DW 
QoL today/generally
All assessment sessions were conducted on the ward, in the privacy of the 
individuals own room, with approximately 3-7 days between each session. 
Hypotheses were explored using questionnaires, administered in an interview 
format. The self-report technique used in previous studies with the present 
population was also retained. Both of these techniques accommodate the 
communication'difficulties, visual disturbances and limited physical abilities of the 
present population.
The relationships among the SEIQoL-DW, WHOQOL-BREF domains and QoL 
‘generally’ and ’today’ ratings were investigated using Pearson product moment 
correlation coefficients. The effect of autobiographical memory on QoL was 
investigated using univariate ANOVAs, and the effects of extent of disability and 
years since diagnosis on WHOQOL-BREF scores were investigated using a 3 x 2 
factorial design that was amenable to ANOVA. The frequency of happy/unhappy
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and satisfied/dissatisfied individuals making social comparisons was examined 
using K-means cluster analysis and chi-square tests, and additional analyses were 
conducted using Pearson product moment correlation coefficients, hierarchical 
cluster analysis and multidimensional scaling.
6.34 Procedure
Residents were invited to participate after consultation with the chartered clinical 
psychologist responsible for their care. In each case, the study was explained using 
both an information sheet (see Appendix 6.3) and by personal explanation. 
Informed consent was then obtained according to hospital guidelines (see 
Appendix 6.4). The procedures outlined in Studies 1-4 concerning making 
appointments and conducting assessments continued to apply in the present study.
Individuals whose AJS scores fell within the ‘borderline’ range for any of the three 
subscales, or for the total AIS score in Study 4 were reassessed using the 
Autobiographical Memory Interview. QoL and social comparison assessments 
were then conducted using the time-plan presented previously in Table 6.4.
6.35 Ethical Considerations
The ethical concerns of Study-S' mirror those of Studies 1-1^ , namely the amount of 
assessment to be conducted with each individual. This issue was discussed in full 
within Section 3.22.4, pp.137-138. The administration time for each session was 
approximately half an hour. Every care was taken to break the tasks down into 
shorter periods of assessment that were tolerable for the participants. Ethical 
procedures concerning informed consent, termination of testing and confidentiality 
continued to apply.
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6.4 Results
WHOQOL-BREF domain scores were calculated according to instructions outlined 
by the WHOQOL Group (1998a). Each domain score was then linearly 
transformed to a 0-100  scale, in order that direct comparisons could be made with 
the SEIQOL-DW and QoL ‘today’ and generally’ ratings. A global QoL score was 
derived from the SEIQoL-DW data using procedures outlined by O’Boyle et al 
(1996). All other measures were scored according to the methods described in 
Sections 3.32.1 (pp.163-164 ) and 4.32 (pp.214-216).
Means and standard deviations obtained for each variable are presented in Table 
6.5. From this point forward, the QoL ‘today’ and ‘generally’ ratings collected 
alongside the SEIQOL-DW assessment will be referred to with the number (1). 
The same ratings collected within the WHOQOL-BREF assessment session will be 
referred to with (2). Similarly, the number (2) distinguishes Happiness ratings 
collected alongside the WHOQOL-BREF assessment from those obtained during 
the Social Comparisons assessment session, which are labelled as (3).
On inspection of the social comparisons data, it was noted that 2 individuals (8% of 
total asked) said that their QoL rating was based on comparisons with other people, 
and these comparisons involved people who were worse off than the individuals 
concerned (downward comparisons). It is interesting to note that one of these cases 
had the shortest duration of illness observed within the present study (6 years). 
However, the second ‘comparison with other’ case had been diagnosed 32 years 
previously. These observations are discussed in Section 6 .6 . A further 16% of 
individuals (N=4) stated their rating was based on comparisons with other times in
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their lives, but the remaining 76% (N=18) made no comparisons at all in their 
evaluations. The overall number of comparisons made was lower than anticipated, 
and on this basis the comparison with ‘other’ and comparison with ‘past’ cases 
were combined for the purpose of analyses.
Table 6.5: Means and standard deviations obtained for each variable (N=24)
Variable Mean S.D.
EDSS rating 8.21 0.39
Duration of illness (years) 30.21 16.12
Years since admission 10.87 6.60
Pyramids and Palm Trees 18.04 2.05
Similarities (WAIS-R) (scaled score) 7.20 3.56
Digit Span Forward (WAIS-R) 6.29 2.54
Digit Span Backward (WAIS-R) 4.25 2.34
Digit Span: Total (scaled score) 7.45 3.29
Autobiographical Incidents Scale (AMI):
Childhood 2.79 2.44
Early adult life 3.58 3.07
Recent adult life 4.25 3.47
Autobiographical Incidents Scale Total 10.63 8.33
Personal Semantics Scale (AMI):
Childhood 14.89 4.95
Early adult life 14.06 4.80
Recent adult life 13.47 6.45
Personal Semantics Scale Total 42.39 14.22
SEIQoL-DW 66.09 23.00
Quality of life ‘today’ (1) 62.91 20.77
Quality of life ‘generally’ (1) 63.20 22.78
WHOQOL-BREF Environment 68.57 20.27
WHOQOL-BREF Physical 61.11 19.37
WHOQOL-BREF Psychological 65.91 14.33
WHOQOL-BREF Social Relationships 64.15 19.29
Happiness ‘today’ (2) 58.17 26.96
Happiness ‘generally’ (2) 61.83 24.48
Quality of life ‘today’ (2) 64.58 21.33
Quality of life ‘generally’ (2) 62.87 24.23
Life Satisfaction 65.39 20.23
Happiness ‘today’ (3) 61.91 25.05
Happiness ‘generally’ (3) 69.17 19.60
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From observation of the mean in relation to minimum and maximum scores, the 
shape of the distribution of scores appeared relatively normal. This was confirmed 
by calculating descriptive statistics for skewness. None of the variables showed 
skews greater than +1 or less than - 1.
6.5 Analysis of results
6.51 Hypothesis 1
Hypothesis 1 stated that there would be significant relationships among SEIQoL- 
DW scores, QoL and Happiness ‘today’ and ‘generally’ ratings and WHOQOL- 
BREF Environment, Psychological and Social Relationships scores, reflecting their 
orientation towards person-centred QoL. It was anticipated that testing Hypothesis 
1 would assist in clarifying the theoretical basis of the measure and provide further 
recommendations concerning the utility of the WHOQOL-BREF within the present 
population.
SEIQoL-DW, QoL ‘today’, QoL ‘generally’ and WHOQOL-BREF means were 
presented in Table 6.5. In order to determine whether there were significant 
relationships among QoL scores, Pearson product moment correlation coefficients 
were calculated, for all cases and independently for individuals reporting no life 
changes across assessment sessions (see Table 6 .6). QoL and happiness ‘today’ 
and ‘generally’ ratings included in this analysis were those obtained within the 
WHOQOL-BREF assessment session, in order to reduce the number of potential 
sources of error.
337
g'O
g
g
$
I
§
■g
0 
TJ
g
S
1
s
■§
ICA
«
.S
D
I
T3
g
0
g
1
en
.S
'Sn
I'ôS
vo
vo
g
en
S
.Sa
g-
o
aM
n
5b
.2
IPL,
f
I
t
H
î
T3
H
i
GO
S
£kOU
I
S00
to
&
I
o
ex
*
0 \
"T f
O
co
o
toi
I
\q
o
I
È ,
*
G
■a
■it
ï=
o
■a
3
o
eni
I
cd
üf
oJ
%0
1P4
I
0
CZ)
1
B
O
;z: s
338
Correlation coefficients suggested that there were significant relationships among 
the SEIQoL-DW, and WHOQOL-BREF Environment and Social Relationships 
domains. QoL ‘today’ ratings were significantly related to WHOQOL-BREF 
Environment and Psychological domains, although when ‘no change’ cases were 
considered independently only the QoL ‘today’/WHOQOL-BREF Psychological 
relationships remained significant. Only QoL ‘generally’ ratings were significantly 
related to WHOQOL-BREF Environment, Psychological and Social Relationships 
scores. The strongest relationship observed here was between QoL ‘generally’ 
ratings and WHOQOL-BREF Environment scores. This suggests that environment 
factors may be among those used to evaluate QoL ‘generally’ within the present 
population, as discussed in Section 6 .6 .
By comparison. Happiness ‘today’ and ‘generally’ ratings were significantly 
related only to WHOQOL-BREF Psychological scores (‘no change’ cases). This 
suggests that Happiness ratings obtained in the present study may reflect aspects of 
psychological well-being at the time of assessment. WHOQOL-BREF Physical 
scores generally appeared unrelated to SEIQoL-DW scores and QoL and Happiness 
‘today’ and generally’ ratings. This indicates that the SEIQoL-DW and 
QoL/Happiness visual analogue scales assess aspects of well-being that are not 
related to physical status. On the other hand, the remaining WHOQOL-BREF 
domains appear to measure constructs that are related to person-centred QoL within 
the present population.
Generally, these findings provided support for Hypothesis 1, which stated that there 
would be significant relationships among SEIQoL-DW scores, QoL and Happiness 
‘today’ and ‘generally’ ratings and WHOQOL-BREF Environment, Psychological
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and Social Relationships scores, reflecting their orientation towards person-centred 
QoL. The present findings suggest that the WHOQOL-BREF Environment, 
Psychological and Social Relationships domains are more closely related to person- 
centred QoL and happiness than the WHOQOL-BREF Physical domain, a finding 
that is discussed in greater depth in Section 6 .6 . Further exploratory analyses 
relating to this hypothesis are presented in Section 6.55.
It is also worth noting that the strongest relationship observed in Table 6.6 was 
between QoL ‘generally’ and Happiness ‘generally’ ratings. However, when ‘no 
change’ only cases were considered, the strongest relationship observed was 
between QoL and Happiness ‘today’ ratings, which was almost linear. This is 
interesting when compared to correlation analyses in Section 5.34.2 of Study tf- 
(p.294), which suggested that the strongest relationships using averaged 
correlations were between QoL ‘today’ and ‘generally’ ratings, and happiness 
‘today’ and ‘generally’ ratings. In the present study, when ‘no change’ only cases 
were considered, there were also no significant relationships between the SEIQoL- 
DW and (a) Happiness ‘today’ and (b) QoL ‘today’ ratings. This suggests that the 
SEIQoL-DW may be measuring a more long-term perception of QoL than these 
two visual analogue scales, although all interpretations involving the ‘no change’ 
group have to remain tentative given the small number of cases within this group. 
These observations are also discussed in Section 6 .6 .
6.52 Hypothesis 2
Hypothesis 2 stated that there would be a significant effect of duration of illness 
and extent of disability on WHOQOL-BREF Physical scores, reflecting this 
domains orientation towards health-based QoL. It was anticipated that testing
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Hypothesis 2 would assist in clarifying the theoretical basis of the measure, 
providing further recommendations concerning the utility of the WHOQOL-BREF 
with persons with severe neurological disability.
To test this hypothesis, mean WHOQOL-BREF Physical scores were obtained for 
extent of disability and duration of illness groups, as Table 6.7 demonstrates.
Table 6.7: Mean WHOQOL-BREF Physical scores by duration of illness and 
extent of physical disability (EDSS) groups (N=24)
DURATION OF ILLNESS EXTENT OF PHYSICAL DISABILITY
<=28 years
(N=12)
>28 years (N=12) Low (<=8) 
(N=14)
Medium/High (>8) 
(N=10)
Mean S.D. Mean S.D. Mean S.D. Mean S.D.
63.99 14.25 67.85 14.77 66.83 15.31 64.63 13.53
Means suggested that number of years since diagnosis and extent of physical 
disability made little difference to WHOQOL-BREF Physical scores obtained. A 
2 x 2  ANOVA was performed so that the effects of duration of illness and extent of 
disability on QoL (WHOQOL-BREF Physical scores) could be examined (see 
Appendix 6.5). F  values confirmed there were no significant main effects of 
duration of illness or extent of disability on WHOQOL-BREF Physical scores. 
Furthermore, no significant interaction effect was observed between these 
variables. This suggests that individuals with a higher level of physical disability 
and/or a longer duration of illness may still obtain relatively high WHOQOL- 
BREF Physical scores. It is worth noting that this finding was unchanged when the 
influence of years since admission, autobiographical memory and immediate 
memory were accounted for (see Appendix 6 .6). This suggests that the effects of
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duration of illness and extent of disability on WHOQOL-BREF Physical scores 
were not dependent on these factors, and on this basis. Hypothesis 2 was rejected. 
This finding is discussed in Section 6 .6 .
6.53 Hypothesis 3
Hypothesis 3 stated that there would be a significant effect of autobiographical 
memory on QoL; individuals with autobiographical memory deficits would obtain 
significantly higher QoL scores than individuals without autobiographical memory 
deficits. Testing this hypothesis would provide further information concerning the 
factors that influence scores on the WHOQOL-BREF, and also provided an 
opportunity to re-examine the extent to which autobiographical memory influences 
person-centred QoL.
SEIQoL-DW, WHOQOL-BREF, and QoL ‘today’ and ‘generally’ ratings were 
firstly summarised for individuals with and without deficits on the 
Autobiographical Incidents scale of the AMI (this scale shall be referred to using 
the AIS abbreviation firom this point forward). Results obtained are presented in 
Table 6 .8, where the bracketed numbers under ‘QoL variable’ refer to the test 
occasion that each measure was administered.
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Table 6.8; Mean OoL scores for each autobiographical memory group (N=24)
Autobiographical Memory Fuuctiouiug
Deficits (N=15) No Deficits (N=9)
QoL VARIABLE Mean S.D. Mean S.D.
SEIQoL-DW 65.35 21.57 67.32 26.52
QoL ‘today’ (1) 62.27 21.69 64.00 20.35
QoL ‘generally’ (1) 59.93 25.42 68.67 17.55
Environment (W) 72.22 19.35 62.50 21.42
Physical Health (W) 69.76 12.72 59.51 15.27
Psychological (W) 61.11 17.79 61.11 22.91
Social Relationships (W) 65.41 19.94 62.04 19.14
QoL ‘today’ (2) 69.53 21.08 56.33 20.21
QoL ‘generally’ (2) 64.53 27.37 60.11 19.08
Life Satisfaction (3) 68.60 17.56 60.05 24.19
QoL ‘generally’ (3) 66.60 22.87 58.27 24.59
Although SEIQOL-DW and QoL ‘today’ and ‘generally’ (1) means were slightly 
higher for individuals with intact autobiographical memory functioning, all other 
mean QoL scores were higher for individuals with autobiographical memory 
deficits, as predicted in Hypothesis 3. In order to examine the effect of 
autobiographical memory on QoL, univariate ANOVAs were conducted (see 
Appendix 6.7). F  values obtained confirmed there were no significant effects of 
autobiographical memory on QoL; individuals with autobiographical memory 
deficits did not obtain significantly higher QoL scores than individuals without 
these deficits. It is noteworthy that the effect of autobiographical memory on 
WHOQOL-BREF Physical scores just failed to reach significance (F(l, 22)=3.15, 
/?=0.09). It is also interesting to note there were no significant effects of personal 
semantic memory (AMI-PS) on perceived QoL within the present population (see 
Appendix 6 .8). These findings were unchanged when ‘no life change’ cases on 
each test occasion were considered independently (see Appendix 6.9).
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Descriptive statistics showed there was substantial variation around several of the 
QoL mean scores for both AIS groups. Individual scores obtained on the AIS and 
the QoL measures were therefore examined in greater detail. When one outlying 
case was removed from the data set, the mean QoL ‘today’ (2) score for the ‘no 
deficit’ group decreased from 56.33 to 25.00, increasing the mean difference 
between deficit and no deficit group’s scores. The F  value obtained using 
univariate ANOVAs was significant (F(l, 21)=4.56, /><0.05). However, no 
significant effects of autobiographical memory on QoL ‘today’ (1), QoL 
‘generally’ or SEIQoL-DW scores were demonstrated when this outlying score was 
removed (see Appendix 6.10).
In order to explore the effects of autobiographical memory on QoL in greater 
depth, AIS and PS scores were broken down by time period (memory for 
childhood, young adult and recent incidents). Univariate ANOVAs were conducted 
to determine whether the effects of autobiographical memory functioning on QoL 
varied as a function of the time span from which individuals were able to access 
memories (see Appendices 6.11 and 6.12). Results are summarised in Table 6.9.
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Table 6.9: The effects of autobiographical memory (AIS) deficits for 
childhoods vouug adult aud receut life iucideuts ou OoL scores
Memory for childhood iucideuts
QoL Variable Deficit (N=18) No deficit (N=6) F
value
d f Sig.
levelMeau S.D. Meau S.D.
SEIQoL-DW 65.71 21.19 67.25 30.08 0.01 (1, 22) N.S.
QoL ‘today’ (1) 61.11 20.79 68.33 21.60 0.53 (1, 22) N.S.
QoL ‘generally’ (1) 59.17 23.91 75.33 14.44 2.40 (1, 22) N.S.
Environment (W) 68.17 20.47 69.79 21.53 0.03 (1, 22) N.S.
Physical (W) 68.05 13.22 59.50 16.86 1.65 (1, 22) N.S.
Psychological (W) 60.41 17.69 63.19 25.59 0.09 (1, 22) N.S.
Social Rel.(W) 67.01 18.47 55.56 20.85 1.63 (1, 22) N.S.
QoL ‘today’ (2) 66.39 20.45 59.17 24.98 0.51 (1, 22) N.S.
QoL ‘generally’ (2) 63.22 25.62 61.83 21.64 0.01 (1, 22) N.S.
Life Satisfaction (3) 68.44 16.79 56.25 28.09 1.68 (1, 22) N.S.
QoL ‘generally’ (3) 65.39 21.48 57.75 29.81 0.47 (1, 22) N.S.
Memory for youug adult iucideuts
QoL Variable Deficit (N=13) No deficit(N=ll) F
value
d f Sig.
levelMeau S.D. Meau S.D.
SEIQoL-DW 66.87 22.87 65.18 24.23 0.03 (1, 22) N.S.
QoL ‘today’ (1) 65.77 20.77 59.54 21.24 0.52 (1, 22) N.S.
QoL ‘generally’ (1) 59.46 26.91 67.63 16.89 0.75 (1, 22) N.S.
Environment (W) 69.71 19.53 67.23 21.99 0.09 (1, 22) N.S.
Physical (W) 71.70 12.23 59.70 14.06 5.53 (1, 22) /?<0.05
Psychological (W) 61.54 16.23 60.60 23.37 0.01 (1, 22) N.S.
Social Rel. (W) 64.10 19.94 64.21 19.47 0.00 (1, 22) N.S.
QoL ‘today’ (2) 71.77 21.76 56.09 18.22 3.57 (1, 22) N.S.
QoL ‘generally’ (2) 64.46 28.92 61.00 18.44 0.11 (1, 22) N.S.
Life Satisfaction (3) 68.38 18.85 61.86 22.11 0.61 (1, 22) N.S.
QoL ‘generally’ (3) 66.85 23.91 59.50 23.15 0.57 (1, 22) N.S.
Memory for receut iucideuts
QoL Variable Deficit (N=14) No deficit(N=10) F
value
d f Sig.
levelMeau S.D. Meau S.D.
SEIQoL-DW 61.18 24.99 72.97 18.95 1.57 (1, 22) N.S.
QoL ‘today’ (1) 62.07 21.98 64.10 20.03 0.05 (1, 22) N.S.
QoL ‘generally’ (1) 62.43 26.29 64.30 18.04 0.03 (1, 22) N.S.
Environment (W) 73.58 19.32 61.56 20.41 2.15 (1, 22) N.S.
Physical (W) 66.83 14.59 64.63 14.63 0.13 (1, 22) N.S.
Psychological (W) 61.61 18.35 60.41 21.71 0.02 (1, 22) N.S.
Social Rel. (W) 65.33 21.20 62.50 17.23 0.12 (1, 22) N.S.
QoL ‘today’ (2) 71.29 20.80 55.20 19.24 3.71 (1, 22) N.S.
QoL ‘generally’ (2) 67.00 27.75 57.10 18.03 0.97 (1, 22) N.S.
Life Satisfaction (3) 67.25 22.79 62.80 16.81 0.27 (1, 22) N.S.
QoL ‘generally’ (3) 65.11 27.27 61.20 17.62 0.15 (1, 22) N.S.
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With the number of non-significant findings demonstrated in Table 6.9, and the 
lenient alpha level of 0.05 in the present analysis, the increased chance of a Type I 
error is acknowledged. F  values confirmed that there were no significant effects of 
autobiographical memory for facts relating to childhood, young adult life or recent 
adult life (PS) on QoL scores. F  values also suggested that there were no 
significant effects of autobiographical memory for childhood incidents or recent 
life incidents (AIS) on QoL scores obtained. However, there was a significant 
effect of autobiographical memory for young adult incidents on WHOQOL-BREF 
Physical scores. Individuals with a deficit for early adult incidents (AIS) obtained 
significantly higher Physical scores than individuals with intact memory for young 
adult incidents (AIS) (F(l, 22)=5.53, /><0.05). This finding provided further 
support for Hypothesis 3, which suggested that individuals with some types of 
autobiographical memory deficits would obtain significantly higher QoL scores 
than individuals without these deficits.
6.54 Hypotheses 4 and 5
Hypotheses 4 stated that self-rated unhappy individuals would be more likely to 
use social comparisons when evaluating their present QoL than self-rated happy 
individuals. Hypothesis 5 stated that individuals who were generally unsatisfied 
with their life would be more likely to use social comparisons when evaluating 
their present QoL than individuals who are generally satisfied with their life. 
Testing these hypotheses would assist in enhancing our understanding of the 
psychosocial processes that occur when QoL judgements are made, and increase 
knowledge of the factors that influence the use of social comparisons. This 
information would also assist in further development of a psychosocial model of 
QoL, based upon previous literature and from findings obtained in Study 2.
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In order to clarify ‘Happiness’ and Life Satisfaction’ groupings within the data, 
Happiness ‘today’ and ‘generally’, and Life Satisfaction ratings were analysed 
using K-means cluster analysis. Two and three-cluster groupings were obtained, 
but two-cluster solutions were retained in both cases as they provided more logical 
case groupings than the three-cluster solutions. Four iterations were used for the 
life satisfaction cluster and 2 were used for the Happiness cluster. Table 6.10 
provides the means for each cluster group, for both the Happiness and Life 
Satisfaction constructs.
Table 6.10: Final cluster centres identified for Happiness ‘today’ and 
‘generally’ ratines, and Life Satisfaction ratings
HAPPINESS
Cluster 1 (N=14) Cluster 2 (N=10)
VARIABLE Mean S.D. Mean S.D.
Happiness ‘generally’ 80.71 14.92 53.00 12.74
Happiness ‘today’ 77.79 13.85 39.70 19.70
LIFE SAlriSFACTIO>
Life Satisfaction 78.79 11.73 46.65 13.33
From inspection of Happiness cluster means. Group 1 may be said to represent 
‘happier’ individuals; who obtain high Happiness ‘today’ and ‘generally’ ratings. 
Group 2 may be said to indicate ‘less happy’ individuals by comparison; who 
obtain low Happiness ‘today’ ratings and mid-range happiness ‘generally’ ratings. 
From inspection of the Life Satisfaction cluster. Group 1 may be said to represent 
individuals who are very satisfied with life, whereas Group 2 seems representative 
of individuals who are less satisfied with life by comparison. As Table 6.11 
demonstrates, one-way unrelated ANOVAs confirmed there were significant
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differences among cluster group’s mean happiness and life satisfaction ratings (see 
Appendix 6.13).
Table 6.11: The effect of cluster grouping on happiness and life satisfaction 
ratings
VARIABLE Cluster Group Means F  value d f Sig.
levelCluster 1 Cluster 2
Happiness ‘today’ 77.79 39.70 31.11 (1, 22) p<0.01
Happiness ‘generally’ 80.71 53.00 22.61 (1, 22) J9<0.01
Life Satisfaction 78.79 46.65 39.11 (1, 22) /?<0.01
Having identified distinct Happiness and Life Satisfaction groups, the fi*equency of 
social comparisons made within each group was examined in order to address 
Hypotheses 4 and 5, as Table 6.12 demonstrates.
Table 6.12: Comparison strategies employed within each Happiness and Life 
Satisfaction cluster group
HAPPINESS
GROUP 1 (N=14) GROUP 2 (N=10)
Comparison No Comparison Comparison No Comparison
N=2 N=12 N=4 N=6
LIFE SATISFACTION
GROUP 1 (N=14) GROUP 2 (N=10)
Comparison No Comparison Comparison No Comparison
N=2 N=12 N=4 N=6
Seventeen percent (N=2) of individuals who stated they were happy at the time of 
assessment made social comparisons in order to evaluate their QoL. By 
comparison, 40% (N=4) who stated they were unhappy at the time of assessment 
made comparisons in order to evaluate their QoL. Again, 17% (N=2) of individuals
348
who stated they were satisfied with life at the time of assessment made social 
comparisons in order to evaluate their QoL, whilst 40% (N=4) who stated they 
were less satisfied with life at the time of assessment made comparisons in order to 
evaluate their QoL.
These findings were in the direction of the predicted hypothesis, although with 
relatively small numbers in each cell one must remain cautious not to over-interpret 
the data. A modified Pearson chi-square test using Yates correction for continuity 
was applied in order to determine whether the observed frequency of comparisons 
within the happiness and life satisfaction clusters were significantly different fi*om 
those to be expected if there was no association between happiness, life satisfaction 
and comparison strategy. Using df=l, both chi-square values of 0.83 were not 
significant.
Results confirmed there was no significant difference between the frequency of 
social comparisons made by individuals who were (a) happy or unhappy, and (b) 
satisfied or less satisfied with life at the time of assessment. These findings were 
unchanged when the two ‘comparison with other’ cases were removed firom the 
data set, and analyses were conducted using ‘comparison with past’ and ‘no 
comparison’ groups (both Happiness and Life Satisfaction S} values=0.94, df=l, 
N.S.). This analysis confirms that collapsing the ‘comparison with other’ and 
‘comparison with past’ groups for the present analyses did not affect results 
obtained.
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In order to further examine these hypotheses, 2 x 2  unrelated ANOVAs were 
conducted to examine (a) the effect of level of reported happiness and evaluation 
strategy on perceived QoL, and (b) the effect of life satisfaction and evaluation 
strategy on perceived QoL (see Appendix 6.14). There was no significant main 
effect for Happiness, and the effect for Life Satisfaction just failed to reach 
significance (F(l, 20)=4.19, /?=0.054). It is noteworthy that there were no 
significant main effects for evaluation strategy on this occasion. F  values also 
suggested that there was no significant interaction between level of reported 
happiness and evaluation strategy on perceived QoL (F(l, 20)=0.53, N.S.), and no 
significant interaction between life satisfaction and evaluation strategy on 
perceived QoL (F(l, 20)=0.01, N.S.).
These findings were relatively unchanged when autobiographical memory and 
immediate memory were accounted for, suggesting that significant interactions 
were not dependent on these factors (see Appendices 6.15-6.16). When the 
influence of ability to make comparisons (Similarities, WAIS-R) was accounted 
for, a significant main effect for life satisfaction were demonstrated (F(l, 19)=7.31, 
/?<0.05) (see Appendix 6.17). Means suggested that individuals who were less 
satisfied with life reported a significantly lower QoL (% =43.22) than individuals 
who were more satisfied with life {X  =81.65). A similar, albeit weaker main effect 
for life satisfaction was demonstrated when ability to make comparisons was 
covaried using Pyramids and Palm Trees scores (F(l, 19)=6.19, /?<0.05) (see 
Appendix 6.18). Again, means suggested that individuals who were less satisfied 
with life reported a lower QoL ‘generally’ (^=49.61) than individuals who were 
more satisfied with life (% =77.61). These findings provide further support for the 
relationship between the life satisfaction and QoL constructs.
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6.55 Further exploratory analyses
It was anticipated that the first exploratory analysis would examine the interaction 
between evaluation strategy and life change on QoL ‘generally’ that was 
demonstrated in Study 2 (pp.239-241). This finding suggested that when negative 
or positive life changes are reported to occur around the time of assessment, 
perceived QoL remains highest when comparisons are made with one’s past. On 
the other hand, when individuals refrain from using this evaluation strategy, their 
QoL ‘generally’ scores remain relatively low. This was surprising, as one would 
expect perceived QoL to increase in times of positive life change, regardless of 
evaluation strategy. As only one ‘positive change’ case was identified within this 
analysis, further investigation was considered necessary before conclusions could 
be drawn concerning the potential negative consequences of positive life changes 
within the present population. However, no positive life changes were reported to 
have occurred around the time of the QoL/Social Comparison Interview within the 
present study, and on this basis it remains impossible to re-examine this finding 
within the present population. The results of several other exploratory analyses that 
were conducted are now discussed.
Level of autobiographical memory functioning (AISI and OoL
Findings in relation to Hypothesis 3 generally suggested that individuals with 
autobiographical memory deficits (AIS) obtained significantly higher QoL scores 
than individuals without these deficits. Analyses in relation to Study 2 (see Section 
4.64, pp.235-237) also suggested that extent of AIS deficit had a significant effect 
on QoL; individuals with ‘normal’ autobiographical memory obtained significantly 
lower QoL ‘today’ ratings than individuals with moderate and severe 
autobiographical memory deficits. Analyses were therefore conducted to determine
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whether extent of autobiographical memory deficit had affected QoL scores 
obtained in the present study.
Individuals were grouped in the same way as previously described in Study 2 (see 
pp.235-236), according the number of ‘abnormal’ range scores they obtained on the 
childhood, young adult and recent life AIS subscales:
Group 1 = normal autobiographical memory (‘normal’ range scores on all three 
subscales)
Group 2 = moderate autobiographical memory deficits (one/two ‘abnormal’ range 
scores)
Group 3 = severe autobiographical memory deficits (three ‘abnormal’ range scores) 
QoL means were then obtained for each of these groups (see Table 6.13).
Table 6.13: Mean OoL scores for each AIS deficit group
AIS deficit group
Group 1 
(N=5)
Group 2 
(N=8)
Group 3 
(N=ll)
QoL Variable Mean S.D. Mean S.D. Mean S.D.
SEIQoL-DW 7&93 20.67 59.36 22.43 66.05 24.46
QoL ‘Today’ (1) 70.00 23.71 53.75 15.94 66.36 21.99
QoL ‘Generally’ (1) 75.40 16.15 58.37 14.37 61.18 29.11
Environment (W) 73.75 21.49 59.24 19.85 73.01 19.47
Physical (W) 6283 16.49 61.15 14.23 70.77 13.15
Psychological (W) 67.50 26.08 53.13 18.73 64.01 16.27
Social Relationships (W) 58J3 22.05 65.37 16.47 65.91 21.23
QoL ‘Today’ (2) 60.00 27.83 52.12 3.64 75.72 21.36
QoL ‘Generally’ (2) 60.20 23.78 58.75 13.82 67.09 30.89
QoL ‘Generally’ (3) 66.80 22.27 52.56 20.38 69.91 24.89
Mean QoL scores suggested that individuals with ‘normal’ autobiographical 
memory (Group 1) obtained higher QoL scores than individuals with moderate 
(Group 2) and severe (Group 3) autobiographical memory deficits on assessment
352
session 1. However, individuals with ‘severe’ autobiographical memory deficits 
generally obtained higher QoL scores than individuals with moderate deficits and 
normal autobiographical memory on assessment sessions 2 and 3. The relatively 
small number of cases within Group 1 is acknowledged, and is thought to reflect 
the fact that cognitive skills are impaired to some extent in the majority of 
individuals with late-stage neurological illness. This problem was also encountered 
during analyses of Study 2 (see p.236).
A one-way unrelated ANOVA was conducted to examine whether level of 
autobiographical memory functioning affected perceived QoL (see Appendix 6.19). 
Results are summarised in Table 6.14.
Table 6.14; The effects of level of autobiographical memory functioning on 
perceived OoL
QoL Variable d f F  ratio Sig. level
SEIQoL-DW (2 , 21) 0.89 N.S.
QoL ‘Today’ (1) (2 , 21) 1.25 N.S.
QoL ‘Generally’ (1) (2 , 21) 0.93 N.S.
Environment (W) (2 , 21) 1.31 N.S.
Physical (W) (2 , 21) 1.21 N.S.
Psychological (W) (2 , 21) 1.08 N.S.
Social Relationships (W) (2 , 21) 0.27 N.S.
QoL ‘Today’ (2) (2 , 21) 3.67 /?<0.05
QoL ‘Generally’ (2) (2 , 21) 0.29 N.S.
QoL ‘Generally’ (3) (2 , 21) 1.39 N.S.
(W)=WHOQOL-BREF domain
Given the number of non-significant findings demonstrated in Table 6.14, and the 
lenient alpha level of 0.05, the increased chance of Type I errors occurring here is
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acknowledged. F  values confirmed there was a significant effect of level of 
autobiographical memory functioning on QoL ‘today’ (2) ratings (F(2, 21)=3.67, 
/><0.05). Post-hoc comparisons using Tukey’s multiple comparison test confirmed 
that individuals with moderate autobiographical memory deficits obtained 
significantly lower QoL ‘today’ (2) ratings than individuals with severe 
autobiographical memory deficits (p<0.05). There were no significant differences 
between the QoL ‘today’ ratings of individuals with normal autobiographical 
memory and severe autobiographical memory deficits. These findings provide 
further support for Hypothesis 3, and are discussed in Section 6 .6 . It is worth 
noting that there were no significant effects of level of autobiographical memory 
functioning on QoL when Personal Semantic (PS) scores were analysed in this way 
(see Appendix 6.20).
Social comparisons and OoL
Analyses in relation to Hypotheses 4 and 5 suggested that evaluation strategy had 
no significant effect on perceived QoL. This was interesting as previous research 
with the present population suggests that individuals who make comparative 
judgements with their own past when rating their QoL ‘generally’ produce 
significantly lower QoL ratings than individuals who refrain from using this 
comparison strategy (see Study 2, Section 4.63, p.234-235). Further analyses were 
conducted on this basis, mean QoL ‘generally’ ratings for both comparison groups 
are presented in Table 6.15.
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6.15: Mean OoL ‘generally’ ratings by comparison group (N=24)
QoL ‘generally’ rating
Comparison Group Mean S.D.
Comparison made (N=6) 60.67 22.64
No comparison made (N=18) 64.41 24.16
Means suggested that the presence/absence of comparisons made little difference to 
perceived QoL. In order to examine the effect of evaluation strategy on perceived 
QoL, a one-way unrelated ANOVA was conducted (see Appendix 6.21). Results 
confirmed there was no significant effect of evaluation strategy on perceived QoL 
(F(l, 22)=0.11, N.S.). However, once the ability to make comparisons was 
accounted for using a 2 x 2 unrelated design amenable to ANOVA (see Appendix 
6 .22), a significant main effect of evaluation strategy was demonstrated (7^ (1,
20)=4.81, p<0.05). There was also a significant interaction between evaluation 
strategy, ability to make comparisons and QoL (F(l, 20)=5.70, /?<0.05), as 
demonstrated in Figure 6.1.
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Figure 6.1: The interaction effect between evaluation strategy and ability to 
make comparisons on OoL generally’ ratings
o) 80
Deficit No Deficit
Cognitive ability to make comparisons
Comparison made □ No comparison made
The interaction suggests that the QoL evaluations of individuals who lack the 
cognitive capacity to make valid comparative judgements remain highest when 
they use comparative strategies in order to evaluate their present QoL On the 
other hand, the QoL evaluations of individuals who have the cognitive capacity to 
make comparative judgements remain highest when they refrain from using 
comparative strategies in order to evaluate their present QoL. The implications of 
this finding are discussed in Section 6 .6 .
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Relationships among SEIOoL scores. WHOOOL-BREF scores and OoL 
‘generally’ ratings
Analyses in relation to Hypothesis 1 suggested there were significant relationships 
among WHOQOL-BREF domain scores, SEIQoL-DW scores and QoL ‘today’ and 
‘generally’ ratings. To provide further indication of any structure between the QoL 
variables, a multidimensional scaling technique was employed.
Prior to conducting this analysis, F  values confirmed a significant effect of reported 
life changes on QoL ‘today’ (2) ratings; individuals experiencing life changes at the 
time of assessment obtained significantly lower QoL ratings than individuals not 
experiencing life changes (F(l, 21)=3.79, ^<0.05). However, there was no 
significant effect of reported life changes on QoL ‘generally’ (2) ratings (F(l,
21)=0.23, N.S.) (see Appendix 6.23). As QoL ‘today’ ratings appear less stable 
than QoL ‘generally’ ratings, they were not included in the present analysis, as it 
was considered they might reduce the level of fit of the overall model obtained 
using multidimensional scaling. QoL ‘generally’ (2) ratings were used in the model 
as this rating scale was administered within the WHOQOL-BREF assessment 
session.
A Euclidean distance measure was used to obtain two and three-dimensional 
solutions. The two-dimensional solution was retained as the associated stress 
value, presented overleaf, indicated that it produced a better fit of the data. The 
two-dimensional configuration is presented in Figure 6.2.
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Figure 6.2: Two-dimensional scaling model based on SEIOoL-DW. OoL 
‘generally’ (2) and WHOOOL-BREF domain scores
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The stress value obtained for this procedure was 3.9%, indicating a fit of the data 
that is between good (5%) and excellent (2.5%) according to the guidelines
proposed by Kruskal (1964). A scatterplot of distances against dissimilarities
f it  belw €€0 the daba and Mzidel uoai
confirmed that the assumptions of a linear relatieashipTer this-data-were justified.
A possible interpretation of the two-dimensional solution is illustrated in Figure 
6.3. It is recognised that alternative interpretations exist, and important to stress 
that the following interpretation remains tentative.
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Figure 6.3: Possible interpretation of the two-dimensional scaling model 
shown in Figure 6.2
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Points along the y  axis range from WHOQOL-BREF Physical to QoL ’generally’
variables. The WHOQOL-BREF Physical domain includes items such as
dependence on medical substances, pain and discomfort and satisfaction with sleep.
Items nominated as important on the SEIQoL-DW in the present study include
family/going home (58%), going out (41%), friends (25%) and independence
(13%). QoL ‘generally’, the last point on this axis, remains open to individual
interpretation. However, surrounding points may suggest a dimension ranging
health-
from health-dependent functioning to^independent fimctioning (Dimension 1).
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Points along the x axis range from WHOQOL-BREF Social Relationships to 
SEIQoL-DW variables. The WHOQOL-BREF Social Relationships domain 
consists of items relating to satisfaction with personal relationships, social support 
and sexual activity. Areas nominated on the SEIQoL-DW that have not been 
mentioned in interpretation of Dimension 1 include individual hobbies or pleasures 
(37%), mobility (21%) and health (17%). On this basis, the points across the x  axis 
may represent a dimension ranging from appraisal of self in relation to others, to 
appraisal of self as an individual (Dimension 2).
In order to provide further indication of the structure of the QoL variables, these 
results can be usefully combined with those obtained from hierarchical cluster 
analysis of the same data. This technique was employed to indicate the cluster 
structure on the two dimensional solution, providing an indication of the 
relationships between the QoL variables implied by their dissimilarities. Several 
methods of clustering were applied to the data using the Squared Euclidean 
Distance measure, and similar solutions were obtained using average within and 
between groups linkage, complete linkage and Wards linkage techniques. 
Dendograms (see Appendix 6.24) suggested a two-cluster solution, which was also 
indicated by one major jump between correlation coefficients in the Agglomeration 
Schedules for these analyses. The two-cluster solution is presented in Figure 6.4.
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Figure 6.4: Cluster solution for the OoL measures embedded in a two- 
dimensional scaling solution
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It can be seen that the WHOQOL-BREF Physical and Psychological domains 
cluster together, as do the WHOQOL-BREF Environment and Social Relationships 
and QoL ‘generally’ and SEIQoL-DW variables. It is interesting to note that the 
dendograms in Appendix 6.24 suggest scores on the WHOQOL-BREF 
Environment and QoL ‘generally’ variables are the most similar.
The finding that WHOQOL-BREF Physical and Psychological domains cluster 
together may represent their orientation toward health-related well being. This 
would provide further support for the two-dimensional scale solution presented in 
Figure 6.3. The suggestion that the strongest similarities appear between 
WHOQOOL-BREF Environment and QoL ‘generally’ variables may provide
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useful information concerning the factors that contribute to perceived QoL 
‘generally’ within the present population. These findings are discussed in Section 
6 .6 .
6.6 Discussion
Hypothesis 1 stated that there would be significant relationships among the 
SElQoL-DW, QoL and Happiness ‘today’ and ‘generally’ ratings and WHOQOL- 
BREF Environment, Psychological and Social Relationships scores, reflecting their 
orientation towards person-centred QoL. It was anticipated that analyses relating to 
Hypothesis 1 would contribute to establishing the feasibility of using the 
WHOQOL-BREF as a person-centred QoL measure within the present population. 
The results obtained would also clarify the theoretical basis of the measure.
Hypothesis 1 was supported when the relationships between WHOQOL-BREF 
Psychological, Environment and Social Relationships scores and QoL ‘generally’ 
ratings were analysed. However, correlation coefficients suggested that SElQoL- 
DW scores were related to WHOQOL-BREF Environment and Social 
Relationships scores. QoL ‘today’ and Happiness ‘today’ and ‘generally’ ratings 
(‘no change’ only) were related to WHOQOL-BREF Psychological scores. These 
relationships were largely confirmed using multidimensional scaling and 
hierarchical cluster analyses to explore the underlying structure of the data. Results 
indicated that the WHOQOL-BREF Physical and Psychological domains clustered 
together, as did the WHOQOL-BREF Environment and Social Relationships, QoL 
‘generally’ and SElQoL-DW variables.
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These observations are interesting for several reasons. Firstly, they suggest that the 
responses to the SEIQoL-DW, and QoL ‘today’ and ‘generally’ ratings are 
influenced by different factors. If this is the case, then it seems reasonable to 
assume that the SEIQoL-DW is assessing something other than perceived QoL 
‘today’ or QoL ‘generally’. This suggestion is also supported by relationships 
observed between these QoL variables, where QoL and Happiness ‘generally’ 
ratings, and QoL and Happiness ‘today’ ratings, were more strongly related than 
QoL ‘today’, QoL ‘generally’ and SEIQoL-DW scores. Although these findings 
contradicted those of Study 5 (Section 5.34.2, pp.294-295), which suggested that 
the strongest relationships between QoL variables were between QoL ‘today’ and 
‘generally’ ratings, and happiness ‘today’ and ‘generally’ ratings, the averaged 
correlation coefficients in earlier analyses may have contributed to this difference.
It was also interesting to note that Happiness ‘today’ and ‘generally’ ratings were 
significantly related to ‘Psychological’ domain scores of the WHOQOL-BREF (‘no 
change’ cases). The conceptual distinctions between Happiness and QoL were 
discussed within Section 5.3 of Study 5 (pp.277-279). The present findings provide 
additional support for the distinction between Happiness and QoL constructs. 
Happiness appears to be related to psychological well being at the time of 
assessment, whereas perceived QoL may be related to a wide number of external 
dimensions, including social and environmental factors.
Correlation analyses also suggested that WHOQOL-BREF Physical scores were 
generally unrelated to SEIQoL-DW scores and QoL ‘today’ and generally’ ratings, 
providing support for previous research that has suggested that person-centred QoL 
and health status are distinct entities (i.e. Joyce, 1994; Lintem et al., 1999; Murrell
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et al., 1999; O’Boyle, McGee and Joyce, 1994). Whilst results of multidimensional 
scaling and the hierarchical cluster analysis indicate fairly large distances between 
WHOQOL-BREF Physical and QoL (SEIQoL-DW/QoL ‘generally’) variables 
along Dimension 1 of the scale solution, similarities between these same variables 
were observed along Dimension 2. This suggests that some aspects of person- 
centred QoL may be related to health-related functioning as measured by the 
WHOQoL-BREF, whilst other aspects of person-centred QoL are distinct from 
health-related functioning. This is interesting considering that previous research 
with persons with severe neurological disability indicated no significant 
relationships between person-centred QoL (SEIQoL-DW) and Physical 
Functioning as measured by the SF-36 (Lintem et al., 1999; Murrell et al., 1999).
Given that the present population obtained a relatively high WHOQOL-BREF 
Physical mean score, this domain may provide a useful health-related QoL 
indicator that is not dependent on level of functional ability. This would also 
explain the similarities observed between WHOQOL-BREF Physical and QoL 
‘generally’ variables outlined above. This is relatively rare for a Physical QoL 
measure, as previous research using the SF-36 with the present population has 
demonstrated (Lintem et al., 1999; Murrell et al., 1999). Hierarchical cluster 
analysis indicated that WHOQOL-BREF Physical and Psychological domains 
cluster together, as do WHOQOL-BREF Environment and Social Relationships, 
QoL ‘generally’ and SEIQoL-DW variables. This also suggests that the 
WHOQOL-BREF may be measuring aspects of health-related and person-centred 
QoL, a combination that is infrequently encountered within the QoL literature.
The suggestion that the strongest similarities appear between Environment
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(WHOQOL-BREF) and QoL ‘generally’ variables may also provide useful 
information concerning the factors that contribute to perceived QoL ‘generally’ 
within the present population. The Environment domain consists of items relating 
to the extent to which one feels safe in one’s daily life, opportunities for leisure 
activities, finances, living conditions, access to health services and satisfaction with 
transport. Further research is now required to delineate more clearly the proportion 
of the variance in QoL ‘generally’ ratings that each of these factors is likely to 
account for. A clearer understanding of the contribution of social relationships to 
perceived QoL ‘generally’ is also required, in order to obtain a clearer 
understanding of the meaning of QoL in persons with severe neurological 
disability.
Hypothesis 2 stated that there would be a significant effect of duration of illness 
and extent of disability on the WHOQOL-BREF Physical scores, reflecting it’s 
orientation towards health-based QoL. It was anticipated that analyses relating to 
Hypotheses 2 would contribute to establishing the feasibility of using the 
WHOQOL-BREF as a person-centred QoL measure within the present population. 
Analyses in relation to Hypothesis 2 would also provide further information 
concerning the factors that influence scores obtained on the WHOQOL-BREF.
Results confirmed there was no significant effects of duration of illness or extent of 
disability on WHOQOL-BREF Physical scores, and on this basis Hypothesis 2 was 
rejected. This finding holds extremely important implications for the use of the 
WHOQoL-BREF with the present population. The present population generally 
obtain low scores on QoL measures that include a physical health component (such 
as the SF-36; see Section 3.23, p. 140), because of the extent of their physical
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disabilities. However, the present finding suggests that individuals with a higher 
level of physical disability and/or a longer duration of illness may still obtain 
relatively high WHOQOL-BREF Physical scores.
This may reflect the inclusion of WHOQOL-BREF Physical items that are not fully 
dependent on extent of physical disability, such as sleep and rest, and energy and 
fatigue. By comparison, the SF-36 Physical Functioning scale rates individuals 
according to, for example, how far they can walk independently or how many 
flights of stairs they can climb. WHOQOL-BREF Physical scores are based on a 
wider range of physical functions, which appear more applicable to persons with 
severe physical disabilities. On this basis, the WHOQOL-BREF remains better 
suited than the SF-36 for use in populations of persons with severe physical 
disabilities.
Hypothesis 3 stated that there would be a significant effect of autobiographical 
memory on QoL; individuals with autobiographical memory deficits would obtain 
significantly higher QoL scores than individuals without these deficits. It was 
anticipated that results relating to Hypothesis 3 would provide further information 
concerning the factors that influence scores on the WHOQOL-BREF, whilst 
providing an opportunity to re-examine the extent to which autobiographical 
memory influences person-centred QoL.
When one outlying score was removed from the dataset, results confirmed there 
was a significant effect of autobiographical memory on QoL ‘today’ ratings. When 
a second outlying score was removed, a significant effect on QoL ‘generally’ 
ratings was obtained. In both analyses, individuals with AIS deficits obtained
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significantly higher QoL ratings than individuals with normal autobiographical 
memory functioning. These observations were similar to those obtained in Study 2 
(Section 4.61, pp.224-225), when two outlying cases were removed from this data 
set. In Study 2, a significant effect of autobiographical memory functioning on 
person-centred QoL as measured by the SEIQoL-DW was obtained, such that 
individuals with abnormal autobiographical memory obtained higher SEIQoL-DW 
scores than individuals with intact autobiographical memory. The problems 
associated with small sample sizes and individual outlying scores have already 
been addressed in Section 3.34 of Study 1, where it was acknowledged that, short 
of eliminating data, there is very little that can be done to control this problem.
Further support for Hypothesis 3 was obtained when autobiographical memory 
scores (AIS and PS) were broken down by time period (memory for childhood, 
young adult and recent incidents). Results suggested that individuals with a deficit 
for early adult incidents (AIS-AMI) obtained significantly higher WHOQOL- 
BREF Physical scores than individuals with intact memory for young adult 
incidents (AIS). This finding is similar to that of Kenealy et ah (1999), who 
described a main effect of autobiographical memory (AIS-AMI) on Role Physical 
(SF-36) scores in a population of severely disabled MS patients at the Royal 
Hospital for Neuro-disability, Putney. Although the present effect was only 
observed for the ‘young adult’ section of the AIS, this similarity warrants further 
attention.
The present finding suggests that individuals with autobiographical memory 
deficits for early adult life rate themselves as, for example, less affected by pain, 
less dependent on medical substances, and more able to get around than individuals
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with normal autobiographical memory for incidents occurring in young adult life. 
There are several plausible explanations for this, but perhaps the most reasonable 
interpretation is as follows. For the majority of persons in the present population, 
incidents of young adult life are likely be those that take place before the onset of 
illness. If this is the case, then individuals with autobiographical memory deficits 
across this time span will be unlikely to remember their pre-illness status. If the 
process of evaluating present QoL is partially dependent on comparative 
judgements with one’s own past, as previously suggested in analyses relating to 
Study 2 (see Section 4.63, pp.234-235), then, as Kenealy et al. (1999) suggest, 
autobiographical memory deficits will make this process increasingly prone to 
error, or else increasingly inaccessible to the individual. Furthermore, as these 
individuals cannot remember their pre-illness status, they may perceive their 
present physical status as higher than those who can access this information, and 
are able to make comparative judgements of the past and the present. 
Alternatively, as these individuals cannot use their pre-illness status as a basis for 
comparison, they may make comparisons with others in order to evaluate their 
present Physical QoL. This notion remains purely speculative, but if, for example, 
they made comparisons with individuals who they considered to be worse off than 
themselves, this might also result in higher perceived Physical QoL.
Results of exploratory analyses also confirmed there was a significant effect of 
level of autobiographical memory functioning on QoL ‘today’ (2) ratings; 
individuals with moderate autobiographical memory deficits obtained significantly 
lower QoL ‘today’ ratings than individuals with severe autobiographical memory 
deficits. Collectively, these findings suggest that autobiographical memory does 
affect perceived QoL within the present population, although the QoL ratings that
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are affected do not appear consistently across Studies 2 and 5. This may be a 
reflection of the dynamic nature of QoL, as one would not expect individuals to 
rate their QoL in a consistent manner across time. Thus, for example, each set of 
QoL ‘today’ and ‘generally’ ratings obtained across the present research will 
consist of different within-group dynamics.
Hypothesis 4 stated that self-rated unhappy individuals would be more likely to use 
social comparisons when evaluating their present QoL than self-rated happy 
individuals. Hypothesis 5 stated that individuals who are generally unsatisfied with 
their life would be more likely to use social comparisons when evaluating their 
present QoL than individuals who were generally satisfied with their life. The 
theoretical rationale for these hypotheses was presented in Section 6.1, where it 
was also noted that relatively few factors were identified in Study 2 that increased 
the likelihood that social comparisons would be made. It was anticipated that 
Hypotheses 4 and 5 would therefore assist in enhancing our understanding of the 
psychosocial processes that occur when QoL judgements are made, and increase 
our knowledge of the factors that influence the use of social comparisons. In turn, 
this information would assist in further development of a psychosocial model of 
QoL that is based on previous literature and from findings obtained in Study 2.
Present findings suggest there is no significant difference between the frequency of 
social comparisons made by individuals who are (a) happy or unhappy, and (b) 
satisfied or less satisfied with life at the time of assessment. Analyses also 
confirmed that neither level of reported happiness or life satisfaction interacted 
with comparison strategy to affect perceived QoL within the present population. 
These results were unexpected, given that Lyubomirsky and Ross (1997) suggest
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that differences in levels of happiness are associated with a tendency for people to 
compare themselves with less fortunate others.
However, these downward comparisons are thought to occur most often during the 
early stages of disease, as part of the process of adaptation to a negative event 
(Wills, 1981; Wood, Taylor and Lichtman, 1985). If this is the case, one would not 
expect to find support for Lyubomirsky and Ross’ (1997) suggestion in a 
population of severely disabled individuals with an averaged disease duration of 28 
years. Although adjustment is a continual response to the changing disease process, 
longitudinal studies suggest that most adjustment takes place in the early stages 
after diagnosis (Matson and Brooks , 1982).
It has already been observed that a greater number of individuals across Studies 1-4 
appear unhappy (visual analogue scales) than depressed (HADS). Indeed, it was 
this observation that prompted investigation of the effects of level of reported 
happiness and life satisfaction, rather than depression, on comparison strategy 
within the present study. However, only 21% of the present population obtained 
happiness ‘today’ ratings of less than 50 on the 0-100 ratings scale. Similarity, 17% 
obtained happiness ‘generally’ ratings of less than 50, and 12.5% reported life 
satisfaction ratings of less than 50. This relatively small number of cases may also 
have contributed to the non-significant effects observed between reported 
happiness/life satisfaction and comparison strategy on perceived QoL.
With N=24, the alpha level of 0.05, and a specified effect size of 0.10 (given that 
this is a relatively new area of research inquiry), 196 participants would be required 
for the conventional power of 0.80 for these tests of interaction effects. Even if a
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medium effect size was specified, 126 participants would be necessary for power of
0.80. It remains impractical to attempt to recruit this number of participants within 
the present research setting, given the severe cognitive and physical disabilities and 
the increased communication difficulties often encountered in the late stages of 
neurodegenerative disease, that prevent many individuals fi-om participating in 
research.
The interaction effect demonstrated in exploratory analyses relating to Hypotheses 
4 and 5 is also worth commenting on. Findings suggested that the QoL evaluations 
of individuals who lack the cognitive capacity to make valid comparative 
judgements remain highest when they use comparative strategies in order to 
evaluate their present QoL. On the other hand, the QoL evaluations of individuals 
who have the cognitive capacity to make comparative judgements remain highest 
when they refrain from using comparative strategies in order to evaluate their 
present QoL.
This suggests that invalid comparative judgements, made by persons who lack the 
cognitive capacities to make valid comparative judgements, produce higher 
perceived QoL than when these individuals refrain from making comparisons 
altogether. The validity of comparisons that are made by this group may remain 
open to question, but this evaluation strategy appears to hold positive QoL benefits 
nonetheless. The interaction also suggests that individuals with intact cognitive 
functioning obtain higher QoL ratings when they refrain from making comparative 
judgements.
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Most individuals within the present study reported that comparisons with their own 
past involved comparisons with pre-illness status. Findings of Study 2 suggest that 
this type of comparison has a detrimental affect on perceived QoL within the 
present population (see Section 4.63, pp.234-235). The interaction effect outlined 
above builds upon this suggestion, as comparisons with one’s own past appear 
detrimental to perceived QoL only where individuals have the cognitive capacity to 
make the comparisons. However, this finding is based upon analyses of sub­
groups with relatively small cell counts, and it remains important not to over­
interpret this finding.
As previously stated, the findings obtained concerning social comparisons and QoL 
in the present study enabled further development of a Social Comparisons/QoL 
model, which is presented in Figure 6.5.
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As the model in Figure 6.5 suggests, persons with severe neurological disability 
may, or may not use comparisons when evaluating their present QoL ‘generally’. 
Where comparisons were not used to evaluate QoL in the present study, individuals 
were asked to explain how they had evaluated their QoL. All participants stated 
their judgements were based simply on how they felt about their life at the time of 
assessment. Comparisons that are made may involve comparisons with one’s own 
past (pre-illness status), or comparisons with others. The choice of better or worse 
off as a basis for comparison may be influenced by a shorter duration of illness, as 
the majority of these comparisons have been made by persons with the shortest 
illness duration. However, as these comparisons have been made by a small 
proportion of cases in Studies 2 and 5, this is an area of research that warrants 
further attention.
The influence of life change and cognitive functioning on the effect of comparison 
strategy on QoL have already been discussed above. However, it is worth 
commenting on the nature of the influence of life change on QoL. Results of Study 
1 (Part 2) suggested that perceived QoL increases when positive life changes are 
reported to occur, and decreases when negative life changes are reported to occur 
(see Section 3.31.1, pp. 166-167). However, findings relating to Study 2 suggested 
that negative and positive life changes result in a lower perceived QoL if 
comparison strategies are not utilised in order to evaluate present QoL, and a higher 
perceived QoL when comparison strategies are used in order to evaluate present 
QoL.
This suggestion has been incorporated in the present model, although this finding 
was based upon results derived from a small number of cases. The question mark
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and dashed arrow linking positive life change to a lower perceived QoL, and the 
question mark beside the role of life changes when comparisons are made, indicate 
that these relationships remain speculative at the time of writing. Although the 
model is based on research with a relatively small number of participants, it 
provides a useful basis for further research concerning social comparisons and QoL 
in severe neurological disability, and contributes to our understanding of the 
process of evaluation that may take place when these individuals are asked to judge 
their present QoL.
The factors that influence the use of comparisons still remain uncertain. The 
double-ended arrow linking ‘life change’ to ‘comparison’ in Figure 6.5 indicates 
that the presence of life changes may also influence the use of social comparisons 
in order to evaluate QoL. Although this suggestion remains tentative, findings of 
Study 2 provide reasonable grounds for this suggestion. As already stated, 
individuals experiencing life changes at the time of assessment obtain higher QoL 
ratings when they use comparison strategies in order to evaluate their QoL, than 
when they refrain from using this process. Comparison strategies could therefore 
be used intentionally in some cases, to enhance well-being in times of uncertainty. 
This suggestion supports previous research by Molleman, Pruyn and van 
Knippenberg (1986), who suggest that periods of stress and uncertainty are 
associated with the increased use of social comparison information.
In order to examine this possibility, further research would be required using a 
larger population of persons with neurological disability in order to study a larger 
proportion of life changes across time. This would include an increased number of 
participants a shorter duration of illness, because communication difficulties, visual
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disturbances and cognitive dysfunction limit the number of individuals at the later 
stages of neurological illness who are able to participate in research. However, 
incorporating a greater number of individuals with a shorter duration of illness 
would also enable the effects of depression, adaptation stage and comparison 
strategy on QoL to he examined.
The second dimension identified using multidimensional scaling, of self in relation 
to others, supports previous research suggesting that comparisons with others may 
be used in order to evaluate QoL (i.e. Hemphill and Lehman, 1991; Sartorius, 
1987; Skevington, 1994). Although few individuals within the present study stated 
they made this type of comparison, the proposed research outlined above would 
also enable investigation of this hypothesis. The knowledge gained through such 
research would contribute further valuable information to the Social 
Comparisons/QoL model presented in Figure 6.5.
The relatively small number of cases in the present study who stated they made 
comparative judgements in order to evaluate their present QoL may prompt 
speculation concerning whether individuals with severe neurological disability are 
prepared to acknowledge engaging in social comparisons. Gibbons and Buunk 
(1999) suggest that everyone engages in social comparisons from time to time, and 
continue that the process and information generated by social comparisons are 
thought to have evolutionary benefits. Along with several other researchers (i.e. 
Gilbert, Price and Allen, 1995; Hemphill and Lehman, 1991; Steil and Hay, 1997; 
Taylor, Buunk, Collins and Reed, 1992) they also believe that the extent to which 
people engage in comparative evaluations varies considerably from one person to 
the next.
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On this basis, since the present study was conducted. Gibbons and Buunk (1999) 
have published details of the lowa-Netherlands Comparison Orientation Measure 
(INCOM). This is an 11-item scale they claim assesses individual differences in 
comparison orientation, such as the extent to which individuals make comparisons 
based on the abilities and opinions of others. Results of initial psychometric 
testing, using 10 different American samples (N>4,300) and 12 different Dutch 
samples (N>3,200), provide initial support for the construct, discriminant and 
criterion-related validity, and the internal consistency and temporal stability of the 
measure (see Gibbons and Buunk, 1999 for full details). The medical and 
demographic details of these samples were not reported.
The scale consists of items including T often compare myself to others with respect 
to what I have accomplished in life’ and T always like to know what others in a 
similar situation would do’. For each item, individuals are asked to indicate how 
strongly they agree or disagree with each statement, using a 5-point Likert scale 
ranging from ‘disagree strongly’ (1) to agree strongly (5). It would be interesting 
to use this scale in future QoL assessment with persons with severe neurological 
disability, to examine whether individuals who are generally more likely to use 
comparison strategies obtain higher or lower QoL scores than those who are less 
likely to use this evaluation process. Gibbons and Buunk (1999) suggest that the 
INCOM is not related to measures of social desirability such as the Marlowe- 
Crowne scale (Crowne and Marlowe, 1960) and the Eysenck Lie scale. On this 
basis, if individuals in the present population are reluctant to acknowledge the use 
of comparison information when evaluating QoL, the INCOM may provide a 
useful means of investigating the social comparisons/QoL relationship.
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The aim of the present study was to assess the feasibility of using the WHOQOL- 
BREF with persons with severe neurological disability. Although the WHOQOL- 
BREF contains references to capacity for work, sexual activity, and extent of 
energy, which may be less relevant to some individuals with severe physical 
disability, no negative comments were reported by persons who took part in the 
present study concerning the suitability of questions. All participants were able to 
select an appropriate response for each item, and all stated that the questionnaire 
was of an appropriate length (on average the administration time for the 
WHOQOL-BREF was 15 minutes). Furthermore, no ceiling or floor effects were 
obtained on the WHOQOL-BREF Physical domain.
On the basis of this preliminary data, the WHOQOL-BREF may be a suitable QoL 
measure for use in the present population in cases where the SEIQoL-DW cannot 
be completed due to a reduced level of cognitive functioning. However, using the 
WHOQOL-BREF compromises the wealth of person-centred information obtained 
using the SEIQoL-DW, and for this reason the SEIQoL-DW may remain more 
preferable for use with individuals who are cognitively able to complete this 
measure.
In order to establish the feasibility of using the WHOQOL-BREF as a measure of 
QoL with persons with severe neurological disability, rigorous psychometric 
testing is now required. The SEIQoL-DW would provide a suitable comparison 
measure for testing the concurrent validity of the WHOQOL-BREF, as the 
concurrent validity of the SEIQoL-DW has previously been demonstrated in a 
population of persons with severe neurological disability associated with MS (see 
Study 1, Section 3.33.3, pp.176-178). The lack of suitable comparison measures
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for tests of concurrent validity is a problem that has generally hindered the 
psychometric testing of QoL measures in the past. It would also be interesting to 
compare re-test reliability coefficients and the responsiveness of the WHOQOL- 
BREF with corresponding findings previously obtained for the SEIQoL-DW within 
Studies 1 and 2.
The present findings suggest that the WHOQOL-BREF is a potentially useful QoL 
assessment tool that may feasibly be used by persons with severe neurological 
disability. It provides important information concerning aspects of health-related 
QoL that are not dependent on level of physical functioning, and may also be well 
suited for use in populations with less severe disabilities associated with 
neurological illness. However, until the psychometric properties of the WHOQOL- 
BREF have been established using the criteria outlined in Section 3.2 of Chapter 3 
(pp. 127-128), further conclusions regarding its suitability within the present and 
other neurological patient groups remain uncertain.
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CHAPTER?
General Discussion
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7.1 Overview of research aims
Collectively, the main aims of the present research were as follows:
1. To establish the feasibility of assessing QoL in persons with severe 
neurological disability.
2. To find a suitable QoL measure for use with persons with severe 
neurological disability.
3. To examine the factors that influence QoL in persons with severe neurological 
disability
4. To enhance our understanding of the psychosocial processes that are used to 
construct QoL judgements in persons with severe neurological disability
5. To investigate the dynamic nature of QoL in persons with severe neurological 
disability
6 . To obtain a clearer understanding of the conceptual basis of QoL in persons 
with severe neurological disability
The present chapter considers how these aims have been addressed across Studies 1 
to 5, the knowledge that subsequent results will contribute to existing knowledge, 
and the wider implications of each set of findings obtained.
7.2 General discussion
As previously outlined in Section 2.52 a large proportion of disease-specific QoL 
measures that have been developed to date focus on patient groups with cancer, 
HIV/AIDS, diabetes, and rheumatological and respiratory conditions. To date, 
there has been a relative paucity of research concerning the QoL of persons with 
neurological illness. Where QoL has been conducted in a neurological setting, 
participants have generally been at the early to middle stages of disease. This may
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reflect the deterioration in physical and cognitive functioning that is generally 
encountered at the latter stages of neurodegenerative disease. Communication may 
also become difficult, and any combination of these factors may render assessment 
of any kind more difficult. At the outset of the present research, the feasibility of 
assessing QoL in persons with severe neurological disability therefore remained 
uncertain.
The outcomes of Study 1 demonstrate that is it possible to assess QoL during the 
latter stages of neurological illness using the SEIQoL-DW, a person-centred QoL 
measure. When QoL is considered from the participant’s perspective, the present 
research suggests that individuals with severe neurological disability generally 
have high perceptions of their QoL, despite the extent of their physical disabilities. 
Indeed, the majority of traditional assessment tools, by their very nature, suggest 
that as a disease progresses, the patient’s QoL will decrease accordingly. In relation 
to persons with MS, Stuifbergen (1995) suggests that despite living with a chronic 
disabling condition, individuals generally report positive perceptions of their 
current health. The SEIQoL-DW and QoL visual analogue scale ratings obtained 
across Studies 1-5 suggest that individuals with chronic disabling conditions may 
also generally report positive perceptions of their current QoL. Results of Study 1 
also demonstrate that using a traditional health-based QoL measure (the SF-36 
Health Survey) with persons with severe neurological disability may misrepresent 
their perceived QoL, as they obtain relatively low scores due the measures focus on 
health-based entities.
The SEIQoL-DW represents a relatively new development in person-centred 
methodology, and previous studies supporting its use have focussed on QoL with
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the elderly (Browne et al., 1994), and persons with HIV/AIDS (Hickey et al., 
1996) and dementia (Coen et ah, 1993). For the purpose of the present studies, the 
SEIQoL-DW was adapted to a form previously demonstrated to be suitable for MS 
patients by Parker and Pimm (1995, see Appendix 3.4). The original apparatus was 
too small and complex for individuals with MS, where symptoms may include 
blurred vision, tremor and uncoordinated, limited arm movements. However, with 
this adaptation. Study 1 demonstrated that the SEIQoL-DW is both a valid and 
responsive QoL measure to use with persons with severe neurological disability 
associated with MS.
At the time of writing there are no previous accounts of studies conducted across 
an extended time period using the SEIQoL-DW. However, this approach to 
assessment across the present studies has generated a vast amount of information 
concerning the factors that are important to overall QoL in persons with severe 
neurological disability. Previous research with patients with neurological illness 
suggests that individuals adapt to the consequences of disease by re-evaluating that 
which is important in life (e.g. Engstrom and Nordeson, 1995). Stensman (1985) 
suggests that areas such as basic mood, conversation and relations with family and 
close friends are considered valuable to QoL in severely mobility disabled 
individuals. On the basis of information collected across Studies 1 to 5, the five 
most commonly nominated life areas that are important to persons within the 
present population are as follows: Family (Joint 1®^), Going Out (Joint 1®% Social 
Contact (Joint F ‘); Friends (4^ )^; Hobbies (5^ )^.
It is interesting to note that Health does not appear in this listing; it was the 6 ‘^  most 
frequently nominated life area alongside Independence and Quality of care. This
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observation supports Schipper’s (1990) argument, that focussing on what people 
can/cannot do, or have/do not have does not constitute a good or bad QoL, at least 
not in the eyes of the individual concerned. These findings also provide support for 
the conceptual distinction between health-related and person-centred QoL. It was 
noted in Section 2.4 that the terms health-related QoL and QoL are often used 
interchangeably in the literature, although they refer to very different entities. The 
distinction between HRQoL and QoL rests on the former being based wholly on 
(health) domains that can be easily measured and quantified. As the SEIQoL-DW 
areas nominated across the present studies suggest, person-centred QoL may 
consist of a much broader range of elements, many of which are generally un­
related to the range of factors monitored by physicians and health-care systems.
The range of areas nominated as important across Studies 1 to 5 suggests that the 
meaning of QoL varies from one person to the next. For example, no two 
individuals nominated the same life areas when using the SEIQoL-DW. 
Furthermore, many of the areas listed in each study were nominated by one person 
only, such as “having fresh flowers in my room” and “my pets”. The items listed 
above would not necessarily be considered by outsiders to be important 
determiners of QoL in severe neurological disability, but each factor held great 
relevance for the individuals who nominated them. This observation supports 
previous research by Engstrom and Nordeson (1995), who suggest that patients 
with progressive neurological disease experience QoL as subjective and individual.
This finding also adds further credibility to the assumption that the SEIQoL-DW is 
measuring individual QoL. At the time of writing, neither of these areas feature 
specifically on the QoL measures currently available for use with persons with
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neurological illness. The content of these measures are generally based on 
questions relating to areas that have been nominated by health professionals, 
clinicians, or other groups of individuals with the disease in question.
Across Studies 1-5, the adapted version of the SEIQoL-DW and QoL visual 
analogue scales have proved relatively simple to administer within the present 
population, although some individuals remain unable to complete the SEIQoL-DW 
due to reduced cognitive abilities. Despite this problem, the SEIQoL-DW provides 
a unique insight into the QoL of many individuals with severe neurological 
disability, and on this basis, alone, the SEIQOL-DW remains an invaluable 
assessment tool within the present population. The information obtained 
concerning the areas that persons with severe neurological disability consider 
important to their overall QoL provides an important foundation for understanding 
the meaning of QoL within this population. At an individual level, this information 
can also be used to modify existing routines and care plans in order to assist in 
contributing to improved QoL within this client group.
In relation to Study 1, it was noted that the guidelines for establishing the 
psychometric properties of QoL measures remain inconsistent across studies. 
Furthermore, several scales that claim to measure QoL have not undergone 
thorough psychometric testing. On the basis of previous QoL research and 
psychometric theory, psychometric criteria were developed in order to assess the 
feasibility of using the SEIQOL-DW and the SF-36 Health Survey within the 
present population. The proposed criteria incorporated the traditional standard of 
0.70 (Nunally, 1978), but introduced a second, lower criterion of 0.60-0.69, to 
acknowledge the dynamic nature of QoL discussed by Allison, Locker and Feine
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(1997) and Campbell, Converse and Rogers (1976). The introduction of these 
criteria within Study 1 provides a potential basis upon which to establish the 
feasibility of using other person-centred and health-based QoL measures across a 
variety of health-based settings, whilst acknowledging that the QoL construct is 
likely to change across short-and longer time spans.
A second important contribution to the theory of psychometric testing of QoL 
measures stems from the emphasis in Study 1 (Part 2) on responsiveness to change 
as a psychometric feature that requires assessment alongside re-test reliability and 
concurrent validity. Several authors suggest that the QoL construct is sensitive to 
fluctuation in individual state, and therefore not as stable as traits such as intellect. 
On this basis, a measure that demonstrates high reliability may be a poor indicator 
of QoL as it will be insensitive to changes over time. QoL measures should 
therefore demonstrate a high level of stability in unchanging situations and 
sensitivity to changing circumstances (Atkinson, 1982).
The assessment of responsiveness to change provides us with the opportunity to 
study the dynamic nature of QoL. This in turn means that potential improvement 
and deterioration in individual QoL can be monitored across an extended time 
period. The domains that are assessed on health-based measures may reflect a 
proportion of the dynamism associated with QoL. Emotional appraisal of QoL 
may fluctuate significantly from one assessment to the next, whereas appraisal of 
physical fimctioning may remain relatively constant across test occasion (there are 
of course exceptions to this notion, for example in cases of relapsing-remitting 
MS). Comparison of subscales may acknowledge aspects of QoL dynamism, but as 
health-based and disease-specific measures usually assess pre-defined areas, there
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is no guarantee that their content will measure the life area that is experiencing 
change. Many of the factors that cause QoL perceptions to fluctuate will be unique 
to the individual, and collectively these will be far more varied than the content of 
the majority of established generic and disease-specific measures. For this reason, 
person-centred QoL measures may be the most appropriate tools for investigation 
of QoL in dynamic terms.
Rather than ignore or underplay the dynamism associated with QoL perceptions, 
we should embrace it, for it may provide useful insights for clinicians and 
researchers regarding relatively high, or relatively low individual QoL scores 
obtained. Longitudinal QoL research, and studies designed to evaluate the 
psychometric properties of QoL measures may also benefit from these insights. A 
combination of the person-centred approach to QoL measurement and a greater 
emphasis on the relationship between assessment of QoL and reported life change 
may provide a valid starting point for investigation of QoL dynamism.
On this basis, the criteria for psychometric testing of QoL measures requires 
reformulation, to a standard form that replaces the contradictory criteria that have 
been utilised to date. Within this reformulation, the traditional emphasis on 
demonstrating re-test reliability should be re-considered to acknowledge QoL 
dynamism. A greater focus on the investigation of responsiveness to reported 
changes when they occur between assessments, and stability of scores where no 
changes are reported to occur, may provide one logical means of obtaining an 
accurate representation of the psychometric properties of QoL measures.
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Having found a suitable means of assessing QoL in persons with severe 
neurological disability, it became possible to investigate the processes that are used 
to evaluate QoL within this population in greater depth. In previous studies of 
social comparison information in individuals with serious medical problems, 
‘downward’ comparisons (e.g. a comparison with a worse-off other) are said to 
occur most frequently (Affleck and Tennen, 1991; Blalock, DeVellis and DeVellis, 
1989; DeVellis et a l, 1990; Skevington, 1994). However, in Studies 2 and 5, the 
most common type of comparison made were those relating to the individual’s own 
past. This observation supports previous research conducted with healthy 
participants by Dube, Jodoin and Kairouz (1998), who suggest that in older 
persons, comparisons with the distant and near past are more common than social 
comparisons.
This type of comparison, sometimes referred to as a ‘temporal’ or ‘intrapersonal’ 
comparison, has received little attention in previous studies of QoL in a health- 
based setting. The notion of psychosocial comparisons in relation to QoL is 
especially interesting in persons with severe neurological disability, given the 
cognitive deficits that are present in the majority of individuals within this 
population group. This includes the reduced ability to make comparative 
judgements. Although one might think that comparisons made with one’s pre­
illness status would have a detrimental affect on present QoL, the present findings 
suggest that this is not always the case, being partially dependent on the 
presence/absence of life changes, and the cognitive ability to make comparisons.
The present findings suggest that individuals experiencing positive or negative life 
change at the time of assessment, and those who are unable to make consistent
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comparative judgements, obtain higher QoL judgements when they make 
comparisons with their own past in order to evaluate their present QoL, These 
findings hold a number of important implications relating to the day-to-day care of 
persons with severe neurological disability. Individuals who are experiencing life 
change, for example, may be encouraged to make comparisons with their own past, 
in the knowledge that it may improve how they feel about their present QoL in 
times of uncertainty and instability. Furthermore, individuals with a reduced level 
of cognitive functioning should not be discouraged from attempting to make 
comparisons with their own past in order to evaluate present QoL, as this process 
may enhance their perceived QoL.
There are still several gaps in our knowledge concerning the factors that influence 
the use of intrapersonal, upward and downward comparisons in persons with severe 
neurological disability. Indeed, there has been a paucity of research on social 
comparisons and QoL, even though the number of studies on social comparisons in 
health-based settings has increased within the past 10 years. The findings obtained 
within Studies 2 and 5 contribute new insights to the relationship between social 
comparisons and QoL, although it is recognised that these findings are based on 
research conducted with a relatively small number of participants. However, the 
building of a theoretical model of Social Comparisons and QoL in persons with 
severe neurological disability (see Figure 6.5, p.373) provides a valuable 
foundation for further research within this population group. With the paucity of 
published literature currently available on social comparisons and QoL, the model 
may also provide useful information for QoL researchers working with other 
patient groups, who wish to study the relationship between evaluation strategies 
and perceived QoL.
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With the sharp increase in new QoL measures developed across the last 15 years, 
and the diversity of hoth ‘healthy’ and ‘ill population groups that have been studied 
within this time, QoL research appears to have reached a crossroads. The need for 
new measures has now declined, and the quest for information concerning the QoL 
of specific population groups is an area that researchers are currently pursuing at an 
international level. There are, however, several areas of QoL research that remain 
relatively underdeveloped. If we are to leam more about the concept of QoL across 
diverse population groups, then we must work towards obtaining an understanding 
of how these perceptions are formed. The research to date certainly suggests that 
the psychosocial processes used to evaluate QoL affect the subsequent perceptions 
that are formulated. However, at the present time we know very little concerning 
the factors that influence the choice of process, and the factors that mediate QoL 
outcomes.
At the present time, the factors that influence choice of comparison strategy (i.e. 
social versus intrapersonal comparisons) remain uncertain. Furthermore, there is 
little consensus concerning the alternative judgement strategies that may be used to 
evaluate QoL when individuals refi*ain from making comparisons. Individuals who 
did not make comparative judgements during Study 5 generally stated that their 
QoL evaluations were based on how they felt about life at the time of assessment. 
This suggestion supports research by Dube, Jodoin and Kairouz (1998), who state 
that attributions of positive and negative events, consideration of the positive and 
negative aspects of one’s life, and consideration of one’s perceived mood at the 
time of assessment may also contribute towards one’s perceived level of well­
being. Several other researchers suggest that individuals rely more on their 
affective state at the time of judgement than on any comparison process (e.g.
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Diener, Sandvick and Pavot, 1991; Schwartz and Clore, 1983; Schwarz and Strack, 
1991). Further research is now required to delineate more clearly the process of 
QoL evaluation, and how different processes affect perceptions of QoL. In the 
future, this type of information may help to explain individual differences in 
perceived QoL. It may also be used to assist in increasing the perceived QoL of 
persons who obtain low QoL ratings either (a) on a long-term basis, or (b) on a 
short-term basis, due to perceived life changes or times of uncertainty.
As there have been few published attempts to study QoL in persons with severe 
neurological disability, the factors that influence QoL within this population group 
remain unclear. Previous studies with early to middle stage MS patients have 
suggested that contact with healthy people (Maybury and Brewin, 1984), perceived 
support from family and friends (Mclvor, Reziknoff and Riklan, 1984) and 
engagement in health promoting behaviours (Stuifbergen, 1995; Petajan et al., 
1996) facilitate better psychosocial adaptation and QoL. Finding relating to 
Studies 3 and 4 also suggest that time spent outside and time spent in one-to-one 
company may increase perceived QoL, whereas time spent alone on the ward 
appears to lower perceived QoL in some cases.
These findings reaffirm the beliefs behind the care strategies employed at the Royal 
Hospital for Neuro-disability. The busy schedules of many of the patients here was 
commented on during the course of the present research. Indeed, individuals have 
the opportunity to take part in an array of activities within the Hospital, including 
computer sessions, relaxation classes, painting, pottery and gardening. Many of 
these activities require specialised, and often expensive equipment, and the hospital 
also hires full-time employees to take individuals to their chosen session, collect
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them afterwards and bring them back to the ward. A substantial amount of time, 
money and effort continues to be invested in order to maintain existing provisions, 
and introduce new ones, in the hope that such activities may improve patient QoL. 
The finding that perceived QoL may decrease when patients are left on their own 
on the ward, and increase when patients spend 20 minutes in one-to-one company 
or 20 minutes outside, highlights the importance of continued provisions of this 
kind within the present setting, and, indeed, in other long-term care establishments.
The present findings also suggest that interventions aimed at improving patient 
QoL need not be wholly dependent on expensive new facilities, or pre-planned 
outings and holidays. Although tight financial budgets are commonplace among 
residential care settings, the present research suggests that simple 20-minute 
activities such as spending time outside, or spending time in one-to-one company 
may improve patient QoL. This knowledge could also be used to assist in 
enhancing the QoL of persons who, for example, are bed-ridden and cannot attend 
the activities outlined above. The present findings certainly suggest that enhancing 
patient QoL is an accessible goal for health-care workers, and one that may be 
achievable despite financial constraints.
Results obtained within the present research also suggest that reported life changes 
may influence the perceived QoL of persons with severe neurological disability. 
Many of the significant results obtained across Studies 1-5 either (a) were 
demonstrated when ‘no life change’ cases were analysed, or (b) increased in 
statistical strength when ‘no life change’ cases were analysed independently. This 
adds further support to the notion that the QoL construct is sensitive to fluctuation 
in individual circumstance. At the time of writing, the majority of existing QoL
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measures do not record information on recent significant life changes. Furthermore, 
the majority of published QoL research papers do not address the issue of 
perceived life changes occurring at the time of assessment. The changes taking 
place within and around each individual are often neglected, and yet these sources 
of dynamism may contribute significantly to overall results obtained.
Many of the perceived life changes reported across Studies 1 to 5 explained marked 
differences between individual’s scores. Significant negative events or changes 
reported included being ill, disputes with nursing staff or a family member, a faulty 
wheelchair, being put too bed too early, being got up too late, the cold weather 
causing joint problems, and simply feeling fed up. Significant positive events or 
changes reported included having been on an outing, fine weather, having had a 
manicure, and simply feeling good. In many cases, these factors affected perceived 
QoL ‘today’ ratings; the negative changes lowered ratings and the positive changes 
increased ratings in relation to the individual’s perceived QoL ‘generally’. In other 
cases these same reported changes made no difference to QoL ‘today’ ratings, 
which remained similar to QoL ‘generally’ ratings. As previously discussed in 
relation to Study 2, positive and negative life changes also appeared to decrease 
QoL ‘generally’ ratings in some cases.
The factors that influence person-centred QoL appear to he highly individualised. 
Again, these items are generally not incorporated on generic or disease-specific 
health-based measures of QoL. When one considers the reported positive and 
negative life changes/events listed above, it seems reasonable to assume that QoL 
may fluctuate on a day-to-day basis, due to factors that are unlikely to have any 
long-lasting effect on perceived QoL. Indeed, this notion was considered when
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discussing the theoretical basis of QoL in Section 3.2 (pp. 122-127). It was also 
suggested that positive and negative fluctuations may balance each other out across 
an extended time period, as the incidents that cause QoL to fluctuate are likely to 
be relatively short-lived. If this is the case, then where no major life changes are 
reported to occur, perceived QoL may appear relatively stable across an 8-month 
period. By comparison, perceived QoL across an 8-day duration of this 8-month 
period may appear relatively unstable. Although this theory remains speculative, 
the present findings certainly suggest that changes in perceived QoL are caused by 
significant, long-term life changes and significant short-term events and 
occurrences. Further research would therefore benefit from controlling for both of 
these influences when assessing patient QoL. This information may assist in 
explaining outlying QoL scores, and may also account for a reasonable proportion 
of the variance in QoL ratings that is often observed.
It is interesting to note across Studies 1 to 5 that other individuals mentioned the 
changes or events outlined above but their QoL ratings remained relatively high. 
This may be explained by individual coping strategies and attribution styles. For 
example, the QoL of persons who are better able to cope in times of uncertainty 
may be less affected by life events than that of individuals who are less able to 
cope in times of change. External support systems may also have a mediating affect 
on the extent to which life changes influence perceived QoL in persons with severe 
neurological disability. Perhaps factors such as level of cognitive functioning also 
contribute to this process. The present research suggests, for example, that 
comparisons with one’s own past in times of perceived life change may enhance 
QoL ratings, though the same comparison strategy may decrease ratings when no 
life changes are reported. Further research is now required to determine more
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precisely the factors that contribute to increased and decreased perceived QoL 
when life changes are reported at the time of assessment. For example, enhanced 
knowledge of the factors that modify the potentially detrimental effects of negative 
and positive life changes on perceived QoL could assist in enhancing QoL in 
individuals who are experiencing times of instability and uncertainty, at least until 
a sense of equilibrium is restored.
Whilst great emphasis is often placed on assessment of emotional functioning and 
level of disability when QoL assessments are conducted within a neurological 
setting, few disease-specific QoL measures that have been developed for use within 
a neurological setting incorporate assessment of cognition. Vickrey et al (1995) 
supplemented the SF-36 with four items related to concentration and thinking, 
attention and memory when developing the MSQOL-54. Celia et al (1996) also 
included four cognitive items in the Functional Assessment of Multiple Sclerosis 
(FAMS) QoL instrument. In both cases, the questions generally ask individuals 
whether they feel they have cognitive difficulties on a day-to-day basis. 
Individuals may be reluctant to offer this information, especially where cognitive 
impairment is just becoming apparent, and individuals with more severe 
impairments have limited insight concerning the extent of their cognitive 
deterioration. Furthermore, the MSQoL-54 and the FAMS remains inappropriate 
for use with individuals with moderate to severe physical disabilities, due to their 
general focus on health-based entities.
The cognitive domains included in the MSQoL-54 and the FAMS are generally 
crude and unable to provide the wealth of information that would be gained from 
separate assessment using tests like the WAIS-R to assess cognitive functioning.
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However, few researchers seem to take this initiative. Although Kwa, Limburg and 
de Haan (1996) suggest that cognitive impairment has no significant impact on the 
QoL of stroke patients, this conclusion was based on research with a relatively 
healthy group of stroke survivors. By contrast, results of Studies 2 and 5 suggest 
that autobiographical memory across the life span, autobiographical memory for 
recent or young adult life incidents, autobiographical memory for facts from recent 
adult life, and general cognitive functioning all affect perceived QoL in persons 
with severe neurological disability. Generally speaking, individuals with an 
autobiographical memory deficit obtain higher QoL ratings than individuals with 
intact functioning.
This finding suggests that individuals with severe neurological disability may be 
happier when they lack full insight into their condition. This seems plausible when 
one considers the range of cognitive and physical abilities of individuals at the 
Royal Hospital for Neuro-disability. Those with intact cognitive functioning may 
see those who are less cognitively and/or physically able and question whether they 
will retain their functional and intellectual capacities in the future. This type of 
questioning may be more prevalent in an institutionalised setting than within 
community residences, where day-to-day living would generally occur 
independently of others with a greater disability. If this type of comparison does 
occur, then further research would benefit from investigating (a) the prevalence of 
comparisons made across different care establishments, and (b) the effects of such 
comparisons on perceived QoL in persons with moderate, rather than severe, 
neurological disabilities.
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The present findings suggest that the relationship between cognition and QoL in 
persons with neurodegenerative disease warrants closer attention. Further studies 
are now required with populations of individuals with different neurological 
diagnoses with a wide range of cognitive abilities, in order to establish further the 
relationships between cognition and QoL. The validity of person-centred QoL 
statements may be especially difficult to judge in persons with reduced cognitive 
functioning, when QoL is viewed as “that which the patient says it is” (Joyce, 
1994, p.47). The relationship between cognitive status and health-based QoL 
should also be examined, as cognitive dysfunction is thought to disrupt many of the 
areas assessed using heath-based measures (e.g., physical and psychosocial 
functioning; Dodrill, Batzel, Queisser and Temkin, 1980; Klonoff, Costa and 
Snow, 1986).
Cognitive assessment is therefore recommended alongside assessment of QoL, if 
detailed, up to date clinical records concerning cognitive ability are not available. 
Whilst it is recognised that individuals with severe cognitive deficits should not be 
exempt from QoL assessment, it remains impossible to validly assess their QoL 
with the measures that are currently available for use. The development of an 
appropriate assessment technique is a laborious task, but one which is undoubtedly 
recognised as necessary. In the meantime, the results of cognitive tests may serve 
as a useful basis for indicating which participants will produce potentially invalid 
responses. On this basis alone additional cognitive testing is recommended 
alongside QoL assessment in patients with neurological illness.
Although the SEIQoL-DW appears to be a suitable measure to use with persons 
with severe neurological disability, it has already been noted that individuals with a
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reduced level of cognitive functioning may find it difficult to grasp the concepts 
associated with this measure. This observation supports previous research by Coen 
et al. (1993), who suggest that the SEIQOL-DW is a feasible and valid instrument 
to use with patients with mild cognitive deficits associated with dementia. 
However, as cognitive impairment increases, they suggest that patients are less 
likely to be willing or able to complete the SEIQoL-DW. Coen et al. (1993) 
suggest that proxy QoL responses may be a necessary alternative in such cases.
The problems associated with the use of proxy QoL ratings have already been 
outlined in Section 2.51 (pp.86-89). However, few studies have been conducted to 
test the reliability of using proxy ratings in a neurological setting, and there is great 
scope for their use given the rate of cognitive and/or emotional impairment, 
behavioural disturbance and communication deficits that are often encountered in 
this context. Studies are now required to evaluate the relationship between proxy 
and patient ratings of person-centred QoL in a variety of neurological settings, so 
that appropriate recommendations can be made concerning their utility. If further 
information was obtained concerning the areas of greatest discrepancy between 
raters, this knowledge could be used to assist in decreasing future contradiction 
rates. If it is possible to incorporate proxy QoL ratings successfully, our breadth of 
our knowledge of QoL and individuals with neurodegenerative disease might 
increase substantially.
It may be difficult to use the SEIQoL-DW successfully for this purpose, as proxy 
raters may nominate different life areas, or a different number of life areas than 
persons with severe neurological disability. This potential problem becomes 
especially apparent when one considers the alterations in a person’s value system
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that are also likely to occur in the process of adaptation to neurological illness. For 
example, Stensman (1985) reported that behaviours such as going to the toilet 
alone, taking a bath by oneself or feeding oneself were rated as significantly less 
important by people with disabilities (particularly those lacking the function in 
question) than able-bodied people. Proxy raters may also assign different relative 
values to each life area nominated, or may produce different evaluations of how 
good or bad each area is going, when compared to patient ratings on stages 1 and 2 
of the SEIQoL-DW. As each stage of the SEIQOL-DW combined produces a total 
QoL score, even slight differences between patient and proxy raters on one or more 
of these stages would lead to larger discrepancies between patient and proxy QoL 
ratings.
Although the SEIQoL-DW is rightly praised for its focus on individual QoL, QoL 
measures suited for use with proxy raters may require a more defined framework. 
On the WHOQOL-BREF for example, respondents answer each of the 24 
questions using a 5-point Likert scale. This technique might reduce the potential 
differences that one would expect if staff or relatives were to rate patient QoL 
using the SEIQoL-DW. The extent to which patient and proxy ratings would 
disagree using the SEIQoL-DW or the WHOQOL-BREF remains uncertain, and at 
the time of writing there have been no published attempts to examine the utility of 
proxy ratings using either QoL measure. It would also be interesting to investigate 
whether QoL ‘today’ and ‘generally’ visual analogue scales provide a reliable 
means of obtaining proxy QoL ratings on behalf of persons with severe 
neurological disability. Until such research is conducted, the utility of proxy 
ratings in relation to patients with profound neurological disabilities remains 
uncertain.
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The recently developed WHOQOL-BREF may also provide a feasible alternative 
to proxy ratings, in cases where the SEIQoL-DW cannot be completed due to 
severe cognitive impairments. In Study 5, the WHOQOL-BREF was easily 
understood by persons who found the SEIQoL-DW more difficult to comprehend 
due to reduced cognitive fimctioning. In such cases, the administration time for the 
SEIQoL-DW may increase from 10 to 30 minutes, as the procedures and 
conceptual basis requires more careful explanation. However, individuals with 
severe cognitive impairments generally completed the WHOQOL-BREF within 15 
minutes. Furthermore, no floor effects were obtained on the Physical domain, a 
problem which has previously been reported when using the SF-36 with persons 
with moderate to severe neurological disability associated with MS (Lintem et a l, 
1999; Murrell et a l, 1999; Vickrey et al, 1995).
The WHOQOL-BREF must undergo extensive psychometric testing to determine 
whether it is a valid and responsive measure for use with persons with severe 
neurological disability. Some individuals may find the questions relating to 
capacity for work and sexual activity inapplicable to their present life, although 
individuals within the present population were able to answer every question on the 
WHOQOL-BREF without, they stated, feeling offended or uncomfortable. If the 
WHOQOL-BREF can be demonstrated as valid and responsive to change within 
this population, then this measure could provide a logistic answer to the problem of 
assessing QoL in persons with reduced cognitive functioning, without resorting to 
the use of proxy respondents.
Results of Study 5 suggest that the WHOQoL-BREF assesses aspects of person- 
centred and health-based QoL. This combination of constructs is relatively
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unheard of within the QoL literature, and on this basis the WHOQOL-BREF 
provides a rich source of information. As previously stated, no floor effects were 
obtained on the Physical domain, suggesting that this scale measures something 
broader than physical functioning. If this is so, then the WHOQOL-BREF may 
possess the relatively unique property of assessing physical well being on a wider 
basis than simply having functional ability. Meeberg (1993) suggests that health is 
a life experience that reflects QoL from a subjective and objective perspective. The 
present findings suggest that the WHOQOL-BREF may represent physical health 
from this wider viewpoint, and on this basis alone the WHOQOL-BREF may 
become one of the most utilised QoL measures available within the next 5 or so 
years. The WHOQOL-BREF shows great promise for use with persons with severe 
neurological disability, although further conclusions regarding its suitability within 
this population remain unwarranted until psychometric testing is conducted.
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Appendix 3.2
Stage 1 of the SEIQoL-DW
CUE DEFINITIONS RECORD FORM
DESCRIPTION OF CUE CUE LABEL
1._____
2 .
(Tick any cues elicited by reading list to person).
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stage 2 of the SEIOoL-DW
Appendix 3.2 (cont.)
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Appendix 3.2 (cont^
INTERVIEW RECORD FORM
1.
2.
TIME TAKEN
UNDERSTANDING OF METHOD
- not understood
- poor/ uncertain 
understanding
- understood
3. FATIGUE/ BOREDOM
- none______ /_____
- som e /______
-alot  _____ /_____ _
OVERALL VALIDITY OF INFORMATION (in the light of 2 & 3 above)
- definitely invalid _______
- uncertain _______
- valid _______
SCORES ON VISUAL ANALOGUE SCALES (in mm)
1 _ 
2 _
3 _
4 _
5 _
6 _
7 _
8 _
9 _
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
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The revised version of the SEIQoL Direct Weighting tool
The original version (O'Boyle et a l, 1996) (Diameter =20cm)
Appendix 3.3
A
/  ' ’~ i  i
The revised version (adapted from Parker and Pimm, 1995) (Diameter = 32cm)
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Appendix 3.5
PARTICIPANT INFORMATION SHEET 
RESEARCH INTO QUALITY OF LIFE IN PERSONS 
WITH MULTIPLE SCLEROSIS
In the Spring of last year research was carried out at the Royal Hospital for 
Neuro-disability to find out which aspects of life are important to patients with 
multiple sclerosis. We also assessed whether residents were satisfied with their 
level of functioning in the areas of life that are most important to them.
In relation to this work, we are now considering how a persons satisfaction with 
their life changes over time and what might influence these changes. We will 
therefore be considering background information such as the number of outings 
and activities, different therapies, and the time of year. How these life-satisfaction 
judgements are actually made will also be examined.
If you want to take part in this research, we will initially work through three 
questionnaires together, on five occasions, two weeks apart. After this my visits 
will become less frequent, but will continue until May 1998. The questions you 
will be asked address the following areas:
1. Y our present health and activities of daily life.
2. Your views on which aspects of life are important to you and how 
satisfactory each of these are for you at the moment.
3. How satisfied you are with your current life in comparison to people around
you.
Each interview will be divided into a number of smaller sessions, and you will not 
be required to complete all the tasks in one sitting. Each questionnaire takes about 
10 minutes to complete. If at any time during the interviews you feel tired or 
would like to stop, you can tell the investigator who will be happy to continue at a 
later date. You can, of course, withdraw from the study at any point in time.
All appointments will be made for times most convenient to you and will not 
interfere with any therapy or social activities that you may be involved in.
If you require any further information, please contact 
Graham Beaumont or Rachel Murrell 
Department of Clinical Psychology 
0181 780 4500 (Ext. 5013/5128)
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Appendix 3.6
CONSENT FORM 
ROYAL HOSPITAL FOR NEURO-DISABILITY
West Hill, Putney.
RESEARCH INTO QUALITY OF LIFE IN PATIENTS WITH 
MULTIPLE SCLEROSIS
Investigator: Ms Rachel Murrell, Postgraduate Student.
Roehampton Institute London.
Under the supervision of Professor LG. Beaumont, Chartered Clinical 
Psychologist, Head of Department of Psychology, Royal Hospital.
Aim of the studv
The purpose of this study is to establish the changes which occur in judgements of 
life satisfaction over time, and examine some of the factors which contribute to 
these changes.
What vou will be asked to do
You will be asked a number of questions relating to how you satisfied you are with 
your life at the moment and how you have been feeling lately. You may also be 
asked to rate how satisfied you are with your life in comparison to others (for 
example, other individuals on the ward). If you are unsure about any of the 
questions, you may ask us and we will try to explain.
You will be asked to take part in a series of 5 small studies, each one covering a 
three month period. These will be spread over an 18 month period. In the first of 
these studies, you will be interviewed 5 times, at fortnightly intervals. For the 
remainder of the studies, assessments will be given less frequently. Each interview 
should take up no more than 30 minutes of your time, and this can be broken down 
into shorter sessions if you would prefer. If during any stage of the assessments 
you feel tired or have had enough and would like to take a break, please tell the 
investigator who will be happy to continue at a later date.
I..............................................................of...............................................................
agree to take part in the study. I understand what I have been asked to do which 
has been explained to me. I understand that I can withdraw from the study at any 
time and without a reason for doing so. I realise that the study may not he of direct 
benefit to me. I have been told that there are no risks involved and that 
confidentiality will be maintained, so that anything I say to the investigator 
throughout the period of assessment will not be told to anyone else.
Signed.............................................   (Participant/Ward Sister)
Signed.......................................................................... (Investigator)
Date................................................................................
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One-way repeated measures ANOVA summary table
Factor: Test occasion
Appendix 3.7
SEIQoL-DW
A) Comparison A (Baseline Measure of 1996 and re-tests of 1997)
Source of Variation Sum of
squares df
Within + residual 
Time
25115.34 105 
4279.90 5
Mean
square
239.19
855.98
F
ratio
3.57
F
Prob.
0.00
B) Comparison B (Re-tests of 1997)
Source of Variation Sum of
squares df
Within + residual 
Time
18765.58 105
1686.53
Mean
square
223.40
421.63
F
ratio
1.89
F
Prob.
0.12
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Appendix 3.8
One wav repeated ANOVA summary tables (SF-36)
Factor: Test Occasion
Bodily Pain: Comparison A tBaseline and re-tests)
Effect Value F  Hypothesis df Error df Sig.
Hotelling’s Trace 0.25 0.86 5.00 17.00 0.52
Bodily Pain: Comparison B (Re-tests)
Effect Value F  Hypothesis df Error iÿ" Sig.
Hotelling’s Trace 0.13 0.59 4.00 18.00 0.67
General Health: Comparison A (Baseline and re-tests)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Test occasion 668.04 5 133.61 0.66 0.65
Within + Residual 21278.79 105 202.66
General Health: Comparison B (Re-tests)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Test occasion 577.09 4 144.27 0.75 0.55
Within + Residual 16000.51 84 190.48
Mental Health: Comparison A (Baseline and re-tests)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob,
Test occasion 0.56 5 0.11 2.04 0.08
Within + Residual 5.81 105 0.06
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Appendix 3.8 (cont.)
Mental Health: Comparison B (Re-tests)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Test occasion 0.51 4 0.13 2.30 0.07
Within + Residual 4.69 84 0.05
Physical Functioning: Comparison A (Baseline and re-tests)
Effect Value F  Hypothesis d f  Error d f  Sig.
Hotelling’s Trace 0.27 1.25 5.00 17.00 0.32
Physical Functioning: Comparison B (Re-tests)
Effect Value F  Hypothesis df Error df Sig.
Hotelling’s Trace 0.25 1.13 4.00 18.00 0.37
Test Name Value F Hypothesis df Error df
Hotellings 1.30 4.44 5.00 17.00
Role Emotional: Comparison B (Re-tests)
Test Name Value F Hypothesis df Error df
Hotellings 1.11 5.03 4 18.00
Role Physical: Comparison A (Baseline and re-tests)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Test occasion 5826.70 5 1165.34 1.89 0.10
Within + Residual 64694.13 105 616.13
Role Physical: Comparison B (Re-tests)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Test occasion 1.15 4 0.29 2.06 0.09
Within + Residual 11.74 84 0.14
Sig.
0.00
Sig.
.007
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Appendix 3.8 (cont.)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Test occasion 1695.45 5 339.09 1.64 0.16
Within + Residual 21696.21 105 206.63
Vitality: Comparison B (Re-tests)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Test occasion 1585.00 4 396.25 2.17 0.07
Within + Residual 15295.00 84 182.08
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Royal Hospital for Neuro-disability Appendix 3.9
DEPARTMENT OF CLINICAL PSYCHOLOGY 
QUALITY OF LIFE ASSESSMENT
Extent of therapeutic intervention questionnaire
Name,
Ward..
Does this client refuse therapy? If not, what groups/activities have they been 
involved in since Mar 96?
Frequency of sessions. Mar 96 to present.
Have these sessions been 
continual?........................
Average length of 
session?................
Any other comments.
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Appendix 3.10
One-way unrelated ANOVA summary table (SEIOoL-DW)
Factor: Reported life change
Source of Variation
df
Sum of 
squares
Mean
square
F
ratio
F
Prob.
Between Groups 2 3620.55 1810.27 7.57 0.00
Within Groups 36 8603.35 238.98
Total 38 12223.90
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Appendix 3.11
One-way unrelated ANOVA summary tables (SF-36)
Factor: Reported life change
Source of Sum of Mean F F
Variation squares d f square ratio Prob.
General Health Between Groups 2411.30 2 1205.65 3.71 0.03
Within Groups 1670.97 36 324.19
Total 4082.27 38
Mental Health Between Groups 1644.22 2 822.11 2.96 0.06
Within Groups 10004.65 36 277.91
Total 1648.88 38
Role Emotional Between Groups 1446.27 2 723.13 0.69 0.51
Within Groups 37580.23 36 1043.89
Total 39026.51 38
Role Physical Between Groups 1.03 2 0.51 2.19 0.13
Within Groups 8.41 36 0.23
Total 9.43 38
Vitality Between Groups 3182.31 2 1591.15 5.07 0.01
Within Groups 11302.58 36 313.96
Total 14484.89 38
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One wav unrelated ANOVA summary tables (HAPS)
Factor: Reported life change
Appendix 3.12
Anxiety
Anxiety
Depression
Source of 
Variation
Between Groups 
Within Groups 
Total
Between Groups 
Within Groups 
Total
Sum of Mean
squares df square
43.69 2
954.27 36 
997.97 38
14.34 2
142.35 36 
156.67 38
21.85
26.51
7.17
3.95
F F
ratio Prob.
0.82 0.45
1.81 0.17
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Appendix 3.13
5 x 2  mixed ANOVA summary table (SEIOoL-DW)
Factor 1 : Test occasion
Factor 2: Extent of therapeutic intervention
Sum of Mean F F
Source of variation squares df square ratio Prob
Between Groups 25516.58 21
Therapy 16.81 1 16.81 0.01 0.91
Within + Residual 25499.77 20 467.18
Within Groups 20452.11 88
Test occasion 1686.53 4 421.63 1.88 0.12
Test occasion x therapy 834.73 4 208.68 0.93 0.45
Within + Residual 17930.85 80 224.13
Total 45968.69 109
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Appendix 3.14
5 x 2  mixed ANOVA summary tables (SF-36)
Factor 1 : Test occasion Factor 2: Extent of therapeutic intervention
Bodilv Pain
Sum of Mean F F
Source of variation squares df square ratio Prob.
Between Groups 2777.60 21
Therapy 30.09 1 30.09 0.21 0.65
Within + Residual 2747.51 20 137.37
Within Groups
Effect Value F  Hypothesis d f Error d f
Test occasion (H) 14.08 59.84 4.00 17.00
Test occasion x therapy (H) 0.16 0.66 4.00 17.00
General Health
Sum of Mean F F
Source of variation squares df square ratio Prob.
Between Groups 39347.16 21
Therapy 404.73 1 404.73 0.21 0.65
Within + Residual 38942.43 20 1947.12
Within Groups 16577.60 88
Test occasion 577.09 4 144.23 0.77 0.55
Test occasion x therapy 1080.95 4 270.23 1.45 0.23
Within + Residual 14919.56 80 186.49
Total 55924.76 109
Mental Health
Sum of Mean F F
Source of variation squares df square ratio Prob.
Between Groups 4855.86 21
Therapy 326.71 1 326.71 1.53 0.23
Within + Residual 4259.15 20 212.96
Sig.
0.00
0.63
Within Groups 
Effect Value F  Hypothesis df Error df
Test occasion (H) 24.73 105.14 4.00
Test occasion X therapy (H) 0.36 1.53 4.00
17.00
17.00
Sig.
0.00
0.23
(H) = Hotellings multivariate test was employed, as Mauchly’s test of sphericity was 
significant.
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Appendix 3.14 (cont.)
Physical Functioning
Source of variation
Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups
Therapy
Within + Residual
124.26
6.28
117.98
21
1
20
6.28
5.90
1.07 0.31
Within Groups 
Effect Value F Hypothesis d f Error d f Sig.
Test occasion (H) 0.34 1.44 4.00 17.00 0.26
Test occasion X therapy 0.11 0.47 4.00 17.00 0.75
Role Emotional
Source of variation
Between Groups
Therapy
Within + Residual
Within Groups 
Effect
Test occasion (H)
Sum of 
squares
21.75
4.10
17.65
df
21
1
20
Mean
square
4.10
0.88
F
ratio
4.64
F
Prob.
0.04
Value F Hypothesis df Error df Sig.
1.12
Test occasion x therapy (H) 0.65 
Role Physical
4.76
0.70
4.00
4.00
17.00
17.00
0.00
0.60
Source of variation
Sum of 
squares df
Between Groups 51924.66 21
Therapy 521.59 1
Within + Residual 51403.07 20
Within Groups 11807.51 88
Test occasion 70399.71 4
Test occasion x therapy 1482.97 4
Within + Residual 46193.83 80
Total 63102.17 109
Mean
square
521.59
2570.15
F
ratio
0.20
17599.93 30.48
370.74 0.64
577.42
F
Prob.
0.65
0.00
0.63
(H) = Hotellings multivariate test was employed, as Mauchly’s test of sphericity was 
significant.
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Social Functioning
Appendix 3.14 (cont.)
Sum of Mean F F
Source of variation squares df square ratio Prob.
Between Groups 13.66 21
Therapy 0.59 1 0.59 0.91 0.35
Within + Residual 13.07 20 0.65
Within Groups 11.87 88
Test occasion 1.14 4 0.28 2.15 0.08
Test occasion x therapy 0.14 4 0.04 0.27 0.89
Within + Residual 10.59 80 0.13
Total 25.53 109
Vitality
Sum of Mean F F
Source of variation squares df square ratio Prob.
Between Groups 43067.50 21
Therapy 502.05 1 502.05 0.23 0.63
Within + Residual 42565.45 20 2128.27
Within Groups
Test occasion 1585.00 4 396.25 2.21 0.07
Test occasion x therapy 933.18 4 233.29 1.30 0.27
Within + Residual 14361.81 80 179.52
Total 16879.99 109
471
Appendix 3.15
One-way repeated measures ANOVA summary table
Factor: Extent of physical disability 
Overall Physical Functioning (SF-36) score
(A) All cases
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 14833.72 2 7416.86 1.43 0.26
Within + Residual 98367.77 19 5177.25
Total 113201.50 21
(B) ‘EDSS = 7.5’ cases removed
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 318.15 2 159.07 0.76 0.48
Within + Residual 3551.65 17 208.92
Total 3869.80 19
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Appendix 3.16
One-way unrelated ANOVA summary table
Factor: Extent of physical disability 
Overall Physical Functioning (SF-36) score
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 
Within + Residual 
Total
69.99
505.74
575.73
2
107
109
34.99
4.73
7.41 0.00
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Example triad from the Pyramids and Palm Trees test 
(Not shown to scale. Each picture box = 9.4cm x 6.3cm, font size 28)
Appendix 4.1
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Appendix 4.2
The Similarities sub-test of the WAIS-R
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Appendix 4.3
The Digit Span sub-test of the WAIS-R
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Appendix 4.5
Example stimulus from the Coloured Progressive Matrices
488
Appendix 4.6
SOCIAL COMPARISONS/OoL INTERVIEW
How would you rate your quality of life generally?
Worst I I Best
Possible Possible
SECTION 1
1) When making this judgement about your quality of life, did you
a) Make comparisons with other times in your life 
If so, which times in particular were these?
b) Make comparisons with other people
If so, do you consider these people better or worse off than you?
Were they people that you know, or people that you don’t know, but would 
like to be like or admire (this could be, for example people in the pubhc eye)?
2) Did you not use either of the methods outlined above?
SECTION 2
2) To what extent do you feel you need to have information about other people’s
experiences of illness within the Hospital in relation to your own?
1 2 3 4  5 6 7
Not at Hardly Occasionally Sometimes Often Very All the 
All Ever Often Time
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Appendix 4.6 fcont.l
3) How would you rate your:
a) Prospects for your Future?
1
Worst
Possible
2
Veiy
Poor
3
Quite
Poor
4 5 6 7
Reasonable Quite Very Best
Good Good Possible
b) Quality of Life in relation to people around you?
1 2 3 4  5 6 7
Worst Very Quite Reasonable Quite Very Best 
Possible Poor Poor Good Good Possible
4) How often do you compare yourself with:
a) other people who you think are worse off than you?
1 2 3 4 5
Not at Hardly Occasionally Sometimes Often 
All Ever
6
Very
Often
7
All the 
Time
b) other people who you think are better off then you?
1 2 3 4 5 6 7
Not at Hardly Occasionally Sometimes Often Very All the 
All Ever Often Time
SECTION 3
Today you have rated your own quality of life. Several other residents within the 
hospital have given me ratings of their quality of life over the last 2 weeks. If you were 
given the choice, would you rather know about people whose quality of life ratings were 
higher or lower than yours, both, or would neither interest you?
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Appendix 4.7 
PARTICIPANT INFORMATION SHEET
RESEARCH INTO QUALITY OF LIFE IN PERSONS 
WITH NEUROLOGICAL DISABILITY
In the summer of last year research was carried out at the Royal Hospital for 
Neuro-disability to find out which aspects of life are important to persons with 
multiple sclerosis. We also assessed whether residents were satisfied with their 
level of functioning in the areas of life that were most important to them, how 
levels of satisfaction change over time and what might influence these changes.
We are currently looking at how these life-satisfaction judgements are made and 
whether knowing about other people’s lives influences how you feel about your 
own life. In relation to this work, we will also be looking at your ability to 
remember things and make comparisons.
If you want to take part in this research, we will initially work through three 
questionnaires, all of which consider memory ability and ability to make 
comparisons. We will then work through four more questionnaires over a period of 
7 weeks. The questions you will be asked address the following areas:
1. Your present health and activities of daily life.
2. Your views on which aspects of life are important to you and how 
satisfactory each of these are for you at the moment.
3. How satisfied you are with your current life in comparison to people around 
you, and how interested you are in knowing about their levels of 
satisfaction.
Each interview will be divided into a number of smaller sessions, and you will not 
be required to complete all the tasks in one sitting. Each questionnaire takes about 
10 minutes to complete. If at any time during the interviews you feel tired or 
would like to stop, you can tell the investigator who will be happy to continue at a 
later date. You can, of course, withdraw from the study at any point in time.
All appointments will be made for times most convenient to you and will not 
interfere with any therapy or social activities that you may be involved in.
If you require any further information, please contact 
Graham Beaumont or Rachel Murrell 
Department of Clinical Psychology 
0181 780 4500 (Ext. 5013/5128)
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Appendix 4.8
CONSENT FORM 
ROYAL HOSPITAL FOR NEURO-DISABILITY
West Hill, Putney.
RESEARCH INTO QUALITY OF LIFE IN PATIENTS WITH 
NEUROLOGICAL DISABILITY
Investigator: Ms Rachel Murrell, Postgraduate Student.
Roehampton Institute London.
Under the supervision of Professor J.G. Beaumont, Chartered Clinical 
Psychologist, Head of Department of Psychology, Royal Hospital.
Aim of the studv
The purpose of this study is to establish the way in which memory ability affects 
judgements of life satisfaction, and to examine how these judgements of life 
satisfaction are actually made.
What vou will be asked to do
You will be asked a number of questions relating to how you satisfied you are with 
your life at the moment and how you have been feeling lately. You will also be 
asked to rate how satisfied you are with your life in comparison to others (for 
example, other individuals on the ward). If you are unsure about any of the 
questions, you may ask me and I will try to explain.
After completing 3 questionnaires that look at memory and the ability to make 
comparisons, you will be interviewed 4 times, at fortnightly intervals. Each 
interview should take up to no more than 30 minutes of your time, and this can be 
broken down into shorter sessions if you would prefer. If during any stage of the 
assessments you feel tired or have had enough and would like to take a break, 
please tell the investigator who will be happy to continue at a later date.
I..............................................................of..............................................................
agree to take part in the study. I understand what I have been asked to do which 
has been explained to me. I understand that I can withdraw fi*om the study at any 
time and without a reason for doing so. I realise that the study may not be of direct 
benefit to me. I have been told that there are no risks involved and that 
confidentiality will be maintained, so that anything I say to the investigator 
throughout the period of assessment will not be told to anyone else.
Signed.......................................................................... (Participant/Ward Sister)
Signed.......................................................................... (Investigator)
Signed............................................................................(Witness)
Date.......................................
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Univariate ANOVA summary tables (All cases)
Factor: Autobiographical memory functioning
Appendix 4.9
SEIOoL-DW
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 606.13 1 606.13 2.00 0.17
Within Groups 6515.67 21 296.17
Total 7013.95 22
OoL ‘today’
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 911.19 1 911.19 1.49 0.23
Within Groups 12875.25 21 613.11
Total 13786.43 22
OoL ‘Generally’
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 187.43 1 187.43 0.31 0.57
Within Groups 12330.48 21 587.17
Total 12517.91 22
OoL ‘generally’ (2)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 7.05 1 7.05 0.01 0.91
Within Groups 11406.77 21 543.17
Total 11413.83 22
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Univariate ANOVA summary tables (‘No life change’ cases)
Factor: Autobiographical memory functioning
SEIOoL-DW
Appendix 4.10
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 963.04 1 963.05 321 0.09
Within Groups 4430.57 15 295.37
Total 5393.61 16
OoL ‘todav’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 111.67 1 111.68 0.20 0.66
Within Groups 8454.54 15 563.63
Total 8566.23 16
OoL ‘eenerallv’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 482.79 1 482.79 1.10 0.31
Within Groups 6570.97 15 438.06
Total 7053.76 16
OoL ‘eenerallv’ (2)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 86.75 1 86.75 0.14 0.71
Within Groups 9178.18 15 611.88
Total 9264.94 16
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Appendix 4.11
Univariate ANOVA summary table (Two outliers removed) 
Factor: Autobiographical memory functioning
SEIOoL-DW
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 1311.82 1 1311.82 6.45 0.02
Within Groups 3864.46 19 203.39
Total 5176.29 20
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Appendix 4.12
Univariate ANOVA summary table
Factor : Memory for childhood incidents
Source of Sum of Mean F F
Variation squares df square ratio Prob.
SEIQoL-DW Between Groups 912.15 1 912.15 3.15 0.09
Within Groups 6063.01 21 288.71
Total 6975.16 22
QoL ‘today’ Between Groups 1951.83 1 1951.83 3.46 0.07
Within Groups 11834.61 21 563.55
Total 13786.43 22
QoL ‘generally’ Between Groups 719.31 1 719.31 1.28 0.27
Within Groups 11798.61 21 561.83
Total 12517.91 22
QoL ‘generally’ Between Groups 0.09 1 0.09 0.00 0.99
(2) Within Groups 11413.73 21 543.51
Total 11413.83 22
Factor: Memory for young adult incidents
Source of Sum of Mean F F
Variation squares df square ratio Prob.
SEIQoL-DW Between Groups 82.57 1 82.57 0.25 0.62
Within Groups 6892.59 21 328.21
Total 6975.16 22
QoL ‘today’ Between Groups 468.79 1 468.79 0.73 0.40
Within Groups 13317.64 21 634.17
Total 13786.43 22
QoL ‘generally’ Between Groups 42.45 1 42.45 0.07 0.79
Within Groups 12475.46 21 594.07
Total 12517.91 22
QoL ‘generally’ Between Groups 44.36 1 44.36 0.08 0.77
(2) Within Groups 11369.46 21 541.40
Total 11413.83 22
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Appendix 4.12 (cont.)
Factor: Memory for recent incidents
Source of Sum of Mean F F
Variation squares df square ratio Prob.
SEIQoL-DW Between Groups 901.76 1 901.76 3.11 0.09
Within Groups 6073.40 21 289.21
Total 6975.16 22
QoL ‘today’ Between Groups 5442.53 1 5442.53 13.69 0.00
Within Groups 8343.91 21 397.33
Total 13786.43 22
QoL ‘generally’ Between Groups 633.23 1 633.23 1.11 0.30
Within Groups 11884.67 21 565.93
Total 12517.91 22
QoL ‘generally’ Between Groups 634.15 1 634.15 1.23 027
(2) Within Groups 10779.67 21 513.31
Total 11413.83 22
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Appendix 4.13
Univariate ANCOVA summary table
Factor: Memory for childhood incidents Covariate: Immediate memory 
OoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Autobiographical memory for
recent incidents 5656.73 1 5656.73 14.03 0.00
Immediate memory 281.83 1 281.83 0.69 0.41
Within + Residual 8062.07 20 403.10
Corrected Model 5724.30 2 2862.18 7.10 0.00
Corrected Total 13786.43 22
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One-way unrelated ANOVA summary tables
Independent variable: Cognitive cluster group
Appendix 4.14
Autobiographical memory (AISI
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 1251.73 2 625.87 85.58 0.00
Within Groups 146.26 20 7.31
Total 1398.00 22
Pyramids and Palm Trees
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 117.03 2 58.51 11.83 0.00
Within Groups 98.87 20 4.94
Total 215.91 22
Similarities tWAIS-RI
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 132.62 2 66.31 8.15 0.00
Within Groups 162.59 20 8.13
Total 295.21 22
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Appendix 4.15
One-way unrelated ANOVA summary table
Factor: Cognitive cluster group
Digit Span tWAIS-R)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 80.39 2 40.19 827 0.00
Within Groups 97.26 20 4.86
Total 177.65 22
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One-way unrelated ANOVA summary tables
Factor: Evaluation strategy
Appendix 4.16
OoL ‘generally’ (2): All cases
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 2575.51 1 2575.51 6.11 0.02
Within Groups 8838.31 21 420.87
Total 11413.83 22
OoL ‘generally’ (2): ‘No significant life change’ cases
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 5034.07 1 5034.07 17.85 0.00
Within Groups 4230.87 15 282.05
Total 9264.94 16
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Appendix 4.17
One-way unrelated ANCOVA summary table
Factor: Evaluation strategy Covariate: Depression
OoL ‘generally’ (2): All cases
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Evaluation strategy 2388.73 1 2388.73 5.42 0.03
Depression 29.33 1 29.33 0.07 0.79
Within + Residual 8808.99 20 440.45
Corrected Model 2604.83 2 1302.41 2.95 0.07
Corrected Total 11413.83 23
OoL ‘generally’ (2): ‘No significant life change’ cases
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Evaluation strategy 4219.61 1 4219.61 14.13 0.00
Depression 51.00 1 51.00 0.17 0.69
Within + Residual 4179.87 14 298.56
Corrected Model 5085.07 2 2542.23 8.51 0.00
Corrected Total 9264.94 16
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One-way unrelated ANOVA summary tables
Factor: Extent of autobiographical memory deficit
Appendix 4.18
SEIOoL-DW
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 371.23 2 371.23 1.19 0.32
Within Groups 6232.69 20 311.63
Total 6975.16 22
OoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 5224.35 2 2612.17 6.10 0.00
Within Groups 8562.09 20 428.10
Total 13786.43 22
OoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 1671.11 2 835.55 1.54 0.23
Within Groups 10846.80 20 549.34
Total 12517.91 22
OoL ‘generally’ (2)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 433.38 2 216.69 0.39 0.67
Within Groups 10980.44 20 549.02
Total 11413.83 22
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One-way unrelated ANOVA summary table (All cases)
Factor: General cognitiye functioning
Appendix 4.19
SEIOoL-DW 
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘today’
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘generally’ 
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘generally’ (1) 
Source of Variation
Between Groups 
Within Groups 
Total
Sum of Mean F F
squares df square ratio Prob.
1444.61 2 722.31 2.61 0.09
5530.55 20 276.53
6975.16 22
Sum of Mean F F
squares df square ratio Prob.
1637.60 2 818.80 1.35 0.28
12148.83 20 607.44
13786.43 22
Sum of Mean F F
squares df square ratio Prob.
662.41 2 331.21 0.55 0.58
11855.50 20 592.77
12517.91 22
Sum of Mean F F
squares df square ratio Prob.
261.43
11152.39
11413.83
2
20
22
130.71
557.61
0.23 0.79
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Appendix 4.20
One-way unrelated ANOVA summary tables (‘No life change’ cases)
Factor: General cognitive functioning
SEIOoL-DW 
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘today’
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘generally’ 
Source of Variation
Between Groups 
Within Groups 
Total
OoL ‘generally’ (2) 
Source of Variation
Between Groups 
Within Groups 
Total
Sum of Mean F F
squares df square ratio Prob.
2246.60 2 1123.30 4.99 0.02
3147.01 14 224.79
5393.91 16
Sum of Mean F F
squares df square ratio Prob.
430.87 2 215.43 0.37 0.69
8135.37 14 581.10
8566.23 16
Sum of Mean F F
squares df square ratio Prob.
1161.73 2 580.87 1.38 0.28
5892.87 14 420.86
7053.77 16
Sum of Mean F F
squares df square ratio Prob.
1362.11 2 681.05 1.21 0.33
7902.83 14 564.49
9264.94 16
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Appendix 4.21
2 x 2  unrelated ANOVA summary table (All cases)
Factor 1: Eyaluation strategy 
Factor 2: Life change
OoL ‘generally’ (2)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Eyaluation strategy 296.93 1 296.93 1.01 0.33
Life change 38.61 1 38.61 0.13 0.72
Eyaluation strategy x life change 3257.35 1 3257.35 11.09 0.00
Within Groups 5579.61 19 293.66
Corrected Model 5834.21 3 1944.73
Corrected Total 11413.83 22
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Appendix 4.22
2 x 2  unrelated ANOVA summary table (MS cases!
Factor 1: Eyaluation strategy 
Factor 2: Life change
OoL ‘generally’ (2)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Eyaluation strategy 33.55 1 33.55 0.10 0.75
Life change 16.26 1 16.26 0.05 0.83
Eyaluation strategy x life change 1929.03 1 1929.03 5.74 0.03
Within + Residual 4030.17 12 335.85
Corrected Model 2451.83 3 817.27 2.43 0.11
Corrected Total 6482.00 15
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2 x 2  unrelated ANOVA summary tables
Factor 1; Autobiographical memory (AM) for recent life incidents 
Factor 2: Life change
Appendix 4.23
SEIQoL-DW
QoL ‘today’
QoL ‘generally’
QoL ‘generally’ (2)
Source of Sum of Mean F F
Variation Squares df square ratio Prob.
AM 24.09 1 24.09 0.11 0.74
Life change 2.19 1 2.19 0.01 0.92
AM X life change 1988.15 1 1988.15 9.33 0.00
Within + Residual 4045.25 19 212.91
Corrected Model 2929.91 3 967.63 4.59 0.01
Corrected Total 6975.16 22
AM 3560.31 1 3560.31 9.75 0.00
Life change 1052.22 1 1052.22 2.88 0.11
AM X life change 170.47 1 170.47 0.47 0.50
Within + Residual 6932.51 19 364.87
Corrected Model 6853.92 3 2284.64 6.26 0.00
Corrected Total 13786.43 22
AM 27.09 1 27.09 0.11 0.74
Life change 1704.93 1 1704.93 3A1 0.07
AM X life change 1306.36 1 1306.36 2.67 0.11
Within + Residual 9312.63 19 490.13
Corrected Model 3205.28 3 1068.43 2.18 0.12
Corrected Total 12517.91 22
AM 0.33 1 0.33 0.00 0.97
Life change 256.73 1 256.73 0.53 0.47
AM X life change 1581.36 1 1581.36 3.29 0.09
Within + Residual 9112.08 19 479.58
Corrected Model 2301.74 3 767.25
Corrected Total 11413.83 22
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‘Frequency of time spent outside’ Likert scale Appendix 5.1
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Appendix 5.2
PARTICIPANT INFORMATION SHEET
RESEARCH INTO QUALITY OF LIFE IN INDIVIDUALS 
WITH SEVERE NEUROLOGICAL DISABILITY
Since the Spring of 1996, research carried out at the Royal Hospital for Neuro­
disability has been trying to find a way of measuring how satisfied patients are with 
their life. We have also been assessing whether residents are satisfied with their 
level of functioning in the areas of life that are most important to them, how life 
satisfaction changes over time and what might influence these changes. We have 
therefore considered background information such as the number of outings and 
activities, different therapies, and the time of year. How these life-satisfaction 
judgements are actually made has also been examined.
Through the research conducted to date we have found a way of measuring 
satisfaction with life, and are now looking to see if how if we can use this measure 
to detect improvement in levels of life satisfaction of individuals within the 
Hospital. In order to do this we will be considering the effect of time spent outside 
on life satisfaction. If you want to take part in this research, we will initially work 
through three questionnaires together. A week later, we will spend a short amount 
of time outside in the hospital grounds, and then complete the same questionnaires 
afterwards. The questions you will be asked address the following areas:
1. Your views on which aspects of life are important to you and how 
satisfactory each of these are for you at the moment.
2. How happy you feel at the time of each assessment.
The questionnaires do not take very long to complete. If at any time during the 
interviews you feel tired or would like to stop, you can tell the investigator who 
will be happy to continue at a later date. You can, of course, withdraw from the 
study at any point in time.
All appointments will be made for times most convenient to you and will not 
interfere with any therapy or social activities that you may be involved in.
If you require any further information, please contact 
Graham Beaumont or Rachel Murrell 
Department of Clinical Psychology 
0181 780 4500 (Ext. 5013/5128)
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Appendix 5.3
CONSENT FORM
ROYAL HOSPITAL FOR NEURO-DISABILITY
West Hill, Putney.
RESEARCH INTO QUALITY OF LIFE IN INDIVIDUALS WITH 
SEVERE NEUROLOGICAL DISABILITY
Investigator: Ms Rachel Murrell, Postgraduate Student.
Roehampton Institute London.
Under the supervision of Professor J.G. Beaumont, Chartered Clinical 
Psychologist, Head of Department of Psychology, Royal Hospital.
Aim of the studv
The purpose of this study is to determine whether spending time outside improves 
individuals perceptions of life satisfaction. We will also be examining some of the 
factors that contribute to these perceptions.
What vou will be asked to do
You will be asked a number of questions relating to how you satisfied you are with 
your life at the moment and how you have been feeling lately. If you are unsure 
about any of the questions, you may ask us and we will try to explain.
You will be asked to take part in two assessments. These will be spread over a 
period of 2 weeks. In the first of these assessments we will go through 2 
questionnaires together. Then, the following week we will go outside in the 
hospital grounds for about 15 mins. You will be interviewed immediately 
afterwards, using the same two questionnaires. Each interview session should take 
up no more than 30 minutes of your time. If during any stage of the assessments 
you feel tired or have had enough and would like to take a break, please tell the 
investigator who will be happy to continue at a later date.
I..............................................................of.............................................................
agree to take part in the study. I understand what I have been asked to do which 
has been explained to me. I understand that I can withdraw from the study at any 
time and without a reason for doing so. I realise that the study may not be of direct 
benefit to me. I have been told that there are no risks involved and that 
confidentiality will be maintained, so that anything I say to the investigator 
throughout the period of assessment will not be told to anyone else.
Signed......................................................................... (Participant/Ward Sister)
Signed........................................................................... (Investigator)
Date.
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2 x 2  mixed ANOVA summary tables
Factor 1 : Test occasion Factor 2: Life change
Appendix 5.4
A) SEIQoL-DW
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 10188.86 24
Life change 131.93 1 131.93 0.30 0.59
Within and Residual 10056.93 23 437.26
Within Groups 1667.07 25
Test occasion 1.11 1 1.11 0.01 0.90
Test occasion x life change 93.81 1 93.81 1.37 0.25
Residual 1572.15 23 1572.15
Total 11855.93 49
B) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 12867.47 24
Life change 853.76 1 853.71 1.63 0.21
Within + Residual 12013.71 23 522.33
Within Groups 6551.75 25
Test occasion 141.47 1 141.47 0.78 0.39
Test occasion x life change 2256.03 1 2256.03 12.49 0.00
Residual 4154.25 23 180.61
Total 19419.22 49
C) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 16715.00 24
Life change 140.53 1 140.53 0.19 0.66
Within + Residual 16574.47 23 720.63
Within Groups 2413.77 25
Test occasion 262.41 1 262.41 1.42 0.25
Test occasion x life change 579.21 1 579.21 3.13 0.90
Residual 1572.15 23 1572.15
Total 19128.77 49
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2 x2 mixed ANCOVA summary table
Appendix 5.5
Factor 1 : Test occasion Factor 2: Life change 
Coyariate: Amount of time generally spent outside
A) SEIQoL-DW
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 10153.51 24
Life change 96.59 1 96.59 0.21 0.65
Outside 168.57 1 168.57 0.37 0.55
Within + Residual 9888.35 22 449.47
Within Groups 1673.41 25
Test occasion 4.49 1 4.49 0.06 0.80
Test occasion x Life change 96.78 1 96.78 1.35 0.25
Test occasion x Outside 3.39 1 3.39 0.05 0.83
Residual 1568.75 22 1568.75
Total 11826.92 49
B) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 12826.47 24
Life change 812.75 1 812.75 1.49 0.23
Outside 16.67 1 16.67 0.03 0.86
Within + Residual 11997.05 22 545.32
Within Groups 6417.21 25
Test occasion 8.45 1 8.45 0.04 0.83
Test occasion x Life change 2254.52 1 2254.52 11.96 0.00
Test occasion x Outside 7.60 1 7.60 0.04 0.83
Residual 4146.64 22 188.48
Total 25660.89 49
C) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 16650.94 24
Life change 76.47 1 76.47 0.11 0.75
Outside 621.94 1 621.94 0.85 0.36
Within + Residual 15952.53 22 725.11
Within Groups 5165.17 25
0.14Test occasion 428.79 1 428.79 2.34
Test occasion x Life change 487.07 1 487.07 2.66 0.11
Test occasion x Outside 225.40 1 225.40 1.23 O il
Residual 4023.91 22 182.91
Total 21816.11 49
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-Happiness ‘today’ and ‘generally’ visual analogue scales Appendix 5.6
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Appendix 5.7
PARTICIPANT INFORMATION SHEET
RESEARCH INTO QUALITY OF LIFE IN INDIVIDUALS 
WITH SEVERE NEUROLOGICAL DISABILITY
Since the Spring of 1996, research carried out at the Royal Hospital for Neuro­
disability has been trying to find a way of measuring how satisfied patients are with 
their life. We have also been assessing whether residents are satisfied with their 
level of fimctioning in the areas of life that are most important to them, how life 
satisfaction changes over time and what might influence these changes. We have 
therefore considered background information such as the number of outings and 
activities, different therapies, and the time of year. How these life-satisfaction 
judgements are actually made has also been examined.
Through the research conducted to date we have found a way of measuring 
satisfaction with life, and are now looking to see if how if we can use this measure 
to detect improvement in levels of life satisfaction of individuals within the 
Hospital. In order to do this we will be considering the effect of time spent outside, 
and of time spent in one-to-one company, on life satisfaction. If you want to take 
part in this research, the investigator will be asking you to spend a short amount of 
time outside in the hospital grounds with her. You will also be spending a short 
amount of time on the ward together, and a short amount of time on the ward 
without this company. You will be asked to take part in one of these activities each 
time the investigator comes to see you, and she will ask you some questions about 
how you feel before and after each activity. The questions take about 3 minutes to 
complete, and address the following areas:
1. How you feel about your life at the time of each assessment
2. How happy you feel at the time of each assessment.
To complete the three activities, the investigator will be coming to see you three 
times. There will be about 3 days between each visit. If at any time during the 
interviews you feel tired or would like to stop, you can tell the investigator who 
will be happy to continue at a later date. You can, of course, withdraw firom the 
study at any point in time.
All appointments will be made for times most convenient to you and will not 
interfere with any therapy or social activities that you may be involved in.
If you require any further information, please contact 
Graham Beaumont or Rachel Murrell 
Department of Clinical Psychology 
0181 780 4500 (Ext. 5013/5128)
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3 x 2  repeated measures ANOVA summary tables
Factor 1: Experimental condition Factor 2: Test occasion
Appendix 5.8
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob
Between Groups 33464.08 23 1454.96
Within Groups 33143.66 120
Experimental condition 241.12 2 120.56 0.29 0.75
Residual 18751.54 46 407.64
Test occasion 1.00 1 1.00 0.00 0.93
Residual 3288.67 23 142.99
Experimental condition x test occasion (H) 1079.29 1.71 632.76 2.53 0.10
Residual 9782.04 46 212.65
Total 66607.74 143
B) QoL‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23 1998.09
Within Groups 8557.66 120
Experimental condition 87.79 2 43.89 0.41 0.66
Residual 4874.21 46 105.96
Test occasion 10.03 1 10.03 0.06 0.80
Residual 3585.63 23 155.89
Experimental condition X test occasion (H) 511.68 1.55 330.99 1.13 0.32
Residual 10409.65 46 226.29
Total 54513.66 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test of 
sphericity was significant.
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Appendix 5.8 (cont.l
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.08 23 1884.61
Within Groups 31631.66 120
Experimental condition 871.62 2 435.81 1.77 0.18
Residual 11346.04 46 246.65
Test occasion 348.44 1 348.44 0.85 0.36
Residual 9349.89 23 406.51
Experimental condition x test occasion 407.18 2 203.59 1.00 0.37
Residual 9308.49 46 202.35
Total 74977.74 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.27 23 2112.36
Within Groups 22969.17 120
Experimental condition (H) 1443.17 1.63 882.00 2.46 0.11
Residual 13474.50 46 292.92
Test occasion 45.56 1 45.56 0.35 0.55
Residual 2967.60 23 129.03
Experimental condition x test occasion (H) 45.56 1 45.56 0.35 0.55
Residual 4940.17 46 107.39
Total 71553.44 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test of 
sphericity was significant.
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3 x 2 x 2  mixed ANOVA summary table
Factor 1: Experimental condition Factor 2: Test occasion 
A) QoL ‘today’
Appendix 5.9
Factor 3: Life change
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
Life change 1510.01 1 1510.01 1.04 0.31
Within + Residual 31954.07 22 1452.45
Within Groups 33228.33 120
Experimental condition 174.39 2 87.19 0.21 0.81
Experimental condition x life change 262.05 2 131.03 0.31 0.73
Residual 18489.49 44 420.21
Test occasion 1.55 1 1.55 0.01 0.92
Test occasion x life change 1.25 1 1.25 0.01 0.92
Residual 3287.11 22 110.13
Experimental condition x test occasion (H) 1230.45 1.73 711.77 2.83 0.07
Experimental condition x test occasion
X life change 245.50 2 122.75 0.57 0.57
Residual 9536.54 44 216.74
Total 66692.41 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23
Life change 986.85 1 986.85 0.48 0.49
Within + Residual 44969.15 22 2044.05
Within Groups 19494.39 120
Experimental condition 89.92 2 44.96 0.41 0.66
Experimental condition x life change 153.07 2 76.53 0.71 0.11
Residual 4721.14 44 107.23
Test occasion 19.26 1 19.26 0.11 0.72
Test occasion x life change 28.01 1 28.01 0.17 0.68
Residual 3557.62 22 161.71
Experimental condition x test occasion (H) 515.72 1.59 323.72 1.10 0.33
Experimental condition x test occasion
X life change 120.81 2 60.40 0.25 0.77
Residual 10288.84 44 233.83
Total 45163.54 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Appendix 5.9 fcont.)
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.08 23
Life change 3634.81 1 3634.81 2.01 0.17
Within + Residual 39711.27 22 1805.05
Within Groups 31183.97 120
Experimental condition 813.95 2 406.97 1.57 0.21
Experimental condition x life change 7.71 2 3.91 0.01 0.99
Residual 11338.33 44 257.69
Test occasion 106.67 1 106.67 0.28 0.60
Test occasion x life change 960.00 1 960.00 2.51 0.13
Residual 8389.89 22 381.35
Experimental condition x test occasion 258.93 2 129.47 0.65 0.53
Experimental condition x test occasion
X life change 552.69 2 276.34 1.39 0.26
Residual 8755.80 44 198.99
Total 74530.05 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.26 23
Life change 335.27 1 335.27 0.15 0.70
Within + Residual 48248.99 22 2193.13
Within Groups 22568.31 120
Experimental condition (H) 1031.78 1.70 605.64 1.83 0.17
Experimental condition x life change 1071.33 2 535.67 1.90 0.16
Residual 12403.16 44 281.89
Test occasion 62.35 1 62.35 0.47 0.50
Test occasion x life change 29.63 1 29.63 0.22 0.64
Residual 2937.97 22 133.54
Experimental condition x test occasion (H) 91.93 1.48 62.13 0.43 0.59
Experimental condition x test occasion
X life change 217.49 2 108.74 1.01 0.37
Residual 4722.67 44 107.33
Total 71152.57 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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One-way unrelated ANOVA summary tables
Factor: QoL/Happiness cluster groups
Appendix 5.10
CONDITION A
Source of Sum of Mean F F
Variation squares df square ratio Prob.
QoL ‘today’ Between Groups 8240.42 1 8240.42 74.07 0.00
Within Groups 2447.41 22 111.25
Total 10687.83 23
QoL ‘generally’ Between Groups 6576.92 1 6576.92 36.67 0.00
Within Groups 3741.03 22 170.05
Total 10317.95 23
Happiness ‘today’ Between Groups 8632.35 1 8632.35 41.61 0.00
Within Groups 4564.60 22 207.48
Total 13196.95 23
Happiness ‘generally’ Between Groups 6921.87 1 6921.87 32.30 0.00
Within Groups 4713.95 22 214.27
Total 11635.83 23
CONDITION B
Source of Sum of Mean F F
Variation squares df square ratio Prob.
QoL ‘today’ Between Groups 6258.33 1 6258.33 19.47 0.00
Within Groups 7070.62 22 321.39
Total 13328.95 23
QoL ‘generally’ Between Groups 4073.67 1 4073.67 10.27 0.00
Within Groups 8719.95 22 396.36
Total 12793.62 23
Happiness ‘today’ Between Groups 9849.13 1 9849.13 36.93 0.00
Within Groups 5867.82 22 266.71
Total 15716.95 23
Happiness ‘generally’ Between Groups 4694.44 1 4694.44 13.31 0.00
Within Groups 7758.89 22 352.67
Total 12453.33 23
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Appendix 5.10 (cont.)
CONDITION C
Source of Sum of Mean F F
Variation squares df square ratio Prob.
QoL ‘today’ Between Groups 2850.47 1 2850.47 10.42 0.00
Within Groups 6017.15 22 273.51
Total 8867.62 23
QoL ‘generally’ Between Groups 6068.01 1 6068.01 27.31 0.00
Within Groups 4888.49 22 222.20
Total 10956.50 23
Happiness ‘today’ Between Groups 7353.13 1 7353.13 26.69 0.00
Within Groups 6061.82 22 275.53
Total 13414.95 23
Happiness ‘generally’ Between Groups 8624.01 1 8624.01 39.86 0.00
Within Groups 4759.82 22 216.35
Total 13383.83 23
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3 x 2  repeated measures ANCOVA summary tables
Appendix 5.11
Factor 1: Experimental condition Factor 2: Test occasion 
Covariate: Outside temperature
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
Temperature 1008.51 1 1008.51 0.68 0.41
Within + Residual 32455.57 22 1475.25
Within Groups 32806.81 120
Experimental condition 922.28 2 461.14 0.39 0.67
Experimental condition x temperature 968.20 2 484.10 0.44 0.65
Residual 17783.33 44 404.17
Test occasion 19.98 1 19.98 0.62 0.43
Test occasion x temperature 21.31 1 21.31 0.65 0.43
Residual 3267.35 22 148.51
Experimental condition x test occasion 111.63 2 55.81 0.12 0.86
Experimental condition x test occasion
X temperature 69.31 2 34.65 0.28 0.75
Residual 9712.73 44 220.74
Total 66270.89 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45955.99 23
Temperature 1539.17 1 1539.17 0.76 0.39
Within + Residual 44416.82 22 2018.95
Within Groups 18945.80 120
Experimental condition 57.55 2 28.77 0.26 0.77
Experimental condition x temperature 45.51 2 22.75 0.21 0.81
Residual 4828.69 44 109.74
Test occasion 3.70 1 3.70 0.02 0.88
Test occasion x temperature 2.46 1 2.46 0.01 0.90
Residual 3583.17 22 162.87
Experimental condition x test occasion (H) 15.06 1.62 9.28 0.03 0.95
Experimental condition x test occasion
X temperature 42.05 2 21.02 0.09 0.91
Residual 10367.61 44 235.63
Total 64901.79 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Appendix 5.11 (cont.)
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.27 23
Temperature 176.50 1 176.50 0.08 0.78
Within + Residual 48407.77 22 2200.35
Within Groups 22794.75 120
Experimental condition 973.87 2 486.93 1.75 0.19
Experimental condition x temperature 1255.99 2 627.99 2.26 0.11
Residual 12218.51 44 277.69
Test occasion 2.45 1 2.45 0.01 0.89
Test occasion x temperature 5.58 1 5.58 0.04 0.84
Residual 2962.02 22 134.63
Experimental condition x test occasion 436.17 2 218.08 2.12 0.13
Experimental condition x test occasion
X temperature 419.57 2 209.79 2.04 0.14
Residual 4520.59 44 102.74
Total 71379.02 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.27 23
Temperature 176.50 1 176.50 0.08 0.78
Within + Residual 48407.77 22 2200.35
Within Groups 22794.75 120
Experimental condition 973.87 2 486.93 1.75 0.19
Experimental condition x temperature 1255.99 2 627.99 2.26 0.11
Residual 12218.51 44 277.69
Test occasion 2.45 1 2.45 0.01 0.89
Test occasion x temperature 5.58 1 5.58 0.04 0.84
Residual 2962.02 22 134.63
Experimental condition x test occasion (H) 436.17 1.57 276.24 2.12 0.14
Experimental condition x test occasion
X temperature 419.57 2 209.79 2.04 0.14
Residual 4520.59 44 102.74
Total 71379.02 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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One-way unrelated ANOVA summary tables
Factor: Cognitive cluster groups
Appendix 5.12
1. Autobiographical Incidents Scale (AIS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 1265.92 2 632.77 100.45 0.00
Within Groups 132.29 21 6.29
Total 1397.83 23
2. Pyramids and Palm Trees
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 65.53 2 32.77 11.20 0.00
Within Groups 61.43 21 2.92
Total 1397.83 23
3. Similarities (WAIS-R)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 
Within Groups 
Total
192.69
137.30
330.00
2
21
23
96.35
6.53
11.73 0.00
4. Personal Semantic Scale (PS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 4357.92 2 2178.96 19.66 0.00
Within Groups 2327.31 21 110.45
Total 6685.24 23
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One-way unrelated ANOVA summary tables
Factor: Cognitiye cluster groups (2)
Appendix 5.13
1. Autobiographical Incidents Scale (AIS) 
Source of Variation
Between Groups 
Within Groups 
Total
2. Pyramids and Palm Trees 
Source of Variation
Between Groups 
Within Groups 
Total
Sum of Mean F F
squares df square ratio Prob.
975.85 2 487.92 89.63 0.00
103.43 19 5.44
1079.27 21
Sum of Mean F F
squares df square ratio Prob.
34.13 2 17.07 6.52 0.00
49.68 19 2.61
83.81 21
3. Similarities (WAIS-R)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 107.39 2 53.69 6.23 0.00
Within Groups 163.56 19 8.61
Total 270.95 21
4. Personal Semantic Scale (PS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 2746.71 2 1373.35 11.94 0.00
Within Groups 2184.87 19 114.99
Total 4931.59 21
526
3 x 3 x 2  mixed ANOVA summary tables
Appendix 5.14
Factor 1: Experimental condition Factor 2; General cognitive functioning 
Factor 3: Test occasion
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
Cognitive functioning 8002.85 2 4001.42 3.30 0.06
Within + Residual 25461.23 21 1212.44
Within Groups 33305.59 120
Experimental condition 290.18 2 145.09 0.34 0.71
Experimental condition x cognitive
functioning 811.74 4 202.93 0.47 0.75
Residual 17939.80 42 427.13
Test occasion 11.54 1 11.54 0.09 0.76
Test occasion x cognitive functioning 656.43 2 328.21 2.61 0.09
Residual 2632.23 21 125.34
Experimental condition x test occasion (H) 1181.63 1.85 637.18 2.72 0.08
Experimental condition x test occasion
X cognitive functioning 683.17 4 170.79
Residual 9098.87 42 216.64
Total 66769.67 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23
Cognitive functioning 3609.28 2 1804.64 0.89 0.42
Within + Residual 42346.72 21 2016.51
Within Groups 19571.46 120
Experimental condition 77.99 2 38.99 0.39 0.67
Experimental condition x cognitive
functioning 695.79 4 173.95 1.75 0.15
Residual 4178.42 42 99.49
Test occasion 0.21 1 0.21 0.00 0.97
Test occasion x cognitive functioning 817.43 2 408.71 3.10 0.07
Residual 2768.21 21 131.82
Experimental condition x test occasion (H) 623.76 1.75 356.07 1.35 0.27
Experimental condition x test occasion
X cognitive functioning 732.11 4 183.03
Residual 9677.54 42 230.41
Total 65527.46 143
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Appendix 5.14 (cont.)
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
Cognitive functioning 3883.27 2 4141.63 1.03 0.37
Within + Residual 39462.81 21 1879.18
Within Groups 33903.70 120
Experimental condition 1036.40 2 518.20 2.08 0.13
Experimental condition x cognitive
Functioning 900.32 4 225.08 0.91 0.47
Residual 12445.71 42 248.71
Test occasion 426.87 1 426.87 1.08 0.31
Test occasion x cognitive functioning 1072.02 2 536.01 1.36 0.27
Residual 8277.87 21 394.18
Experimental condition x test occasion 436.03 2 218.01 1.07 0.35
Experimental condition x test occasion
X cognitive functioning 703.21 4 175.81 0.85 0.49
Residual 8605.27 42 204.89
Total 67367.78 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob
Between Groups 48584.27 23
Cognitive functioning 5435.40 2 2717.70 1.32 0.29
Within + Residual 43148.87 21 2054.71
Within Groups 21143.34 120
Experimental condition (H) 1732.35 1.69 1023.55 3.21 0.06
Experimental condition x cognitive
functioning 2150.68 4 535.17 0.47 0.75
Residual 11333.81 42 269.85
Test occasion 61.71 1 61.71 0.09 0.76
Test occasion x cognitive functioning 300.07 2 150.03 2.61 0.09
Residual 2667.53 21 127.03
Experimental condition x test occasion (H) 107.71 1.65 65.71 0.49 0.61
Experimental condition x test occasion
X cognitive functioning 336.77 4 84.19
Residual 4603.39 42 109.60
Total 69727.61 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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3 x 2  repeated measures ANCOVA summary tables
Appendix 5.15
Factor 1: Experimental condition Factor 2: Test occasion 
Covariate; Autobiographical memory (AIS)
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 8336.68 23
AIS 7140.14 1 7140.14 5.97 0.02
Within + Residual 26323.94 22 1196.54
Within Groups 33565.16 120
Experimental condition 352.01 2 176.01 0.41 0.66
Experimental condition x AIS 158.36 2 79.18 0.19 0.83
Residual 18593.18 44 422.57
Test occasion 402.40 1 402.40 3.21 0.09
Test occasion x AIS 533.35 1 533.35 4.25 0.05
Residual 2755.31 22 125.24
Experimental condition x test occasion (H) 988.51 1.77 557.97 2.29 0.12
Experimental condition x test occasion x AIS 271.21 2 135.61 0.63 0.53
Residual 9510.83 44 216.15
Total 41901.84 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23
AIS 2329.37 1 2329.37 1.17 0.29
Within + Residual 43626.63 22 1983.03
Within Groups 20411.52 120
Experimental condition 301.11 2 150.55 1.49 0.23
Experimental condition x AIS 415.75 2 207.87 2.05 0.14
Residual 4458.45 44 101.33
Test occasion 239.03 1 239.03 1.65 0.21
Test occasion x AIS 411.53 1 411.53 2.85 0.11
Residual 3174.10 22 144.27
Experimental condition x test occasion (H) 1001.90 1.65 603.79 2.25 0.13
Experimental condition x test occasion x AIS 610.07 2 305.03 1.37 0.27
Residual 9799.58 44 222.71
Total 66367.52 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Appendix 5.15 (cont.)
C) Happiness ‘today’ 
Source of Variation
Between Groups
AIS
Within + Residual
Sum of 
squares
43346.08
2969.49
40376.59
df
23
1
22
Mean
square
2969.49
1835.30
F F  
ratio Prob.
1.61 0.21
Within Groups 32419.15 120
Experimental condition 1090.57 2 545.28 2.19 0.12
Experimental condition x AIS 417.09 2 208.55 0.84 0.43
Residual 10928.94 44 248.39
Test occasion 1034.20 1 1034.20 2.63 0.11
Test occasion x AIS 688.87 1 688.87 1.75 0.19
Residual 8661.01 22 393.68
Experimental condition x test occasion 289.99 2 144.99 0.69 0.51
Experimental condition x test occasion x AIS 92.95 2 46.47 0.22 0.80
Residual 9215.53 44 209.44
Total 75765.23 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.57 23
AIS 3947.94 1 3947.94 3.95 0.17
Within + Residual 44636.63 22 2028.92
Within Groups 23842.53 120
Experimental condition (H) 2256.39 1.71 1318.23 3.99 0.03
Experimental condition x AIS 1044.19 2 522.09 1.85 0.17
Residual 12430.31 44 282.51
Test occasion 73.43 1 73.43 0.55 0.47
Test occasion x AIS 34.47 1 34.47 0.25 0.61
Residual 2933.13 22 133.32
Experimental condition x test occasion (H) 130.45 1.55 83.95 0.59 0.51
Experimental condition x test occasion x AIS 85.64 2 42.81 0.38 0.68
Residual 4854.52 44 110.33
Total 72427.10 143
(H) -  The Huynh-Feldt Epilson procedure was employed to adjust the df  as Mauchly’s test
of sphericity was significant.
530
3 x 2  repeated measures ANCOVA summary tables
Appendix 5.16
Factor 1: Experimental condition Factor 2: Test occasion 
Covariate: Autobiographical memory (PS)
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
PS 3410.19 1 3410.19 2.49 0.12
Within + Residual 30053.89 22 1366.09
Within Groups 34735.40 120
Experimental condition 493.79 2 246.89 0.59 0.55
Experimental condition x PS 324.94 2 162.47 0.39 0.68
Residual 18426.59 44 418.79
Test occasion 416.46 1 416.46 3.25 0.09
Test occasion x PS 468.12 1 468.12 4.65 0.07
Residual 2820.54 22 128.21
Experimental condition x test occasion 2002.93 2 1001.47 5.17 0.01
Experimental condition x test occasion x PS 1272.59 2 636.29 3.29 0.04
Residual 8509.44 44 193.39
Total 68199.48 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23
PS 82.15 1 82.15 0.03 0.84
Within + Residual 45873.85 22 2085.17
Within Groups 22241.46 120
Experimental condition 612.32 2 612.32 3.21 0.06
Experimental condition x PS 688.01 2 688.01 3.61 0.03
Residual 4186.19 44 95.14
Test occasion 574.03 1 574.03 4.43 0.05
Test occasion x PS 738.47 1 738.47 5.71 0.03
Residual 2845.16 22 129.41
Experimental condition x test occasion (H) 2187.64 1.75 1246.78 5.57 0.05
Experimental condition x test occasion x PS 1774.79 2 887.39 4.52 0.16
Residual 8634.85 44 196.25
Total 68197.46 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Appendix 5.16 (cont.)
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.08 23
PS 61.48 1 61.48 0.03 0.86
Within + Residual 43284.60 22 1967.48
Within Groups 32685.55 120
Experimental condition 1257.45 2 628.72 2.59 0.09
Experimental condition x PS 692.49 2 346.24 1.43 0.25
Residual 10653.55 44 242.13
Test occasion 704.19 1 704.19 1.73 0.20
Test occasion x PS 442.67 1 442.67 1.09 0.31
Residual 8907.21 22 404.87
Experimental condition x test occasion 19.51 2 9.75 0.46 0.95
Experimental condition x test occasion x PS 25.76 2 12.88 0.06 0.94
Residual 9982.72 44 210.97
Total 76031.63 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.26 23
PS 23.81 1 23.81 0.01 0.91
Within + Residual 48560.45 22 2207.29
Within Groups 23478.71 120
Experimental condition (H) 1807.30 1.64 1100.44 3.18 0.06
Experimental condition x PS 979.99 2 489.99 1.73 0.19
Residual 12494.51 44 283.97
Test occasion 12.69 1 12.69 0.09 0.76
Test occasion x PS 1.19 1 1.19 0.00 0.92
Residual 2966.41 22 2966.41
Experimental condition x test occasion (H) 276.46 1.57 176.11 1.29 0.28
Experimental condition x test occasion x PS 241.84 2 120.92 1.13 0.33
Residual 4698.32 44 106.78
Total 72062.97 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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3 x 2  repeated measures ANCOVA summary tables
Appendix 5.17
Factor 1; Experimental condition Factor 2: Test occasion 
Covariate: Immediate memory (DS)
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob
Between Groups 33464.08 23
DS 9491.18 1 9491.18 8.71 0.00
Within + Residual 23972.90 22 1089.67
Within Groups 33266.93 120
Experimental condition 804.91 2 402.45 0.97 0.38
Experimental condition x DS 628.05 2 314.03 0.76 0.47
Residual 18123.49 44 411.89
Test occasion 353.42 1 353.42 2.69 0.11
Test occasion x DS 401.38 1 401.38 3.05 0.09
Residual 2887.29 22 131.24
Experimental condition x test occasion (H) 286.35 1.79 160.31 0.64 0.51
Experimental condition x test occasion x DS 19.18 2 9.59 0.04 0.95
Residual 9762.86 44 221.88
Total 66731.01 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45955.99 23
DS 8131.71 1 8131.71 4.73 0.04
Within + Residual 37824.28 22 1719.29
Within Groups 19923.39 120
Experimental condition 71.12 2 35.56 0.33 0.72
Experimental condition x DS 143.18 2 71.59 0.66 0.51
Residual 4731.03 44 107.52
Test occasion 156.89 1 156.89 1.03 0.32
Test occasion x DS 224.91 1 224.91 1.47 0.23
Residual 3360.73 22 152.76
Experimental condition x test occasion (H) 825.89 1.65 501.55 1.83 0.18
Experimental condition x test occasion x DS 477.93 2 238.97 1.05 0.35
Residual 9931.71 44 225.72
Total 65879.38 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.07 23
DS 8501.16 1 8501.16 5.36 0.03
Within + Residual 34844.91 22 1583.86
Within Groups 33100.13 120
Experimental condition 1082.02 2 541.01 2.20 0.12
Experimental condition x DS 547.22 2 273.61 0.39 0.68
Residual 10798.82 44 245.43
Test occasion 1192.47 1 1192.47 3.25 0.09
Test occasion X DS 873.91 1 873.91 4.65 0.07
Residual 8475.97 22 385.27
Experimental condition x test occasion 821.24 2 410.62 2.09 0.13
Experimental condition x test occasion x DS 659.83 2 329.91 3.29 0.04
Residual 8648.65 44 196.56
Total 76446.20 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.26 23
DS 12148.65 1 2148.65 2.49 0.12
Within + Residual 36435.61 22 1656.16
Within Groups 23848.80 120
Experimental condition (H) 2251.87 1.78 1264.63 4.05 0.02
Experimental condition x DS 1259.68 2 629.84 2.27 0.11
Residual 12214.81 44 277.61
Test occasion 175.49 1 175.49 1.36 0.25
Test occasion x DS 132.65 1 132.65 1.03 0.32
Residual 2834.95 22 128.86
Experimental condition x test occasion (H) 39.19 2 25.53 0.17 0.77
Experimental condition x test occasion x DS 117.16 2 58.58 0.53 0.59
Residual 4823.00 44 109.61
Total 72433.06 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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3 x 2 x 2  mixed ANOVA summary tables
Appendix 5.18
Factor 1: Experimental condition Factor 2: Test occasion 
Factor 3: The importance attributed to time spent outside
A) QoL ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 33464.08 23
Importance 647.15 1 647.15 0.43 0.51
Within + Residual 32816.93 22 1491.67
Within Groups 33219.29 120
Experimental condition 443.92 2 221.96 0.61 0.55
Experimental condition X importance 2706.56 2 1353.28 3.71 0.32
Residual 16044.98 44 364.65
Test occasion 0.57 1 0.57 0.00 0.95
Test occasion x importance 1.83 1 1.83 0.01 0.91
Residual 3286.83 22 149.40
Experimental condition X test occasion (H) 952.57 1.78 533.89 2.16 0.13
Experimental condition x test occasion
X importance 84.82 2 42.41 0.19 0.82
Residual 9697.21 44 220.39
Total 66683.37 143
B) QoL ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 45956.00 23
Importance 3206.43 1 3206.43 1.65 0.21
Within + Residual 42749.57 22 1943.16
Within Groups 19518.83 120
Experimental condition 41.81 2 20.91 0.20 0.81
Experimental condition x importance 279.36 2 139.68 1.33 0.27
Residual 4594.84 44 104.43
Test occasion 22.67 1 22.67 0.14 0.71
Test occasion x importance 401.38 1 401.38 0.61 0.44
Residual 3488.97 22 158.59
Experimental condition x test occasion (H) 354.39 1.65 213.63 0.79 0.45
Experimental condition x test occasion
X importance 572.55 2 286.27 1.28 0.29
Residual 9762.86 44 221.88
Total 65474.83 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Appendix 5.18 (cont.)
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.08 23
Importance 900.17 1 900.17 0.47 0.50
Within + Residual 42445.91 22 1929.35
Within Groups 30784.54 120
Experimental condition 895.31 2 447.65 1.77 0.18
Experimental condition x
importance 267.95 2 133.97 0.53 0.59
Residual 11078.09 44 251.77
Test occasion 336.35 1 336.35 0.79 0.38
Test occasion x importance 0.15 1 0.15 0.00 0.99
Residual 9349.73 22 424.99
Experimental condition x test occasion 443.79 2 221.89 1.14 0.32
Experimental condition x test occasion
X importance 741.65 2 370.82 1.90 0.16
Residual 8566.83 44 194.70
Total 74130.62 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.27 23
Importance 1810.80 1 1810.80 0.85 0.37
Within + Residual 46773.47 22 2126.07
Within Groups 22742.24 120
Experimental condition (H) 1229.92 1.72 713.63 2.07 0.15
Experimental condition x importance 418.56 2 209.19 0.71 0.50
Residual 13056.12 44 296.70
Test occasion 39.29 1 39.29 0.29 0.59
Test occasion x importance 5.40 1 5.40 0.04 0.84
Residual 2962.20 22 134.65
Experimental condition x test occasion (H) 90.59 1.55 58.57 0.41 0.84
Experimental condition x test occasion
X importance 9.31 2 4.67 0.04 0.93
Residual 4930.85 44 112.07
Total 71326.51 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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3 x 2  repeated measures ANCOVA summary tables
Factor 1: Experimental condition Factor 2: Test occasion 
Covariate: Frequency of time generally spent outside
A) QoL ‘today’
Appendix 5.19
Source of Variation
Between Groups
Frequency of time...
Within + Residual
Within Groups
Experimental condition 
Experimental condition x frequency of time... 261.01 
Residual 
Test occasion
Test occasion x frequency of time...
Residual
Experimental condition x test occasion 
Experimental condition x test occasion 
X frequency of time...
Residual 
Total
B) QoL ‘generally’
Source of Variation
Between Groups
Frequency of time...
Within + Residual
Within Groups
Experimental condition
Experimental condition x frequency of time.
Residual
Test occasion
Test occasion x frequency of time... 
Residual
Experimental condition x test occasion (H) 
Experimental condition x test occasion 
X frequency of time
Residual
Total
Sum of Mean F F
squares df square ratio Prob.
33464.00 23
470.00 1 470.00 0.31 0.58
32994.08 22 1499.73
33082.80 120
395.65 2 197.83 0.47 0.63
. 2 130.51 3.11 0.73
18490.53 44 420.23
233.81 1 233.81 1.62 0.21
260.09 1 260.09 1.89 0.18
3028.58 22 137.66
631.09 2 315.54 1.45 0.25
192.01 2 96.00 0.44 0.65
9590.03 44 217.95
66546.80 143
Sum of Mean F F
squares df square ratio Prob.
45956.00 23
4347.69 1 4337.69 2.29 0.14
41608.31 22 1891.29
20843.42 120
699.04 2 349.52 3.83 0.03
.. 858.87 2 429.43 4.71 0.01
4015.33 44 91.25
163.78 1 163.78 1.07 0.31
247.61 1 247.61 1.63 0.21
3338.03 22 151.73
1111.11 1.66 667.57 2.53 0.10
771.94 2 385.97 1.76 0.18
9637.71 44 219.03
66799.42 143
(H) = The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
537
Appendix 5.19 (cont.l
C) Happiness ‘today’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 43346.08 23
Frequency of time... 3497.61 1 3497.61 1.93 0.17
Within + Residual 39848.47 22 1811.29
Within Groups 31842.74 120
Experimental condition 1025.25 2 512.63 2.11 0.13
Experimental condition x frequency of time... 655.03 2 327.51 1.35 0.27
Residual 10691.01 44 251.15
Test occasion 710.79 1 710.79 1.75 0.19
Test occasion x fi*equency of time... 424.22 1 424.22 1.05 0.31
Residual 8925.67 22 405.71
Experimental condition x test occasion 102.29 2 51.14 0.24 0.79
Experimental condition x test occasion
X fi-equency of time... 28.65 2 14.33 0.07 0.93
Residual 9279.83 44 210.91
Total 75188.82 143
D) Happiness ‘generally’
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups 48584.27 23
Frequency of time... 5666.96 1 5666.96 2.91 0.10
Within + Residual 42917.31 22 1950.79
Within Groups 22671.91 120
Experimental condition (H) 1226.15 1.74 703.91 2.07 0.15
Experimental condition x frequency of time. .. 448.51 2 224.25 0.75 0.47
Residual 13025.98 44 296.05
Test occasion 12.79 1 12.27 0.09 0.77
Test occasion x firequency of time... 0.40 1 0.40 0.00 0.95
Residual 2967.20 22 134.87
Experimental condition x test occasion (H) 250.75 1.57 160.21 1.17 0.31
Experimental condition x test occasion
X fi-equency of time... 218.83 2 109.41 1.02 0.37
Residual 4721.33 44 107.30
Total 71456.21 143
(H) -  The Huynh-Feldt Epilson procedure was employed to adjust the df, as Mauchly’s test
of sphericity was significant.
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Life satisfaction visual analogue scale Appendix 6.1
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Appendix 6.2
Identity Niimber:_ 
Date: /____ /
Time: 1 / 2 / 3 / 4 .
U.K. Field Trial Version 
December 1996.
PROGRAM M E ON M EN TA L H E A L T H  
WORT.D HF.ATTH ORGANISATION  
GENEVA
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Appendix 6.2 (cont.)
Very poor Poor Neither 
poor nor 
good
Good Very good
1 How would you rate your quality of life? 1 2 3 4 5
Very
Dissatisfied Dissatisfied
Neither 
Satisfied nor 
Dissatisfied
Satisfied
Very
Satisfied
2 How satisfied are you with your health? I 2 3 4 5
The following questions ask about how much you have experienced certain things in the last two weeks.
Not at all A little A moderate 
amount
Very much An extreme 
amount
3 How much do you feel that pain prevents 
you from doing what you need to do? 1 2 3 4 5
4 How much do you need medical 
treatment to function in your daily life?
1 2 3 4 5
5 How much do you enjoy life? 1 2 3 4 D
Not at all A little A moderate 
amount
Very much Extremely
6 To what extent do you feel life to be 
meaningful?
1 2 3 4 5
7 How well are you able to concentrate? 1 2 3 4 5
8 How safe do you feel in your daily life? 1 2 3 4 5
9 How healthy is your physical 
enviroiunent?
1 2 3 4 5
The following questions ask about how completely you experience or were able to do certain things in the last two 
weeks.
Not at all A little Moderately Mostly Completely
10 Do you have enough energy for everyday 
life?
1 2 3 4 5
11 Are you able to accept your bodily 
appearance?
1 2 3 4 5
12 To what extent do you have enough money 
to meet your needs?
1 2 3 4 5
13 How available to you is the information that 
you need in your day-to-day life?
1 2 3 4 5
14 To what extent do you have the opportunity 
for leisure activities?
1 2 3 4 5
The following questions ask you to say how good or satisfied you have felt about various aspects of your life over tl 
last two weeks.
Very poor Poor Neither poor' 
nor eood
Good Very gooc
How well are you able to get around? 1 2 3 4 5
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Appendix 6.2 (conU
Very
dissatisfied
Dissatisfied Neither 
satisfied nor 
dissatisfied
Satisfied Very
satisfiec
16 How. satisfied are you with your sleep? 1 2 3 4 5
17 How satisfied are you with your ability 
to perform daily living activities?
1 2 3 4 5
18 How satisfied are you with your capacity 
for work?
1 2 3 4 5
19 How satisfied are you with yourself? 1 2 3 4 5
20 How satisfied are you with your personal 
relationships?
1 2 3 4 5
21 How satisfied are you with your sex hfe? 1 2 3 4 5
22 How satisfied are you with the support 
you get from your friends?
2 3 4 5
23 How satisfied are you with the conditions 
o f your hving place?
2 3 4 5
24 How satisfied are you with your access 
to health services?
1 2 3 4 5
25 How satisfied are you with your 
transport?
1 2 3 4 5
The following question refers to how often you have felt or experienced certain things in the last two weeks.
Never Seldom Quite often Very often Alway:
26
How often do you have negative feelings, 
such as blue mood, despair, anxiety, 
depression?
I 2 3 4 5
Did someone help you to fill out this form? YES / NO  
How long did it take to fill this form out?.................................
Do you have any comments about the questionnaire'
THANK YOU FOR YOUR HELP.
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Appendix 6.3
PARTICIPANT INFORMATION SHEET 
RESEARCH INTO QUALITY OF LIFE IN PERSONS WITH 
SEVERE NEUROLOGICAL DISABILITY
Since the Spring of 1996, research carried out at the Royal Hospital for Neuro­
disability has been trying to find a way of measuring how satisfied patients are with 
their quality of life. We have also been assessing whether residents are satisfied 
with their level of functioning in the areas of life that are most important to them, 
how quality of life perceptions change over time and what might influence these 
changes. We are now in the final stages of research, with one last study to conduct. 
This study will consider the feasibility of using a newly developed measure of 
quality of life, the WHOQOL-BREF, with residents within the hospital. It is 
possible that this study will also assist in further development of this measure. The 
study will also continue to investigate the factors that influence patient quality of 
life perceptions.
If willing to take part in this study, residents will be asked to complete four 
assessment sessions. The first involves a memory test, which may take up to 45 
minutes. This session can be broken down into two shorter assessment sessions as 
required. Two quality of life measures will then be administered on two separate 
occasions (sessions 2 and 3), and individuals will also be asked to complete 2 
questionnaires (session 4). These scales generally take no longer than 15 minutes to 
complete. It is anticipated that there will be a 4-7 day period between assessment 
sessions. The measures used in sessions 2-4 address the following areas:
1. How happy patients feel at the time of each assessment.
2. How satisfied patients are with their quality of life, both generally and on 
the day of each assessment.
3. How individuals arrive at judgements concerning their quality of life
The study will be explained to each resident by personal explanation. Before each 
test commences, each participant will be made aware of the following points:
1. If the participant feels tired or has had enough at any stage of the assessments, 
they can stop and the interviewer will be happy to continue the assessment at a 
later date.
2. The participant will be able to withdraw from the study at any time and without 
a reason for doing so.
3. The study may not be of direct benefit to the participant.
4. There will be no risks involved,
5. Confidentiality will be maintained, so that anything the participant says to the 
investigator throughout the period of assessment will not be told to anyone else.
All appointments will be made for times most convenient to the individual and will 
not interfere with any therapy or social activities that they may be involved in, 
unless agreed by all relevant parties before assessment takes place.
If you require any further information, please contact:
Graham Beaumont or Rachel Murrell, Department of Clinical Psychology 
0181 780 4500 (Ext. 5013/5128) OR 0181 392 3000 Ext. 4602
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CONSENT FORM 
ROYAL HOSPITAL FOR NEURO-DISABILITY
West Hill, Putney
RESEARCH INTO QUALITY OF LIFE IN INDIVIDUALS WITH 
SEVERE NEUROLOGICAL DISABILITY
Investigator: Ms Rachel Murrell, Postgraduate Student.
Roehampton Institute London.
Under the supervision of Professor J.G. Beaumont, Chartered Clinical 
Psychologist, Head of Department of Psychology, Royal Hospital.
Aim of the studv
The purpose of this study is to establish whether a newly developed quality of life 
measure is suitable to use with individuals here at the Royal Hospital for 
Neuro-disability. The present research also aims to establish how individuals make 
judgements about their quality of life. This research builds upon previous research 
conducted by the investigator at the Royal Hospital for Nuero-disability.
What vou will be asked to do
You will be asked to complete four questionnaires, across a 2-3 week period (one 
every 4-7 days). I will firstly be asking you questions about your own life, to see 
what aspects you remember best. I will also be asking you questions relating to 
how satisfied you are with your life at the moment and how you have been feeling 
lately. If you are unsure about any of the questions, you may ask and I will try to 
explain.
Each session should take up no more than 25 minutes of your time. If during any 
stage of the assessments you feel tired or have had enough and would like to take a 
break, please tell the investigator who will be happy to continue at a later date.
I..............................................................of.............................................................
agree to take part in the study. I understand what I have been asked to do which 
has been explained to me. I understand that I can withdraw from the study at any 
time and without a reason for doing so. I realise that the study may not be of direct 
benefit to me. I have been told that there are no risks involved and that 
confidentiality will be maintained, so that anything I say to the investigator 
throughout the period of assessment will not be told to anyone else.
Signed.......................................................................... (Participant/W ard Sister)
Signed........................................................................... (Investigator)
Date..................................................................
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2 x 2  unrelated ANOVA summary table Appendix 6.5
Factor 1: Duration of illness 
Factor 2: Extent of disability
WHOQOL-BREF Physical
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Duration of illness 125.39 1 125.39 0.55 0.47
Extent of disability 74.77 1 74.77 0.32 0.57
Duration of illness x Extent
of disability 5.61 1 5.61 0.02 0.87
Within + Residual 4547.13 20 227.35
Corrected Model 176.73 3 58.91 0.25 0.85
Corected Total 4723.87 23
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2 x 2  mixed ANCOVA summary tables
Factor 1 : Duration of illness Factor 2: Extent of disability
Appendix 6.6
WHOQOL-BREF Physical 
Covariate (1): Years since admission
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Years since admission 210.36 1 210.36 0.92 0.35
Duration of illness 17.42 1 17.42 0.07 0.78
Extent of disability 89.25 1 89.25 0.39 0.53
Duration of illness x Extent
of disability 17.37 1 17.37 0.07 0.79
Within + Residual 4336.77 19 228.25
Corrected Model 387.09 4 96.77 0.42 0.79
Corrected Total 4723.87 23
Coyariate (2): Autobiographical memory (AIS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
AIS 705.51 1 705.51 3.49 0.07
Duration of illness 12.71 1 12.71 0.06 0.81
Extent of disability 79.84 1 79.84 0.39 0.53
Duration of illness x Extent
of disability 8.07 1 8.07 0.04 0.84
Within + Residual 3841.62 19 202.19
Corrected Model 882.24 4 220.56 1.09 0.39
Corrected Total 4723.87 23
Coyariate (3): Autobiographical memory (PS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
PS 129.53 1 129.53 0.55 0.47
Duration of illness 218.83 1 218.83 0.94 0.34
Extent of disability 62.67 1 62.67 0.27 0.61
Duration of illness x Extent
of disability 25.03 1 25.03 0.11 0.75
Within + Residual 4417.61 19 232.51
Corrected Model 306.25 4 76.56 0.33 0.85
Corrected Total 4723.87 23
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Appendix 6.6 (cont.)
WHOQOL-BREF Physical 
Coyariate (4): Immediate memory
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Immediate memory 205.59 1 205.59 0.90 0.35
Duration of illness 12.31 1 12.31 0.05 0.81
Extent of disability 77.30 1 77.30 0.33 0.57
Duration of illness x Extent
of disability 4.29 1 4.29 0.01 0.89
Within + Residual 4341.55 19 228.50
Corrected Model 382.31 4 95.57 0.41 0.79
Corrected Total 4723.87 23
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Factor: Autobiographical memory (AIS)
Source of Variation Sum of Mean
Between Groups
squares df square
SEIQoL-DW 21.81 1 21.81
QoL ‘today’ 16.90 1 16.90
QoL ‘generally’ 429.05 1 429.05
Environment (W) 531.53 1 531.53
Physical (W) 591.61 1 591.61
Psychological (W) 0.00 1 0.00
Social Relationships (W) 64.07 1 64.07
QoL ‘today’ (2) 980.10 1 980.10
QoL ‘generally’ (2) 110.00 1 110.00
Life Satisfaction (3) 410.67 1 410.67
QoL ‘generally’ (3) 389.58 1 389.58
Within + Residual
SEIQoL-DW 12145.59 22 552.07
QoL ‘today’ 9902.93 22 450.13
QoL ‘generally’ 11510.93 22 523.22
Environment (W) 8918.09 22 405.37
Physical (W) 4132.25 22 187.83
Psychological (W) 8633.11 22 392.41
Social Relationships (W) 8501.24 22 386.42
QoL ‘today’ (2) 9489.73 22 431.35
QoL ‘generally’ (2) 13402.62 22 609.21
Life Satisfaction (3) 9001.82 22 409.17
QoL ‘generally’ (3) 12161.15 22 552.78
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.95 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
Appendix 6.7
F
ratio
0.04
0.03
0.82
1.31
3.15
0.00
0.17
2.27
0.18
1.00
0.71
F
Prob.
0.84
0.85
0.37
0.26
0.09
1.00
0.69
0.15
0.67
0.33
0.41
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Univariate ANOVA summary tables
Factor: Autobiographical memory (PS)
Source of Variation Sum of Mean
squares df square
Between Groups
SEIQoL-DW 720.23 1 720.23
QoL ‘today’ 162.15 1 162.15
QoL ‘generally’ 1.23 1 1.23
Environment (W) 9.33 1 9.33
Physical (W) 2.39 1 2.39
Psychological (W) 272.14 1 272.14
Social Relationships (W) 20.40 1 20.40
QoL ‘today’ (2) 393.43 1 393.43
QoL ‘generally’ (2) 14.75 1 14.75
Life Satisfaction (3) 93.83 1 93.83
QoL ‘generally’ (3) 220.79 1 220.79
Within + Residual
SEIQoL-DW 11447.17 22 520.33
QoL ‘today’ 9757.67 22 443.53
QoL ‘generally’ 11938.73 22 542.67
Environment (W) 9940.29 22 429.10
Physical (W) 4721.47 22 214.61
Psychological (W) 8360.96 22 380.04
Social Relationships (W) 8544.91 22 388.41
QoL ‘today’ (2) 10076.41 22 458.01
QoL ‘generally’ (2) 13497.87 22 613.54
Life Satisfaction (3) 9318.65 22 423.57
QoL ‘generally’ (3) 12329.94 22 560.45
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.95 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
Appendix 6.8
F
ratio
1.38
0.37
0.00
0.02
0.01
0.71
0.05
0.85
0.02
0.22
0.39
F
Prob.
0.25
0.55
0.96
0.88
0.91
0.41
0.82
0.36
0.87
0.64
0.53
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Appendix 6.9
Univariate ANOVA summary tables (‘No life change’ cases only)
Factor: Autobiographical memory (AIS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 100.29 1 100.29 0.14 0.71
QoL ‘today’ 3.43 1 3.43 0.00 0.93
QoL ‘generally’ 773.43 1 773.43 1.28 0.27
Environment (W) 197.95 1 197.95 0.37 0.55
Physical (W) 648.09 1 648.09 2.62 0.13
Psychological (W) 5.21 1 5.21 0.01 0.91
Social Relationships (W) 1.27 1 1.27 0.00 0.96
QoL ‘today’ (2) 410.70 1 410.70 0.85 0.36
QoL ‘generally’ (2) 28.03 1 28.03 0.03 0.85
Life Satisfaction (3) 43.65 1 43.65 0.15 0.70
QoL ‘generally’ (3) 109.37 1 109.37 0.23 0.63
Within + Residual
SEIQoL-DW 10038.63 13 717.04
QoL ‘today’ 6744.00 13 481.71
QoL ‘generally’ 8436.00 13 602.57
Environment (W) 6856.41 13 527.41
Physical (W) 3212.35 13 247.10
Psychological (W) 6148.79 13 472.98
Social Relationships (W) 6504.63 13 500.35
QoL ‘today’ (2) 6302.90 13 484.83
QoL ‘generally’ (2) 9727.70 13 748.29
Life Satisfaction (3) 4288.22 13 285.88
QoL ‘generally’ (3) 7195.72 13 479.71
Corrected Total
SEIQoL-DW 10138.93 14
QoL ‘today’ 6747.43 14
QoL ‘generally’ 9209.43 14
Environment (W) 7054.36 14
Physical (W) 3860.45 14
Psychological (W) 6153.99 14
Social Relationships (W) 6505.91 14
QoL ‘today’ (2) 6713.60 14
QoL ‘generally’ (2) 9755.73 14
Life Satisfaction (3) 4413.77 14
QoL ‘generally’ (3) 7270.23 14
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Appendix 6.9 (cont.)
Factor: Autobiographical memory (PS)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 641.73 1 641.73 0.95 0.35
QoL ‘today’ 4.00 1 4.00 0.00 0.93
QoL ‘generally’ 10.00 1 10.00 0.01 0.27
Environment (W) 226.63 1 226.63 0.43 0.52
Physical (W) 72.89 1 72.89 0.25 0.62
Psychological (W) 26.56 1 26.56 0.05 0.81
Social Relationships (W) 120.95 1 120.95 0.25 0.63
QoL ‘today’ (2) 270.87 1 270.87 0.55 0.47
QoL ‘generally’ (2) 23.00 1 23.00 0.03 0.85
Life Satisfaction (3) 125.54 1 125.54 0.43 0.51
QoL ‘generally’ (3) 74.51 1 74.51 0.15 0.69
Within + Residual
SEIQoL-DW 9497.19 13 678.37
QoL ‘today’ 6743.43 13 481.67
QoL ‘generally’ 9199.43 13 657.10
Environment (W) 6827.73 13 525.21
Physical (W) 3787.79 13 291.35
Social Relationships (W) 6384.95 13 491.15
QoL ‘today’ (2) 6442.73 13 495.59
QoL ‘generally’ (2) 9732.73 13 748.67
Life Satisfaction (3) 125.54 13 125.54
QoL ‘generally’ (3) 74.51 13 477.39
Corrected Total
SEIQoL-DW 10138.93 14
QoL ‘today’ 6747.43 14
QoL ‘generally’ 9209.43 14
Environment (W) 7054.36 14
Physical (W) 3860.45 14
Psychological (W) 6153.99 14
Social Relationships (W) 6505.91 14
QoL ‘today’ (2) 6713.60 14
QoL ‘generally’ (2) 9755.73 14
Life Satisfaction (3) 4413.77 14
QoL ‘generally’ (3) 7270.23 14
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Univariate ANOVA summary table Appendix 6.10
Factor: Autobiographical memory (AIS) 
One outlier removed from the data set
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 2.30 1 2.30 0.00 0.95
QoL ‘today’ 23.93 1 23.93 0.05 0.81
QoL ‘generally’ 192.02 1 192.02 0.37 0.55
QoL ‘today’ (2) 1696.70 1 1696.70 4.56 0.04
QoL ‘generally’ (2) 347.26 1 347.26 0.59 0.45
QoL ‘generally’ Ù) 869.91 1 869.91 1.71 0.20
Within + Residual
SEIQoL-DW 11646.37 21 554.59
QoL ‘today’ 8821.81 21 420.09
QoL ‘generally’ 10998.93 21 523.75
QoL ‘today’ (2) 7807.73 21 371.79
QoL ‘generally’ (2) 12397.61 21 590.36
QoL ‘generally’ (3) 10644.07 21 506.86
Corrected Total
SEIQoL-DW 11648.67 22
QoL ‘today’ 8845.73 22
QoL ‘generally’ 11190.95 22
QoL ‘today’ (2) 9504.43 22
QoL ‘generally’ (2) 12744.87 22
QoL ‘generally’ (3) 11513.97 22
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Univariate ANOVA summary tables
Factor: Autobiographical memory (AIS)
Appendix 6.11
Childhood incidents
Source of Variation Sum of Mean
Between Groups
squares df square
SEIQoL-DW 10.65 1 10.65
QoL ‘today’ 234.72 1 234.72
QoL ‘generally’ 1176.12 1 1176.12
Environment (W) 11.83 1 11.83
Physical (W) 329.39 1 329.39
Psychological (W) 34.81 1 34.81
Social Relationships (W) 590.10 1 590.10
QoL ‘today’ (2) 234.72 1 234.72
QoL ‘generally’ (2) 8.68 1 8j#
Life Satisfaction (3) 669.17 1 669.17
QoL ‘generally’ (3) 262.59 1 262.59
Within + Residual
SEIQoL-DW 7975.21 22 362.51
QoL ‘today’ 9685.11 22 440.23
QoL ‘generally’ 10763.83 22 489.27
Environment (W) 9437.79 22 428.99
Physical (W) 4394.47 22 199.75
Psychological (W) 8598.30 22 390.83
Social Relationships (W) 7975.21 22 362.51
QoL ‘today’ (2) 10235.11 22 465.23
QoL ‘generally’ (2) 13503.94 22 613.81
Life Satisfaction (3) 8743.31 22 397.42
QoL ‘generally’ (3) 12288.15 22 558.55
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
F
ratio
0.01
0.53
2.40
0.03
1.65
0.09
1.63
0.51
0.01
1.68
0.47
F
Prob.
0.89
0.47
0.13
0.87
0.21
0.77
0.21
0.49
0.91
0.21
0.50
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Young adult incidents
Appendix 6.11 (cent)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 16.85 1 16.85 0.03 0.07
QoL ‘today’ 230.79 1 230.79 0.52 0.47
QoL ‘generally’ 398.18 1 398.18 0.75 0.39
Environment (W) 36.60 1 36.60 0.09 0.77
Physical (W) 949.31 1 949.31 5.53 0.02
Psychological (W) 5.27 1 5.27 0.01 0.91
Social Relationships (W) 0.01 1 0.01 0.00 0.99
QoL ‘today’ (2) 1464.61 1 1464.61 3.57 0.07
QoL ‘generally’ (2) 71.39 1 71.39 0.11 0.73
Life Satisfaction (3) 253.37 1 253.37 0.61 0.44
QoL ‘generally’ (3) 321.55 1 321.55 0.57 0.45
Within + Residual
SEIQoL-DW 12150.55 22 552.29
QoL ‘today’ 9689.03 22 440.41
QoL ‘generally’ 11541.77 22 524.63
Environment (W) 9413.01 22 427.86
Physical (W) 3774.55 22 171.57
Psychological (W) 8627.83 22 392.17
Social Relationships (W) 8565.24 22 389.33
QoL ‘today’ (2) 9689.03 22 440.41
QoL ‘generally’ (2) 13441.23 22 610.96
Life Satisfaction (3) 9159.12 22 416.32
QoL ‘generally’ (3) 13441.23 22 610.97
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
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Recent life incidents
Appendix 6.11 (contA
Source of Variation Sum of Mean
Between Groups
squares df square
SEIQoL-DW 810.56 1 810.56
QoL ‘today’ 24.05 1 24.05
QoL ‘generally’ 20.43 1 20.43
Environment (W) 843.13 1 843.13
Physical (W) 28.33 1 28.33
Psychological (W) 8.23 1 8J3
Social Relationships (W) 46.73 1 46.73
QoL ‘today’ (2) 1509.37 1 1509.37
QoL ‘generally’ (2) 571.73 1 571.73
Life Satisfaction (3) 115.51 1 115.51
QoL ‘generally’ (3) 89.05 1 89.05
Within + Residual
SEIQoL-DW 11356.84 22 516.22
QoL ‘today’ 9695.83 22 449.81
QoL ‘generally’ 11919.53 22 541.79
Environment (W) 8606.49 22 391.20
Physical (W) 4695.54 22 213.43
Psychological (W) 8624.87 22 392.04
Social Relationships (W) 8518.58 22 387.21
QoL ‘today’ (2) 8960.45 22 407.29
QoL ‘generally’ (2) 12940.90 22 588.22
Life Satisfaction (3) 9296.97 22 422.59
QoL ‘generally’ (3) 12461.69 22 566.44
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
F
ratio
1.57
0.05
0.03
2.15
0.13
0.02
0.12
3.71
0.97
0.27
0.15
F
Prob.
0.22
0.81
0.85
0.15
0.71
0.89
0.73
0.07
0.33
0.61
0.69
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Univariate ANOVA summary tables Appendix 6.12
Factor: Autobiographical memory (PS)
Facts relating to childhood
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 32.62 1 32.62 0.08 0.77
QoL ‘today’ 176.33 1 176.33 0.39 0.53
QoL ‘generally’ 102.08 1 102.08 0.19 0.67
Environment (W) 37.96 1 37.96 0.08 0.77
Physical (W) 180.43 1 180.43 0.87 0.36
Psychological (W) 283.67 1 283.67 0.75 0.39
Social Relationships (W) 749.11 1 749.11 2.11 0.16
QoL ‘today’ (2) 28.52 1 28.52 0.06 0.81
QoL ‘generally’ (2) 90.75 1 90.75 0.15 0.70
Life Satisfaction (3) 188.02 1 188.02 0.45 0.51
QoL ‘generally’ (3) 46.02 1 46.02 0.08 0.77
Within + Residual
SEIQoL-DW 12134.78 22 551.58
QoL ‘today’ 9743.50 22 442.89
QoL ‘generally’ 11837.87 22 538.09
Environment (W) 9411.65 22 427.80
Physical (W) 4543.43 22 206.52
Psychological (W) 8349.44 22 379.52
Social Relationships (W) 7816.19 22 355.28
QoL ‘today’ (2) 10441.31 22 474.61
QoL ‘generally’ (2) 13421.87 22 610.09
Life Satisfaction (3) 9224.47 22 419.29
QoL ‘generally’ (3) 12504.71 22 568.39
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
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Appendix 6.12 (cont.)
Facts relating to young adult life
Source of Variation Sum of Mean
Between Groups
squares df square
SEIQoL-DW 1556.39 1 1556.39
QoL ‘today’ 2.67 1 2.67
QoL ‘generally’ 145.04 1 145.04
Environment (W) 72.41 1 72.41
Physical (W) 13.50 1 13.50
Psychological (W) 350.27 1 350.27
Social Relationships (W) 30.65 1 30.65
QoL ‘today’ (2) 88.17 1 88.17
QoL ‘generally’ (2) 222.04 1 222.04
Life Satisfaction (3) 11.34 1 11.34
QoL ‘generally’ (3) 15.84 1 15.84
Within + Residual
SEIQoL-DW 10611.01 22 482.31
QoL ‘today’ 9917.17 22 450.78
QoL ‘generally’ 11794.21 22 536.13
Environment (W) 9377.79 22 426.23
Physical (W) 4710.37 22 214.11
Psychological (W) 8282.83 22 376.49
Social Relationships (W) 8534.65 22 387.93
QoL ‘today’ (2) 10381.67 22 471.89
QoL ‘generally’ (2) 13290.58 22 604.11
Life Satisfaction (3) 9401.37 22 427.33
QoL ‘generally’ (3) 12534.89 22 569.77
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
F
ratio
3.23
0.01
0.27
0.17
0.06
0.93
0.07
0.19
0.37
0.03
0.03
F
Prob.
0.09
0.93
0.61
0.68
0.80
0.34
0.78
0.67
0.55
0.87
0.87
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Facts relating to recent life
Appendix 6.12 (cont.)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Between Groups
SEIQoL-DW 1552.39 1 1552.39 3.21 0.09
QoL ‘today’ 100.27 1 100.27 0.22 0.64
QoL ‘generally’ 195.07 1 195.07 0.36 0.55
Environment (W) 729.42 1 729.42 1.84 0.19
Physical (W) 22.50 1 22.50 0.11 0.75
Psychological (W) 27.81 1 27.81 0.07 0.79
Social Relationships (W) 133.07 1 133.07 0.35 0.56
QoL ‘today’ (2) 1173.61 1 1173.61 2.77 0.11
QoL ‘generally’ (2) 282.67 1 282.67 0.47 0.50
Life Satisfaction (3) 264.37 1 264.37 0.63 0.43
QoL ‘generally’ (3) 9.51 1 9.51 0.01 0.89
Within + Residual
SEIQoL-DW 10615.11 22 482.50
QoL ‘today’ 9819.55 22 446.34
QoL ‘generally’ 11744.89 22 533.85
Environment (W) 8720.19 22 396.37
Physical (W) 4701.37 22 213.69
Psychological (W) 8605.29 22 391.15
Social Relationships (W) 8432.23 22 383.28
QoL ‘today’ (2) 9296.22 22 422.55
QoL ‘generally’ (2) 13229.95 22 601.36
Life Satisfaction (3) 9148.12 22 415.82
QoL ‘generally’ (3) 12541.23 22 570.05
Corrected Total
SEIQoL-DW 12167.40 23
QoL ‘today’ 9919.83 23
QoL ‘generally’ 11939.96 23
Environment (W) 9449.61 23
Physical (W) 4723.87 23
Psychological (W) 8633.11 23
Social Relationships (W) 8565.31 23
QoL ‘today’ (2) 10469.83 23
QoL ‘generally’ (2) 13512.63 23
Life Satisfaction (3) 9412.49 23
QoL ‘generally’ (3) 12550.74 23
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One-way unrelated ANOVA summary tables
Independent variable: Happiness cluster group
Appendix 6.13
Happiness ‘today’ 01
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 8461.37 1 8461.37 31.31 0.00
Within Groups 5982.45 22 271.93
Total 14443.83 23
Happiness ‘generally’ 131
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 4480.47 1 4480.47 22.61 0.00
Within Groups 4358.85 22 198.13
Total 8839.33 23
Independent variable: Life Satisfaction cluster group
Life Satisfaction (3)
Source of Variation Sum of 
squares df
Mean
square
F
ratio
F
Prob.
Between Groups 6024.11 1 6024.11 39.11 0.00
Within Groups 3388.38 22 154.01
Total 9412.49
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2 x 2  unrelated ANOVA summary tables Appendix 6.14
Factor 1 : Level of reported happiness 
Factor 2: Evaluation strategy
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Level of reported happiness 506.25 1 506.25 0.93 0.35
Evaluation strategy 0.00 1 0.00 0.00 1.00
Level of reported happiness x
Evaluation strategy 289.00 1 289.00 0.53 0.47
Within + Residual 10917.13 20 545.85
Corrected Model 1633.61 3 544.53 0.99 0.41
Corrected Total 12550.74 23
Factor 1 : Life satisfaction 
Factor 2: Evaluation strategy
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Life satisfaction 2025.00 1 2025.00 4.19 0.05
Evaluation strategy 56.25 1 56.25 0.11 0.73
Life satisfaction x evaluation
strategy 4.00 1 4.00 0.01 0.93
Within + Residual 9662.13 20 483.11
Corrected Model 2888.61 3 962.87 1.99 0.15
Corrected Total 12550.74 23
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2 x 2  unrelated ANCOVA summary table Appendix 6.15
Factor 1: Level of reported happiness Factor 2: Evaluation strategy 
Covariate: Autobiographical memory (AIS)
OoL ‘generally’ T3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
AIS 38.61 1 38.61 0.06 0.79
Level of reported happiness 396.84 1 396.84 0.69 0.41
Evaluation strategy 1.91 1 1.91 0.00 0.95
Level of reported happiness x
Evaluation strategy 246.83 1 246.83 0.43 0.51
Within + Residual 10878.51 19 572.55
Corrected Model 1672.23 4 418.05 0.73 0.58
Corrected Total 12550.74 23
Factor 1: Level of reported happiness Factor 2: Evaluation strategy 
Covariate: Autobiographical memory (PS)
OoL ‘generally’ (31
Source of Variation Sum of Mean F F
squares df square ratio Prob.
PS 37.51 1 37.51 0.06 0.80
Level of reported happiness 444.09 1 444.09 0.77 0.39
Evaluation strategy 0.00 1 0.00 0.00 0.99
Level of reported happiness x
Evaluation strategy 272.75 1 272.75 0.47 0.49
Within + Residual 10879.61 19 572.61
Corrected Model 1671.13 4 417.78 0.73 0.58
Corrected Total 12550.74 23
Factor 1: Level of reported happiness Factor 2: Evaluation strategy 
Covariate: Immediate memory (Digit Span, WAIS-R)
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Immediate memory 94.23 1 94.23 0.17 0.69
Level of reported happiness 411.27 1 411.27 0.72 0.39
Evaluation strategy 0.00 1 0.00 0.00 0.41
Level of reported happiness x
Evaluation strategy 268.56 1 268.56 0.47 0.50
Within + Residual 10822.90 19 569.63
Corrected Model 1727.84 4 431.96 0.75 0.57
Corrected Total 12550.74 23
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2 x 2  unrelated ANCOVA summary table Appendix 6.16
Factor 1: Life Satisfaction Factor 2: Evaluation strategy 
Covariate: Autobiographical memory (AIS)
OoL ‘generally’ 01
Source of Variation Sum of Mean F F
squares df square ratio Prob.
AIS 132.57 1 132.57 0.26 0.61
Life satisfaction 1292.48 1 1292.48 2.57 0.13
Evaluation strategy 88.40 1 88.40 0.17 0.67
Life satisfaction x evaluation
strategy 43.41 1 43.41 0.09 0.77
Within + Residual 9529.55 19 501.55
Corrected Model 3021.19 4 755.29 1.51 0.24
Corrected Total 12550.74 23
Factor 1 : Life Satisfaction Factor 2: Evaluation strategy
Covariate: Autobiographical memory (PS)
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
PS 111.03 1 111.03 0.22 0.64
Life satisfaction 1189.29 1 1189.29 2.37 0.14
Evaluation strategy 43.20 1 43.20 0.09 0.77
Life satisfaction x evaluation
strategy 61.94 1 61.94 0.12 0.73
Within + Residual 9551.09 19 502.69
Corrected Model 2999.64 4 749.91 1.49 0.24
Corrected Total 12550.74 23
Factor 1: Life Satisfaction Factor 2: Evaluation strategy
Covariate: Immediate memory (Digit Span, WAIS-R)
OoL ‘generally’ 131
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Immediate memory 358.11 1 358.11 0.73 0.40
Life satisfaction 1720.77 1 1720.29 3.51 0.07
Evaluation strategy 30.31 1 30.31 0.06 0.81
Life satisfaction x evaluation
strategy 46.62 1 46.62 0.09 0.76
Within + Residual 9304.01 19 489.69
Corrected Model 3246.73 4 811.68 1.65 0.20
Corrected Total 12550.74 23
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2 x 2  unrelated ANCOVA summary tables
Factor 1: Level of reported happiness Factor 2: Evaluation strategy 
Covariate: Ability to make comparisons (Similarities, WAIS-R)
OoL ‘generally’ 131
Appendix 6.17
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Ability to make comparisons 38.20 1 38.20 0.07 0.79
Level of reported happiness 535.15 1 535.15 0.93 0.35
Evaluation strategy 0.11 1 0.11 0.00 0.98
Level of reported happiness x
Evaluation strategy 258.03 1 258.03 0.45 0.51
Within + Residual 10878.92 19 572.57
Corrected Model 1671.41 4 417.95 0.73 0.58
Corrected Total 12550.74 23
Factor 1: Life Satisfaction Factor 2: Evaluation strategy 
Covariate: Ability to make comparisons (Similarities, WAIS-R)
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Ability to make comparisons 1236.63 1 1236.63 2.79 0.11
Life satisfaction 3244.43 1 3244.43 7.31 0.01
Evaluation strategy 92.27 1 92.27 0.21 0.65
Life satisfaction x evaluation
strategy 114.36 1 114.36 0.25 0.61
Within + Residual 8425.49 19 443.45
Corrected Model 4125.25 4 1031.31 2.33 0.09
Corrected Total 12550.74 23
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2 x 2  unrelated ANCOVA summary tables
Factor 1: Level of reported happiness Factor 2: Evaluation strategy
Covariate: Ability to make comparisons (Pyramids and Palm Trees)
OoL ‘generally’ (31
Appendix 6.18
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Ability to make comparisons 833.33 1 833.33 1.57 0.23
Level of reported happiness 698.51 1 698.51 1.31 0.27
Evaluation strategy 2.99 1 2.99 0.00 0.94
Level of reported happiness x
Evaluation strategy 280.62 1 280.62 0.53 0.47
Within + Residual 10083.79 19 530.73
Corrected Model 2466.95 4 616.73 1.16 0.35
Corrected Total 12550.74 23
Factor 1: Life Satisfaction Factor 2: Evaluation strategy
Covariate: Ability to make comparisons (Pyramids and Palm Trees)
OoL ‘generally’ (3)
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Ability to make comparisons 1004.05 1 1004.05 2.02 0.15
Life satisfaction 2818.46 1 2818.46 6.19 0.02
Evaluation strategy 134.91 1 134.91 0.29 0.59
Life satisfaction x evaluation
strategy 150.05 1 150.05 0.33 0.57
Within + Residual 8658.07 19 455.69
Corrected Model 3892.67 4 973.17 2.13 0.11
Corrected Total 12550.74 23
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One-way unrelated ANOVA summary tables Appendix 6.19
Independent variable: Extent of autobiographical memory deficit (AIS)
Source of Sum of Mean F F
Variation squares df square ratio Prob.
SEIQoL-DW Between Groups 949.99 2 474.99 0.89 0.43
Within Groups 11217.41 21 534.16
Total 12167.40 23
QoL ‘today’ (1) Between Groups 1053.79 2 526.89 1.25 0.31
Within Groups 10964.71 21 422.19
Total 9919.83 23
QoL ‘generally (1) Between Groups 975.25 2 487.62 0.93 0.41
Within Groups 10964.71 21 522.13
Total 11939.95 23
Environment (W) Between Groups 1047.21 2 523.60 1.31 0.29
Within Groups 8402.41 21 400.11
Total 9449.61 23
Physical (W) Between Groups 488.70 2 244.35 1.21 0.31
Within Groups 4235.16 21 201.67
Total 4723.86 23
Psychological (W) Between Groups 807.20 2 403.60 1.08 0.35
Within Groups 7825.91 21 372.66
Total 8633.11 23
Social Rel.(W) Between Groups 214.81 2 107.41 0.27 0.77
Within Groups 8350.49 21 397.64
Total 8565.31 23
QoL ‘today (2) Between Groups 2712.77 2 1356.38 3.67 0.04
Within Groups 7757.05 21 369.38
Total 10469.83 23
QoL ‘generally’ (2) Between Groups 367.41 2 183.71 0.29 0.75
Within Groups 13145.21 21 625.96
Total 13512.63 23
QoL ‘generally’ (3) Between Groups 1463.31 2 731.65 1.39 0.27
Within Groups 11087.43 21 527.97
Total 12550.74 23
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One-way unrelated ANOVA summary tables Appendix 6.20
Independent variable: Extent of autobiographical memory deficit (PS)
Source of Sum of Mean F F
Variation squares df square ratio Prob.
SEIQoL-DW Between Groups 1702.57 2 851.29 1.71 0.21
Within Groups 10464.83 21 498.33
Total 12167.40 23
QoL ‘today’ (1) Between Groups 285.15 2 142.57 0.31 0.73
Within Groups 9634.68 21 458.79
Total 9919.83 23
QoL ‘generally’ (1) Between Groups 318.87 2 159.43 0.29 0.75
Within Groups 11621.08 21 553.38
Total 11939.95 23
Environment (W) Between Groups 1404.65 2 702.32 1.83 0.19
Within Groups 8044.97 21 383.09
Total 9449.61 23
Physical (W) Between Groups 424.87 2 212.43 1.03 0.37
Within Groups 4298.99 21 204.71
Total 4723.86 23
Psychological (W) Between Groups 470.19 2 235.09 0.61 0.55
Within Groups 8162.91 21 388.71
Total 8633.11 23
Social Rel. (W) Between Groups 677.01 2 338.51 0.90 0.42
Within Groups 7888.30 21 375.63
Total 8565.31 23
QoL ‘today (2) Between Groups 221.85 2 110.93 0.23 0.79
Within Groups 10247.97 21 487.99
Total 10469.83 23
QoL ‘generally’ (2) Between Groups 87.31 2 43.65 0.07 0.93
Within Groups 13425.31 21 639.30
Total 13512.63 23
QoL ‘generally’ (3) Between Groups 101.37 2 50.69 0.09 0.91
Within Groups 12449.36 21 592.83
Total 12550.74 23
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One-way unrelated ANOVA summary table Appendix 6.21
Independent variable: Evaluation strategy
OoL ‘generallv’
Source of Sum of Mean F F
Variation squares df square ratio Prob.
Between Groups 63.28 1 63.28 0.11 0.74
Within Groups 12487.45 22 567.61
Total 12550.74 23
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2 x 2  unrelated ANOVA summary table Appendix 6.22
Factor 1: Evaluation strategy
Factor 2; Ability to make comparisons (Pyramids and Palm Trees)
OoL ‘generallv’ 01
Source of Variation Sum of Mean F F
squares df square ratio Prob.
Evaluation strategy 2089.12 1 2089.12 4.81 0.04
Ability to make comparisons 45.46 1 45.56 0.11 0.75
Evaluation strategy x Ability to
make comparisons 2475.06 1 2475.06 5.70 0.02
Within + Residual 8678.87 20 433.94
Corrected Total 12550.74 23
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One-way unrelated ANOVA summary table
Independent variable: Life change
Appendix 6.23
OoL ‘todav’ (21 
Source of Variation
Between Groups 
Within Groups 
Corrected Total
OoL ‘generallv’ (21 
Source of Variation
Between Groups 
Within Groups 
Corrected Total
Sum of Mean F F
squares df square ratio Prob.
2780.81 2 1390.40 3.79 0.03
7689.03 21 366.14
10469.83 23
Sum of Mean F F
squares df square ratio Prob.
285.53 2 142.77 0.23 0.79
13227.09 21 629.86
13512.63 23
569
Hierarchical cluster analysis dendograms Appendix 6.24
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Appendix 6.24 (cont)
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